Region,SubRegion,Country,DrugGroup,DrugSubGroup,DrugName,Reference year,Kilograms,msCode
Africa,East Africa,Comoros,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,45,COM
Africa,East Africa,Comoros,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,2263,COM
Africa,East Africa,Comoros,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,57.5,COM
Africa,East Africa,Comoros,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2023,10,COM
Africa,East Africa,Comoros,Opioids,Opiates,Heroin,2023,0.5,COM
Africa,East Africa,Djibouti,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,119.8,DJI
Africa,East Africa,Djibouti,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,0.032,DJI
Africa,East Africa,Djibouti,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,1.389,DJI
Africa,East Africa,Djibouti,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,0.028,DJI
Africa,East Africa,Kenya,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,12911,KEN
Africa,East Africa,Kenya,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,814.8,KEN
Africa,East Africa,Kenya,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,0.35,KEN
Africa,East Africa,Kenya,Opioids,Opiates,Heroin,2020,39.01,KEN
Africa,East Africa,Kenya,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.00035,KEN
Africa,East Africa,Kenya,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,11713,KEN
Africa,East Africa,Kenya,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,1329.1,KEN
Africa,East Africa,Kenya,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,2.53,KEN
Africa,East Africa,Kenya,Opioids,Opiates,Heroin,2021,30.3,KEN
Africa,East Africa,Kenya,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,10.84,KEN
Africa,East Africa,Kenya,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,8474.41,KEN
Africa,East Africa,Kenya,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,2534.4,KEN
Africa,East Africa,Kenya,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,10.99,KEN
Africa,East Africa,Kenya,Opioids,Opiates,Heroin,2022,38.94,KEN
Africa,East Africa,Kenya,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.005,KEN
Africa,East Africa,Kenya,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,2.2,KEN
Africa,East Africa,Kenya,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,8.7,KEN
Africa,East Africa,Kenya,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,25840.4,KEN
Africa,East Africa,Kenya,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,35.3,KEN
Africa,East Africa,Kenya,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,1270.1,KEN
Africa,East Africa,Kenya,Opioids,Opiates,Heroin,2023,32.9,KEN
Africa,East Africa,Kenya,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,1,KEN
Africa,East Africa,Kenya,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,KEN
Africa,East Africa,Kenya,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,1,KEN
Africa,East Africa,Kenya,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,3773,KEN
Africa,East Africa,Kenya,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,13,KEN
Africa,East Africa,Kenya,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,6,KEN
Africa,East Africa,Kenya,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,0,KEN
Africa,East Africa,Kenya,Opioids,Opiates,Heroin,2019,41,KEN
Africa,East Africa,Kenya,Opioids,Opiates,Heroin,2019,0,KEN
Africa,East Africa,Kenya,Opioids,Opiates,Heroin,2019,1,KEN
Africa,East Africa,Kenya,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,4,KEN
Africa,East Africa,Madagascar,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.03487,MDG
Africa,East Africa,Madagascar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,29492.73,MDG
Africa,East Africa,Madagascar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,377311.9,MDG
Africa,East Africa,Madagascar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,295.7,MDG
Africa,East Africa,Madagascar,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,0.001,MDG
Africa,East Africa,Madagascar,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,3.60924,MDG
Africa,East Africa,Madagascar,Opioids,Opiates,Heroin,2022,0.02315,MDG
Africa,East Africa,Madagascar,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.00025,MDG
Africa,East Africa,Madagascar,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.03,MDG
Africa,East Africa,Madagascar,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.00025,MDG
Africa,East Africa,Madagascar,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.512,MDG
Africa,East Africa,Madagascar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,13448.88,MDG
Africa,East Africa,Madagascar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,494.9,MDG
Africa,East Africa,Madagascar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,67.272,MDG
Africa,East Africa,Madagascar,Opioids,Opiates,Heroin,2023,0.00003,MDG
Africa,East Africa,Madagascar,Opioids,Opiates,Heroin,2023,0.43339,MDG
Africa,East Africa,Mauritius,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.00813,MUS
Africa,East Africa,Mauritius,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.05627,MUS
Africa,East Africa,Mauritius,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,72.634201,MUS
Africa,East Africa,Mauritius,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,6271.2,MUS
Africa,East Africa,Mauritius,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,3.0872,MUS
Africa,East Africa,Mauritius,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,0.47242,MUS
Africa,East Africa,Mauritius,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.00000095,MUS
Africa,East Africa,Mauritius,Opioids,Opiates,Heroin,2020,22.815235,MUS
Africa,East Africa,Mauritius,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.0068,MUS
Africa,East Africa,Mauritius,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,0.13977,MUS
Africa,East Africa,Mauritius,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.000542,MUS
Africa,East Africa,Mauritius,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.00119,MUS
Africa,East Africa,Mauritius,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,189.333812,MUS
Africa,East Africa,Mauritius,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,5005.8,MUS
Africa,East Africa,Mauritius,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,41.65686,MUS
Africa,East Africa,Mauritius,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,0.8,MUS
Africa,East Africa,Mauritius,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,0.0057,MUS
Africa,East Africa,Mauritius,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2021,12.689513,MUS
Africa,East Africa,Mauritius,Opioids,Opiates,Heroin,2021,297.563309,MUS
Africa,East Africa,Mauritius,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,0.05102,MUS
Africa,East Africa,Mauritius,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.000542,MUS
Africa,East Africa,Mauritius,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.3089,MUS
Africa,East Africa,Mauritius,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,143.15734,MUS
Africa,East Africa,Mauritius,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,5572.6,MUS
Africa,East Africa,Mauritius,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,51.43957,MUS
Africa,East Africa,Mauritius,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,0.06432,MUS
Africa,East Africa,Mauritius,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0000035,MUS
Africa,East Africa,Mauritius,Opioids,Opiates,Heroin,2022,54.77668,MUS
Africa,East Africa,Mauritius,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.03375,MUS
Africa,East Africa,Mauritius,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2022,3.07566,MUS
Africa,East Africa,Mauritius,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.1062,MUS
Africa,East Africa,Mauritius,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2023,0.01003,MUS
Africa,East Africa,Mauritius,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,0.00025,MUS
Africa,East Africa,Mauritius,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,211959.2,MUS
Africa,East Africa,Mauritius,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,5441.9,MUS
Africa,East Africa,Mauritius,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,2580.16,MUS
Africa,East Africa,Mauritius,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,2.10291,MUS
Africa,East Africa,Mauritius,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.00000035,MUS
Africa,East Africa,Mauritius,Opioids,Opiates,Heroin,2023,36.99551,MUS
Africa,East Africa,Mauritius,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.00185,MUS
Africa,East Africa,Mauritius,Opioids,Pharmaceutical opioids,Methadone,2023,0.01,MUS
Africa,East Africa,Mauritius,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,0.09639,MUS
Africa,East Africa,Seychelles,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,5.89,SYC
Africa,East Africa,Seychelles,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,0.027,SYC
Africa,East Africa,Uganda,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,1,UGA
Africa,East Africa,Uganda,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,8.5,UGA
Africa,East Africa,Uganda,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,24.23298,UGA
Africa,East Africa,Uganda,Opioids,Opiates,Heroin,2023,9.33785,UGA
Africa,East Africa,United Republic of Tanzania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,10930,TZA
Africa,East Africa,United Republic of Tanzania,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,4.52,TZA
Africa,East Africa,United Republic of Tanzania,NPS,Plant-based NPS,Khat,2020,11800,TZA
Africa,East Africa,United Republic of Tanzania,Opioids,Opiates,Heroin,2020,349.81,TZA
Africa,East Africa,United Republic of Tanzania,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,430.77,TZA
Africa,East Africa,United Republic of Tanzania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,22740,TZA
Africa,East Africa,United Republic of Tanzania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,22740,TZA
Africa,East Africa,United Republic of Tanzania,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,0.811,TZA
Africa,East Africa,United Republic of Tanzania,NPS,Plant-based NPS,Khat,2021,10930,TZA
Africa,East Africa,United Republic of Tanzania,Opioids,Opiates,Heroin,2021,1130,TZA
Africa,East Africa,United Republic of Tanzania,Precursors,Non-specified precursors,Non-specified precursors,2021,3655970,TZA
Africa,East Africa,United Republic of Tanzania,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.97,TZA
Africa,East Africa,United Republic of Tanzania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,20580,TZA
Africa,East Africa,United Republic of Tanzania,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,1.73,TZA
Africa,East Africa,United Republic of Tanzania,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,0.056,TZA
Africa,East Africa,United Republic of Tanzania,Opioids,Opiates,Heroin,2022,254.71,TZA
Africa,East Africa,United Republic of Tanzania,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,2410.82,TZA
Africa,East Africa,United Republic of Tanzania,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,1.96,TZA
Africa,East Africa,United Republic of Tanzania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,1757.56,TZA
Africa,East Africa,United Republic of Tanzania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,12550,TZA
Africa,East Africa,United Republic of Tanzania,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,3.04,TZA
Africa,East Africa,United Republic of Tanzania,NPS,Plant-based NPS,Khat,2023,202740,TZA
Africa,East Africa,United Republic of Tanzania,Opioids,Opiates,Heroin,2023,1314.28,TZA
Africa,East Africa,United Republic of Tanzania,Precursors,Non-specified precursors,Other precursors,2023,22673.9,TZA
Africa,North Africa,Algeria,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,120.122647,DZA
Africa,North Africa,Algeria,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2020,1511.32225,DZA
Africa,North Africa,Algeria,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,1.925,DZA
Africa,North Africa,Algeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,16.496,DZA
Africa,North Africa,Algeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,741,DZA
Africa,North Africa,Algeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,88702.581,DZA
Africa,North Africa,Algeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,4.547,DZA
Africa,North Africa,Algeria,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,32.353,DZA
Africa,North Africa,Algeria,Opioids,Opiates,Heroin,2020,2.372,DZA
Africa,North Africa,Algeria,Opioids,Opiates,Opium,2020,0.012,DZA
Africa,North Africa,Algeria,Opioids,Pharmaceutical opioids,Tramadol,2020,36.55625,DZA
Africa,North Africa,Algeria,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.31469,DZA
Africa,North Africa,Algeria,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,36.926189,DZA
Africa,North Africa,Algeria,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2021,1316.9235,DZA
Africa,North Africa,Algeria,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,1.52,DZA
Africa,North Africa,Algeria,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0,DZA
Africa,North Africa,Algeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,8.66,DZA
Africa,North Africa,Algeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,42.9,DZA
Africa,North Africa,Algeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,71439.42,DZA
Africa,North Africa,Algeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,1.04316,DZA
Africa,North Africa,Algeria,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,0.004,DZA
Africa,North Africa,Algeria,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,512.96506,DZA
Africa,North Africa,Algeria,Opioids,Opiates,Heroin,2021,1.876892,DZA
Africa,North Africa,Algeria,Opioids,Opiates,Poppy plants,2021,8.3,DZA
Africa,North Africa,Algeria,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2021,0.7898,DZA
Africa,North Africa,Algeria,Opioids,Pharmaceutical opioids,Buprenorphine,2021,2,DZA
Africa,North Africa,Algeria,Opioids,Pharmaceutical opioids,Tramadol,2021,1.26115,DZA
Africa,North Africa,Algeria,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.10688,DZA
Africa,North Africa,Algeria,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,91.857076,DZA
Africa,North Africa,Algeria,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2022,2742.59025,DZA
Africa,North Africa,Algeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,5.25011,DZA
Africa,North Africa,Algeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,0.005,DZA
Africa,North Africa,Algeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,248.5,DZA
Africa,North Africa,Algeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,58258.031,DZA
Africa,North Africa,Algeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,0.935713,DZA
Africa,North Africa,Algeria,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,0.03695,DZA
Africa,North Africa,Algeria,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,61.844897,DZA
Africa,North Africa,Algeria,Cocaine-type,Other coca/cocaine-type drugs,Other coca/cocaine-type drugs,2022,1.62,DZA
Africa,North Africa,Algeria,Opioids,Opiates,Heroin,2022,8.591957,DZA
Africa,North Africa,Algeria,Opioids,Opiates,Poppy plants,2022,19.1,DZA
Africa,North Africa,Algeria,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2022,0.1263,DZA
Africa,North Africa,Algeria,Opioids,Pharmaceutical opioids,Tramadol,2022,1.8623,DZA
Africa,North Africa,Algeria,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.0525,DZA
Africa,North Africa,Algeria,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,447.405553,DZA
Africa,North Africa,Algeria,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2023,4050.329,DZA
Africa,North Africa,Algeria,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,1.02,DZA
Africa,North Africa,Algeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,25.87696,DZA
Africa,North Africa,Algeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,674.6,DZA
Africa,North Africa,Algeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,44536.099,DZA
Africa,North Africa,Algeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,2.085552,DZA
Africa,North Africa,Algeria,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,0.0064,DZA
Africa,North Africa,Algeria,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,256.393138,DZA
Africa,North Africa,Algeria,Opioids,Opiates,Heroin,2023,3.666171,DZA
Africa,North Africa,Algeria,Opioids,Opiates,Poppy plants,2023,42.7,DZA
Africa,North Africa,Algeria,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2023,0.46166,DZA
Africa,North Africa,Algeria,Opioids,Pharmaceutical opioids,Tramadol,2023,4.8644,DZA
Africa,North Africa,Algeria,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.12124,DZA
Africa,North Africa,Algeria,Any other drugs/substances,Other miscellaneous,Psychotropic substances,2019,,DZA
Africa,North Africa,Algeria,Any other drugs/substances,Other miscellaneous,Psychotropic substances,2019,0,DZA
Africa,North Africa,Algeria,Any other drugs/substances,Other miscellaneous,Psychotropic substances,2019,21,DZA
Africa,North Africa,Algeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,158,DZA
Africa,North Africa,Algeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,55133,DZA
Africa,North Africa,Algeria,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,316,DZA
Africa,North Africa,Algeria,Opioids,Opiates,Poppy plants,2019,88,DZA
Africa,North Africa,Algeria,Opioids,Other illicit opioids,Other illicit opioids,2019,0,DZA
Africa,North Africa,Algeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,8,DZA
Africa,North Africa,Algeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,1,DZA
Africa,North Africa,Algeria,Opioids,Opiates,Heroin,2019,0,DZA
Africa,North Africa,Egypt,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.592,EGY
Africa,North Africa,Egypt,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,5.675553,EGY
Africa,North Africa,Egypt,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2020,3664.54375,EGY
Africa,North Africa,Egypt,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,100,EGY
Africa,North Africa,Egypt,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,78,EGY
Africa,North Africa,Egypt,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,487333,EGY
Africa,North Africa,Egypt,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,44416,EGY
Africa,North Africa,Egypt,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,10897,EGY
Africa,North Africa,Egypt,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,4,EGY
Africa,North Africa,Egypt,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.000106,EGY
Africa,North Africa,Egypt,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2020,0.002,EGY
Africa,North Africa,Egypt,Opioids,Opiates,Heroin,2020,1282,EGY
Africa,North Africa,Egypt,Opioids,Opiates,Opium,2020,259,EGY
Africa,North Africa,Egypt,Opioids,Pharmaceutical opioids,Tramadol,2020,686.68515,EGY
Africa,North Africa,Egypt,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2021,453.248,EGY
Africa,North Africa,Egypt,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,466615.03,EGY
Africa,North Africa,Egypt,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,,EGY
Africa,North Africa,Egypt,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,28062.09,EGY
Africa,North Africa,Egypt,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,4369,EGY
Africa,North Africa,Egypt,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,5.08,EGY
Africa,North Africa,Egypt,Opioids,Opiates,Heroin,2021,2148.5,EGY
Africa,North Africa,Egypt,Opioids,Opiates,Opium,2021,172.3,EGY
Africa,North Africa,Egypt,Opioids,Opiates,Poppy plants,2021,,EGY
Africa,North Africa,Egypt,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2021,3626.5,EGY
Africa,North Africa,Egypt,Opioids,Pharmaceutical opioids,Codeine,2021,0.03,EGY
Africa,North Africa,Egypt,Opioids,Pharmaceutical opioids,Tramadol,2021,,EGY
Africa,North Africa,Egypt,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,,EGY
Africa,North Africa,Egypt,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.237,EGY
Africa,North Africa,Egypt,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,2.222742,EGY
Africa,North Africa,Egypt,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2022,507.717,EGY
Africa,North Africa,Egypt,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,610.511,EGY
Africa,North Africa,Egypt,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,1041.41,EGY
Africa,North Africa,Egypt,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,368398.19,EGY
Africa,North Africa,Egypt,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,,EGY
Africa,North Africa,Egypt,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,49791.35,EGY
Africa,North Africa,Egypt,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,851.04,EGY
Africa,North Africa,Egypt,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,0.75,EGY
Africa,North Africa,Egypt,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,7.3,EGY
Africa,North Africa,Egypt,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.000088,EGY
Africa,North Africa,Egypt,Opioids,Opiates,Heroin,2022,2999.8,EGY
Africa,North Africa,Egypt,Opioids,Opiates,Opium,2022,264.92,EGY
Africa,North Africa,Egypt,Opioids,Opiates,Poppy plants,2022,,EGY
Africa,North Africa,Egypt,Opioids,Pharmaceutical opioids,Tramadol,2022,1119.8116,EGY
Africa,North Africa,Egypt,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,0.01,EGY
Africa,North Africa,Egypt,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,4.19,EGY
Africa,North Africa,Egypt,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,2.24117,EGY
Africa,North Africa,Egypt,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2023,1955.55475,EGY
Africa,North Africa,Egypt,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,3.52,EGY
Africa,North Africa,Egypt,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,1824.5,EGY
Africa,North Africa,Egypt,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,239527.97,EGY
Africa,North Africa,Egypt,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,11724.15,EGY
Africa,North Africa,Egypt,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,,EGY
Africa,North Africa,Egypt,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,191046.14,EGY
Africa,North Africa,Egypt,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,17615.67,EGY
Africa,North Africa,Egypt,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,20.04,EGY
Africa,North Africa,Egypt,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.00002555,EGY
Africa,North Africa,Egypt,Opioids,Opiates,Heroin,2023,6604.91,EGY
Africa,North Africa,Egypt,Opioids,Opiates,Opium,2023,537.09,EGY
Africa,North Africa,Egypt,Opioids,Opiates,Poppy plants,2023,,EGY
Africa,North Africa,Egypt,Opioids,Pharmaceutical opioids,Codeine,2023,0.103,EGY
Africa,North Africa,Egypt,Opioids,Pharmaceutical opioids,Tramadol,2023,146.6329,EGY
Africa,North Africa,Egypt,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2019,0,EGY
Africa,North Africa,Egypt,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,7,EGY
Africa,North Africa,Egypt,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2019,8729,EGY
Africa,North Africa,Egypt,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,EGY
Africa,North Africa,Egypt,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,263,EGY
Africa,North Africa,Egypt,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,EGY
Africa,North Africa,Egypt,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,62097,EGY
Africa,North Africa,Egypt,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,0,EGY
Africa,North Africa,Egypt,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,101,EGY
Africa,North Africa,Egypt,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,35928,EGY
Africa,North Africa,Egypt,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,2830,EGY
Africa,North Africa,Egypt,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,25,EGY
Africa,North Africa,Egypt,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,EGY
Africa,North Africa,Egypt,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2019,657,EGY
Africa,North Africa,Egypt,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2019,171,EGY
Africa,North Africa,Egypt,Opioids,Opiates,Heroin,2019,3194,EGY
Africa,North Africa,Egypt,Opioids,Opiates,Opium,2019,188,EGY
Africa,North Africa,Egypt,Opioids,Opiates,Poppy plants,2019,0,EGY
Africa,North Africa,Egypt,Opioids,Pharmaceutical opioids,Tramadol,2019,596,EGY
Africa,North Africa,Egypt,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2019,0,EGY
Africa,North Africa,Libya,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,5163.219011,LBY
Africa,North Africa,Libya,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,3.786962,LBY
Africa,North Africa,Libya,Opioids,Opiates,Heroin,2020,0.173002,LBY
Africa,North Africa,Libya,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2020,86.701025,LBY
Africa,North Africa,Libya,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,7694.844138,LBY
Africa,North Africa,Libya,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,7.80192,LBY
Africa,North Africa,Libya,Opioids,Opiates,Heroin,2021,0.0163,LBY
Africa,North Africa,Libya,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2021,15.2393125,LBY
Africa,North Africa,Libya,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,2467,LBY
Africa,North Africa,Libya,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,44,LBY
Africa,North Africa,Libya,Opioids,Opiates,Heroin,2019,2,LBY
Africa,North Africa,Libya,Opioids,Pharmaceutical opioids,Tramadol,2019,43,LBY
Africa,North Africa,Morocco,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,51.53336,MAR
Africa,North Africa,Morocco,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0,MAR
Africa,North Africa,Morocco,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,256640,MAR
Africa,North Africa,Morocco,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,450830,MAR
Africa,North Africa,Morocco,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,136.36,MAR
Africa,North Africa,Morocco,Opioids,Opiates,Heroin,2020,8.24,MAR
Africa,North Africa,Morocco,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,3.78656,MAR
Africa,North Africa,Morocco,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,15.255674,MAR
Africa,North Africa,Morocco,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0,MAR
Africa,North Africa,Morocco,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,328135,MAR
Africa,North Africa,Morocco,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,511566,MAR
Africa,North Africa,Morocco,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,1807.242,MAR
Africa,North Africa,Morocco,Opioids,Opiates,Heroin,2021,3.22846,MAR
Africa,North Africa,Morocco,Opioids,Pharmaceutical opioids,Tramadol,2021,24.5,MAR
Africa,North Africa,Morocco,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,9.82857,MAR
Africa,North Africa,Morocco,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,26.250686,MAR
Africa,North Africa,Morocco,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2022,504.625,MAR
Africa,North Africa,Morocco,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0,MAR
Africa,North Africa,Morocco,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,209974,MAR
Africa,North Africa,Morocco,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,300965,MAR
Africa,North Africa,Morocco,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,257.21,MAR
Africa,North Africa,Morocco,Opioids,Opiates,Heroin,2022,2.862353,MAR
Africa,North Africa,Morocco,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,6.64948,MAR
Africa,North Africa,Morocco,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,93.91234,MAR
Africa,North Africa,Morocco,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,MAR
Africa,North Africa,Morocco,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,315391,MAR
Africa,North Africa,Morocco,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,168966,MAR
Africa,North Africa,Morocco,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,1775.768,MAR
Africa,North Africa,Morocco,Opioids,Opiates,Heroin,2023,7.217,MAR
Africa,North Africa,Morocco,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,11.20937,MAR
Africa,North Africa,Morocco,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,280,MAR
Africa,North Africa,Morocco,Any other drugs/substances,Other miscellaneous,Psychotropic substances,2019,0,MAR
Africa,North Africa,Morocco,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,295879,MAR
Africa,North Africa,Morocco,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,320926,MAR
Africa,North Africa,Morocco,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,1462,MAR
Africa,North Africa,Morocco,Opioids,Opiates,Heroin,2019,7,MAR
Africa,North Africa,Morocco,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,5,MAR
Africa,North Africa,Tunisia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,42.832634,TUN
Africa,North Africa,Tunisia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,0.77873,TUN
Africa,North Africa,Tunisia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,30.2,TUN
Africa,North Africa,Tunisia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,611.685,TUN
Africa,North Africa,Tunisia,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,23.859,TUN
Africa,North Africa,Tunisia,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,0.0006,TUN
Africa,North Africa,Tunisia,Opioids,Opiates,Heroin,2021,6.172,TUN
Africa,North Africa,Tunisia,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.39885,TUN
Africa,North Africa,Tunisia,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,2.65027,TUN
Africa,North Africa,Tunisia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,57.376933,TUN
Africa,North Africa,Tunisia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,431.966,TUN
Africa,North Africa,Tunisia,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,96.60488,TUN
Africa,North Africa,Tunisia,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,0.0008,TUN
Africa,North Africa,Tunisia,Opioids,Opiates,Heroin,2020,11.58269,TUN
Africa,North Africa,Tunisia,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.4,TUN
Africa,North Africa,Tunisia,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.9802,TUN
Africa,North Africa,Tunisia,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,11.34326,TUN
Africa,North Africa,Tunisia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,0.00424,TUN
Africa,North Africa,Tunisia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,112.482073,TUN
Africa,North Africa,Tunisia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,30.2,TUN
Africa,North Africa,Tunisia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,1003.321,TUN
Africa,North Africa,Tunisia,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,140.021946,TUN
Africa,North Africa,Tunisia,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2023,0.0421,TUN
Africa,North Africa,Tunisia,Opioids,Opiates,Heroin,2023,3.96273,TUN
Africa,North Africa,Tunisia,Opioids,Opiates,Poppy plants,2023,1.6,TUN
Africa,North Africa,Tunisia,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.02875,TUN
Africa,North Africa,Tunisia,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,11.04555,TUN
Africa,North Africa,Tunisia,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,48,TUN
Africa,North Africa,Tunisia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,2042,TUN
Africa,North Africa,Tunisia,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,9,TUN
Africa,North Africa,Tunisia,Hallucinogens,Non-specified hallucinogens,Non-specified hallucinogens,2019,0,TUN
Africa,North Africa,Tunisia,Opioids,Opiates,Heroin,2019,1,TUN
Africa,North Africa,Tunisia,Opioids,Pharmaceutical opioids,Buprenorphine,2019,1,TUN
Africa,North Africa,Tunisia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,3,TUN
Africa,Southern Africa,Angola,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,13816.435,AGO
Africa,Southern Africa,Angola,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,20.564,AGO
Africa,Southern Africa,Angola,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,156.339,AGO
Africa,Southern Africa,Botswana,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,14.113,BWA
Africa,Southern Africa,Botswana,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Methcathinone,2023,12.8902,BWA
Africa,Southern Africa,Botswana,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,1324.6647,BWA
Africa,Southern Africa,Botswana,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,1.6852532,BWA
Africa,Southern Africa,Botswana,Opioids,Opiates,Illicit morphine,2023,3.96296,BWA
Africa,Southern Africa,Botswana,Precursors,Non-specified precursors,Other precursors,2023,3.96296,BWA
Africa,Southern Africa,Botswana,Precursors,Precursors,Ephedrine,2023,0.1263559,BWA
Africa,Southern Africa,Botswana,Sedatives and tranquillizers,Barbiturates,Methaqualone,2023,0.0249265,BWA
Africa,Southern Africa,Eswatini,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,950,SWZ
Africa,Southern Africa,Eswatini,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,265000,SWZ
Africa,Southern Africa,Eswatini,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,50,SWZ
Africa,Southern Africa,Eswatini,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,1000,SWZ
Africa,Southern Africa,Eswatini,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,4575,SWZ
Africa,Southern Africa,Eswatini,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,730,SWZ
Africa,Southern Africa,Lesotho,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,1,LSO
Africa,Southern Africa,Lesotho,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,2.175,LSO
Africa,Southern Africa,Lesotho,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,0.2,LSO
Africa,Southern Africa,Lesotho,NPS,Plant-based NPS,Khat,2023,1,LSO
Africa,Southern Africa,Lesotho,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2023,0.5,LSO
Africa,Southern Africa,Malawi,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,142097.848,MWI
Africa,Southern Africa,Malawi,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,0.00296156,MWI
Africa,Southern Africa,Malawi,Opioids,Opiates,Heroin,2020,0.0009424,MWI
Africa,Southern Africa,Malawi,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,36149.88,MWI
Africa,Southern Africa,Malawi,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,0.42,MWI
Africa,Southern Africa,Malawi,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,137615.46,MWI
Africa,Southern Africa,Malawi,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,7.84,MWI
Africa,Southern Africa,Malawi,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,918523.335,MWI
Africa,Southern Africa,Malawi,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,0.056,MWI
Africa,Southern Africa,Mozambique,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.001355,MOZ
Africa,Southern Africa,Mozambique,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,25,MOZ
Africa,Southern Africa,Mozambique,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,6317.941,MOZ
Africa,Southern Africa,Mozambique,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,17.141,MOZ
Africa,Southern Africa,Mozambique,NPS,Plant-based NPS,Khat,2020,193,MOZ
Africa,Southern Africa,Mozambique,Opioids,Opiates,Heroin,2020,143.915,MOZ
Africa,Southern Africa,Mozambique,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,1.4,MOZ
Africa,Southern Africa,Mozambique,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.001084,MOZ
Africa,Southern Africa,Mozambique,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,596.06,MOZ
Africa,Southern Africa,Mozambique,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,1579.385,MOZ
Africa,Southern Africa,Mozambique,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,3348.41,MOZ
Africa,Southern Africa,Mozambique,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,42.96,MOZ
Africa,Southern Africa,Mozambique,NPS,Plant-based NPS,Khat,2021,146.82,MOZ
Africa,Southern Africa,Mozambique,Opioids,Opiates,Heroin,2021,759.863,MOZ
Africa,Southern Africa,Mozambique,Precursors,Precursors,Sulphuric acid,2021,5,MOZ
Africa,Southern Africa,Mozambique,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,1211.91,MOZ
Africa,Southern Africa,Mozambique,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,1542.148,MOZ
Africa,Southern Africa,Mozambique,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,14.02,MOZ
Africa,Southern Africa,Mozambique,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,36.388,MOZ
Africa,Southern Africa,Mozambique,NPS,Plant-based NPS,Khat,2022,8,MOZ
Africa,Southern Africa,Mozambique,Opioids,Opiates,Heroin,2022,15.032,MOZ
Africa,Southern Africa,Mozambique,Precursors,Precursors,Ephedrine,2022,0.008,MOZ
Africa,Southern Africa,Mozambique,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,125,MOZ
Africa,Southern Africa,Mozambique,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,78.57,MOZ
Africa,Southern Africa,Mozambique,NPS,Plant-based NPS,Khat,2023,158,MOZ
Africa,Southern Africa,Mozambique,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,307,MOZ
Africa,Southern Africa,Mozambique,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,2729,MOZ
Africa,Southern Africa,Mozambique,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,20,MOZ
Africa,Southern Africa,Mozambique,Opioids,Opiates,Heroin,2019,231,MOZ
Africa,Southern Africa,Namibia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.035501,NAM
Africa,Southern Africa,Namibia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,2.922,NAM
Africa,Southern Africa,Namibia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Methcathinone,2020,2.743,NAM
Africa,Southern Africa,Namibia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,1414153,NAM
Africa,Southern Africa,Namibia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,0.029,NAM
Africa,Southern Africa,Namibia,Cocaine-type,Cocaine,"""Crack"" cocaine",2020,0.1179,NAM
Africa,Southern Africa,Namibia,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,1.431,NAM
Africa,Southern Africa,Namibia,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2020,0.035,NAM
Africa,Southern Africa,Namibia,Sedatives and tranquillizers,Barbiturates,Methaqualone,2020,1.8905,NAM
Africa,Southern Africa,Namibia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.00271,NAM
Africa,Southern Africa,Namibia,Amphetamine-type stimulants (excluding “ecstasy”),Non-specified amphetamine-type stimulants,Non-specified amphetamine-type stimulants,2021,0.00025,NAM
Africa,Southern Africa,Namibia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,2.743,NAM
Africa,Southern Africa,Namibia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Methcathinone,2021,2743,NAM
Africa,Southern Africa,Namibia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,2634.048,NAM
Africa,Southern Africa,Namibia,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,0.074,NAM
Africa,Southern Africa,Namibia,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,0.937,NAM
Africa,Southern Africa,Namibia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.00000205,NAM
Africa,Southern Africa,Namibia,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2021,0.4,NAM
Africa,Southern Africa,Namibia,Sedatives and tranquillizers,Barbiturates,Methaqualone,2021,15.0885,NAM
Africa,Southern Africa,Namibia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.014634,NAM
Africa,Southern Africa,Namibia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.012,NAM
Africa,Southern Africa,Namibia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,3799.56542,NAM
Africa,Southern Africa,Namibia,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,0.2102,NAM
Africa,Southern Africa,Namibia,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,1.10833,NAM
Africa,Southern Africa,Namibia,Opioids,Opiates,Heroin,2022,8.107,NAM
Africa,Southern Africa,Namibia,Sedatives and tranquillizers,Barbiturates,Methaqualone,2022,5.928,NAM
Africa,Southern Africa,Namibia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,0.007588,NAM
Africa,Southern Africa,Namibia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2023,0.24,NAM
Africa,Southern Africa,Namibia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,4031.55687,NAM
Africa,Southern Africa,Namibia,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,0.145827,NAM
Africa,Southern Africa,Namibia,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,14902.83,NAM
Africa,Southern Africa,Namibia,Sedatives and tranquillizers,Barbiturates,Methaqualone,2023,2.807,NAM
Africa,Southern Africa,South Africa,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.1626,ZAF
Africa,Southern Africa,South Africa,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,3251.34,ZAF
Africa,Southern Africa,South Africa,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,76,ZAF
Africa,Southern Africa,South Africa,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,12.451,ZAF
Africa,Southern Africa,South Africa,Cocaine-type,Cocaine,"""Crack"" cocaine",2020,3,ZAF
Africa,Southern Africa,South Africa,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2020,3,ZAF
Africa,Southern Africa,South Africa,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,0.00008,ZAF
Africa,Southern Africa,South Africa,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,0.01,ZAF
Africa,Southern Africa,South Africa,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2020,1,ZAF
Africa,Southern Africa,South Africa,Cocaine-type,Coca-type,Coca leaf,2020,3,ZAF
Africa,Southern Africa,South Africa,NPS,Plant-based NPS,Khat,2020,263.57,ZAF
Africa,Southern Africa,South Africa,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,1,ZAF
Africa,Southern Africa,South Africa,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.00271,ZAF
Africa,Southern Africa,South Africa,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.1,ZAF
Africa,Southern Africa,South Africa,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,20,ZAF
Africa,Southern Africa,South Africa,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,459.91,ZAF
Africa,Southern Africa,South Africa,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2021,6,ZAF
Africa,Southern Africa,South Africa,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,69.78,ZAF
Africa,Southern Africa,South Africa,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,10,ZAF
Africa,Southern Africa,South Africa,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,344.6,ZAF
Africa,Southern Africa,South Africa,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,0.3439,ZAF
Africa,Southern Africa,South Africa,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,5286.79,ZAF
Africa,Southern Africa,South Africa,Hallucinogens,Other Hallucinogens,Psilocybine,2021,100,ZAF
Africa,Southern Africa,South Africa,NPS,Plant-based NPS,Khat,2021,258.68,ZAF
Africa,Southern Africa,South Africa,Opioids,Opiates,Heroin,2021,158.26,ZAF
Africa,Southern Africa,South Africa,Opioids,Opiates,Heroin,2021,1.50036,ZAF
Africa,Southern Africa,South Africa,Sedatives and tranquillizers,Barbiturates,Methaqualone,2021,309,ZAF
Africa,Southern Africa,South Africa,Sedatives and tranquillizers,Barbiturates,Methaqualone,2021,49.76875,ZAF
Africa,Southern Africa,South Africa,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,238.58884,ZAF
Africa,Southern Africa,South Africa,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2022,34.14,ZAF
Africa,Southern Africa,South Africa,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,369487.615,ZAF
Africa,Southern Africa,South Africa,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,318.6,ZAF
Africa,Southern Africa,South Africa,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,304,ZAF
Africa,Southern Africa,South Africa,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,0.1301,ZAF
Africa,Southern Africa,South Africa,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,944,ZAF
Africa,Southern Africa,South Africa,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,6.717841,ZAF
Africa,Southern Africa,South Africa,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,80.08,ZAF
Africa,Southern Africa,South Africa,NPS,Plant-based NPS,Khat,2022,1398.13,ZAF
Africa,Southern Africa,South Africa,Opioids,Opiates,Heroin,2022,0.59097,ZAF
Africa,Southern Africa,South Africa,Opioids,Opiates,Heroin,2022,106.27041,ZAF
Africa,Southern Africa,South Africa,Precursors,Precursors,Ephedrine,2022,22.008,ZAF
Africa,Southern Africa,South Africa,Sedatives and tranquillizers,Barbiturates,Methaqualone,2022,107.90038,ZAF
Africa,Southern Africa,South Africa,Sedatives and tranquillizers,Barbiturates,Methaqualone,2022,1011.57275,ZAF
Africa,Southern Africa,South Africa,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.603788,ZAF
Africa,Southern Africa,South Africa,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,10774.97,ZAF
Africa,Southern Africa,South Africa,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2023,10.3,ZAF
Africa,Southern Africa,South Africa,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,130483.42,ZAF
Africa,Southern Africa,South Africa,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,2.25,ZAF
Africa,Southern Africa,South Africa,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,3642.5,ZAF
Africa,Southern Africa,South Africa,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,2.911,ZAF
Africa,Southern Africa,South Africa,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.6116,ZAF
Africa,Southern Africa,South Africa,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,0.00059,ZAF
Africa,Southern Africa,South Africa,NPS,Plant-based NPS,Khat,2023,2529.3141,ZAF
Africa,Southern Africa,South Africa,Opioids,Opiates,Heroin,2023,2650.5,ZAF
Africa,Southern Africa,South Africa,Opioids,Opiates,Heroin,2023,0.32883,ZAF
Africa,Southern Africa,South Africa,Sedatives and tranquillizers,Barbiturates,Methaqualone,2023,315.849,ZAF
Africa,Southern Africa,South Africa,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.01,ZAF
Africa,Southern Africa,Zambia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.03815,ZMB
Africa,Southern Africa,Zambia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2020,226.23,ZMB
Africa,Southern Africa,Zambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,29404.61242,ZMB
Africa,Southern Africa,Zambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,26.45,ZMB
Africa,Southern Africa,Zambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,69833.42701,ZMB
Africa,Southern Africa,Zambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,2.414,ZMB
Africa,Southern Africa,Zambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,51.52249,ZMB
Africa,Southern Africa,Zambia,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,0.47044,ZMB
Africa,Southern Africa,Zambia,Opioids,Opiates,Heroin,2020,1.86225,ZMB
Africa,Southern Africa,Zambia,Opioids,Other illicit opioids,Other illicit opioids,2020,0.0277,ZMB
Africa,Southern Africa,Zambia,Opioids,Other illicit opioids,Other illicit opioids,2020,0.0024,ZMB
Africa,Southern Africa,Zambia,Opioids,Other illicit opioids,Other illicit opioids,2020,0.027,ZMB
Africa,Southern Africa,Zambia,Opioids,Pharmaceutical opioids,Codeine,2020,1.42382,ZMB
Africa,Southern Africa,Zambia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.10258,ZMB
Africa,Southern Africa,Zambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,9263.624,ZMB
Africa,Southern Africa,Zambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,0.00004,ZMB
Africa,Southern Africa,Zambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,39738.009,ZMB
Africa,Southern Africa,Zambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,31.61,ZMB
Africa,Southern Africa,Zambia,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,1,ZMB
Africa,Southern Africa,Zambia,Opioids,Opiates,Heroin,2021,6,ZMB
Africa,Southern Africa,Zambia,Opioids,Pharmaceutical opioids,Codeine,2021,0.002232,ZMB
Africa,Southern Africa,Zambia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.063,ZMB
Africa,Southern Africa,Zambia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,7,ZMB
Africa,Southern Africa,Zambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,23258,ZMB
Africa,Southern Africa,Zambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,37896,ZMB
Africa,Southern Africa,Zambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,0.005,ZMB
Africa,Southern Africa,Zambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,43,ZMB
Africa,Southern Africa,Zambia,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,7,ZMB
Africa,Southern Africa,Zambia,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2022,0.036,ZMB
Africa,Southern Africa,Zambia,NPS,Plant-based NPS,Khat,2022,2,ZMB
Africa,Southern Africa,Zambia,Opioids,Opiates,Heroin,2022,13,ZMB
Africa,Southern Africa,Zambia,Opioids,Pharmaceutical opioids,Codeine,2022,0.028,ZMB
Africa,Southern Africa,Zambia,Precursors,Precursors,Ephedrine,2022,0.001,ZMB
Africa,Southern Africa,Zambia,Sedatives and tranquillizers,Barbiturates,Barbiturates,2022,0.006,ZMB
Africa,Southern Africa,Zambia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.044,ZMB
Africa,Southern Africa,Zambia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,40.01628,ZMB
Africa,Southern Africa,Zambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,16577.25809,ZMB
Africa,Southern Africa,Zambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,23268.53778,ZMB
Africa,Southern Africa,Zambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,156.09023,ZMB
Africa,Southern Africa,Zambia,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,10.86,ZMB
Africa,Southern Africa,Zambia,NPS,Plant-based NPS,Khat,2023,65.9,ZMB
Africa,Southern Africa,Zambia,Opioids,Opiates,Heroin,2023,0.29792,ZMB
Africa,Southern Africa,Zambia,Opioids,Pharmaceutical opioids,Codeine,2023,6.2,ZMB
Africa,Southern Africa,Zambia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.1846212,ZMB
Africa,Southern Africa,Zambia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,ZMB
Africa,Southern Africa,Zambia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2019,0,ZMB
Africa,Southern Africa,Zambia,Any other drugs/substances,Substances not under int. control,Other drugs/substances,2019,0,ZMB
Africa,Southern Africa,Zambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,22453,ZMB
Africa,Southern Africa,Zambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,109523,ZMB
Africa,Southern Africa,Zambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,278,ZMB
Africa,Southern Africa,Zambia,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,2,ZMB
Africa,Southern Africa,Zambia,NPS,Plant-based NPS,Khat,2019,178,ZMB
Africa,Southern Africa,Zambia,Opioids,Opiates,Heroin,2019,4,ZMB
Africa,Southern Africa,Zambia,Opioids,Opiates,Illicit morphine,2019,6,ZMB
Africa,Southern Africa,Zambia,Precursors,Precursors,Ephedrine,2019,57,ZMB
Africa,Southern Africa,Zimbabwe,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.01,ZWE
Africa,Southern Africa,Zimbabwe,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.743,ZWE
Africa,Southern Africa,Zimbabwe,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,338,ZWE
Africa,Southern Africa,Zimbabwe,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,100.1,ZWE
Africa,Southern Africa,Zimbabwe,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,1.3,ZWE
Africa,Southern Africa,Zimbabwe,Opioids,Pharmaceutical opioids,Codeine,2020,1021,ZWE
Africa,Southern Africa,Zimbabwe,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.00075,ZWE
Africa,Southern Africa,Zimbabwe,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,0.025,ZWE
Africa,Southern Africa,Zimbabwe,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,25.099,ZWE
Africa,Southern Africa,Zimbabwe,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,0.017,ZWE
Africa,Southern Africa,Zimbabwe,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,627.081,ZWE
Africa,Southern Africa,Zimbabwe,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,1.565,ZWE
Africa,Southern Africa,Zimbabwe,Opioids,Opiates,Heroin,2023,4.8,ZWE
Africa,West and Central Africa,Benin,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,7.26,BEN
Africa,West and Central Africa,Benin,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,10509.602,BEN
Africa,West and Central Africa,Benin,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,2.44356287,BEN
Africa,West and Central Africa,Benin,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,3558.49128,BEN
Africa,West and Central Africa,Benin,NPS,Plant-based NPS,Khat,2021,6.777,BEN
Africa,West and Central Africa,Benin,Opioids,Opiates,Heroin,2021,32.44728,BEN
Africa,West and Central Africa,Benin,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2021,171728.482,BEN
Africa,West and Central Africa,Benin,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,4.1,BEN
Africa,West and Central Africa,Benin,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,1522.91,BEN
Africa,West and Central Africa,Benin,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,8810.4,BEN
Africa,West and Central Africa,Benin,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2022,217.01,BEN
Africa,West and Central Africa,Benin,NPS,Plant-based NPS,Khat,2022,88.8,BEN
Africa,West and Central Africa,Benin,Opioids,Opiates,Heroin,2022,32.39,BEN
Africa,West and Central Africa,Benin,Opioids,Pharmaceutical opioids,Tramadol,2022,10682.09,BEN
Africa,West and Central Africa,Benin,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.055,BEN
Africa,West and Central Africa,Benin,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,6673.64,BEN
Africa,West and Central Africa,Benin,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2023,378.27,BEN
Africa,West and Central Africa,Benin,Opioids,Opiates,Heroin,2023,2.55,BEN
Africa,West and Central Africa,Benin,Opioids,Opiates,Illicit morphine,2023,0.023,BEN
Africa,West and Central Africa,Benin,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,613.661,BEN
Africa,West and Central Africa,Benin,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,867,BEN
Africa,West and Central Africa,Benin,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,1,BEN
Africa,West and Central Africa,Benin,NPS,Plant-based NPS,Khat,2019,2,BEN
Africa,West and Central Africa,Benin,Opioids,Opiates,Heroin,2019,0,BEN
Africa,West and Central Africa,Benin,Opioids,Pharmaceutical opioids,Tramadol,2019,59195,BEN
Africa,West and Central Africa,Burkina Faso,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,8.45,BFA
Africa,West and Central Africa,Burkina Faso,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,13865.146,BFA
Africa,West and Central Africa,Burkina Faso,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,0.468,BFA
Africa,West and Central Africa,Burkina Faso,Opioids,Opiates,Heroin,2020,0.071,BFA
Africa,West and Central Africa,Burkina Faso,Opioids,Pharmaceutical opioids,Tramadol,2020,30.14,BFA
Africa,West and Central Africa,Burkina Faso,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,4494,BFA
Africa,West and Central Africa,Burkina Faso,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,2,BFA
Africa,West and Central Africa,Burkina Faso,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,106156,BFA
Africa,West and Central Africa,Burkina Faso,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,12161.95,BFA
Africa,West and Central Africa,Burkina Faso,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,3.11,BFA
Africa,West and Central Africa,Burkina Faso,Opioids,Opiates,Heroin,2021,0.00473,BFA
Africa,West and Central Africa,Burkina Faso,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,15.54,BFA
Africa,West and Central Africa,Burkina Faso,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,150,BFA
Africa,West and Central Africa,Burkina Faso,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,231383.5,BFA
Africa,West and Central Africa,Burkina Faso,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,7502.16,BFA
Africa,West and Central Africa,Burkina Faso,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,0.02,BFA
Africa,West and Central Africa,Burkina Faso,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,1085.74,BFA
Africa,West and Central Africa,Burkina Faso,Opioids,Opiates,Heroin,2022,0.19,BFA
Africa,West and Central Africa,Burkina Faso,Opioids,Pharmaceutical opioids,Tramadol,2022,848,BFA
Africa,West and Central Africa,Burkina Faso,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,680,BFA
Africa,West and Central Africa,Burkina Faso,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,6145,BFA
Africa,West and Central Africa,Burkina Faso,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,291309.75,BFA
Africa,West and Central Africa,Burkina Faso,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,18984.77221,BFA
Africa,West and Central Africa,Burkina Faso,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,42.5,BFA
Africa,West and Central Africa,Burkina Faso,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,2.053248,BFA
Africa,West and Central Africa,Burkina Faso,Opioids,Opiates,Heroin,2023,50.255931,BFA
Africa,West and Central Africa,Burkina Faso,Opioids,Pharmaceutical opioids,Tramadol,2023,584.8,BFA
Africa,West and Central Africa,Burkina Faso,Any other drugs/substances,Other miscellaneous,Other miscellaneous,2019,30011,BFA
Africa,West and Central Africa,Burkina Faso,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,3497,BFA
Africa,West and Central Africa,Burkina Faso,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,2,BFA
Africa,West and Central Africa,Burkina Faso,Opioids,Opiates,Heroin,2019,0,BFA
Africa,West and Central Africa,Cabo Verde,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,0.03801,CPV
Africa,West and Central Africa,Cabo Verde,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,9280.9996,CPV
Africa,West and Central Africa,Cabo Verde,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,40.907304,CPV
Africa,West and Central Africa,Cabo Verde,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,5913.0378,CPV
Africa,West and Central Africa,Cabo Verde,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,9578.9941,CPV
Africa,West and Central Africa,Cabo Verde,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,34.58578,CPV
Africa,West and Central Africa,Cabo Verde,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,2390,CPV
Africa,West and Central Africa,Cabo Verde,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,11074,CPV
Africa,West and Central Africa,Cameroon,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,27351,CMR
Africa,West and Central Africa,Cameroon,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,19.313,CMR
Africa,West and Central Africa,Cameroon,Opioids,Opiates,Heroin,2020,0.011,CMR
Africa,West and Central Africa,Cameroon,Opioids,Pharmaceutical opioids,Tramadol,2020,9,CMR
Africa,West and Central Africa,Cameroon,Opioids,Pharmaceutical opioids,Tramadol,2020,0.09825,CMR
Africa,West and Central Africa,Cameroon,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,1386.308,CMR
Africa,West and Central Africa,Cameroon,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,56.338,CMR
Africa,West and Central Africa,Cameroon,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,1.08,CMR
Africa,West and Central Africa,Cameroon,Opioids,Opiates,Heroin,2021,3.013,CMR
Africa,West and Central Africa,Cameroon,Opioids,Pharmaceutical opioids,Tramadol,2021,5.114,CMR
Africa,West and Central Africa,Cameroon,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,31.9,CMR
Africa,West and Central Africa,Cameroon,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,8293.023,CMR
Africa,West and Central Africa,Cameroon,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,94.205,CMR
Africa,West and Central Africa,Cameroon,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,0.03,CMR
Africa,West and Central Africa,Cameroon,Opioids,Opiates,Heroin,2022,0.067,CMR
Africa,West and Central Africa,Cameroon,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2022,136.159,CMR
Africa,West and Central Africa,Cameroon,Opioids,Pharmaceutical opioids,Tramadol,2022,1.44565,CMR
Africa,West and Central Africa,Cameroon,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,31.9,CMR
Africa,West and Central Africa,Cameroon,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.622,CMR
Africa,West and Central Africa,Cameroon,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,6639.135,CMR
Africa,West and Central Africa,Cameroon,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,125.709,CMR
Africa,West and Central Africa,Cameroon,Opioids,Opiates,Heroin,2023,12.08,CMR
Africa,West and Central Africa,Cameroon,Opioids,Pharmaceutical opioids,Tramadol,2023,144,CMR
Africa,West and Central Africa,Cameroon,Opioids,Pharmaceutical opioids,Tramadol,2023,168.1221,CMR
Africa,West and Central Africa,Cameroon,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,44,CMR
Africa,West and Central Africa,Cameroon,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.048,CMR
Africa,West and Central Africa,Central African Republic,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,0.779,CAF
Africa,West and Central Africa,Central African Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,99,CAF
Africa,West and Central Africa,Central African Republic,Opioids,Pharmaceutical opioids,Tramadol,2020,1,CAF
Africa,West and Central Africa,Central African Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,106,CAF
Africa,West and Central Africa,Central African Republic,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,0.473,CAF
Africa,West and Central Africa,Central African Republic,Opioids,Opiates,Illicit morphine,2021,0.216,CAF
Africa,West and Central Africa,Central African Republic,Opioids,Pharmaceutical opioids,Tramadol,2021,1,CAF
Africa,West and Central Africa,Central African Republic,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,0.769,CAF
Africa,West and Central Africa,Central African Republic,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2022,0.109,CAF
Africa,West and Central Africa,Central African Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,116.5,CAF
Africa,West and Central Africa,Central African Republic,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,0.473,CAF
Africa,West and Central Africa,Central African Republic,Opioids,Opiates,Illicit morphine,2022,6.009,CAF
Africa,West and Central Africa,Central African Republic,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.159,CAF
Africa,West and Central Africa,Central African Republic,Opioids,Pharmaceutical opioids,Tramadol,2022,18,CAF
Africa,West and Central Africa,Central African Republic,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.0044,CAF
Africa,West and Central Africa,Central African Republic,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,0.909,CAF
Africa,West and Central Africa,Central African Republic,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2023,0.109,CAF
Africa,West and Central Africa,Central African Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,220,CAF
Africa,West and Central Africa,Central African Republic,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,0.869,CAF
Africa,West and Central Africa,Central African Republic,Opioids,Opiates,Illicit morphine,2023,8.009,CAF
Africa,West and Central Africa,Central African Republic,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.269,CAF
Africa,West and Central Africa,Central African Republic,Opioids,Pharmaceutical opioids,Tramadol,2023,0.25,CAF
Africa,West and Central Africa,Central African Republic,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.0146,CAF
Africa,West and Central Africa,Chad,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,1719,TCD
Africa,West and Central Africa,Chad,Opioids,Pharmaceutical opioids,Tramadol,2021,2.8213,TCD
Africa,West and Central Africa,Chad,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,1.4,TCD
Africa,West and Central Africa,Chad,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,1015,TCD
Africa,West and Central Africa,Chad,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,46,TCD
Africa,West and Central Africa,Chad,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,239,TCD
Africa,West and Central Africa,Chad,Opioids,Pharmaceutical opioids,Tramadol,2022,1.15,TCD
Africa,West and Central Africa,Chad,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.5,TCD
Africa,West and Central Africa,Chad,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2022,0.227,TCD
Africa,West and Central Africa,Chad,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,125,TCD
Africa,West and Central Africa,Chad,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,4,TCD
Africa,West and Central Africa,Chad,Opioids,Pharmaceutical opioids,Tramadol,2023,0.35,TCD
Africa,West and Central Africa,Côte d'Ivoire,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,2.26,CIV
Africa,West and Central Africa,Côte d'Ivoire,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,13600,CIV
Africa,West and Central Africa,Côte d'Ivoire,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,406.66,CIV
Africa,West and Central Africa,Côte d'Ivoire,Opioids,Opiates,Heroin,2020,48.89,CIV
Africa,West and Central Africa,Côte d'Ivoire,Opioids,Pharmaceutical opioids,Tramadol,2020,15.67,CIV
Africa,West and Central Africa,Côte d'Ivoire,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,21.25,CIV
Africa,West and Central Africa,Côte d'Ivoire,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,16.15,CIV
Africa,West and Central Africa,Côte d'Ivoire,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,2.2,CIV
Africa,West and Central Africa,Côte d'Ivoire,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,121.476,CIV
Africa,West and Central Africa,Côte d'Ivoire,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,15020,CIV
Africa,West and Central Africa,Côte d'Ivoire,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,358.2,CIV
Africa,West and Central Africa,Côte d'Ivoire,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,0.002,CIV
Africa,West and Central Africa,Côte d'Ivoire,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,2062,CIV
Africa,West and Central Africa,Côte d'Ivoire,Opioids,Opiates,Heroin,2022,4.071,CIV
Africa,West and Central Africa,Côte d'Ivoire,Opioids,Pharmaceutical opioids,Tramadol,2022,15.443,CIV
Africa,West and Central Africa,Côte d'Ivoire,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2022,4.232,CIV
Africa,West and Central Africa,Côte d'Ivoire,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,254.61,CIV
Africa,West and Central Africa,Côte d'Ivoire,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,13267,CIV
Africa,West and Central Africa,Côte d'Ivoire,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,399.7,CIV
Africa,West and Central Africa,Côte d'Ivoire,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,37.785,CIV
Africa,West and Central Africa,Côte d'Ivoire,Opioids,Opiates,Heroin,2023,4.991,CIV
Africa,West and Central Africa,Côte d'Ivoire,Opioids,Pharmaceutical opioids,Tramadol,2023,220.344,CIV
Africa,West and Central Africa,Côte d'Ivoire,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.065,CIV
Africa,West and Central Africa,Côte d'Ivoire,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,53.107,CIV
Africa,West and Central Africa,Côte d'Ivoire,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,27888,CIV
Africa,West and Central Africa,Côte d'Ivoire,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,0,CIV
Africa,West and Central Africa,Côte d'Ivoire,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,1,CIV
Africa,West and Central Africa,Côte d'Ivoire,Opioids,Opiates,Heroin,2019,24,CIV
Africa,West and Central Africa,Côte d'Ivoire,Sedatives and tranquillizers,Non-specified sedatives and tranquillizers,Non-specified sedatives and tranquillizers,2019,645,CIV
Africa,West and Central Africa,Democratic Republic of the Congo,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,1200,COD
Africa,West and Central Africa,Democratic Republic of the Congo,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,1,COD
Africa,West and Central Africa,Democratic Republic of the Congo,Opioids,Opiates,Heroin,2023,191.4,COD
Africa,West and Central Africa,Gambia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,0.008672,GMB
Africa,West and Central Africa,Gambia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.02125,GMB
Africa,West and Central Africa,Gambia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2021,0.00025,GMB
Africa,West and Central Africa,Gambia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2021,0.0002,GMB
Africa,West and Central Africa,Gambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,274.969203,GMB
Africa,West and Central Africa,Gambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,2.447314,GMB
Africa,West and Central Africa,Gambia,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,0.00087,GMB
Africa,West and Central Africa,Gambia,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2021,2953,GMB
Africa,West and Central Africa,Gambia,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,0.953,GMB
Africa,West and Central Africa,Gambia,Opioids,Opiates,Heroin,2021,0.21358,GMB
Africa,West and Central Africa,Gambia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,,GMB
Africa,West and Central Africa,Gambia,Sedatives and tranquillizers,Benzodiazepines,Bromazepam,2021,0.00001,GMB
Africa,West and Central Africa,Gambia,Sedatives and tranquillizers,Benzodiazepines,Bromazepam,2021,0.00005,GMB
Africa,West and Central Africa,Gambia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,,GMB
Africa,West and Central Africa,Gambia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.028455,GMB
Africa,West and Central Africa,Gambia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.13525,GMB
Africa,West and Central Africa,Gambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,1383,GMB
Africa,West and Central Africa,Gambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,2.2,GMB
Africa,West and Central Africa,Gambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,5.579,GMB
Africa,West and Central Africa,Gambia,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,844.731,GMB
Africa,West and Central Africa,Gambia,Opioids,Opiates,Heroin,2022,0.0081,GMB
Africa,West and Central Africa,Gambia,Opioids,Pharmaceutical opioids,Tramadol,2022,0.0565,GMB
Africa,West and Central Africa,Gambia,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2022,0.024,GMB
Africa,West and Central Africa,Gambia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.00512,GMB
Africa,West and Central Africa,Gambia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,3.085335,GMB
Africa,West and Central Africa,Gambia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.078266,GMB
Africa,West and Central Africa,Gambia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.9635,GMB
Africa,West and Central Africa,Gambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,1954.34492,GMB
Africa,West and Central Africa,Gambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,133.6,GMB
Africa,West and Central Africa,Gambia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,9.598883,GMB
Africa,West and Central Africa,Gambia,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,1.841554,GMB
Africa,West and Central Africa,Gambia,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,184.046398,GMB
Africa,West and Central Africa,Gambia,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2023,7.352121,GMB
Africa,West and Central Africa,Gambia,Opioids,Opiates,Heroin,2023,0.074,GMB
Africa,West and Central Africa,Gambia,Opioids,Pharmaceutical opioids,Tramadol,2023,0.00415,GMB
Africa,West and Central Africa,Gambia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.00037,GMB
Africa,West and Central Africa,Gambia,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2023,0.00003,GMB
Africa,West and Central Africa,Ghana,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,8228.34,GHA
Africa,West and Central Africa,Ghana,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,158.91,GHA
Africa,West and Central Africa,Ghana,NPS,Plant-based NPS,Khat,2020,287.61,GHA
Africa,West and Central Africa,Ghana,Opioids,Opiates,Heroin,2020,28.94,GHA
Africa,West and Central Africa,Ghana,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,6.29,GHA
Africa,West and Central Africa,Ghana,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,14190.534,GHA
Africa,West and Central Africa,Ghana,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,2,GHA
Africa,West and Central Africa,Ghana,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,8.99,GHA
Africa,West and Central Africa,Ghana,Opioids,Opiates,Heroin,2021,1.89,GHA
Africa,West and Central Africa,Ghana,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,13.65,GHA
Africa,West and Central Africa,Ghana,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,2.26,GHA
Africa,West and Central Africa,Ghana,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,162.66,GHA
Africa,West and Central Africa,Ghana,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,61716.43,GHA
Africa,West and Central Africa,Ghana,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,5.78,GHA
Africa,West and Central Africa,Ghana,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,4.32,GHA
Africa,West and Central Africa,Ghana,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,17.01,GHA
Africa,West and Central Africa,Ghana,NPS,Plant-based NPS,Khat,2022,42.685,GHA
Africa,West and Central Africa,Ghana,Opioids,Pharmaceutical opioids,Codeine,2022,1.4,GHA
Africa,West and Central Africa,Ghana,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,16,GHA
Africa,West and Central Africa,Ghana,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,3,GHA
Africa,West and Central Africa,Ghana,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,31000,GHA
Africa,West and Central Africa,Ghana,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,51,GHA
Africa,West and Central Africa,Ghana,Opioids,Opiates,Heroin,2023,33,GHA
Africa,West and Central Africa,Ghana,Opioids,Pharmaceutical opioids,Tramadol,2023,5.4,GHA
Africa,West and Central Africa,Ghana,Precursors,Precursors,Ephedrine,2023,26,GHA
Africa,West and Central Africa,Ghana,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,50650,GHA
Africa,West and Central Africa,Ghana,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,76,GHA
Africa,West and Central Africa,Ghana,NPS,Plant-based NPS,Khat,2019,456,GHA
Africa,West and Central Africa,Ghana,Opioids,Pharmaceutical opioids,Codeine,2019,,GHA
Africa,West and Central Africa,Guinea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,1480,GIN
Africa,West and Central Africa,Guinea,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,275,GIN
Africa,West and Central Africa,Guinea,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0,GIN
Africa,West and Central Africa,Guinea,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0,GIN
Africa,West and Central Africa,Guinea,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0,GIN
Africa,West and Central Africa,Guinea,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0,GIN
Africa,West and Central Africa,Guinea,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0,GIN
Africa,West and Central Africa,Guinea,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0,GIN
Africa,West and Central Africa,Guinea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,11447,GIN
Africa,West and Central Africa,Guinea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,0.0041,GIN
Africa,West and Central Africa,Guinea,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,0.0041,GIN
Africa,West and Central Africa,Guinea,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,2937.3,GIN
Africa,West and Central Africa,Guinea,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2022,12.124,GIN
Africa,West and Central Africa,Guinea,Opioids,Pharmaceutical opioids,Tramadol,2022,0.054,GIN
Africa,West and Central Africa,Guinea-Bissau,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.236,GNB
Africa,West and Central Africa,Guinea-Bissau,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,291,GNB
Africa,West and Central Africa,Guinea-Bissau,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,0.001058,GNB
Africa,West and Central Africa,Guinea-Bissau,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,91,GNB
Africa,West and Central Africa,Guinea-Bissau,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,9578.9941,GNB
Africa,West and Central Africa,Guinea-Bissau,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,0.264379,GNB
Africa,West and Central Africa,Guinea-Bissau,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,34.585776,GNB
Africa,West and Central Africa,Liberia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,3000,LBR
Africa,West and Central Africa,Liberia,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,26.3,LBR
Africa,West and Central Africa,Liberia,Opioids,Opiates,Heroin,2020,272,LBR
Africa,West and Central Africa,Liberia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,1000,LBR
Africa,West and Central Africa,Liberia,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,4.1,LBR
Africa,West and Central Africa,Liberia,Opioids,Opiates,Heroin,2021,5.3,LBR
Africa,West and Central Africa,Liberia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,232,LBR
Africa,West and Central Africa,Liberia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,595.903,LBR
Africa,West and Central Africa,Liberia,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,30.437,LBR
Africa,West and Central Africa,Liberia,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,0.928,LBR
Africa,West and Central Africa,Liberia,Opioids,Opiates,Heroin,2023,5.04,LBR
Africa,West and Central Africa,Liberia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,7430,LBR
Africa,West and Central Africa,Liberia,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,3,LBR
Africa,West and Central Africa,Liberia,Opioids,Opiates,Heroin,2019,46,LBR
Africa,West and Central Africa,Liberia,Opioids,Pharmaceutical opioids,Tramadol,2019,10,LBR
Africa,West and Central Africa,Mali,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,26.25,MLI
Africa,West and Central Africa,Mali,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,14342.43,MLI
Africa,West and Central Africa,Mali,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,1874.42,MLI
Africa,West and Central Africa,Mali,Cocaine-type,Cocaine,"""Crack"" cocaine",2020,0.058,MLI
Africa,West and Central Africa,Mali,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,1.252,MLI
Africa,West and Central Africa,Mali,Opioids,Pharmaceutical opioids,Tramadol,2020,1.229,MLI
Africa,West and Central Africa,Mali,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.09307,MLI
Africa,West and Central Africa,Mali,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,106.5,MLI
Africa,West and Central Africa,Mali,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,1.54,MLI
Africa,West and Central Africa,Mali,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.5,MLI
Africa,West and Central Africa,Mali,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2021,29.25,MLI
Africa,West and Central Africa,Mali,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2021,3.5,MLI
Africa,West and Central Africa,Mali,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2021,0.024,MLI
Africa,West and Central Africa,Mali,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,18109.476,MLI
Africa,West and Central Africa,Mali,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,6145,MLI
Africa,West and Central Africa,Mali,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,201.1,MLI
Africa,West and Central Africa,Mali,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,3.86,MLI
Africa,West and Central Africa,Mali,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,0.08075,MLI
Africa,West and Central Africa,Mali,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,37.568,MLI
Africa,West and Central Africa,Mali,Opioids,Pharmaceutical opioids,Tramadol,2021,3.35475,MLI
Africa,West and Central Africa,Mali,Precursors,Precursors,Ephedrine,2021,0.001935,MLI
Africa,West and Central Africa,Mali,Sedatives and tranquillizers,Benzodiazepines,Diazepam (Stesolid),2021,0.17306,MLI
Africa,West and Central Africa,Mali,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2021,0.00045,MLI
Africa,West and Central Africa,Mali,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,1.08025,MLI
Africa,West and Central Africa,Mali,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.5,MLI
Africa,West and Central Africa,Mali,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.003,MLI
Africa,West and Central Africa,Mali,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,3680.09,MLI
Africa,West and Central Africa,Mali,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,22216.75,MLI
Africa,West and Central Africa,Mali,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,1874.545,MLI
Africa,West and Central Africa,Mali,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,201.1,MLI
Africa,West and Central Africa,Mali,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,859.71,MLI
Africa,West and Central Africa,Mali,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,2.032,MLI
Africa,West and Central Africa,Mali,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,160.689,MLI
Africa,West and Central Africa,Mali,Opioids,Opiates,Heroin,2022,240,MLI
Africa,West and Central Africa,Mali,Opioids,Pharmaceutical opioids,Tramadol,2022,9.3561,MLI
Africa,West and Central Africa,Mali,Precursors,Precursors,Ephedrine,2022,0.000195,MLI
Africa,West and Central Africa,Mali,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2022,0.00212,MLI
Africa,West and Central Africa,Mali,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.7869,MLI
Africa,West and Central Africa,Mali,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,300,MLI
Africa,West and Central Africa,Mali,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,357,MLI
Africa,West and Central Africa,Mali,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,32000,MLI
Africa,West and Central Africa,Mali,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,440,MLI
Africa,West and Central Africa,Mali,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,0.2655,MLI
Africa,West and Central Africa,Mali,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,26,MLI
Africa,West and Central Africa,Mali,Opioids,Opiates,Heroin,2023,0.03675,MLI
Africa,West and Central Africa,Mali,Opioids,Pharmaceutical opioids,Tramadol,2023,41.1853,MLI
Africa,West and Central Africa,Mali,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,9.96639,MLI
Africa,West and Central Africa,Mali,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,MLI
Africa,West and Central Africa,Mali,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,11659,MLI
Africa,West and Central Africa,Mali,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,75,MLI
Africa,West and Central Africa,Mali,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,0,MLI
Africa,West and Central Africa,Mali,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,5,MLI
Africa,West and Central Africa,Mali,Opioids,Opiates,Opium,2019,12,MLI
Africa,West and Central Africa,Mali,Opioids,Pharmaceutical opioids,Tramadol,2019,1,MLI
Africa,West and Central Africa,Mali,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2019,0,MLI
Africa,West and Central Africa,Mauritania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,172.48352,MRT
Africa,West and Central Africa,Mauritania,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,0.1098,MRT
Africa,West and Central Africa,Mauritania,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2020,0.01168,MRT
Africa,West and Central Africa,Mauritania,Sedatives and tranquillizers,Benzodiazepines,Valium,2020,0.00135,MRT
Africa,West and Central Africa,Mauritania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,216.74,MRT
Africa,West and Central Africa,Mauritania,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.5191,MRT
Africa,West and Central Africa,Mauritania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,522.594,MRT
Africa,West and Central Africa,Mauritania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,7.79,MRT
Africa,West and Central Africa,Mauritania,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,0.0066,MRT
Africa,West and Central Africa,Mauritania,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.00988,MRT
Africa,West and Central Africa,Niger,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,,NER
Africa,West and Central Africa,Niger,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,4214.765,NER
Africa,West and Central Africa,Niger,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,3.498,NER
Africa,West and Central Africa,Niger,Cocaine-type,Cocaine,"""Crack"" cocaine",2020,1.268,NER
Africa,West and Central Africa,Niger,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,0.60061,NER
Africa,West and Central Africa,Niger,Opioids,Opiates,Heroin,2020,0.014,NER
Africa,West and Central Africa,Niger,Opioids,Pharmaceutical opioids,Tramadol,2020,49.2881,NER
Africa,West and Central Africa,Niger,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,9.42083,NER
Africa,West and Central Africa,Niger,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,23.19475,NER
Africa,West and Central Africa,Niger,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,2.385,NER
Africa,West and Central Africa,Niger,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2021,113.0065,NER
Africa,West and Central Africa,Niger,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,5144.446,NER
Africa,West and Central Africa,Niger,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,16807.815,NER
Africa,West and Central Africa,Niger,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,0.1161,NER
Africa,West and Central Africa,Niger,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,0.228,NER
Africa,West and Central Africa,Niger,Opioids,Opiates,Heroin,2021,0.343,NER
Africa,West and Central Africa,Niger,Opioids,Pharmaceutical opioids,Codeine,2021,0.0028,NER
Africa,West and Central Africa,Niger,Opioids,Pharmaceutical opioids,Tramadol,2021,195.3426,NER
Africa,West and Central Africa,Niger,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,7.95084,NER
Africa,West and Central Africa,Niger,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,1.436,NER
Africa,West and Central Africa,Niger,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0,NER
Africa,West and Central Africa,Niger,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,4271.532,NER
Africa,West and Central Africa,Niger,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,10.467,NER
Africa,West and Central Africa,Niger,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,1.197,NER
Africa,West and Central Africa,Niger,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,216.852,NER
Africa,West and Central Africa,Niger,Opioids,Opiates,Heroin,2022,2.843,NER
Africa,West and Central Africa,Niger,Opioids,Pharmaceutical opioids,Tramadol,2022,128.95955,NER
Africa,West and Central Africa,Niger,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,8.1004,NER
Africa,West and Central Africa,Niger,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.16,NER
Africa,West and Central Africa,Niger,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,211.33025,NER
Africa,West and Central Africa,Niger,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2023,210.5485,NER
Africa,West and Central Africa,Niger,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,10761.73,NER
Africa,West and Central Africa,Niger,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,77.528,NER
Africa,West and Central Africa,Niger,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,8.5,NER
Africa,West and Central Africa,Niger,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,61.63,NER
Africa,West and Central Africa,Niger,Opioids,Opiates,Heroin,2023,11.41,NER
Africa,West and Central Africa,Niger,Opioids,Pharmaceutical opioids,Codeine,2023,51.84,NER
Africa,West and Central Africa,Niger,Opioids,Pharmaceutical opioids,Tramadol,2023,117.72985,NER
Africa,West and Central Africa,Niger,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.0006,NER
Africa,West and Central Africa,Niger,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,24.42726,NER
Africa,West and Central Africa,Niger,Sedatives and tranquillizers,Benzodiazepines,"Flunitrazepam (Disomnilan, Flumipam, Rohypnol)",2023,0.00049,NER
Africa,West and Central Africa,Niger,Sedatives and tranquillizers,Benzodiazepines,"Flunitrazepam (Disomnilan, Flumipam, Rohypnol)",2023,0.01258,NER
Africa,West and Central Africa,Niger,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,NER
Africa,West and Central Africa,Niger,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,6293,NER
Africa,West and Central Africa,Niger,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,6,NER
Africa,West and Central Africa,Niger,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,0,NER
Africa,West and Central Africa,Niger,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,1,NER
Africa,West and Central Africa,Niger,Opioids,Opiates,Heroin,2019,0,NER
Africa,West and Central Africa,Niger,Opioids,Opiates,Illicit morphine,2019,0,NER
Africa,West and Central Africa,Niger,Opioids,Pharmaceutical opioids,Tramadol,2019,193,NER
Africa,West and Central Africa,Niger,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2019,9,NER
Africa,West and Central Africa,Nigeria,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,1.406,NGA
Africa,West and Central Africa,Nigeria,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,40.666,NGA
Africa,West and Central Africa,Nigeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,124473.3,NGA
Africa,West and Central Africa,Nigeria,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,128.579,NGA
Africa,West and Central Africa,Nigeria,Opioids,Opiates,Heroin,2020,5.321,NGA
Africa,West and Central Africa,Nigeria,Opioids,Opiates,Opium,2020,414.86,NGA
Africa,West and Central Africa,Nigeria,Opioids,Pharmaceutical opioids,Codeine,2020,1622.3,NGA
Africa,West and Central Africa,Nigeria,Opioids,Pharmaceutical opioids,Tramadol,2020,1814.69,NGA
Africa,West and Central Africa,Nigeria,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,7230.066,NGA
Africa,West and Central Africa,Nigeria,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,76.6985,NGA
Africa,West and Central Africa,Nigeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,469246,NGA
Africa,West and Central Africa,Nigeria,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,326.051,NGA
Africa,West and Central Africa,Nigeria,Opioids,Opiates,Heroin,2021,122.551,NGA
Africa,West and Central Africa,Nigeria,Opioids,Pharmaceutical opioids,Codeine,2021,68198.98,NGA
Africa,West and Central Africa,Nigeria,Opioids,Pharmaceutical opioids,Tramadol,2021,32709.43,NGA
Africa,West and Central Africa,Nigeria,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,1814.53,NGA
Africa,West and Central Africa,Nigeria,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,669.89657,NGA
Africa,West and Central Africa,Nigeria,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2022,18178.04833,NGA
Africa,West and Central Africa,Nigeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,691884.6029,NGA
Africa,West and Central Africa,Nigeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,1365135.444,NGA
Africa,West and Central Africa,Nigeria,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,2540.013,NGA
Africa,West and Central Africa,Nigeria,NPS,Plant-based NPS,Khat,2022,5343.6552,NGA
Africa,West and Central Africa,Nigeria,Opioids,Opiates,Heroin,2022,65.19453,NGA
Africa,West and Central Africa,Nigeria,Opioids,Pharmaceutical opioids,Codeine,2022,15858.21,NGA
Africa,West and Central Africa,Nigeria,Opioids,Pharmaceutical opioids,Tramadol,2022,42808.48,NGA
Africa,West and Central Africa,Nigeria,Precursors,Precursors,Ephedrine,2022,131.4807,NGA
Africa,West and Central Africa,Nigeria,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,2289.125,NGA
Africa,West and Central Africa,Nigeria,Sedatives and tranquillizers,Benzodiazepines,"Flunitrazepam (Disomnilan, Flumipam, Rohypnol)",2022,432.1457,NGA
Africa,West and Central Africa,Nigeria,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,1349.301,NGA
Africa,West and Central Africa,Nigeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,572642.8,NGA
Africa,West and Central Africa,Nigeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,516823,NGA
Africa,West and Central Africa,Nigeria,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,513.5026,NGA
Africa,West and Central Africa,Nigeria,Opioids,Opiates,Heroin,2023,205.7934,NGA
Africa,West and Central Africa,Nigeria,Opioids,Pharmaceutical opioids,Codeine,2023,207655.6,NGA
Africa,West and Central Africa,Nigeria,Opioids,Pharmaceutical opioids,Tramadol,2023,36128.44,NGA
Africa,West and Central Africa,Nigeria,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.00001,NGA
Africa,West and Central Africa,Nigeria,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,6518.927,NGA
Africa,West and Central Africa,Nigeria,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,146,NGA
Africa,West and Central Africa,Nigeria,Amphetamine-type stimulants (excluding “ecstasy”),Non-specified amphetamine-type stimulants,Non-specified amphetamine-type stimulants,2019,1,NGA
Africa,West and Central Africa,Nigeria,Any other drugs/substances,Other miscellaneous,Psychotropic substances,2019,4155,NGA
Africa,West and Central Africa,Nigeria,Any other drugs/substances,Substances not under int. control,Other drugs/substances,2019,1226,NGA
Africa,West and Central Africa,Nigeria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,602654,NGA
Africa,West and Central Africa,Nigeria,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,113,NGA
Africa,West and Central Africa,Nigeria,NPS,Plant-based NPS,Khat,2019,93,NGA
Africa,West and Central Africa,Nigeria,Opioids,Opiates,Heroin,2019,24,NGA
Africa,West and Central Africa,Nigeria,Opioids,Other illicit opiates,Other illicit opiates,2019,2,NGA
Africa,West and Central Africa,Nigeria,Opioids,Other illicit opioids,Other illicit opioids,2019,287,NGA
Africa,West and Central Africa,Nigeria,Opioids,Pharmaceutical opioids,Tramadol,2019,2079,NGA
Africa,West and Central Africa,Nigeria,Precursors,Precursors,Ephedrine,2019,454,NGA
Africa,West and Central Africa,Nigeria,Sedatives and tranquillizers,Barbiturates,Barbiturates,2019,23,NGA
Africa,West and Central Africa,Nigeria,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,1647,NGA
Africa,West and Central Africa,Senegal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,20989.264,SEN
Africa,West and Central Africa,Senegal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,1.5,SEN
Africa,West and Central Africa,Senegal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,5162.515,SEN
Africa,West and Central Africa,Senegal,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,132.361,SEN
Africa,West and Central Africa,Senegal,Opioids,Opiates,Heroin,2020,3.28,SEN
Africa,West and Central Africa,Senegal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,29985.8,SEN
Africa,West and Central Africa,Senegal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,0.8,SEN
Africa,West and Central Africa,Senegal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,16757.964,SEN
Africa,West and Central Africa,Senegal,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,2706.242,SEN
Africa,West and Central Africa,Senegal,Opioids,Opiates,Heroin,2021,3.441,SEN
Africa,West and Central Africa,Senegal,Opioids,Pharmaceutical opioids,Tramadol,2021,0.0163,SEN
Africa,West and Central Africa,Senegal,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.962321,SEN
Africa,West and Central Africa,Senegal,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,3162.075,SEN
Africa,West and Central Africa,Senegal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,213869.52,SEN
Africa,West and Central Africa,Senegal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,4,SEN
Africa,West and Central Africa,Senegal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,33.29,SEN
Africa,West and Central Africa,Senegal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,5000,SEN
Africa,West and Central Africa,Senegal,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,2.05,SEN
Africa,West and Central Africa,Senegal,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2022,336.158,SEN
Africa,West and Central Africa,Senegal,NPS,Plant-based NPS,Khat,2022,60,SEN
Africa,West and Central Africa,Senegal,NPS,Plant-based NPS,Khat,2022,60,SEN
Africa,West and Central Africa,Senegal,NPS,Plant-based NPS,Plant-based new psychoactive substances,2022,21.716,SEN
Africa,West and Central Africa,Senegal,Opioids,Opiates,Heroin,2022,4.395,SEN
Africa,West and Central Africa,Senegal,Opioids,Opiates,Illicit morphine,2022,2,SEN
Africa,West and Central Africa,Senegal,Opioids,Pharmaceutical opioids,Tramadol,2022,0.3107,SEN
Africa,West and Central Africa,Senegal,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2022,0.21336,SEN
Africa,West and Central Africa,Senegal,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,1.280204,SEN
Africa,West and Central Africa,Senegal,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,1209.02,SEN
Africa,West and Central Africa,Senegal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,12737.79,SEN
Africa,West and Central Africa,Senegal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,23.125,SEN
Africa,West and Central Africa,Senegal,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,7503.68,SEN
Africa,West and Central Africa,Senegal,Hallucinogens,Other Hallucinogens,Other hallucinogens,2023,2050,SEN
Africa,West and Central Africa,Senegal,NPS,Plant-based NPS,Khat,2023,300,SEN
Africa,West and Central Africa,Senegal,Opioids,Opiates,Heroin,2023,6.409,SEN
Africa,West and Central Africa,Senegal,Opioids,Opiates,Illicit morphine,2023,3.08,SEN
Africa,West and Central Africa,Senegal,Opioids,Pharmaceutical opioids,Tramadol,2023,0.1693,SEN
Africa,West and Central Africa,Senegal,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,2,SEN
Africa,West and Central Africa,Senegal,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2019,175,SEN
Africa,West and Central Africa,Senegal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,3473,SEN
Africa,West and Central Africa,Senegal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,0,SEN
Africa,West and Central Africa,Senegal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,1,SEN
Africa,West and Central Africa,Senegal,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,8,SEN
Africa,West and Central Africa,Senegal,Opioids,Opiates,Heroin,2019,0,SEN
Africa,West and Central Africa,Sierra Leone,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,1.5,SLE
Africa,West and Central Africa,Sierra Leone,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,14,SLE
Africa,West and Central Africa,Sierra Leone,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,243,SLE
Africa,West and Central Africa,Sierra Leone,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,15000,SLE
Africa,West and Central Africa,Sierra Leone,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,45,SLE
Africa,West and Central Africa,Sierra Leone,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,10,SLE
Africa,West and Central Africa,Sierra Leone,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2023,15000,SLE
Africa,West and Central Africa,Sierra Leone,Opioids,Opiates,Heroin,2023,1.5,SLE
Africa,West and Central Africa,Sierra Leone,Opioids,Pharmaceutical opioids,Tramadol,2023,72.505,SLE
Africa,West and Central Africa,Togo,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,3.4,TGO
Africa,West and Central Africa,Togo,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,6317.553,TGO
Africa,West and Central Africa,Togo,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,0.859,TGO
Africa,West and Central Africa,Togo,NPS,Plant-based NPS,Khat,2020,16.3,TGO
Africa,West and Central Africa,Togo,Opioids,Opiates,Heroin,2020,0.00871,TGO
Africa,West and Central Africa,Togo,Opioids,Pharmaceutical opioids,Tramadol,2020,5.89,TGO
Africa,West and Central Africa,Togo,Precursors,Precursors,Ephedrine,2020,33.3,TGO
Africa,West and Central Africa,Togo,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,15,TGO
Africa,West and Central Africa,Togo,Sedatives and tranquillizers,Benzodiazepines,"Flunitrazepam (Disomnilan, Flumipam, Rohypnol)",2020,1.94,TGO
Africa,West and Central Africa,Togo,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,1.25231,TGO
Africa,West and Central Africa,Togo,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,2887.20701,TGO
Africa,West and Central Africa,Togo,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,0.00278,TGO
Africa,West and Central Africa,Togo,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,289.56679,TGO
Africa,West and Central Africa,Togo,NPS,Plant-based NPS,Khat,2021,17.8,TGO
Africa,West and Central Africa,Togo,Opioids,Opiates,Heroin,2021,7.112,TGO
Africa,West and Central Africa,Togo,Opioids,Other illicit opioids,Other illicit opioids,2021,1710.8,TGO
Africa,West and Central Africa,Togo,Opioids,Other illicit opioids,Other illicit opioids,2021,3271.3,TGO
Africa,West and Central Africa,Togo,Opioids,Pharmaceutical opioids,Tramadol,2021,672.25982,TGO
Africa,West and Central Africa,Togo,Precursors,Precursors,Ephedrine,2021,152.75,TGO
Africa,West and Central Africa,Togo,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,51.64538,TGO
Africa,West and Central Africa,Togo,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,4.88759,TGO
Africa,West and Central Africa,Togo,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0.169,TGO
Africa,West and Central Africa,Togo,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,8245.68239,TGO
Africa,West and Central Africa,Togo,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,0.007,TGO
Africa,West and Central Africa,Togo,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,5.84628,TGO
Africa,West and Central Africa,Togo,Opioids,Opiates,Heroin,2022,0.37817,TGO
Africa,West and Central Africa,Togo,Opioids,Opiates,Illicit morphine,2022,2.3,TGO
Africa,West and Central Africa,Togo,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2022,1119.29856,TGO
Africa,West and Central Africa,Togo,Opioids,Pharmaceutical opioids,Tramadol,2022,9.21248,TGO
Africa,West and Central Africa,Togo,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,1.30368,TGO
Africa,West and Central Africa,Togo,Sedatives and tranquillizers,Benzodiazepines,"Flunitrazepam (Disomnilan, Flumipam, Rohypnol)",2022,0.45,TGO
Africa,West and Central Africa,Togo,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.222,TGO
Africa,West and Central Africa,Togo,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,7908.52582,TGO
Africa,West and Central Africa,Togo,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,0.00165,TGO
Africa,West and Central Africa,Togo,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,0.6001,TGO
Africa,West and Central Africa,Togo,Opioids,Opiates,Heroin,2023,0.06306,TGO
Africa,West and Central Africa,Togo,Opioids,Pharmaceutical opioids,Tramadol,2023,92.0053,TGO
Africa,West and Central Africa,Togo,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,56.455,TGO
Africa,West and Central Africa,Togo,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,2,TGO
Africa,West and Central Africa,Togo,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,4416,TGO
Africa,West and Central Africa,Togo,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,10,TGO
Africa,West and Central Africa,Togo,Opioids,Opiates,Heroin,2019,1,TGO
Africa,West and Central Africa,Togo,Opioids,Other illicit opioids,Other illicit opioids,2019,1,TGO
Africa,West and Central Africa,Togo,Opioids,Pharmaceutical opioids,Tramadol,2019,17,TGO
Africa,West and Central Africa,Togo,Opioids,Pharmaceutical opioids,Tramadol,2019,4,TGO
Americas,Caribbean,Antigua and Barbuda,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,831.737,ATG
Americas,Caribbean,Antigua and Barbuda,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,,ATG
Americas,Caribbean,Antigua and Barbuda,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,3.477,ATG
Americas,Caribbean,Antigua and Barbuda,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,2.086,ATG
Americas,Caribbean,Antigua and Barbuda,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,733.67,ATG
Americas,Caribbean,Antigua and Barbuda,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,35.75,ATG
Americas,Caribbean,Antigua and Barbuda,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,2.223,ATG
Americas,Caribbean,Antigua and Barbuda,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,0,ATG
Americas,Caribbean,Aruba,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,280,ABW
Americas,Caribbean,Aruba,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,300,ABW
Americas,Caribbean,Aruba,Opioids,Opiates,Heroin,2021,4,ABW
Americas,Caribbean,Bahamas,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.011924,BHS
Americas,Caribbean,Bahamas,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.041,BHS
Americas,Caribbean,Bahamas,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.045,BHS
Americas,Caribbean,Bahamas,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2020,0.011,BHS
Americas,Caribbean,Bahamas,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,1951.221242,BHS
Americas,Caribbean,Bahamas,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.0185,BHS
Americas,Caribbean,Bahamas,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,150.5,BHS
Americas,Caribbean,Bahamas,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,3.73759808,BHS
Americas,Caribbean,Bahamas,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,74.93793432,BHS
Americas,Caribbean,Bahamas,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,1500,BHS
Americas,Caribbean,Bahamas,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,349,BHS
Americas,Caribbean,Bahamas,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,5800,BHS
Americas,Caribbean,Bahamas,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,367,BHS
Americas,Caribbean,Bahamas,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,225700,BHS
Americas,Caribbean,Bahamas,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,1000,BHS
Americas,Caribbean,Dominican Republic,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,0.67,DOM
Americas,Caribbean,Dominican Republic,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,103.37,DOM
Americas,Caribbean,Dominican Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,2490.29,DOM
Americas,Caribbean,Dominican Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,226,DOM
Americas,Caribbean,Dominican Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,5.24,DOM
Americas,Caribbean,Dominican Republic,Cocaine-type,Cocaine,"""Crack"" cocaine",2020,6.95,DOM
Americas,Caribbean,Dominican Republic,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,10369.05,DOM
Americas,Caribbean,Dominican Republic,Opioids,Opiates,Opium,2020,3.44,DOM
Americas,Caribbean,Dominican Republic,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,2.92,DOM
Americas,Caribbean,Dominican Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,6262.66,DOM
Americas,Caribbean,Dominican Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,25.13,DOM
Americas,Caribbean,Dominican Republic,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,16.73,DOM
Americas,Caribbean,Dominican Republic,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,19146.7,DOM
Americas,Caribbean,Dominican Republic,Opioids,Opiates,Heroin,2021,8.21,DOM
Americas,Caribbean,Dominican Republic,Opioids,Opiates,Opium,2021,0.08,DOM
Americas,Caribbean,Dominican Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,2859.34,DOM
Americas,Caribbean,Dominican Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,1.75,DOM
Americas,Caribbean,Dominican Republic,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,10.62,DOM
Americas,Caribbean,Dominican Republic,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,27027.19,DOM
Americas,Caribbean,Dominican Republic,Opioids,Opiates,Opium,2022,0.91,DOM
Americas,Caribbean,Dominican Republic,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,1.02,DOM
Americas,Caribbean,Dominican Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,6899.76,DOM
Americas,Caribbean,Dominican Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,20.51,DOM
Americas,Caribbean,Dominican Republic,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,101.52,DOM
Americas,Caribbean,Dominican Republic,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,17980.7,DOM
Americas,Caribbean,Dominican Republic,Opioids,Opiates,Opium,2023,39.31,DOM
Americas,Caribbean,Dominican Republic,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,13,DOM
Americas,Caribbean,Dominican Republic,Any other drugs/substances,Other miscellaneous,Psychotropic substances,2019,0,DOM
Americas,Caribbean,Dominican Republic,Any other drugs/substances,Other miscellaneous,Psychotropic substances,2019,812661,DOM
Americas,Caribbean,Dominican Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,1971,DOM
Americas,Caribbean,Dominican Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,50,DOM
Americas,Caribbean,Dominican Republic,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,5768,DOM
Americas,Caribbean,Dominican Republic,Cocaine-type,Cocaine,Non-specified cocaine,2019,4947,DOM
Americas,Caribbean,Dominican Republic,Opioids,Opiates,Heroin,2019,0,DOM
Americas,Caribbean,Dominican Republic,Opioids,Opiates,Opium,2019,0,DOM
Americas,Caribbean,Dominican Republic,Opioids,Pharmaceutical opioids,Oxycodone,2019,0,DOM
Americas,Caribbean,Dominican Republic,Opioids,Pharmaceutical opioids,Tramadol,2019,0,DOM
Americas,Caribbean,Haiti,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,2718.754,HTI
Americas,Caribbean,Haiti,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,111.598,HTI
Americas,Caribbean,Haiti,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,2760,HTI
Americas,Caribbean,Haiti,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,94,HTI
Americas,Caribbean,Haiti,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,130.7,HTI
Americas,Caribbean,Haiti,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,0.0065,HTI
Americas,Caribbean,Haiti,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,1322,HTI
Americas,Caribbean,Haiti,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,10,HTI
Americas,Caribbean,Jamaica,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,26000,JAM
Americas,Caribbean,Jamaica,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,670,JAM
Americas,Caribbean,Jamaica,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,32000,JAM
Americas,Caribbean,Jamaica,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,1184,JAM
Americas,Caribbean,Jamaica,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,1300,JAM
Americas,Caribbean,Jamaica,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,24000,JAM
Americas,Caribbean,Jamaica,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,1630,JAM
Americas,Caribbean,Trinidad and Tobago,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,2360.2,TTO
Americas,Caribbean,Trinidad and Tobago,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,,TTO
Americas,Caribbean,Trinidad and Tobago,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,,TTO
Americas,Caribbean,Trinidad and Tobago,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,679.1,TTO
Americas,Caribbean,Trinidad and Tobago,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,3486.9,TTO
Americas,Caribbean,Trinidad and Tobago,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,2510.7,TTO
Americas,Caribbean,Trinidad and Tobago,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,1.16,TTO
Americas,Caribbean,Trinidad and Tobago,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,221.1,TTO
Americas,Caribbean,Trinidad and Tobago,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.0084,TTO
Americas,Caribbean,Trinidad and Tobago,Sedatives and tranquillizers,Benzodiazepines,Diazepam (Stesolid),2021,0.352,TTO
Americas,Caribbean,Trinidad and Tobago,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,584,TTO
Americas,Caribbean,Trinidad and Tobago,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,691.5,TTO
Americas,Caribbean,Trinidad and Tobago,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2022,19.6,TTO
Americas,Caribbean,Trinidad and Tobago,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,12.7,TTO
Americas,Caribbean,Trinidad and Tobago,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,0.0017,TTO
Americas,Caribbean,Trinidad and Tobago,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.54,TTO
Americas,Caribbean,Trinidad and Tobago,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,3.21,TTO
Americas,Caribbean,Trinidad and Tobago,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2023,0.7,TTO
Americas,Caribbean,Trinidad and Tobago,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.0053,TTO
Americas,Caribbean,Trinidad and Tobago,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,0.0016,TTO
Americas,Caribbean,Trinidad and Tobago,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,2890,TTO
Americas,Caribbean,Trinidad and Tobago,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,320,TTO
Americas,Central America,Belize,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,868.9,BLZ
Americas,Central America,Belize,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,2.6,BLZ
Americas,Central America,Belize,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,989.7,BLZ
Americas,Central America,Belize,Opioids,Opiates,Heroin,2021,4.4,BLZ
Americas,Central America,Belize,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,8.9,BLZ
Americas,Central America,Belize,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,249,BLZ
Americas,Central America,Belize,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,1400,BLZ
Americas,Central America,Belize,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.015,BLZ
Americas,Central America,Belize,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,337.50146,BLZ
Americas,Central America,Belize,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,1997.3,BLZ
Americas,Central America,Belize,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,0.229,BLZ
Americas,Central America,Belize,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,0.951,BLZ
Americas,Central America,Belize,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,3.37149,BLZ
Americas,Central America,Belize,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,14.95161,BLZ
Americas,Central America,Belize,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,BLZ
Americas,Central America,Belize,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,421,BLZ
Americas,Central America,Belize,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,1,BLZ
Americas,Central America,Belize,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,2,BLZ
Americas,Central America,Belize,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2019,3,BLZ
Americas,Central America,Belize,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,1369,BLZ
Americas,Central America,Belize,Opioids,Opiates,Heroin,2019,2,BLZ
Americas,Central America,Costa Rica,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2020,5.13775,CRI
Americas,Central America,Costa Rica,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,12552.3,CRI
Americas,Central America,Costa Rica,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,36739.7,CRI
Americas,Central America,Costa Rica,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,47127.36,CRI
Americas,Central America,Costa Rica,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2020,29.2103,CRI
Americas,Central America,Costa Rica,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.0000253,CRI
Americas,Central America,Costa Rica,Opioids,Opiates,Heroin,2020,0.0025,CRI
Americas,Central America,Costa Rica,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,2.159328,CRI
Americas,Central America,Costa Rica,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,21660.19,CRI
Americas,Central America,Costa Rica,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,81619.2,CRI
Americas,Central America,Costa Rica,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,0.01,CRI
Americas,Central America,Costa Rica,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,36.002,CRI
Americas,Central America,Costa Rica,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,44312.1,CRI
Americas,Central America,Costa Rica,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.0000341,CRI
Americas,Central America,Costa Rica,Opioids,Opiates,Heroin,2021,0.52,CRI
Americas,Central America,Costa Rica,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,4.498329,CRI
Americas,Central America,Costa Rica,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,25097.63,CRI
Americas,Central America,Costa Rica,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,64227.2,CRI
Americas,Central America,Costa Rica,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,0.45,CRI
Americas,Central America,Costa Rica,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,48.0623,CRI
Americas,Central America,Costa Rica,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,24751.8,CRI
Americas,Central America,Costa Rica,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0001215,CRI
Americas,Central America,Costa Rica,Opioids,Opiates,Heroin,2022,0.001,CRI
Americas,Central America,Costa Rica,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,153.57841,CRI
Americas,Central America,Costa Rica,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,15847,CRI
Americas,Central America,Costa Rica,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,36624.9,CRI
Americas,Central America,Costa Rica,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,2.5178,CRI
Americas,Central America,Costa Rica,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,15680,CRI
Americas,Central America,Costa Rica,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.0000243,CRI
Americas,Central America,Costa Rica,Opioids,Opiates,Heroin,2023,0.02,CRI
Americas,Central America,Costa Rica,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.10325,CRI
Americas,Central America,Costa Rica,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.06005,CRI
Americas,Central America,Costa Rica,Amphetamine-type stimulants (excluding “ecstasy”),Non-specified amphetamine-type stimulants,Non-specified amphetamine-type stimulants,2019,11,CRI
Americas,Central America,Costa Rica,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,16815,CRI
Americas,Central America,Costa Rica,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,141950,CRI
Americas,Central America,Costa Rica,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,0,CRI
Americas,Central America,Costa Rica,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,28,CRI
Americas,Central America,Costa Rica,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,31132,CRI
Americas,Central America,Costa Rica,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,CRI
Americas,Central America,Costa Rica,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,0,CRI
Americas,Central America,Costa Rica,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,0,CRI
Americas,Central America,Costa Rica,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,0,CRI
Americas,Central America,Costa Rica,Opioids,Opiates,Heroin,2019,0,CRI
Americas,Central America,El Salvador,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,1.7081,SLV
Americas,Central America,El Salvador,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,3.99909,SLV
Americas,Central America,El Salvador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,1058.6861,SLV
Americas,Central America,El Salvador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,54.4,SLV
Americas,Central America,El Salvador,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,1868.42016,SLV
Americas,Central America,El Salvador,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2020,7.0172,SLV
Americas,Central America,El Salvador,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.45,SLV
Americas,Central America,El Salvador,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,1.189,SLV
Americas,Central America,El Salvador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,921.85414,SLV
Americas,Central America,El Salvador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,0.05,SLV
Americas,Central America,El Salvador,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,3.20404,SLV
Americas,Central America,El Salvador,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,10900.76126,SLV
Americas,Central America,El Salvador,Opioids,Opiates,Heroin,2021,0.028,SLV
Americas,Central America,El Salvador,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,7.121,SLV
Americas,Central America,El Salvador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,982.841,SLV
Americas,Central America,El Salvador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,67.6,SLV
Americas,Central America,El Salvador,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,7.024,SLV
Americas,Central America,El Salvador,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,12016.629,SLV
Americas,Central America,El Salvador,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.1119,SLV
Americas,Central America,El Salvador,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,1.4,SLV
Americas,Central America,El Salvador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,468.05,SLV
Americas,Central America,El Salvador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,0.084,SLV
Americas,Central America,El Salvador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,27.4,SLV
Americas,Central America,El Salvador,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,2.6,SLV
Americas,Central America,El Salvador,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,31831,SLV
Americas,Central America,El Salvador,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,SLV
Americas,Central America,El Salvador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,1300,SLV
Americas,Central America,El Salvador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,59,SLV
Americas,Central America,El Salvador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,1,SLV
Americas,Central America,El Salvador,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,8,SLV
Americas,Central America,El Salvador,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,100,SLV
Americas,Central America,El Salvador,Opioids,Opiates,Heroin,2019,1,SLV
Americas,Central America,El Salvador,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,SLV
Americas,Central America,Guatemala,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,0.001355,GTM
Americas,Central America,Guatemala,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.02,GTM
Americas,Central America,Guatemala,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.02,GTM
Americas,Central America,Guatemala,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,2745.138784,GTM
Americas,Central America,Guatemala,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,351539.8,GTM
Americas,Central America,Guatemala,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,55.55311321,GTM
Americas,Central America,Guatemala,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,13628.32,GTM
Americas,Central America,Guatemala,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2020,5.66,GTM
Americas,Central America,Guatemala,Opioids,Opiates,Heroin,2020,0.39,GTM
Americas,Central America,Guatemala,Opioids,Opiates,Poppy plants,2020,1150729.1,GTM
Americas,Central America,Guatemala,Precursors,Non-specified precursors,Non-specified precursors,2020,13949.24322,GTM
Americas,Central America,Guatemala,Precursors,Precursors,Ephedrine,2020,0,GTM
Americas,Central America,Guatemala,Precursors,Precursors,Ephedrine,2020,,GTM
Americas,Central America,Guatemala,Precursors,Precursors,Ephedrine,2020,79.46,GTM
Americas,Central America,Guatemala,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.009,GTM
Americas,Central America,Guatemala,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,11.14,GTM
Americas,Central America,Guatemala,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,2248.001952,GTM
Americas,Central America,Guatemala,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,333952.6,GTM
Americas,Central America,Guatemala,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,3.75063885,GTM
Americas,Central America,Guatemala,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,10.41,GTM
Americas,Central America,Guatemala,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,11014.22,GTM
Americas,Central America,Guatemala,Opioids,Opiates,Heroin,2021,0.47,GTM
Americas,Central America,Guatemala,Opioids,Opiates,Poppy plants,2021,2152284,GTM
Americas,Central America,Guatemala,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.021951,GTM
Americas,Central America,Guatemala,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.03,GTM
Americas,Central America,Guatemala,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,23.38,GTM
Americas,Central America,Guatemala,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,756,GTM
Americas,Central America,Guatemala,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,173546.5,GTM
Americas,Central America,Guatemala,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,0.907184,GTM
Americas,Central America,Guatemala,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,7.88,GTM
Americas,Central America,Guatemala,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,5037.01,GTM
Americas,Central America,Guatemala,Cocaine-type,Coca-type,Coca bush,2023,8904889,GTM
Americas,Central America,Guatemala,Opioids,Opiates,Heroin,2023,1.74,GTM
Americas,Central America,Guatemala,Opioids,Opiates,Poppy plants,2023,66739.8,GTM
Americas,Central America,Guatemala,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,16877,GTM
Americas,Central America,Guatemala,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,1,GTM
Americas,Central America,Guatemala,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,1926,GTM
Americas,Central America,Guatemala,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,344798,GTM
Americas,Central America,Guatemala,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,16,GTM
Americas,Central America,Guatemala,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,9,GTM
Americas,Central America,Guatemala,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,18911,GTM
Americas,Central America,Guatemala,Cocaine-type,Coca-type,Coca bush,2019,2343845,GTM
Americas,Central America,Guatemala,Opioids,Opiates,Heroin,2019,12,GTM
Americas,Central America,Guatemala,Opioids,Opiates,Opium,2019,100,GTM
Americas,Central America,Guatemala,Precursors,Precursors,Ephedrine,2019,156,GTM
Americas,Central America,Guatemala,Precursors,Precursors,Pseudoephedrine,2019,162,GTM
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,8442.0678,HND
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,2,HND
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,27815.7,HND
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,3.345241,HND
Americas,Central America,Honduras,Cocaine-type,Cocaine,"""Crack"" cocaine",2020,5.74133,HND
Americas,Central America,Honduras,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,3258.0528,HND
Americas,Central America,Honduras,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2020,10,HND
Americas,Central America,Honduras,Cocaine-type,Coca-type,Coca bush,2020,443500,HND
Americas,Central America,Honduras,Precursors,Precursors,Acetone,2020,37.85412,HND
Americas,Central America,Honduras,Solvents and Inhalants,Solvents and Inhalants,Solvents and inhalants,2020,56.78118,HND
Americas,Central America,Honduras,Solvents and Inhalants,Solvents and Inhalants,Solvents and inhalants,2020,37.85412,HND
Americas,Central America,Honduras,Solvents and Inhalants,Solvents and Inhalants,Solvents and inhalants,2020,4285.843466,HND
Americas,Central America,Honduras,Solvents and Inhalants,Solvents and Inhalants,Solvents and inhalants,2020,11.99975604,HND
Americas,Central America,Honduras,Solvents and Inhalants,Solvents and Inhalants,Solvents and inhalants,2020,56.78118,HND
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,18266.27,HND
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,48.2235,HND
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,0.000015,HND
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,12.1,HND
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,29.937072,HND
Americas,Central America,Honduras,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,10.82,HND
Americas,Central America,Honduras,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,17545,HND
Americas,Central America,Honduras,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,2.1007,HND
Americas,Central America,Honduras,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.0034,HND
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,13352,HND
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,24.1,HND
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,14200.6,HND
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,7.2,HND
Americas,Central America,Honduras,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,30.9874,HND
Americas,Central America,Honduras,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,7279.8,HND
Americas,Central America,Honduras,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,2.7866,HND
Americas,Central America,Honduras,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0000141,HND
Americas,Central America,Honduras,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.032791,HND
Americas,Central America,Honduras,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.0175,HND
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,6126.14,HND
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,1531.535,HND
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,90199.1,HND
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,32.4,HND
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,2.187,HND
Americas,Central America,Honduras,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,31.6031,HND
Americas,Central America,Honduras,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,35114.5555,HND
Americas,Central America,Honduras,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,787.65,HND
Americas,Central America,Honduras,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,393.82,HND
Americas,Central America,Honduras,Cocaine-type,Coca-type,Coca bush,2023,8100169,HND
Americas,Central America,Honduras,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.002,HND
Americas,Central America,Honduras,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.00486,HND
Americas,Central America,Honduras,Opioids,Pharmaceutical opioids,Fentanyl,2023,2.43,HND
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,16050,HND
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,97,HND
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,20,HND
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,26,HND
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,22854,HND
Americas,Central America,Honduras,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,262,HND
Americas,Central America,Honduras,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,1,HND
Americas,Central America,Honduras,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,2219,HND
Americas,Central America,Honduras,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,3,HND
Americas,Central America,Honduras,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,HND
Americas,Central America,Honduras,NPS,Synthetic cathinones,Synthetic cathinones,2019,1,HND
Americas,Central America,Honduras,Opioids,Pharmaceutical opioids,Tramadol,2019,5,HND
Americas,Central America,Honduras,Precursors,Non-specified precursors,Potassium permanganate,2019,5,HND
Americas,Central America,Nicaragua,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,3191.91,NIC
Americas,Central America,Nicaragua,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,12513.9,NIC
Americas,Central America,Nicaragua,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,7.23,NIC
Americas,Central America,Nicaragua,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,5252.94,NIC
Americas,Central America,Nicaragua,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2020,7.61,NIC
Americas,Central America,Nicaragua,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,6756.99,NIC
Americas,Central America,Nicaragua,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,2339.1,NIC
Americas,Central America,Nicaragua,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,4.19,NIC
Americas,Central America,Nicaragua,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,6.98,NIC
Americas,Central America,Nicaragua,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,6045.67,NIC
Americas,Central America,Nicaragua,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,2640.5,NIC
Americas,Central America,Nicaragua,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,14.93,NIC
Americas,Central America,Nicaragua,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,2829.05,NIC
Americas,Central America,Nicaragua,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,3586,NIC
Americas,Central America,Nicaragua,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,5780,NIC
Americas,Central America,Nicaragua,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,1,NIC
Americas,Central America,Nicaragua,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,10,NIC
Americas,Central America,Nicaragua,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,5910,NIC
Americas,Central America,Panama,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,25.844,PAN
Americas,Central America,Panama,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,16093.33399,PAN
Americas,Central America,Panama,Cocaine-type,Cocaine,"""Crack"" cocaine",2020,71.9756,PAN
Americas,Central America,Panama,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2020,68628.36457,PAN
Americas,Central America,Panama,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,3,PAN
Americas,Central America,Panama,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.00059,PAN
Americas,Central America,Panama,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.22587,PAN
Americas,Central America,Panama,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,28300,PAN
Americas,Central America,Panama,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,70,PAN
Americas,Central America,Panama,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,116800,PAN
Americas,Central America,Panama,Opioids,Pharmaceutical opioids,Oxycodone,2021,10,PAN
Americas,Central America,Panama,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,32000,PAN
Americas,Central America,Panama,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2022,96000,PAN
Americas,Central America,Panama,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2023,90,PAN
Americas,Central America,Panama,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,33610,PAN
Americas,Central America,Panama,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,470,PAN
Americas,Central America,Panama,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,95670,PAN
Americas,Central America,Panama,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,10,PAN
Americas,Central America,Panama,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,12900,PAN
Americas,Central America,Panama,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2019,5,PAN
Americas,Central America,Panama,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,77960,PAN
Americas,North America,Canada,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,1,CAN
Americas,North America,Canada,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,24.35,CAN
Americas,North America,Canada,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,2.779965,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.48,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,13.94,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,50.6763625,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,33.81,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,2443.47,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,206.3359225,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2020,0.001,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2020,6.19,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2020,0.002,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2020,5.05,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2020,1.4177725,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,208.92,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,5.939175,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,34524.95,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,21.72,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,117.03,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.2832,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,0.01,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,9.5,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,2.8,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,0.02,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,0.0068715,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,103.46,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,16.05,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,0.00907,CAN
Americas,North America,Canada,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2020,0.81,CAN
Americas,North America,Canada,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2020,12.72,CAN
Americas,North America,Canada,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2020,0.0034,CAN
Americas,North America,Canada,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,12.093,CAN
Americas,North America,Canada,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,2096.887,CAN
Americas,North America,Canada,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,0.250225,CAN
Americas,North America,Canada,Cocaine-type,Coca-type,Coca leaf,2020,0.0063,CAN
Americas,North America,Canada,Cocaine-type,Coca-type,Coca leaf,2020,11.39,CAN
Americas,North America,Canada,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,1.02,CAN
Americas,North America,Canada,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,1.1,CAN
Americas,North America,Canada,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.000988978,CAN
Americas,North America,Canada,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2020,0.02,CAN
Americas,North America,Canada,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2020,15.6,CAN
Americas,North America,Canada,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2020,29.03,CAN
Americas,North America,Canada,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2020,0.0081,CAN
Americas,North America,Canada,Hallucinogens,Other Hallucinogens,Psilocybine,2020,3.31,CAN
Americas,North America,Canada,Hallucinogens,Other Hallucinogens,Psilocybine,2020,299.69,CAN
Americas,North America,Canada,Hallucinogens,Other Hallucinogens,Psilocybine,2020,0.0716,CAN
Americas,North America,Canada,Hallucinogens,Other Hallucinogens,Psilocybine,2020,0.218232,CAN
Americas,North America,Canada,Opioids,Opiates,Heroin,2020,0.61,CAN
Americas,North America,Canada,Opioids,Opiates,Heroin,2020,126.21,CAN
Americas,North America,Canada,Opioids,Opiates,Heroin,2020,0.043599,CAN
Americas,North America,Canada,Opioids,Opiates,Illicit morphine,2020,1.48,CAN
Americas,North America,Canada,Opioids,Opiates,Illicit morphine,2020,3.17,CAN
Americas,North America,Canada,Opioids,Opiates,Illicit morphine,2020,1.265012,CAN
Americas,North America,Canada,Opioids,Opiates,Opium,2020,0.54,CAN
Americas,North America,Canada,Opioids,Opiates,Opium,2020,872.33,CAN
Americas,North America,Canada,Opioids,Opiates,Opium,2020,0.8121,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.02,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.0720735,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Codeine,2020,9.97,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Codeine,2020,29.25,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Codeine,2020,0.854122,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Fentanyl,2020,6.21,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Fentanyl,2020,630.99,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Fentanyl,2020,2.373745,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Methadone,2020,8.85,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Methadone,2020,15.85,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Methadone,2020,0.048142,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Oxycodone,2020,13.07,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Oxycodone,2020,5.022991,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Tramadol,2020,0.03,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Tramadol,2020,0.0014,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Barbiturates,Barbiturates,2020,1.1,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Barbiturates,Barbiturates,2020,1.52,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Barbiturates,Barbiturates,2020,0.22605,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.1,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,97.28,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.3419725,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.05,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.75,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.0025622,CAN
Americas,North America,Canada,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2020,0.19,CAN
Americas,North America,Canada,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2020,46.24,CAN
Americas,North America,Canada,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2020,0.0574,CAN
Americas,North America,Canada,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2020,0.0004,CAN
Americas,North America,Canada,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2020,74.91,CAN
Americas,North America,Canada,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2020,162.16,CAN
Americas,North America,Canada,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.02,CAN
Americas,North America,Canada,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,74.09379,CAN
Americas,North America,Canada,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,9.11942,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2021,3.74297,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2021,1668.52831,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2021,271.3567275,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,12975.63,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,48897.41,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,29.424065,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,46.90755,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,173.96331,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,0.6576,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,317.61188,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,96.201656,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,25220.19669,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,2.83845,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,0.00054,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,0.114345,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,1284.55354,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,0.00006,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,13.45443,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,0.02032,CAN
Americas,North America,Canada,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,1006.09,CAN
Americas,North America,Canada,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,2791.94,CAN
Americas,North America,Canada,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,0.335446,CAN
Americas,North America,Canada,Cocaine-type,Coca-type,Coca leaf,2021,468.5855,CAN
Americas,North America,Canada,Cocaine-type,Coca-type,Coca leaf,2021,11.4,CAN
Americas,North America,Canada,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.0056,CAN
Americas,North America,Canada,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,1.92021,CAN
Americas,North America,Canada,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,3631.72158,CAN
Americas,North America,Canada,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,2.349264,CAN
Americas,North America,Canada,Opioids,Opiates,Heroin,2021,3.74647,CAN
Americas,North America,Canada,Opioids,Opiates,Heroin,2021,0.005534429,CAN
Americas,North America,Canada,Opioids,Opiates,Heroin,2021,198.32171,CAN
Americas,North America,Canada,Opioids,Opiates,Illicit morphine,2021,2.49043,CAN
Americas,North America,Canada,Opioids,Opiates,Illicit morphine,2021,4.17471,CAN
Americas,North America,Canada,Opioids,Opiates,Illicit morphine,2021,2.3391,CAN
Americas,North America,Canada,Opioids,Opiates,Opium,2021,1204.02,CAN
Americas,North America,Canada,Opioids,Opiates,Opium,2021,0.42864,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.18493,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.1724,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Codeine,2021,41.85886,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Codeine,2021,138.79545,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Codeine,2021,1.7432,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Fentanyl,2021,25.92512,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Fentanyl,2021,647.91985,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Fentanyl,2021,1.8212705,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Methadone,2021,1.95627,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Methadone,2021,15.09749,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Methadone,2021,0.023775595,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Oxycodone,2021,11.63906,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Oxycodone,2021,5.7438945,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Tramadol,2021,0.0001,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Barbiturates,Barbiturates,2021,1.605,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Barbiturates,Barbiturates,2021,0.671888,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,1.23324,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,1.71992,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.078673438,CAN
Americas,North America,Canada,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,195.7,CAN
Americas,North America,Canada,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,0.025147619,CAN
Americas,North America,Canada,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,1134.62732,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,558.01257,CAN
Americas,North America,Canada,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,1018.5501,CAN
Americas,North America,Canada,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,603.0402954,CAN
Americas,North America,Canada,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,11.3674275,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2022,3250.05978,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2022,4519.23332,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2022,671.148705,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,1200.177782,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,52079.9514,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,28.284261,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,30.5301,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,93.8069344,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,1.5123,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,192.994801,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,85.9,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,1300,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,8017.693,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,31.12911,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,0.02025,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,381.2888028,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,0.118,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,7.20274015,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,0.80461,CAN
Americas,North America,Canada,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2022,12.96236,CAN
Americas,North America,Canada,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2022,0.181743,CAN
Americas,North America,Canada,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2022,3847.560024,CAN
Americas,North America,Canada,Cocaine-type,Coca-type,Coca leaf,2022,169.9525988,CAN
Americas,North America,Canada,Cocaine-type,Coca-type,Coca leaf,2022,2.8,CAN
Americas,North America,Canada,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,1.4946,CAN
Americas,North America,Canada,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,0.0022,CAN
Americas,North America,Canada,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,4364.586294,CAN
Americas,North America,Canada,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,3.062319,CAN
Americas,North America,Canada,Opioids,Opiates,Heroin,2022,0.76296,CAN
Americas,North America,Canada,Opioids,Opiates,Heroin,2022,0.00003,CAN
Americas,North America,Canada,Opioids,Opiates,Heroin,2022,0.007923,CAN
Americas,North America,Canada,Opioids,Opiates,Heroin,2022,356.4617662,CAN
Americas,North America,Canada,Opioids,Opiates,Illicit morphine,2022,2.7192,CAN
Americas,North America,Canada,Opioids,Opiates,Illicit morphine,2022,3.87112901,CAN
Americas,North America,Canada,Opioids,Opiates,Illicit morphine,2022,1.601288,CAN
Americas,North America,Canada,Opioids,Opiates,Opium,2022,0.241,CAN
Americas,North America,Canada,Opioids,Opiates,Opium,2022,640.45586,CAN
Americas,North America,Canada,Opioids,Opiates,Opium,2022,0.7515,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.058587008,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.1361375,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Codeine,2022,57.56882015,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Codeine,2022,1806.58817,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Codeine,2022,1.79585,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Fentanyl,2022,2.63083,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Fentanyl,2022,340.2742394,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Fentanyl,2022,2.20881165,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Methadone,2022,4.32159,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Methadone,2022,114.3291,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Methadone,2022,0.02975,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Oxycodone,2022,4.45,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Oxycodone,2022,18.54778301,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Oxycodone,2022,7.36040865,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Tramadol,2022,0.05243,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Tramadol,2022,0.03975,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Barbiturates,Barbiturates,2022,0.336925,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Barbiturates,Barbiturates,2022,0.475,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.27,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,59.44702086,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.09752,CAN
Americas,North America,Canada,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2022,0.173201,CAN
Americas,North America,Canada,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2022,6.61750003,CAN
Americas,North America,Canada,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,265.0426868,CAN
Americas,North America,Canada,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,2053.829499,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2022,2.2654099,CAN
Americas,North America,Canada,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,2,CAN
Americas,North America,Canada,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,0.08975,CAN
Americas,North America,Canada,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,465,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.01,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,26.858,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2023,19960.562,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2023,1137.4555,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,365.595,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,1.3225,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,9967.862,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,0.0351,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,228,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,296,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,3.6,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,64,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,145.9,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,0.00378,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,168.72,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,307.83,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,1,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,47,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,0.0015,CAN
Americas,North America,Canada,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2023,9764.245,CAN
Americas,North America,Canada,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,4.15,CAN
Americas,North America,Canada,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,0.0263,CAN
Americas,North America,Canada,Cocaine-type,Coca-type,Coca leaf,2023,0.01,CAN
Americas,North America,Canada,Cocaine-type,Coca-type,Coca leaf,2023,241.37,CAN
Americas,North America,Canada,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.0004,CAN
Americas,North America,Canada,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2023,55.82,CAN
Americas,North America,Canada,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2023,7542.74222,CAN
Americas,North America,Canada,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2023,1.397024,CAN
Americas,North America,Canada,Opioids,Opiates,Heroin,2023,17.29,CAN
Americas,North America,Canada,Opioids,Opiates,Heroin,2023,0.00084,CAN
Americas,North America,Canada,Opioids,Opiates,Heroin,2023,674.372,CAN
Americas,North America,Canada,Opioids,Opiates,Illicit morphine,2023,4.16,CAN
Americas,North America,Canada,Opioids,Opiates,Illicit morphine,2023,73.66,CAN
Americas,North America,Canada,Opioids,Opiates,Illicit morphine,2023,2.6423,CAN
Americas,North America,Canada,Opioids,Opiates,Opium,2023,2.05,CAN
Americas,North America,Canada,Opioids,Opiates,Opium,2023,0.0117,CAN
Americas,North America,Canada,Opioids,Opiates,Opium,2023,0.2952,CAN
Americas,North America,Canada,Opioids,Opiates,Opium,2023,1358.314,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Buprenorphine,2023,3.025,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.062,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Codeine,2023,107.729,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Codeine,2023,176.125,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Codeine,2023,0.2827,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Fentanyl,2023,45.944,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.02075,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Fentanyl,2023,6158.854,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Methadone,2023,37.332,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Methadone,2023,1.74646,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Methadone,2023,0.4753,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Oxycodone,2023,4,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Oxycodone,2023,121.309,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Oxycodone,2023,2.4652,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Tramadol,2023,0.0662,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Tramadol,2023,0.1349,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,279.685,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,1232.559,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,0.85643,CAN
Americas,North America,Canada,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2019,1,CAN
Americas,North America,Canada,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2019,46,CAN
Americas,North America,Canada,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2019,9,CAN
Americas,North America,Canada,“Ecstasy”-type substances,“Ecstasy”-type substances,Non-specified “ecstasy”-type substances,2019,0,CAN
Americas,North America,Canada,“Ecstasy”-type substances,“Ecstasy”-type substances,Tenamfetamine (MDA),2019,0,CAN
Americas,North America,Canada,“Ecstasy”-type substances,“Ecstasy”-type substances,Tenamfetamine (MDA),2019,2,CAN
Americas,North America,Canada,“Ecstasy”-type substances,“Ecstasy”-type substances,Tenamfetamine (MDA),2019,0,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,19,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,26,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,112,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,810,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,172,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2019,700,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2019,750,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2019,6,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2019,1,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2019,0,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2019,0,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Adderall,2019,0,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Adderall,2019,0,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Dextroamphetamine (Dexedrine),2019,1,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Dextroamphetamine (Dexedrine),2019,0,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,"Methylphenidate (Ritalin, Concerta)",2019,0,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,"Methylphenidate (Ritalin, Concerta)",2019,1,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2019,0,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2019,0,CAN
Americas,North America,Canada,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Pyrovalerone,2019,0,CAN
Americas,North America,Canada,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2019,20,CAN
Americas,North America,Canada,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2019,1702,CAN
Americas,North America,Canada,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2019,0,CAN
Americas,North America,Canada,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2019,1,CAN
Americas,North America,Canada,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2019,10,CAN
Americas,North America,Canada,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2019,1,CAN
Americas,North America,Canada,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2019,0,CAN
Americas,North America,Canada,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2019,1417,CAN
Americas,North America,Canada,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2019,33720,CAN
Americas,North America,Canada,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2019,0,CAN
Americas,North America,Canada,Any other drugs/substances,Substances not under int. control,Other substances not under int. control,2019,2,CAN
Americas,North America,Canada,Any other drugs/substances,Substances not under int. control,Other substances not under int. control,2019,353,CAN
Americas,North America,Canada,Any other drugs/substances,Substances not under int. control,Other substances not under int. control,2019,0,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,0,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,0,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,1247,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,1968,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,4,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,61,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,0,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,994,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,16982,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,155569,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,0,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,59,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,63,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,248,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,1,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,1,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,3,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,0,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,0,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,5,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,168,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,0,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,232,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,370,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,0,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,24,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,332,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,0,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,4,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,68,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,0,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,78,CAN
Americas,North America,Canada,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,0,CAN
Americas,North America,Canada,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,996,CAN
Americas,North America,Canada,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,0,CAN
Americas,North America,Canada,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,3830,CAN
Americas,North America,Canada,Cocaine-type,Coca-type,Coca bush,2019,4,CAN
Americas,North America,Canada,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,CAN
Americas,North America,Canada,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,CAN
Americas,North America,Canada,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2019,0,CAN
Americas,North America,Canada,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2019,34,CAN
Americas,North America,Canada,Hallucinogens,Other Hallucinogens,Mescaline,2019,3,CAN
Americas,North America,Canada,Hallucinogens,Other Hallucinogens,Mescaline,2019,0,CAN
Americas,North America,Canada,Hallucinogens,Other Hallucinogens,Other hallucinogens,2019,1,CAN
Americas,North America,Canada,Hallucinogens,Other Hallucinogens,Other hallucinogens,2019,0,CAN
Americas,North America,Canada,Hallucinogens,Other Hallucinogens,Phencyclidine (PCP),2019,0,CAN
Americas,North America,Canada,Hallucinogens,Other Hallucinogens,Phencyclidine (PCP),2019,0,CAN
Americas,North America,Canada,Hallucinogens,Other Hallucinogens,Phencyclidine (PCP),2019,0,CAN
Americas,North America,Canada,Hallucinogens,Other Hallucinogens,Psilocybine,2019,1,CAN
Americas,North America,Canada,Hallucinogens,Other Hallucinogens,Psilocybine,2019,0,CAN
Americas,North America,Canada,Hallucinogens,Other Hallucinogens,Psilocybine,2019,0,CAN
Americas,North America,Canada,Hallucinogens,Other Hallucinogens,Psilocybine,2019,491,CAN
Americas,North America,Canada,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,2,CAN
Americas,North America,Canada,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,220,CAN
Americas,North America,Canada,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,0,CAN
Americas,North America,Canada,NPS,Phenethylamines,Phenethylamines,2019,0,CAN
Americas,North America,Canada,NPS,Piperazines,Piperazines,2019,0,CAN
Americas,North America,Canada,NPS,Plant-based NPS,Khat,2019,0,CAN
Americas,North America,Canada,NPS,Plant-based NPS,Khat,2019,8817,CAN
Americas,North America,Canada,NPS,Plant-based NPS,Salvia divinorum,2019,0,CAN
Americas,North America,Canada,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (Spice),2019,0,CAN
Americas,North America,Canada,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (Spice),2019,0,CAN
Americas,North America,Canada,Opioids,Opiates,Heroin,2019,1,CAN
Americas,North America,Canada,Opioids,Opiates,Heroin,2019,98,CAN
Americas,North America,Canada,Opioids,Opiates,Heroin,2019,0,CAN
Americas,North America,Canada,Opioids,Opiates,Illicit morphine,2019,0,CAN
Americas,North America,Canada,Opioids,Opiates,Illicit morphine,2019,1,CAN
Americas,North America,Canada,Opioids,Opiates,Illicit morphine,2019,1,CAN
Americas,North America,Canada,Opioids,Opiates,Opium,2019,0,CAN
Americas,North America,Canada,Opioids,Opiates,Opium,2019,570,CAN
Americas,North America,Canada,Opioids,Opiates,Opium,2019,1,CAN
Americas,North America,Canada,Opioids,Opiates,Poppy plants,2019,12,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Buprenorphine,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Buprenorphine,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Buprenorphine,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Buprenorphine,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Carfentanil,2019,2,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Carfentanil,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Codeine,2019,19,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Codeine,2019,51,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Codeine,2019,2,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Fentanyl,2019,8,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Fentanyl,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Fentanyl,2019,123,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Fentanyl,2019,1,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Fentanyl,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Fentanyl,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Fentanyl,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Hydrocodone,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Hydrocodone,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Methadone,2019,1,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Methadone,2019,6,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Methadone,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Naloxone,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Oxycodone,2019,9,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Oxycodone,2019,5,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Oxycodone,2019,1,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Oxycodone,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Oxycodone,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Oxycodone,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,2,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,1,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,60,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,1,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,0,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,3,CAN
Americas,North America,Canada,Opioids,Pharmaceutical opioids,U-47700,2019,0,CAN
Americas,North America,Canada,Precursors,Non-specified precursors,Other precursors,2019,7,CAN
Americas,North America,Canada,Precursors,Precursors,Pseudoephedrine,2019,0,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Barbiturates,Barbiturates,2019,0,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Barbiturates,Barbiturates,2019,4,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Barbiturates,Barbiturates,2019,0,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Barbiturates,Barbiturates,2019,0,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2019,9,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2019,2,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,2,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,17,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,7,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,Bromazepam,2019,0,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2019,1,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2019,5,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2019,0,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2019,0,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2019,0,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,"Flunitrazepam (Disomnilan, Flumipam, Rohypnol)",2019,0,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,"Lorazepam (Ativan, Temesta)",2019,4,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Benzodiazepines,"Lorazepam (Ativan, Temesta)",2019,0,CAN
Americas,North America,Canada,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,42,CAN
Americas,North America,Canada,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,0,CAN
Americas,North America,Canada,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,324,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2019,1,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2019,0,CAN
Americas,North America,Canada,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2019,0,CAN
Americas,North America,Mexico,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.63,MEX
Americas,North America,Mexico,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.26,MEX
Americas,North America,Mexico,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,18905.03,MEX
Americas,North America,Mexico,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,157724.84,MEX
Americas,North America,Mexico,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,825.1,MEX
Americas,North America,Mexico,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,12.73,MEX
Americas,North America,Mexico,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,316.93,MEX
Americas,North America,Mexico,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,21151.66,MEX
Americas,North America,Mexico,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,2.147,MEX
Americas,North America,Mexico,Opioids,Opiates,Heroin,2020,286.14,MEX
Americas,North America,Mexico,Opioids,Pharmaceutical opioids,Fentanyl,2020,284.4936,MEX
Americas,North America,Mexico,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.097,MEX
Americas,North America,Mexico,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.70925,MEX
Americas,North America,Mexico,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.067,MEX
Americas,North America,Mexico,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,11891.4453,MEX
Americas,North America,Mexico,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,29445.3649,MEX
Americas,North America,Mexico,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,91335.95243,MEX
Americas,North America,Mexico,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,343.9,MEX
Americas,North America,Mexico,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,108.985,MEX
Americas,North America,Mexico,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,0.059,MEX
Americas,North America,Mexico,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,0.0001,MEX
Americas,North America,Mexico,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,15001.11206,MEX
Americas,North America,Mexico,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.0151,MEX
Americas,North America,Mexico,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.00002415,MEX
Americas,North America,Mexico,Opioids,Opiates,Heroin,2021,281.66523,MEX
Americas,North America,Mexico,Opioids,Opiates,Opium,2021,90.19099,MEX
Americas,North America,Mexico,Opioids,Pharmaceutical opioids,Fentanyl,2021,20,MEX
Americas,North America,Mexico,Opioids,Pharmaceutical opioids,Fentanyl,2021,921.68423,MEX
Americas,North America,Mexico,Opioids,Pharmaceutical opioids,Fentanyl,2021,342.38285,MEX
Americas,North America,Mexico,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.0045,MEX
Americas,North America,Mexico,Opioids,Pharmaceutical opioids,Tramadol,2021,15.2,MEX
Americas,North America,Mexico,Opioids,Pharmaceutical opioids,Tramadol,2021,0.044,MEX
Americas,North America,Mexico,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.2258,MEX
Americas,North America,Mexico,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.06625,MEX
Americas,North America,Mexico,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.12575,MEX
Americas,North America,Mexico,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,14676.281,MEX
Americas,North America,Mexico,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,22384.37407,MEX
Americas,North America,Mexico,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,70841.7966,MEX
Americas,North America,Mexico,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,100.16,MEX
Americas,North America,Mexico,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,0.0658,MEX
Americas,North America,Mexico,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,21068.86031,MEX
Americas,North America,Mexico,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,4.1001,MEX
Americas,North America,Mexico,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.00000185,MEX
Americas,North America,Mexico,Opioids,Opiates,Heroin,2022,170.170585,MEX
Americas,North America,Mexico,Opioids,Opiates,Opium,2022,42.33154,MEX
Americas,North America,Mexico,Opioids,Pharmaceutical opioids,Fentanyl,2022,747.806506,MEX
Americas,North America,Mexico,Opioids,Pharmaceutical opioids,Fentanyl,2022,708.8074,MEX
Americas,North America,Mexico,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.8594,MEX
Americas,North America,Mexico,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.6225,MEX
Americas,North America,Mexico,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.09775,MEX
Americas,North America,Mexico,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,19070.64054,MEX
Americas,North America,Mexico,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,45146.803,MEX
Americas,North America,Mexico,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,72872.90211,MEX
Americas,North America,Mexico,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,67.2088,MEX
Americas,North America,Mexico,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,0.354,MEX
Americas,North America,Mexico,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,38882.03764,MEX
Americas,North America,Mexico,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,1.0099,MEX
Americas,North America,Mexico,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.00000605,MEX
Americas,North America,Mexico,Opioids,Opiates,Heroin,2023,72.86025,MEX
Americas,North America,Mexico,Opioids,Opiates,Opium,2023,61.4693,MEX
Americas,North America,Mexico,Opioids,Pharmaceutical opioids,Fentanyl,2023,1198.0235,MEX
Americas,North America,Mexico,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,2,MEX
Americas,North America,Mexico,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,9,MEX
Americas,North America,Mexico,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,0,MEX
Americas,North America,Mexico,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,1,MEX
Americas,North America,Mexico,Opioids,Opiates,Opium,2019,358,MEX
Americas,North America,Mexico,Opioids,Opiates,Poppy plants,2019,7670,MEX
Americas,North America,Mexico,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,1,MEX
Americas,North America,Mexico,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,1,MEX
Americas,North America,Mexico,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,9829,MEX
Americas,North America,Mexico,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,22197,MEX
Americas,North America,Mexico,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,218557,MEX
Americas,North America,Mexico,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,820,MEX
Americas,North America,Mexico,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,235,MEX
Americas,North America,Mexico,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,12430,MEX
Americas,North America,Mexico,Opioids,Opiates,Heroin,2019,409,MEX
Americas,North America,Mexico,Opioids,Opiates,Illicit morphine,2019,4,MEX
Americas,North America,Mexico,Opioids,Opiates,Illicit morphine,2019,440,MEX
Americas,North America,Mexico,Opioids,Opiates,Illicit morphine,2019,0,MEX
Americas,North America,Mexico,Opioids,Pharmaceutical opioids,Fentanyl,2019,185,MEX
Americas,North America,Mexico,Opioids,Pharmaceutical opioids,Fentanyl,2019,28,MEX
Americas,North America,United States of America,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,6249.09232,USA
Americas,North America,United States of America,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,92.72557,USA
Americas,North America,United States of America,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,644.5855,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,3.6605,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,132656,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,7329.723,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2020,25.69372,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,555000,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,5555.08286,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,16.83474,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,140.0084774,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,292101.9082,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,0.013635,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,218.2267,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,3197.94616,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,4.36416949,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,0,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,4618.8659,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,0,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,122.935462,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,0,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,7161.25841,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,435.5021,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,2.39115,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,0,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,3246.16452,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,0,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,273.7014238,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,833.53747,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,0,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,3510.8,USA
Americas,North America,United States of America,Cocaine-type,Cocaine,"""Crack"" cocaine",2020,146.12137,USA
Americas,North America,United States of America,Cocaine-type,Cocaine,"""Crack"" cocaine",2020,0.0181,USA
Americas,North America,United States of America,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2020,0.0364,USA
Americas,North America,United States of America,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2020,963.24209,USA
Americas,North America,United States of America,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,149231,USA
Americas,North America,United States of America,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2020,1025.12037,USA
Americas,North America,United States of America,Cocaine-type,Coca-type,Coca leaf,2020,1799.7142,USA
Americas,North America,United States of America,Cocaine-type,Other coca/cocaine-type drugs,Other coca/cocaine-type drugs,2020,247.90733,USA
Americas,North America,United States of America,Cocaine-type,Other coca/cocaine-type drugs,Other coca/cocaine-type drugs,2020,39.8492,USA
Americas,North America,United States of America,Cocaine-type,Other coca/cocaine-type drugs,Other coca/cocaine-type drugs,2020,237.80612,USA
Americas,North America,United States of America,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2020,620.19642,USA
Americas,North America,United States of America,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2020,0.433,USA
Americas,North America,United States of America,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2020,1.22,USA
Americas,North America,United States of America,Opioids,Opiates,Heroin,2020,7191,USA
Americas,North America,United States of America,Opioids,Opiates,Opium,2020,434.85983,USA
Americas,North America,United States of America,Opioids,Opiates,Opium,2020,4201.35,USA
Americas,North America,United States of America,Opioids,Other illicit opioids,Other illicit opioids,2020,0.000125,USA
Americas,North America,United States of America,Opioids,Other illicit opioids,Other illicit opioids,2020,0.203,USA
Americas,North America,United States of America,Opioids,Other illicit opioids,Other illicit opioids,2020,1732.54465,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.49901471,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Fentanyl,2020,8045.53512,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Fentanyl,2020,273.159075,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Methadone,2020,2.25465,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Methadone,2020,0.053,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Methadone,2020,5.2175968,USA
Americas,North America,United States of America,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,1813,USA
Americas,North America,United States of America,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,59.0915,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.148,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.7975,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,8127,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2021,0.19,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,118473,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2021,0.1,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2021,3.94,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2021,1,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2021,0.02575,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,338272,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,436.128,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,26282.8,USA
Americas,North America,United States of America,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2021,251700,USA
Americas,North America,United States of America,Cocaine-type,Coca-type,Coca leaf,2021,900,USA
Americas,North America,United States of America,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.005,USA
Americas,North America,United States of America,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,20,USA
Americas,North America,United States of America,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.0015699,USA
Americas,North America,United States of America,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2021,0.0004,USA
Americas,North America,United States of America,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2021,8627,USA
Americas,North America,United States of America,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2021,3206.834,USA
Americas,North America,United States of America,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.0966,USA
Americas,North America,United States of America,Hallucinogens,Other Hallucinogens,Psilocybine,2021,1044,USA
Americas,North America,United States of America,Opioids,Opiates,Heroin,2021,0.31,USA
Americas,North America,United States of America,Opioids,Opiates,Heroin,2021,5221,USA
Americas,North America,United States of America,Opioids,Opiates,Heroin,2021,1.25649,USA
Americas,North America,United States of America,Opioids,Opiates,Illicit morphine,2021,48,USA
Americas,North America,United States of America,Opioids,Opiates,Illicit morphine,2021,0.24,USA
Americas,North America,United States of America,Opioids,Opiates,Illicit morphine,2021,0.1524,USA
Americas,North America,United States of America,Opioids,Opiates,Opium,2021,656,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Codeine,2021,322,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Codeine,2021,0.03225,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Codeine,2021,329.414,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Fentanyl,2021,0.244,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Fentanyl,2021,11838,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Fentanyl,2021,389.32695,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Methadone,2021,2,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Methadone,2021,0.00835,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Oxycodone,2021,214,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Oxycodone,2021,5.2275,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Tramadol,2021,277,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Tramadol,2021,17.3465,USA
Americas,North America,United States of America,Sedatives and tranquillizers,Barbiturates,Barbiturates,2021,115,USA
Americas,North America,United States of America,Sedatives and tranquillizers,Barbiturates,Methaqualone,2021,8,USA
Americas,North America,United States of America,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,67,USA
Americas,North America,United States of America,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.60055,USA
Americas,North America,United States of America,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,16,USA
Americas,North America,United States of America,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.0974,USA
Americas,North America,United States of America,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,1287,USA
Americas,North America,United States of America,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,3.785,USA
Americas,North America,United States of America,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,654,USA
Americas,North America,United States of America,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,62.502,USA
Americas,North America,United States of America,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,1880,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,1892.69,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2022,0.03,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,95793,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"3,4-Methylenedioxypyrovalerone (MDPV)",2022,1.96,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2022,1.16,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2022,10.29,USA
Americas,North America,United States of America,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,21490,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,288694,USA
Americas,North America,United States of America,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,242855,USA
Americas,North America,United States of America,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,30,USA
Americas,North America,United States of America,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,3963,USA
Americas,North America,United States of America,NPS,Plant-based NPS,Khat,2022,61218,USA
Americas,North America,United States of America,Opioids,Opiates,Heroin,2022,4140,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Fentanyl,2022,16123,USA
Americas,North America,United States of America,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,284.855776,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,68501.46384,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,133570.1434,USA
Americas,North America,United States of America,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,233785.8527,USA
Americas,North America,United States of America,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,3.628736,USA
Americas,North America,United States of America,Opioids,Opiates,Heroin,2023,560.18612,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Fentanyl,2023,12123.60698,USA
Americas,North America,United States of America,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,4131,USA
Americas,North America,United States of America,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,64,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,169,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,473,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,7441,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,26730,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,197,USA
Americas,North America,United States of America,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,153,USA
Americas,North America,United States of America,Cocaine-type,Coca-type,Coca leaf,2019,328,USA
Americas,North America,United States of America,Hallucinogens,Non-specified hallucinogens,Non-specified hallucinogens,2019,208,USA
Americas,North America,United States of America,Hallucinogens,Non-specified hallucinogens,Non-specified hallucinogens,2019,5,USA
Americas,North America,United States of America,Hallucinogens,Other Hallucinogens,Other hallucinogens,2019,70,USA
Americas,North America,United States of America,Hallucinogens,Other Hallucinogens,Other hallucinogens,2019,0,USA
Americas,North America,United States of America,Opioids,Opiates,Illicit morphine,2019,135,USA
Americas,North America,United States of America,Opioids,Opiates,Illicit morphine,2019,1,USA
Americas,North America,United States of America,Opioids,Opiates,Opium,2019,1122,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Carfentanil,2019,2,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Carfentanil,2019,0,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Fentanyl,2019,3576,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Fentanyl,2019,64,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Fentanyl,2019,840,USA
Americas,North America,United States of America,Opioids,Pharmaceutical opioids,Fentanyl,2019,9,USA
Americas,North America,United States of America,Sedatives and tranquillizers,Barbiturates,Barbiturates,2019,16,USA
Americas,North America,United States of America,Sedatives and tranquillizers,Barbiturates,Barbiturates,2019,0,USA
Americas,North America,United States of America,Sedatives and tranquillizers,Barbiturates,Barbiturates,2019,10,USA
Americas,North America,United States of America,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,41,USA
Americas,North America,United States of America,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,USA
Americas,North America,United States of America,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,1332,USA
Americas,North America,United States of America,Sedatives and tranquillizers,Methaqualone,Methaqualone,2019,0,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,15,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,112897,USA
Americas,North America,United States of America,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,5372,USA
Americas,North America,United States of America,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,432000,USA
Americas,North America,United States of America,Cocaine-type,Cocaine,Non-specified cocaine,2019,187018,USA
Americas,North America,United States of America,Opioids,Opiates,Heroin,2019,8824,USA
Americas,South America,Argentina,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,66.21646,ARG
Americas,South America,Argentina,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,14.434002,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.8912,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.226625,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,44.80857,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.068,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2020,0.16174,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2020,0.073,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2020,0.0075,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,1.2335,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0,ARG
Americas,South America,Argentina,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2020,0.152,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,236624.0792,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.288,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.0177,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,99.767,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,2026.85146,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,3542.8,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,4.5292,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,0.97041,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,0.22705,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,0,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,1631.65185,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,0,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,44.91134,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,0,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,77.86586,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,0.0324,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,7.8877,ARG
Americas,South America,Argentina,Cocaine-type,Cocaine,"""Crack"" cocaine",2020,0.0025,ARG
Americas,South America,Argentina,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,56.206,ARG
Americas,South America,Argentina,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,0.0101,ARG
Americas,South America,Argentina,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,5508.42024,ARG
Americas,South America,Argentina,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2020,0.4813,ARG
Americas,South America,Argentina,Cocaine-type,Coca-type,Coca leaf,2020,93054.281,ARG
Americas,South America,Argentina,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.002548625,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2020,0.01367,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2020,0.0189,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2020,0.2502,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2020,0.0125,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Phencyclidine (PCP),2020,0.00547,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Phencyclidine (PCP),2020,0.0025,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,"STP (DOM, 2,5-dimethoxy-4-methylamphetamine)",2020,0.01495,ARG
Americas,South America,Argentina,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,0.28868,ARG
Americas,South America,Argentina,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,54.332,ARG
Americas,South America,Argentina,Opioids,Opiates,Heroin,2020,0.095,ARG
Americas,South America,Argentina,Opioids,Opiates,Heroin,2020,0.00027,ARG
Americas,South America,Argentina,Opioids,Opiates,Illicit morphine,2020,0.841,ARG
Americas,South America,Argentina,Opioids,Opiates,Poppy plants,2020,23,ARG
Americas,South America,Argentina,Opioids,Other illicit opiates,Poppy seed,2020,0.19,ARG
Americas,South America,Argentina,Opioids,Other illicit opiates,Poppy seed,2020,0.000307,ARG
Americas,South America,Argentina,Opioids,Pharmaceutical opioids,Oxycodone,2020,0.025,ARG
Americas,South America,Argentina,Opioids,Pharmaceutical opioids,Oxycodone,2020,0.0024,ARG
Americas,South America,Argentina,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2020,0.00035,ARG
Americas,South America,Argentina,Opioids,Pharmaceutical opioids,Tramadol,2020,0.0273,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,Barbiturates,Barbiturates,2020,0.004,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.0149,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.098255,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,Non-specified sedatives and tranquillizers,Non-specified sedatives and tranquillizers,2020,0.01337,ARG
Americas,South America,Argentina,Solvents and Inhalants,Solvents and Inhalants,Solvents and inhalants,2020,5.752,ARG
Americas,South America,Argentina,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,3.16535,ARG
Americas,South America,Argentina,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,8.889071,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,5.87823,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,9.3,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.245,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.03,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.63415,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.01975,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2021,0.11407,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2021,0.0145,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2021,1.252,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0.02,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,17.9,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,19.13143,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,254205.6097,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,18.786,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,0.0123,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,43.9675,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,4521.63319,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,4835.8,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,0.162,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,1.1292,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,0.22801,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,0,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,3008.45763,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,0,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,10.2704,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,0,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,59.62852,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,0,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,16.05919,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,0.05,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,0,ARG
Americas,South America,Argentina,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2021,6257.30649,ARG
Americas,South America,Argentina,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2021,1.11465,ARG
Americas,South America,Argentina,Cocaine-type,Coca-type,Coca leaf,2021,132569.197,ARG
Americas,South America,Argentina,Cocaine-type,Other coca/cocaine-type drugs,Other coca/cocaine-type drugs,2021,7.035,ARG
Americas,South America,Argentina,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.00550045,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2021,0.23684,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,"Brolamfetamine (DOB, dimethoxybromoamphetamine, bromo-DMA)",2021,0.0052,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2021,4.049,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2021,5,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Mescaline,2021,0.0005,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2021,0.26287,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2021,0.002,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Other hallucinogens,2021,0.0197,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Other hallucinogens,2021,0.0189,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Phencyclidine (PCP),2021,0.0004,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.015,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.098,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.0205,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,"STP (DOM, 2,5-dimethoxy-4-methylamphetamine)",2021,0.0033,ARG
Americas,South America,Argentina,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,1.27758,ARG
Americas,South America,Argentina,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,0.00015,ARG
Americas,South America,Argentina,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,83.63031,ARG
Americas,South America,Argentina,Opioids,Opiates,Heroin,2021,0.02,ARG
Americas,South America,Argentina,Opioids,Opiates,Heroin,2021,3,ARG
Americas,South America,Argentina,Opioids,Opiates,Heroin,2021,0.01182,ARG
Americas,South America,Argentina,Opioids,Opiates,Illicit morphine,2021,0.036,ARG
Americas,South America,Argentina,Opioids,Opiates,Opium,2021,0.0003,ARG
Americas,South America,Argentina,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.0072,ARG
Americas,South America,Argentina,Opioids,Pharmaceutical opioids,Tramadol,2021,0.00175,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,Barbiturates,Barbiturates,2021,0.0018,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.141825,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,Non-specified sedatives and tranquillizers,Non-specified sedatives and tranquillizers,2021,0.00671,ARG
Americas,South America,Argentina,Solvents and Inhalants,Solvents and Inhalants,Solvents and inhalants,2021,9.76,ARG
Americas,South America,Argentina,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,21.05604,ARG
Americas,South America,Argentina,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,18.889784,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,1.44,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,1.48251,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,2.2175,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,1.2895,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.15475,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2022,0.34166,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0.046,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0.076,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,12,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,14.58022,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,186993.3802,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,5.7531,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,0.0513,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,453.463448,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,3777.65544,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,4524.6,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,14.28089,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,4.72263,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,0.62871,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,0,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,3741.100866,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,0,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,0.05,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,1.0328,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,0,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,4.66167,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,27.3705,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,0,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,1,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,1.1269,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,0,ARG
Americas,South America,Argentina,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2022,13674.96565,ARG
Americas,South America,Argentina,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2022,3.6504,ARG
Americas,South America,Argentina,Cocaine-type,Coca-type,Coca leaf,2022,131808.4569,ARG
Americas,South America,Argentina,Cocaine-type,Other coca/cocaine-type drugs,Other coca/cocaine-type drugs,2022,0.54,ARG
Americas,South America,Argentina,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.009,ARG
Americas,South America,Argentina,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.04,ARG
Americas,South America,Argentina,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.004584188,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2022,0.35941,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2022,0.1211,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2022,0.15,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2022,0.2885,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2022,0.4395,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2022,0.012,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Other hallucinogens,2022,0.0001,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Other hallucinogens,2022,0.0001,ARG
Americas,South America,Argentina,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,1.2831,ARG
Americas,South America,Argentina,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,160.52782,ARG
Americas,South America,Argentina,Opioids,Opiates,Heroin,2022,0.0026,ARG
Americas,South America,Argentina,Opioids,Opiates,Illicit morphine,2022,0.118,ARG
Americas,South America,Argentina,Opioids,Opiates,Illicit morphine,2022,0.204,ARG
Americas,South America,Argentina,Opioids,Opiates,Opium,2022,0.003,ARG
Americas,South America,Argentina,Opioids,Opiates,Opium,2022,0.0138,ARG
Americas,South America,Argentina,Opioids,Other illicit opioids,Other illicit opioids,2022,0.01,ARG
Americas,South America,Argentina,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.012,ARG
Americas,South America,Argentina,Opioids,Pharmaceutical opioids,Tramadol,2022,0.096,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,Barbiturates,Barbiturates,2022,0.0114,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,2.862,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.30237,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2022,14.253,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,Non-specified sedatives and tranquillizers,Non-specified sedatives and tranquillizers,2022,0.00119,ARG
Americas,South America,Argentina,Solvents and Inhalants,Solvents and Inhalants,Solvents and inhalants,2022,7.855,ARG
Americas,South America,Argentina,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,74.05571,ARG
Americas,South America,Argentina,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,46.2676945,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,2.834,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.0165,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.001,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,13.69705,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.05525,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2023,0.83204,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2023,1.7672,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.00408,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.095,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,4.03,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,40.76874,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,149434.2845,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,6.948,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,0.0378,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,339.23033,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,2225.6808,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,2574.8,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,18.463096,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,3.61273,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,1.8864,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,0,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,1.0087,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,0,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,4939.51778,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,0,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,0,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,0.05,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,0,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,1.61964,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,126.68773,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,0,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,0,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,23.8671,ARG
Americas,South America,Argentina,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2023,9883.113214,ARG
Americas,South America,Argentina,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2023,1.1375,ARG
Americas,South America,Argentina,Cocaine-type,Coca-type,Coca leaf,2023,164250.1487,ARG
Americas,South America,Argentina,Cocaine-type,Other coca/cocaine-type drugs,Other coca/cocaine-type drugs,2023,0.00004,ARG
Americas,South America,Argentina,Cocaine-type,Other coca/cocaine-type drugs,Other coca/cocaine-type drugs,2023,60,ARG
Americas,South America,Argentina,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.0138,ARG
Americas,South America,Argentina,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.0008092,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2023,0.68501,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2023,0.015,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2023,0.37644,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2023,0.026,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Other hallucinogens,2023,0.08,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Phencyclidine (PCP),2023,0.09436,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,"STP (DOM, 2,5-dimethoxy-4-methylamphetamine)",2023,0.0001,ARG
Americas,South America,Argentina,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,61.04039,ARG
Americas,South America,Argentina,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,100.7821,ARG
Americas,South America,Argentina,Opioids,Opiates,Heroin,2023,0.02586,ARG
Americas,South America,Argentina,Opioids,Opiates,Heroin,2023,0.00015,ARG
Americas,South America,Argentina,Opioids,Opiates,Illicit morphine,2023,0.003,ARG
Americas,South America,Argentina,Opioids,Opiates,Opium,2023,0.0014,ARG
Americas,South America,Argentina,Opioids,Other illicit opiates,Poppy seed,2023,0.001,ARG
Americas,South America,Argentina,Opioids,Other illicit opioids,Other illicit opioids,2023,0.000275,ARG
Americas,South America,Argentina,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.035,ARG
Americas,South America,Argentina,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.025,ARG
Americas,South America,Argentina,Opioids,Pharmaceutical opioids,Tramadol,2023,0.002,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,Barbiturates,Barbiturates,2023,0.0135,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.008,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.02,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.85141,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2023,0.3559,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2023,6390,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2023,0.01,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,Non-specified sedatives and tranquillizers,Non-specified sedatives and tranquillizers,2023,0.00241,ARG
Americas,South America,Argentina,Solvents and Inhalants,Solvents and Inhalants,Solvents and inhalants,2023,0,ARG
Americas,South America,Argentina,Solvents and Inhalants,Solvents and Inhalants,Solvents and inhalants,2023,4.68981,ARG
Americas,South America,Argentina,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,88,ARG
Americas,South America,Argentina,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,45,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,1,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,60,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,2,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,2,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2019,0,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2019,0,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2019,0,ARG
Americas,South America,Argentina,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2019,0,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2019,3,ARG
Americas,South America,Argentina,Any other drugs/substances,Other miscellaneous,Psychotropic substances,2019,0,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,187353,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,256,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,1,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,1,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,7,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,7,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,1739,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,515,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,1951,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,82,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,14,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,0,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,4,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,3,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,2,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,0,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,0,ARG
Americas,South America,Argentina,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,115,ARG
Americas,South America,Argentina,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,0,ARG
Americas,South America,Argentina,Cocaine-type,Cocaine,Non-specified cocaine,2019,10489,ARG
Americas,South America,Argentina,Cocaine-type,Cocaine,Non-specified cocaine,2019,21,ARG
Americas,South America,Argentina,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2019,0,ARG
Americas,South America,Argentina,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2019,25,ARG
Americas,South America,Argentina,Cocaine-type,Coca-type,Coca leaf,2019,138879,ARG
Americas,South America,Argentina,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,2,ARG
Americas,South America,Argentina,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,25B-NBOMe (2C-B-NBOMe),2019,0,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2019,1,ARG
Americas,South America,Argentina,Hallucinogens,Other Hallucinogens,Mescaline,2019,1,ARG
Americas,South America,Argentina,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,0,ARG
Americas,South America,Argentina,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,178,ARG
Americas,South America,Argentina,NPS,Plant-based NPS,Ayahuasca,2019,7,ARG
Americas,South America,Argentina,NPS,Plant-based NPS,Mushrooms (hallucinogenic),2019,0,ARG
Americas,South America,Argentina,NPS,Plant-based NPS,Mushrooms (hallucinogenic),2019,0,ARG
Americas,South America,Argentina,Opioids,Opiates,Heroin,2019,11,ARG
Americas,South America,Argentina,Opioids,Opiates,Illicit morphine,2019,0,ARG
Americas,South America,Argentina,Opioids,Opiates,Poppy plants,2019,0,ARG
Americas,South America,Argentina,Opioids,Pharmaceutical opioids,Codeine,2019,0,ARG
Americas,South America,Argentina,Opioids,Pharmaceutical opioids,Tramadol,2019,0,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,Barbiturates,Barbiturates,2019,0,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,0,ARG
Americas,South America,Argentina,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2019,0,ARG
Americas,South America,Argentina,Solvents and Inhalants,Solvents and Inhalants,Solvents and inhalants,2019,7,ARG
Americas,South America,Bolivia (Plurinational State of),Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,6530,BOL
Americas,South America,Bolivia (Plurinational State of),Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,457682,BOL
Americas,South America,Bolivia (Plurinational State of),Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2020,9792,BOL
Americas,South America,Bolivia (Plurinational State of),Cocaine-type,Cocaine,Cocaine hydrochloride,2020,5867,BOL
Americas,South America,Bolivia (Plurinational State of),Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.13691,BOL
Americas,South America,Bolivia (Plurinational State of),“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.220865,BOL
Americas,South America,Bolivia (Plurinational State of),Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,9822,BOL
Americas,South America,Bolivia (Plurinational State of),Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,180912,BOL
Americas,South America,Bolivia (Plurinational State of),Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2021,11923,BOL
Americas,South America,Bolivia (Plurinational State of),Cocaine-type,Cocaine,Cocaine hydrochloride,2021,7805,BOL
Americas,South America,Bolivia (Plurinational State of),Precursors,Non-specified precursors,Non-specified precursors,2021,520000,BOL
Americas,South America,Bolivia (Plurinational State of),Precursors,Non-specified precursors,Non-specified precursors,2021,799000,BOL
Americas,South America,Bolivia (Plurinational State of),Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,0.06078,BOL
Americas,South America,Bolivia (Plurinational State of),“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.642,BOL
Americas,South America,Bolivia (Plurinational State of),“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,4.740332,BOL
Americas,South America,Bolivia (Plurinational State of),Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,11194,BOL
Americas,South America,Bolivia (Plurinational State of),Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,179535,BOL
Americas,South America,Bolivia (Plurinational State of),Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2022,10125,BOL
Americas,South America,Bolivia (Plurinational State of),Cocaine-type,Cocaine,Cocaine hydrochloride,2022,10213,BOL
Americas,South America,Bolivia (Plurinational State of),Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0000231,BOL
Americas,South America,Bolivia (Plurinational State of),Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2022,0.13304,BOL
Americas,South America,Bolivia (Plurinational State of),“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,16.78,BOL
Americas,South America,Bolivia (Plurinational State of),“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,18.631792,BOL
Americas,South America,Bolivia (Plurinational State of),Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,6,BOL
Americas,South America,Bolivia (Plurinational State of),Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,19381,BOL
Americas,South America,Bolivia (Plurinational State of),Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,352813,BOL
Americas,South America,Bolivia (Plurinational State of),Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2023,11591,BOL
Americas,South America,Bolivia (Plurinational State of),Cocaine-type,Cocaine,Cocaine hydrochloride,2023,21345,BOL
Americas,South America,Bolivia (Plurinational State of),Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.00005235,BOL
Americas,South America,Bolivia (Plurinational State of),Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.00421,BOL
Americas,South America,Bolivia (Plurinational State of),Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,6200,BOL
Americas,South America,Bolivia (Plurinational State of),Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,239029,BOL
Americas,South America,Bolivia (Plurinational State of),Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2019,10550,BOL
Americas,South America,Bolivia (Plurinational State of),Cocaine-type,Cocaine,Cocaine hydrochloride,2019,15557,BOL
Americas,South America,Brazil,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,44.916353,BRA
Americas,South America,Brazil,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2020,37.5205,BRA
Americas,South America,Brazil,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,544589.44,BRA
Americas,South America,Brazil,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,231092.3,BRA
Americas,South America,Brazil,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,404,BRA
Americas,South America,Brazil,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,3379.1,BRA
Americas,South America,Brazil,Cocaine-type,Cocaine,"""Crack"" cocaine",2020,477.82,BRA
Americas,South America,Brazil,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2020,1923.86,BRA
Americas,South America,Brazil,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,88833.18,BRA
Americas,South America,Brazil,Cocaine-type,Coca-type,Coca leaf,2020,120.9,BRA
Americas,South America,Brazil,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.0001139,BRA
Americas,South America,Brazil,Opioids,Opiates,Heroin,2020,4,BRA
Americas,South America,Brazil,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,9.073351,BRA
Americas,South America,Brazil,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,10.69875,BRA
Americas,South America,Brazil,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,38.576,BRA
Americas,South America,Brazil,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,410223,BRA
Americas,South America,Brazil,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,204444.4,BRA
Americas,South America,Brazil,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,5644,BRA
Americas,South America,Brazil,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,187,BRA
Americas,South America,Brazil,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,417,BRA
Americas,South America,Brazil,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,93420,BRA
Americas,South America,Brazil,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2021,4140,BRA
Americas,South America,Brazil,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,1.82294,BRA
Americas,South America,Brazil,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,238.238539,BRA
Americas,South America,Brazil,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.73025,BRA
Americas,South America,Brazil,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,37.58,BRA
Americas,South America,Brazil,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.6785,BRA
Americas,South America,Brazil,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2022,4.93,BRA
Americas,South America,Brazil,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2022,0.01075,BRA
Americas,South America,Brazil,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,414588.34,BRA
Americas,South America,Brazil,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,285.62,BRA
Americas,South America,Brazil,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,87452.02,BRA
Americas,South America,Brazil,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2022,6191.05,BRA
Americas,South America,Brazil,Cocaine-type,Coca-type,Coca leaf,2022,725.93,BRA
Americas,South America,Brazil,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0001946,BRA
Americas,South America,Brazil,Opioids,Opiates,Heroin,2022,0.005,BRA
Americas,South America,Brazil,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2022,20.2,BRA
Americas,South America,Brazil,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,4674.03,BRA
Americas,South America,Brazil,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,75.30689,BRA
Americas,South America,Brazil,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,54.663681,BRA
Americas,South America,Brazil,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,18.55575,BRA
Americas,South America,Brazil,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,62.12995,BRA
Americas,South America,Brazil,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,408595.46,BRA
Americas,South America,Brazil,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,123706.1,BRA
Americas,South America,Brazil,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,3519.73,BRA
Americas,South America,Brazil,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,113.5,BRA
Americas,South America,Brazil,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,7659.16,BRA
Americas,South America,Brazil,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,64845.19,BRA
Americas,South America,Brazil,Cocaine-type,Coca-type,Coca leaf,2023,114.78,BRA
Americas,South America,Brazil,Opioids,Opiates,Opium,2023,0.02074,BRA
Americas,South America,Brazil,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,152,BRA
Americas,South America,Brazil,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,13,BRA
Americas,South America,Brazil,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,15,BRA
Americas,South America,Brazil,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,261155,BRA
Americas,South America,Brazil,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,988,BRA
Americas,South America,Brazil,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,158732,BRA
Americas,South America,Brazil,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,100657,BRA
Americas,South America,Brazil,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,3848,BRA
Americas,South America,Brazil,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,54381,BRA
Americas,South America,Brazil,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,656,BRA
Americas,South America,Brazil,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2019,1771,BRA
Americas,South America,Brazil,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,102155,BRA
Americas,South America,Brazil,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,BRA
Americas,South America,Brazil,Opioids,Opiates,Opium,2019,0,BRA
Americas,South America,Brazil,Sedatives and tranquillizers,GBL/GHB,GBL,2019,5,BRA
Americas,South America,Brazil,Solvents and Inhalants,Solvents and Inhalants,Solvents and inhalants,2019,,BRA
Americas,South America,Chile,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,16.087915,CHL
Americas,South America,Chile,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,99.13176,CHL
Americas,South America,Chile,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.0275,CHL
Americas,South America,Chile,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.07725,CHL
Americas,South America,Chile,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.0935,CHL
Americas,South America,Chile,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.08275,CHL
Americas,South America,Chile,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,28933,CHL
Americas,South America,Chile,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,28496.5,CHL
Americas,South America,Chile,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,5721,CHL
Americas,South America,Chile,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2020,7.484,CHL
Americas,South America,Chile,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.0011589,CHL
Americas,South America,Chile,Hallucinogens,Other Hallucinogens,25B-NBOMe (2C-B-NBOMe),2020,0.0045,CHL
Americas,South America,Chile,Hallucinogens,Other Hallucinogens,25B-NBOMe (2C-B-NBOMe),2020,0.0726,CHL
Americas,South America,Chile,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,214.5,CHL
Americas,South America,Chile,NPS,Phenethylamines,2C (psychedelics),2020,1.31691,CHL
Americas,South America,Chile,NPS,Phenethylamines,2C (psychedelics),2020,0.41124,CHL
Americas,South America,Chile,Opioids,Pharmaceutical opioids,Codeine,2020,1.44,CHL
Americas,South America,Chile,Precursors,Non-specified precursors,Non-specified precursors,2020,91.7,CHL
Americas,South America,Chile,Precursors,Non-specified precursors,Non-specified precursors,2020,2,CHL
Americas,South America,Chile,Precursors,Non-specified precursors,Non-specified precursors,2020,6750,CHL
Americas,South America,Chile,Precursors,Precursors,Acetone,2020,9.38,CHL
Americas,South America,Chile,Precursors,Precursors,Ephedrine,2020,0.0015,CHL
Americas,South America,Chile,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,1.23391,CHL
Americas,South America,Chile,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.0763,CHL
Americas,South America,Chile,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,22.597606,CHL
Americas,South America,Chile,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,58617,CHL
Americas,South America,Chile,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,62369.4,CHL
Americas,South America,Chile,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2021,10064,CHL
Americas,South America,Chile,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,6366,CHL
Americas,South America,Chile,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,24.793525,CHL
Americas,South America,Chile,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,361.8955003,CHL
Americas,South America,Chile,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,44202.5,CHL
Americas,South America,Chile,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,46125.1,CHL
Americas,South America,Chile,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2022,9988.53376,CHL
Americas,South America,Chile,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,6302.60028,CHL
Americas,South America,Chile,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.00100815,CHL
Americas,South America,Chile,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2022,0.0022,CHL
Americas,South America,Chile,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,26.62393,CHL
Americas,South America,Chile,Opioids,Pharmaceutical opioids,Codeine,2022,0.00645,CHL
Americas,South America,Chile,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,182.327445,CHL
Americas,South America,Chile,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,39301.8,CHL
Americas,South America,Chile,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,66587.6,CHL
Americas,South America,Chile,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,4749.8,CHL
Americas,South America,Chile,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2023,8931.7,CHL
Americas,South America,Chile,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.0004799,CHL
Americas,South America,Chile,Opioids,Pharmaceutical opioids,Codeine,2023,0.01375,CHL
Americas,South America,Chile,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,86,CHL
Americas,South America,Chile,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,124,CHL
Americas,South America,Chile,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,CHL
Americas,South America,Chile,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,CHL
Americas,South America,Chile,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,CHL
Americas,South America,Chile,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2019,57,CHL
Americas,South America,Chile,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,20259,CHL
Americas,South America,Chile,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,1016,CHL
Americas,South America,Chile,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,22891,CHL
Americas,South America,Chile,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,4733,CHL
Americas,South America,Chile,Cocaine-type,Coca-type,Coca leaf,2019,82,CHL
Americas,South America,Chile,Cocaine-type,Other/non-specified coca/cocaine-type drugs OR Miscellaneous coca/cocaine-type drugs,Other coca/cocaine-type drugs,2019,7182,CHL
Americas,South America,Chile,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,CHL
Americas,South America,Chile,Hallucinogens,Other Hallucinogens,25B-NBOMe (2C-B-NBOMe),2019,0,CHL
Americas,South America,Chile,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,140,CHL
Americas,South America,Chile,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,0,CHL
Americas,South America,Chile,NPS,Plant-based NPS,Mushrooms (hallucinogenic),2019,0,CHL
Americas,South America,Chile,NPS,Plant-based NPS,Other hallucinogens,2019,0,CHL
Americas,South America,Chile,Opioids,Opiates,Illicit morphine,2019,0,CHL
Americas,South America,Chile,Sedatives and tranquillizers,Non-specified sedatives and tranquillizers,Other drugs/substances,2019,1,CHL
Americas,South America,Colombia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,25.715732,COL
Americas,South America,Colombia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,534559.3459,COL
Americas,South America,Colombia,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2020,74193.7871,COL
Americas,South America,Colombia,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,505682.5515,COL
Americas,South America,Colombia,Cocaine-type,Coca-type,Coca leaf,2020,546743.833,COL
Americas,South America,Colombia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.0000602,COL
Americas,South America,Colombia,Opioids,Opiates,Heroin,2020,262.69,COL
Americas,South America,Colombia,Precursors,Precursors,Acetic anhydride,2020,1892.706,COL
Americas,South America,Colombia,Precursors,Precursors,Acetone,2020,3235476.43,COL
Americas,South America,Colombia,Precursors,Precursors,Hydrochloric acid,2020,109118.6649,COL
Americas,South America,Colombia,Precursors,Precursors,Potassium permanganate,2020,64597.42,COL
Americas,South America,Colombia,Precursors,Precursors,Sulphuric acid,2020,187787.3242,COL
Americas,South America,Colombia,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,0.17457,COL
Americas,South America,Colombia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,6.914836,COL
Americas,South America,Colombia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2021,8.19225,COL
Americas,South America,Colombia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,490984.2007,COL
Americas,South America,Colombia,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2021,88655.3937,COL
Americas,South America,Colombia,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,669340.0479,COL
Americas,South America,Colombia,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2021,1333.5675,COL
Americas,South America,Colombia,Cocaine-type,Coca-type,Coca leaf,2021,721002.545,COL
Americas,South America,Colombia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.0004597,COL
Americas,South America,Colombia,Opioids,Opiates,Heroin,2021,343.4295,COL
Americas,South America,Colombia,Precursors,Precursors,Acetone,2021,1055119.243,COL
Americas,South America,Colombia,Precursors,Precursors,Hydrochloric acid,2021,207410.2943,COL
Americas,South America,Colombia,Precursors,Precursors,Potassium permanganate,2021,135516,COL
Americas,South America,Colombia,Precursors,Precursors,Sulphuric acid,2021,316748.1345,COL
Americas,South America,Colombia,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,0.28127,COL
Americas,South America,Colombia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,19.642351,COL
Americas,South America,Colombia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2022,9.365,COL
Americas,South America,Colombia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,391068.9482,COL
Americas,South America,Colombia,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2022,106728.45,COL
Americas,South America,Colombia,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,659133.85,COL
Americas,South America,Colombia,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2022,1456.47,COL
Americas,South America,Colombia,Cocaine-type,Coca-type,Coca leaf,2022,676210.73,COL
Americas,South America,Colombia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.00030595,COL
Americas,South America,Colombia,Opioids,Opiates,Heroin,2022,397.33,COL
Americas,South America,Colombia,Precursors,Precursors,Acetic anhydride,2022,4.001180484,COL
Americas,South America,Colombia,Precursors,Precursors,Acetone,2022,877996.0301,COL
Americas,South America,Colombia,Precursors,Precursors,Hydrochloric acid,2022,90883.95671,COL
Americas,South America,Colombia,Precursors,Precursors,Potassium permanganate,2022,98630,COL
Americas,South America,Colombia,Precursors,Precursors,Sulphuric acid,2022,249182.3157,COL
Americas,South America,Colombia,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2022,0.38029,COL
Americas,South America,Colombia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,146.996904,COL
Americas,South America,Colombia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2023,13.1725,COL
Americas,South America,Colombia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,421167,COL
Americas,South America,Colombia,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2023,99356,COL
Americas,South America,Colombia,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,746285,COL
Americas,South America,Colombia,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2023,1088,COL
Americas,South America,Colombia,Cocaine-type,Coca-type,Coca leaf,2023,984366,COL
Americas,South America,Colombia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.0002666,COL
Americas,South America,Colombia,Opioids,Opiates,Heroin,2023,572.44,COL
Americas,South America,Colombia,Precursors,Precursors,Acetone,2023,1326253.163,COL
Americas,South America,Colombia,Precursors,Precursors,Hydrochloric acid,2023,130316.5935,COL
Americas,South America,Colombia,Precursors,Precursors,Potassium permanganate,2023,124769,COL
Americas,South America,Colombia,Precursors,Precursors,Sulphuric acid,2023,244806.3795,COL
Americas,South America,Colombia,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,0.52236,COL
Americas,South America,Colombia,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,67,COL
Americas,South America,Colombia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,376127,COL
Americas,South America,Colombia,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2019,59325,COL
Americas,South America,Colombia,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,428418,COL
Americas,South America,Colombia,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2019,1479,COL
Americas,South America,Colombia,Cocaine-type,Coca-type,Coca leaf,2019,497548,COL
Americas,South America,Colombia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,COL
Americas,South America,Colombia,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2019,1,COL
Americas,South America,Colombia,Opioids,Opiates,Heroin,2019,357,COL
Americas,South America,Colombia,Opioids,Pharmaceutical opioids,Oxycodone,2019,0,COL
Americas,South America,Colombia,Sedatives and tranquillizers,Non-specified sedatives and tranquillizers,Non-specified sedatives and tranquillizers,2019,0,COL
Americas,South America,Ecuador,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.38,ECU
Americas,South America,Ecuador,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.28997,ECU
Americas,South America,Ecuador,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.041,ECU
Americas,South America,Ecuador,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,1.5875,ECU
Americas,South America,Ecuador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,35828.51,ECU
Americas,South America,Ecuador,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,89192.21,ECU
Americas,South America,Ecuador,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2020,2965.65,ECU
Americas,South America,Ecuador,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.00004605,ECU
Americas,South America,Ecuador,Opioids,Opiates,Heroin,2020,446.09,ECU
Americas,South America,Ecuador,Precursors,Non-specified precursors,Other precursors,2020,57550,ECU
Americas,South America,Ecuador,Precursors,Non-specified precursors,Other precursors,2020,17934.58,ECU
Americas,South America,Ecuador,Precursors,Precursors,Potassium permanganate,2020,28,ECU
Americas,South America,Ecuador,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,1.778031,ECU
Americas,South America,Ecuador,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,9.8955,ECU
Americas,South America,Ecuador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,33007.63423,ECU
Americas,South America,Ecuador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,75.1,ECU
Americas,South America,Ecuador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,75.1,ECU
Americas,South America,Ecuador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,0.00011,ECU
Americas,South America,Ecuador,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2021,3129.64328,ECU
Americas,South America,Ecuador,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,173531.16,ECU
Americas,South America,Ecuador,Opioids,Opiates,Heroin,2021,512.85795,ECU
Americas,South America,Ecuador,Opioids,Opiates,Poppy plants,2021,4592.7,ECU
Americas,South America,Ecuador,Precursors,Non-specified precursors,Non-specified precursors,2021,31770,ECU
Americas,South America,Ecuador,Precursors,Non-specified precursors,Non-specified precursors,2021,22130.82,ECU
Americas,South America,Ecuador,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,9.725,ECU
Americas,South America,Ecuador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,16641.59,ECU
Americas,South America,Ecuador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,8.6,ECU
Americas,South America,Ecuador,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2022,5262.544,ECU
Americas,South America,Ecuador,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,179093.078,ECU
Americas,South America,Ecuador,Opioids,Opiates,Opium,2022,353.337,ECU
Americas,South America,Ecuador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,19514.37,ECU
Americas,South America,Ecuador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,79.7,ECU
Americas,South America,Ecuador,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2023,3324.39,ECU
Americas,South America,Ecuador,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,197928.51,ECU
Americas,South America,Ecuador,Opioids,Opiates,Heroin,2023,325.01,ECU
Americas,South America,Ecuador,Precursors,Non-specified precursors,Non-specified precursors,2023,62490,ECU
Americas,South America,Ecuador,Precursors,Non-specified precursors,Non-specified precursors,2023,18427,ECU
Americas,South America,Ecuador,Precursors,Non-specified precursors,Other precursors,2023,18409.62,ECU
Americas,South America,Ecuador,Precursors,Non-specified precursors,Other precursors,2023,64225.75,ECU
Americas,South America,Ecuador,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,4,ECU
Americas,South America,Ecuador,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,2,ECU
Americas,South America,Ecuador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,20154,ECU
Americas,South America,Ecuador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,12771,ECU
Americas,South America,Ecuador,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,0,ECU
Americas,South America,Ecuador,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2019,2961,ECU
Americas,South America,Ecuador,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,30823,ECU
Americas,South America,Ecuador,Cocaine-type,Coca-type,Coca leaf,2019,5120,ECU
Americas,South America,Ecuador,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,ECU
Americas,South America,Ecuador,Opioids,Opiates,Heroin,2019,391,ECU
Americas,South America,Ecuador,Opioids,Opiates,Poppy plants,2019,2953,ECU
Americas,South America,Ecuador,Precursors,Non-specified precursors,Non-specified precursors,2019,159200,ECU
Americas,South America,Ecuador,Precursors,Non-specified precursors,Non-specified precursors,2019,647802,ECU
Americas,South America,Guyana,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,671,GUY
Americas,South America,Guyana,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,518,GUY
Americas,South America,Guyana,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,1545,GUY
Americas,South America,Guyana,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,563,GUY
Americas,South America,Guyana,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.192,GUY
Americas,South America,Guyana,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,1000,GUY
Americas,South America,Guyana,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,62,GUY
Americas,South America,Guyana,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,770,GUY
Americas,South America,Guyana,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,126,GUY
Americas,South America,Paraguay,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.003794,PRY
Americas,South America,Paraguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,469167.268,PRY
Americas,South America,Paraguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,10.107,PRY
Americas,South America,Paraguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,5798.761,PRY
Americas,South America,Paraguay,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2020,182.8,PRY
Americas,South America,Paraguay,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,2179.795,PRY
Americas,South America,Paraguay,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2020,12.086,PRY
Americas,South America,Paraguay,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.0000011,PRY
Americas,South America,Paraguay,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,13.932,PRY
Americas,South America,Paraguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,387328.001,PRY
Americas,South America,Paraguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,12.749,PRY
Americas,South America,Paraguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,4392.105,PRY
Americas,South America,Paraguay,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,4.688,PRY
Americas,South America,Paraguay,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,3029.371,PRY
Americas,South America,Paraguay,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,10.160874,PRY
Americas,South America,Paraguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,1081793,PRY
Americas,South America,Paraguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,6040621,PRY
Americas,South America,Paraguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,0.134,PRY
Americas,South America,Paraguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,5398.255,PRY
Americas,South America,Paraguay,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,5.565,PRY
Americas,South America,Paraguay,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,5.539,PRY
Americas,South America,Paraguay,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2022,,PRY
Americas,South America,Paraguay,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,3032,PRY
Americas,South America,Paraguay,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0000003,PRY
Americas,South America,Paraguay,Opioids,Opiates,Illicit morphine,2022,,PRY
Americas,South America,Paraguay,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,5.87,PRY
Americas,South America,Paraguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,679026,PRY
Americas,South America,Paraguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,5325,PRY
Americas,South America,Paraguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,1.599,PRY
Americas,South America,Paraguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,4150,PRY
Americas,South America,Paraguay,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,608,PRY
Americas,South America,Paraguay,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2023,69,PRY
Americas,South America,Paraguay,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,33,PRY
Americas,South America,Paraguay,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,0,PRY
Americas,South America,Paraguay,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,55,PRY
Americas,South America,Paraguay,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,2,PRY
Americas,South America,Paraguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,390692,PRY
Americas,South America,Paraguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,135,PRY
Americas,South America,Paraguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,8037,PRY
Americas,South America,Paraguay,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,7,PRY
Americas,South America,Paraguay,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,4316,PRY
Americas,South America,Paraguay,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,PRY
Americas,South America,Paraguay,Precursors,Non-specified precursors,Other precursors,2019,55,PRY
Americas,South America,Paraguay,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2019,0,PRY
Americas,South America,Paraguay,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2019,0,PRY
Americas,South America,Paraguay,Sedatives and tranquillizers,Benzodiazepines,"Flunitrazepam (Disomnilan, Flumipam, Rohypnol)",2019,0,PRY
Americas,South America,Paraguay,Precursors,Precursors,Ephedrine,2019,57,PRY
Americas,South America,Peru,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2020,53,PER
Americas,South America,Peru,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,22413,PER
Americas,South America,Peru,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,284349.2,PER
Americas,South America,Peru,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2020,20281,PER
Americas,South America,Peru,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,17988,PER
Americas,South America,Peru,Cocaine-type,Coca-type,Coca leaf,2020,56683,PER
Americas,South America,Peru,Opioids,Opiates,Opium,2020,22,PER
Americas,South America,Peru,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2021,59,PER
Americas,South America,Peru,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,29593,PER
Americas,South America,Peru,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2021,28265,PER
Americas,South America,Peru,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,18719,PER
Americas,South America,Peru,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2022,16,PER
Americas,South America,Peru,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,28451,PER
Americas,South America,Peru,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2022,28024,PER
Americas,South America,Peru,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,28985,PER
Americas,South America,Peru,Cocaine-type,Coca-type,Coca leaf,2022,164284,PER
Americas,South America,Peru,Opioids,Opiates,Heroin,2022,0.3,PER
Americas,South America,Peru,Opioids,Opiates,Opium,2022,5,PER
Americas,South America,Peru,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,14.24,PER
Americas,South America,Peru,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,38703.619,PER
Americas,South America,Peru,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,198658.6,PER
Americas,South America,Peru,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2023,43337.448,PER
Americas,South America,Peru,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,22512.828,PER
Americas,South America,Peru,Cocaine-type,Coca-type,Coca leaf,2023,303270.66,PER
Americas,South America,Peru,Opioids,Opiates,Opium,2023,18.704,PER
Americas,South America,Peru,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,10,PER
Americas,South America,Peru,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,20186,PER
Americas,South America,Peru,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2019,16155,PER
Americas,South America,Peru,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,25050,PER
Americas,South America,Suriname,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.09485,SUR
Americas,South America,Suriname,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,0.09267,SUR
Americas,South America,Suriname,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,203.62173,SUR
Americas,South America,Suriname,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,7.43823,SUR
Americas,South America,Suriname,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2021,2138.68018,SUR
Americas,South America,Suriname,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2021,66.252,SUR
Americas,South America,Suriname,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,4.2475,SUR
Americas,South America,Suriname,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,3.08359518,SUR
Americas,South America,Suriname,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,291.95168,SUR
Americas,South America,Suriname,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,13.30928,SUR
Americas,South America,Suriname,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,114.856,SUR
Americas,South America,Suriname,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,3434.0688,SUR
Americas,South America,Suriname,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,2.36263,SUR
Americas,South America,Suriname,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.8919965,SUR
Americas,South America,Suriname,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,43.14813,SUR
Americas,South America,Suriname,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,7.80249,SUR
Americas,South America,Suriname,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,292.55129,SUR
Americas,South America,Suriname,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2023,30.205,SUR
Americas,South America,Uruguay,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.8218,URY
Americas,South America,Uruguay,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,,URY
Americas,South America,Uruguay,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.5063,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,2048.8631,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,662.8,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,19.513,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,41.16,URY
Americas,South America,Uruguay,Cocaine-type,Cocaine,"""Crack"" cocaine",2020,0.0621,URY
Americas,South America,Uruguay,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,1480.3204,URY
Americas,South America,Uruguay,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2020,642.8591,URY
Americas,South America,Uruguay,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,,URY
Americas,South America,Uruguay,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.4609,URY
Americas,South America,Uruguay,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.5691,URY
Americas,South America,Uruguay,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.009,URY
Americas,South America,Uruguay,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2021,1.732,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,2129.9787,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,413.8,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,18.0051,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,0.00238,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,4.0402,URY
Americas,South America,Uruguay,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,0.0035,URY
Americas,South America,Uruguay,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2021,1196.0259,URY
Americas,South America,Uruguay,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,2075.8519,URY
Americas,South America,Uruguay,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.01658,URY
Americas,South America,Uruguay,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,0.0124,URY
Americas,South America,Uruguay,Opioids,Opiates,Heroin,2021,0.482,URY
Americas,South America,Uruguay,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.333601,URY
Americas,South America,Uruguay,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,42.424,URY
Americas,South America,Uruguay,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.00025,URY
Americas,South America,Uruguay,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.084,URY
Americas,South America,Uruguay,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,2.046,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,585.76417,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,402.8,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,0.6974,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,0.20961,URY
Americas,South America,Uruguay,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,0.0009,URY
Americas,South America,Uruguay,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2022,0.653324,URY
Americas,South America,Uruguay,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2022,1.296,URY
Americas,South America,Uruguay,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,4494.05382,URY
Americas,South America,Uruguay,Cocaine-type,Coca-type,Coca leaf,2022,0.11,URY
Americas,South America,Uruguay,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,0.1747,URY
Americas,South America,Uruguay,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,1.115,URY
Americas,South America,Uruguay,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,1.765294,URY
Americas,South America,Uruguay,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,3.276,URY
Americas,South America,Uruguay,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,2.439,URY
Americas,South America,Uruguay,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,3.228,URY
Americas,South America,Uruguay,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.009,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,933.459,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,277.5,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,42.935,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,0.596,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,0,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,380.974,URY
Americas,South America,Uruguay,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,0.0009,URY
Americas,South America,Uruguay,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2023,218.724,URY
Americas,South America,Uruguay,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,3251.025,URY
Americas,South America,Uruguay,Cocaine-type,Coca-type,Coca leaf,2023,3.259,URY
Americas,South America,Uruguay,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.00007365,URY
Americas,South America,Uruguay,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,0.149,URY
Americas,South America,Uruguay,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,0.571,URY
Americas,South America,Uruguay,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,0,URY
Americas,South America,Uruguay,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,4,URY
Americas,South America,Uruguay,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,2030,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,25,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,0,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,165,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,0,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,0,URY
Americas,South America,Uruguay,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,1,URY
Americas,South America,Uruguay,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,0,URY
Americas,South America,Uruguay,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2019,66,URY
Americas,South America,Uruguay,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,11956,URY
Americas,South America,Uruguay,Cocaine-type,Coca-type,Coca leaf,2019,0,URY
Americas,South America,Uruguay,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,URY
Americas,South America,Uruguay,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,URY
Americas,South America,Uruguay,Opioids,Opiates,Heroin,2019,0,URY
Americas,South America,Venezuela (Bolivarian Republic of),“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.00084,VEN
Americas,South America,Venezuela (Bolivarian Republic of),“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.545252,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,7.685,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,4.4705,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,12395.562,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Cocaine-type,Cocaine,Cocaine hydrochloride,2020,34323.822,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2020,2.429,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Opioids,Opiates,Heroin,2020,1.042,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.000075,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.0015,VEN
Americas,South America,Venezuela (Bolivarian Republic of),“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.03,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.17,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2021,1.996,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,6016.475,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Cocaine-type,Cocaine,"""Crack"" cocaine",2021,4.756,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Cocaine-type,Cocaine,Cocaine hydrochloride,2021,45445.813,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2021,0.228,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.023,VEN
Americas,South America,Venezuela (Bolivarian Republic of),NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,0.149,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Opioids,Opiates,Heroin,2021,5.571,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.002,VEN
Americas,South America,Venezuela (Bolivarian Republic of),“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,0.555,VEN
Americas,South America,Venezuela (Bolivarian Republic of),“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,0.302707,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,1.16,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,2.262,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,19.373,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,14543.852,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Cocaine-type,Cocaine,"""Crack"" cocaine",2022,8.8,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Cocaine-type,Cocaine,Cocaine hydrochloride,2022,32673.183,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2022,0.115,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Cocaine-type,Coca-type,Coca leaf,2022,0.873,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.001,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0000025,VEN
Americas,South America,Venezuela (Bolivarian Republic of),NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,2.06,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Opioids,Opiates,Heroin,2022,9.525,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Opioids,Pharmaceutical opioids,Fentanyl,2022,1.876,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Precursors,Precursors,Ephedrine,2022,0.032,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.091,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.00566,VEN
Americas,South America,Venezuela (Bolivarian Republic of),“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,0.294,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,1.95,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.078,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.91,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,8416.336,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,151.7,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Cocaine-type,Cocaine,"""Crack"" cocaine",2023,22.681,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Cocaine-type,Cocaine,Cocaine hydrochloride,2023,43702.91,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2023,0.239,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.241,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2023,2.132,VEN
Americas,South America,Venezuela (Bolivarian Republic of),NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,26.613,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Opioids,Opiates,Heroin,2023,12.981,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Opioids,Pharmaceutical opioids,Fentanyl,2023,0.054,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.126,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.057,VEN
Americas,South America,Venezuela (Bolivarian Republic of),“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,0,VEN
Americas,South America,Venezuela (Bolivarian Republic of),“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,0,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,1,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,15578,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,126,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Cocaine-type,Cocaine,"""Crack"" cocaine",2019,4,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Cocaine-type,Cocaine,Cocaine hydrochloride,2019,28789,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2019,0,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,2,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,VEN
Americas,South America,Venezuela (Bolivarian Republic of),NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,0,VEN
Americas,South America,Venezuela (Bolivarian Republic of),NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,0,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Opioids,Opiates,Heroin,2019,5,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Solvents and Inhalants,Solvents and Inhalants,Solvents and inhalants,2019,19,VEN
Americas,South America,Venezuela (Bolivarian Republic of),Solvents and Inhalants,Solvents and Inhalants,Solvents and inhalants,2019,0,VEN
Asia,Central Asia and Transcaucasia,Armenia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.130351,ARM
Asia,Central Asia and Transcaucasia,Armenia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.00857,ARM
Asia,Central Asia and Transcaucasia,Armenia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,13.067834,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,19.476615,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.199,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,1019.4,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,0.09573,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,49.65588,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,0.091251,ARM
Asia,Central Asia and Transcaucasia,Armenia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.00001179,ARM
Asia,Central Asia and Transcaucasia,Armenia,Hallucinogens,Other Hallucinogens,Psilocybine,2020,0.00553,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Opiates,Heroin,2020,13.067834,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Opiates,Illicit morphine,2020,0.00106,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Opiates,Opium,2020,19.052034,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Opiates,Poppy plants,2020,510,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2020,0.10821,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.00373062,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Pharmaceutical opioids,Codeine,2020,0.0384429,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.0000007,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Pharmaceutical opioids,Methadone,2020,0.11919766,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Pharmaceutical opioids,Tramadol,2020,0.15,ARM
Asia,Central Asia and Transcaucasia,Armenia,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,7.55224918,ARM
Asia,Central Asia and Transcaucasia,Armenia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.02167,ARM
Asia,Central Asia and Transcaucasia,Armenia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.00553,ARM
Asia,Central Asia and Transcaucasia,Armenia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,11.8,ARM
Asia,Central Asia and Transcaucasia,Armenia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,0.354,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,29,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,0.346,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,1292.2,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,0.838,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,0.973,ARM
Asia,Central Asia and Transcaucasia,Armenia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.000473,ARM
Asia,Central Asia and Transcaucasia,Armenia,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2021,0.00089,ARM
Asia,Central Asia and Transcaucasia,Armenia,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.02009,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Opiates,Heroin,2021,447,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Opiates,Opium,2021,5.262,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2021,0.102,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.00063,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Pharmaceutical opioids,Codeine,2021,0.0515,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Pharmaceutical opioids,Fentanyl,2021,0.00026,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Pharmaceutical opioids,Methadone,2021,0.0325,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.000275,ARM
Asia,Central Asia and Transcaucasia,Armenia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,1.2392,ARM
Asia,Central Asia and Transcaucasia,Armenia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.0061,ARM
Asia,Central Asia and Transcaucasia,Armenia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,13.0099,ARM
Asia,Central Asia and Transcaucasia,Armenia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2022,0.9097,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,31.206,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,0.3426,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,0.6334,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,0.1026,ARM
Asia,Central Asia and Transcaucasia,Armenia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.00341,ARM
Asia,Central Asia and Transcaucasia,Armenia,Hallucinogens,Other Hallucinogens,Psilocybine,2022,0.02567,ARM
Asia,Central Asia and Transcaucasia,Armenia,NPS,Synthetic cathinones,Synthetic cathinones,2022,4.1,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Opiates,Heroin,2022,2.0595,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Opiates,Illicit morphine,2022,0.00224,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Opiates,Opium,2022,12.707,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2022,0.00836,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.0012,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Pharmaceutical opioids,Codeine,2022,0.0545,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Pharmaceutical opioids,Methadone,2022,0.01303,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Pharmaceutical opioids,Oxycodone,2022,0.000115,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Pharmaceutical opioids,Tramadol,2022,0.0455,ARM
Asia,Central Asia and Transcaucasia,Armenia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,12.487,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,13.002,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,1.36,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,2.185,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,1.222,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Opiates,Heroin,2023,0.01862,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Opiates,Opium,2023,2.12,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.004,ARM
Asia,Central Asia and Transcaucasia,Armenia,Sedatives and tranquillizers,Barbiturates,Barbiturates,2023,0.1,ARM
Asia,Central Asia and Transcaucasia,Armenia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,12,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,14,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,0,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,112,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,1,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,0,ARM
Asia,Central Asia and Transcaucasia,Armenia,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,0,ARM
Asia,Central Asia and Transcaucasia,Armenia,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (Spice),2019,0,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Opiates,Heroin,2019,1,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Opiates,Illicit morphine,2019,0,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Opiates,Opium,2019,20,ARM
Asia,Central Asia and Transcaucasia,Armenia,Opioids,Other illicit opioids,Other illicit opioids,2019,0,ARM
Asia,Central Asia and Transcaucasia,Armenia,Any other drugs/substances,Other miscellaneous,Psychotropic substances,2019,2,ARM
Asia,Central Asia and Transcaucasia,Azerbaijan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,1.3,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,200.5,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,919.279,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,9500,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,90,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Opioids,Opiates,Heroin,2020,2300,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Opioids,Opiates,Opium,2020,304.5,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Opioids,Pharmaceutical opioids,Methadone,2020,10.4,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.0021,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,800.704671,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,1266.430794,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,50559.9,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,74.71836,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2021,0.09,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Opioids,Opiates,Heroin,2021,3637.450107,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Opioids,Opiates,Opium,2021,827.729995,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.02392,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,587.434,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,2086.07,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,24797.3,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,42.299,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2022,0.261,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Opioids,Opiates,Heroin,2022,2131.8,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Opioids,Opiates,Opium,2022,295.3,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,411.658,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,1711,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,65.205,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Opioids,Opiates,Heroin,2023,1940,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Opioids,Opiates,Opium,2023,261.166,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Any other drugs/substances,Other miscellaneous,Psychotropic substances,2019,233,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,821,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,28,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Cocaine-type,Cocaine,Non-specified cocaine,2019,4,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Opioids,Opiates,Heroin,2019,2091,AZE
Asia,Central Asia and Transcaucasia,Azerbaijan,Opioids,Opiates,Opium,2019,333,AZE
Asia,Central Asia and Transcaucasia,Georgia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,1.314,GEO
Asia,Central Asia and Transcaucasia,Georgia,NPS,Synthetic cathinones,Alpha-Pyrrolidinohexiophenone (alpha-PHP),2020,90,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Opiates,Heroin,2020,40,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.0482,GEO
Asia,Central Asia and Transcaucasia,Georgia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.25785,GEO
Asia,Central Asia and Transcaucasia,Georgia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.0307,GEO
Asia,Central Asia and Transcaucasia,Georgia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.16852,GEO
Asia,Central Asia and Transcaucasia,Georgia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,0.31,GEO
Asia,Central Asia and Transcaucasia,Georgia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,25.55,GEO
Asia,Central Asia and Transcaucasia,Georgia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,154.691,GEO
Asia,Central Asia and Transcaucasia,Georgia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,2342,GEO
Asia,Central Asia and Transcaucasia,Georgia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,0.00046,GEO
Asia,Central Asia and Transcaucasia,Georgia,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,0.0704,GEO
Asia,Central Asia and Transcaucasia,Georgia,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,2.434,GEO
Asia,Central Asia and Transcaucasia,Georgia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.000005,GEO
Asia,Central Asia and Transcaucasia,Georgia,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2021,0.00128,GEO
Asia,Central Asia and Transcaucasia,Georgia,NPS,Synthetic cathinones,Synthetic cathinones,2021,2.886,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Opiates,Heroin,2021,7.646,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Opiates,Illicit morphine,2021,0.006528,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Opiates,Opium,2021,3.888,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Opiates,Poppy plants,2021,65.128,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2021,0.6735,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.0401,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Pharmaceutical opioids,Codeine,2021,0.02435,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Pharmaceutical opioids,Methadone,2021,0.421,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.09076,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Pharmaceutical opioids,Tramadol,2021,0.19568,GEO
Asia,Central Asia and Transcaucasia,Georgia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,3.152,GEO
Asia,Central Asia and Transcaucasia,Georgia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.00466,GEO
Asia,Central Asia and Transcaucasia,Georgia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.53,GEO
Asia,Central Asia and Transcaucasia,Georgia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2022,0.476,GEO
Asia,Central Asia and Transcaucasia,Georgia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,1.156,GEO
Asia,Central Asia and Transcaucasia,Georgia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,212.063,GEO
Asia,Central Asia and Transcaucasia,Georgia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,2805,GEO
Asia,Central Asia and Transcaucasia,Georgia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,0.000356,GEO
Asia,Central Asia and Transcaucasia,Georgia,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,0.04252,GEO
Asia,Central Asia and Transcaucasia,Georgia,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,12.34,GEO
Asia,Central Asia and Transcaucasia,Georgia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.00009,GEO
Asia,Central Asia and Transcaucasia,Georgia,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2022,0.00016,GEO
Asia,Central Asia and Transcaucasia,Georgia,NPS,Synthetic cathinones,Synthetic cathinones,2022,2.483,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Opiates,Heroin,2022,6.499,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Opiates,Illicit morphine,2022,0.013,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Opiates,Opium,2022,0.000002,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Opiates,Poppy plants,2022,61.942,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2022,1.721,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.0758,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Pharmaceutical opioids,Codeine,2022,0.0143,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.00061,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Pharmaceutical opioids,Methadone,2022,0.595,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Pharmaceutical opioids,Oxycodone,2022,0.08382,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Pharmaceutical opioids,Tramadol,2022,0.905,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Opiates,Heroin,2023,480,GEO
Asia,Central Asia and Transcaucasia,Georgia,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,23,GEO
Asia,Central Asia and Transcaucasia,Georgia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,GEO
Asia,Central Asia and Transcaucasia,Georgia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,GEO
Asia,Central Asia and Transcaucasia,Georgia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,242,GEO
Asia,Central Asia and Transcaucasia,Georgia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,2573,GEO
Asia,Central Asia and Transcaucasia,Georgia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,2,GEO
Asia,Central Asia and Transcaucasia,Georgia,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,1,GEO
Asia,Central Asia and Transcaucasia,Georgia,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,1,GEO
Asia,Central Asia and Transcaucasia,Georgia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Opiates,Heroin,2019,6,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Opiates,Illicit morphine,2019,0,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Opiates,Opium,2019,0,GEO
Asia,Central Asia and Transcaucasia,Georgia,Opioids,Pharmaceutical opioids,Buprenorphine,2019,0,GEO
Asia,Central Asia and Transcaucasia,Georgia,Sedatives and tranquillizers,Non-specified sedatives and tranquillizers,Non-specified sedatives and tranquillizers,2019,2,GEO
Asia,Central Asia and Transcaucasia,Kazakhstan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.31057414,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.00356,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,8963.660511,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,1.1344478,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,9380.406239,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,584.4243348,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,4.63403,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,0.157019,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Opioids,Opiates,Heroin,2020,70.08828811,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Opioids,Opiates,Opium,2020,0.0583492,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Opioids,Opiates,Poppy plants,2020,1071.4,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2020,30.6227254,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.0002502,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.02,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,15.968,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,11487.331,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,1033.213,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Opioids,Opiates,Heroin,2021,76.575,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Opioids,Opiates,Illicit morphine,2021,0.077,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Opioids,Opiates,Opium,2021,52.895,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,10.02523,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,4.94294,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.02275,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Methcathinone,2022,316.19928,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2022,0.00043,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,5782.679,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,1.7891,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,8166.13895,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,918.936,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,3.36732,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,9.55642,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,0.00271,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2022,0.00536,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.00001,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2022,0.00012,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Hallucinogens,Other Hallucinogens,Psilocybine,2022,0.00227,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,NPS,Phenethylamines,2C (psychedelics),2022,0.00005,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2022,0.37356,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,NPS,Synthetic cathinones,Synthetic cathinones,2022,252.94339,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Opioids,Opiates,Heroin,2022,102.064,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Opioids,Opiates,Illicit morphine,2022,0.000001,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Opioids,Opiates,Opium,2022,70.6,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Opioids,Opiates,Poppy plants,2022,6.11012,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2022,293.11277,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Opioids,Other illicit opiates,Acetylated opium,2022,0.00494,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Opioids,Other illicit opiates,Other illicit opiates,2022,0.13705,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Opioids,Other illicit opioids,Other illicit opioids,2022,0.02666,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.40099,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Opioids,Pharmaceutical opioids,Methadone,2022,0.23906,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Precursors,Non-specified precursors,Other precursors,2022,0.07497,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Precursors,Precursors,Acetic anhydride,2022,0.00157,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Precursors,Precursors,Acetone,2022,1325.84558,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Precursors,Precursors,Ephedrine,2022,1.54071,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Precursors,Precursors,Sulphuric acid,2022,91.138,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Sedatives and tranquillizers,Barbiturates,Barbiturates,2022,0.00361,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Sedatives and tranquillizers,Barbiturates,Methaqualone,2022,0.028,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.00037,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,7671,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,809,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,26000,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,1025,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,9691,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,0,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,709,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,0,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Opioids,Opiates,Heroin,2019,1152,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Opioids,Opiates,Illicit morphine,2019,0,KAZ
Asia,Central Asia and Transcaucasia,Kazakhstan,Opioids,Opiates,Opium,2019,1,KAZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.001,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,3.511,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2020,1.844,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2020,0.01,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,232.276,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,2.155,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,284.214,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,509.956,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,747.487,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2020,0.003,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2020,0.014,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Opioids,Opiates,Heroin,2020,16.493,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Opioids,Opiates,Opium,2020,9.244,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Opioids,Opiates,Poppy plants,2020,1.737,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2020,0.04,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.008,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,9.908,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2021,10.386,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,0.04,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,361.152,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,1.967,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,338.746,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,245.93,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Opioids,Opiates,Heroin,2021,449.132,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Opioids,Opiates,Opium,2021,30.998,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Opioids,Opiates,Poppy plants,2021,0.0905,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2021,1.618,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,65.922,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2022,0.001,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,434.136,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,0.081,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,26.867,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,284.201,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,50.653,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,23.249,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2022,0.484,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,NPS,Synthetic cathinones,Synthetic cathinones,2022,13.206,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,NPS,Synthetic cathinones,Synthetic cathinones,2022,9.646,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Opioids,Opiates,Heroin,2022,100.931,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Opioids,Opiates,Opium,2022,11.861,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Precursors,Non-specified precursors,Other precursors,2022,5675.361,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Precursors,Non-specified precursors,Other precursors,2022,118.22,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Precursors,Non-specified precursors,Other precursors,2022,142,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.004,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.001,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,149.56,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,264.551,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,2.688,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,113.634,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,234.57,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,10.488,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,87.2,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,NPS,Synthetic cathinones,Synthetic cathinones,2023,0.522,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Opioids,Opiates,Heroin,2023,14.435,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Opioids,Opiates,Opium,2023,5.294,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Precursors,Non-specified precursors,Other precursors,2023,3807.788,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Precursors,Precursors,Hydrochloric acid,2023,573.213,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Precursors,Precursors,Sulphuric acid,2023,2218.75,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2019,0,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Any other drugs/substances,Other miscellaneous,Psychotropic substances,2019,5,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,1141,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,1,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,14324,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,466,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,170,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Opioids,Opiates,Heroin,2019,54,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Opioids,Opiates,Poppy plants,2019,0,KGZ
Asia,Central Asia and Transcaucasia,Kyrgyzstan,Precursors,Non-specified precursors,Non-specified precursors,2019,3,KGZ
Asia,Central Asia and Transcaucasia,Tajikistan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,1.5342,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,39.88,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.06579,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,1315.669,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,158.915,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Opioids,Opiates,Heroin,2020,118.451,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Opioids,Opiates,Opium,2020,788.795,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Opioids,Pharmaceutical opioids,Methadone,2020,0.356,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Opioids,Pharmaceutical opioids,Tramadol,2020,0.1742,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Sedatives and tranquillizers,Barbiturates,Barbiturates,2020,0.037,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.004,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.00141,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,1.5264,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,2.007,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,101.474,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,142.352,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,154703.8,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,2989.441,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Opioids,Opiates,Heroin,2021,251.915,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Opioids,Opiates,Opium,2021,593.936,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Opioids,Pharmaceutical opioids,Tramadol,2021,0.0015,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Sedatives and tranquillizers,Barbiturates,Barbiturates,2021,0.029,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.1,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.089,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,91.413,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,155.658,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,90978.2,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,3597.288,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Opioids,Opiates,Heroin,2022,243.588,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Opioids,Opiates,Opium,2022,870.355,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Sedatives and tranquillizers,Barbiturates,Barbiturates,2022,0.007,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.31,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.3657,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,68.221,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,90.33,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,233723.9,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,4294.159,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Opioids,Opiates,Heroin,2023,422.48,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Opioids,Opiates,Opium,2023,405.919,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Opioids,Pharmaceutical opioids,Methadone,2023,0.092,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Sedatives and tranquillizers,Barbiturates,Barbiturates,2023,0.077,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Sedatives and tranquillizers,Barbiturates,Barbiturates,2023,0.0176,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,5,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,61,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,223802,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Opioids,Opiates,Heroin,2019,172,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Opioids,Opiates,Opium,2019,788,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,2,TJK
Asia,Central Asia and Transcaucasia,Tajikistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,2,TJK
Asia,Central Asia and Transcaucasia,Uzbekistan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.070483,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.00906,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2020,0.15051,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,19.96095,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,1.2297,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,692.8049,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,127.2547,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,223.9405,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,0.27942,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.001331,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Opiates,Heroin,2020,28.3096,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Opiates,Opium,2020,124.1263,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2020,323.9134,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.22186,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,1.93,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,5.92792,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,790.86616,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,0.0021,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,511.14842,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2021,0.01519,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.0158,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Opiates,Heroin,2021,102.964692,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Opiates,Opium,2021,342.69832,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2021,77.85829,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Pharmaceutical opioids,Methadone,2021,0.01656,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.0002,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Pharmaceutical opioids,Tramadol,2021,2.636225,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.20969,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,2.0914,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2022,7.51453,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2022,6.71298,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,753.01278,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,0.2983,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,636.77253,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.00003,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Opiates,Heroin,2022,276.9004,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Opiates,Opium,2022,387.26466,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2022,138.338,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Pharmaceutical opioids,Methadone,2022,0.0012,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Pharmaceutical opioids,Tramadol,2022,3.6161,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.7147,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.00449,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,23.65184,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,35.2336,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,660.68,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,622.6,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,0.00648,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.00102,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Opiates,Heroin,2023,101.8,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Opiates,Opium,2023,322.9,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2023,208.9,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Pharmaceutical opioids,Carfentanil,2023,1.208,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Pharmaceutical opioids,Carfentanil,2023,6.784,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Pharmaceutical opioids,Codeine,2023,0.00611,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Pharmaceutical opioids,Methadone,2023,0.00148,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Pharmaceutical opioids,Tramadol,2023,0.8643,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2023,0,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2023,0.105,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2023,0.06,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,0.19058,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,736,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,112,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (Spice),2019,0,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Opiates,Heroin,2019,41,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Opiates,Opium,2019,225,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2019,63,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Opioids,Pharmaceutical opioids,Tramadol,2019,24,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Sedatives and tranquillizers,Non-specified sedatives and tranquillizers,Non-specified sedatives and tranquillizers,2019,1,UZB
Asia,Central Asia and Transcaucasia,Uzbekistan,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2019,1,UZB
Asia,East and South-East Asia,Brunei Darussalam,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.03,BRN
Asia,East and South-East Asia,Brunei Darussalam,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,31.98253,BRN
Asia,East and South-East Asia,Brunei Darussalam,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,1.3,BRN
Asia,East and South-East Asia,Brunei Darussalam,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,0.17923,BRN
Asia,East and South-East Asia,Brunei Darussalam,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,0.2299,BRN
Asia,East and South-East Asia,Brunei Darussalam,Sedatives and tranquillizers,Benzodiazepines,"Nimetazepam (Erimin, “Happy Five”)",2020,0.0003,BRN
Asia,East and South-East Asia,Brunei Darussalam,Sedatives and tranquillizers,Benzodiazepines,"Nimetazepam (Erimin, “Happy Five”)",2020,0.00162,BRN
Asia,East and South-East Asia,Brunei Darussalam,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.0005,BRN
Asia,East and South-East Asia,Brunei Darussalam,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,3.39529,BRN
Asia,East and South-East Asia,Brunei Darussalam,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,0.08428,BRN
Asia,East and South-East Asia,Brunei Darussalam,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.00029,BRN
Asia,East and South-East Asia,Brunei Darussalam,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,1.27712,BRN
Asia,East and South-East Asia,Brunei Darussalam,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,1.19508,BRN
Asia,East and South-East Asia,Brunei Darussalam,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,0.4,BRN
Asia,East and South-East Asia,Brunei Darussalam,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,0.06156,BRN
Asia,East and South-East Asia,Brunei Darussalam,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2022,0.007075,BRN
Asia,East and South-East Asia,Brunei Darussalam,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.00124,BRN
Asia,East and South-East Asia,Brunei Darussalam,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.0018,BRN
Asia,East and South-East Asia,Brunei Darussalam,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,4.42228,BRN
Asia,East and South-East Asia,Brunei Darussalam,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,6.2917,BRN
Asia,East and South-East Asia,Brunei Darussalam,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,0.1,BRN
Asia,East and South-East Asia,Brunei Darussalam,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2023,5,BRN
Asia,East and South-East Asia,Brunei Darussalam,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2019,3,BRN
Asia,East and South-East Asia,Brunei Darussalam,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,6,BRN
Asia,East and South-East Asia,Brunei Darussalam,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2019,80,BRN
Asia,East and South-East Asia,Brunei Darussalam,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,6,BRN
Asia,East and South-East Asia,Brunei Darussalam,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,0,BRN
Asia,East and South-East Asia,Brunei Darussalam,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2019,1,BRN
Asia,East and South-East Asia,Brunei Darussalam,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2019,5,BRN
Asia,East and South-East Asia,Brunei Darussalam,Sedatives and tranquillizers,Benzodiazepines,"Nimetazepam (Erimin, “Happy Five”)",2019,0,BRN
Asia,East and South-East Asia,Brunei Darussalam,Sedatives and tranquillizers,Benzodiazepines,"Nimetazepam (Erimin, “Happy Five”)",2019,0,BRN
Asia,East and South-East Asia,Cambodia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,73.5,KHM
Asia,East and South-East Asia,Cambodia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2020,3.88998,KHM
Asia,East and South-East Asia,Cambodia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,863.5,KHM
Asia,East and South-East Asia,Cambodia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,292.2,KHM
Asia,East and South-East Asia,Cambodia,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,0.5,KHM
Asia,East and South-East Asia,Cambodia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,112.5,KHM
Asia,East and South-East Asia,Cambodia,Opioids,Opiates,Heroin,2020,299,KHM
Asia,East and South-East Asia,Cambodia,Sedatives and tranquillizers,Benzodiazepines,"Nimetazepam (Erimin, “Happy Five”)",2020,9.4,KHM
Asia,East and South-East Asia,Cambodia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,58.4118,KHM
Asia,East and South-East Asia,Cambodia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2021,5.6817,KHM
Asia,East and South-East Asia,Cambodia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,947.947,KHM
Asia,East and South-East Asia,Cambodia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,135.1,KHM
Asia,East and South-East Asia,Cambodia,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2021,1.989,KHM
Asia,East and South-East Asia,Cambodia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,2782.774,KHM
Asia,East and South-East Asia,Cambodia,Opioids,Opiates,Heroin,2021,275.576,KHM
Asia,East and South-East Asia,Cambodia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,198.54,KHM
Asia,East and South-East Asia,Cambodia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2022,27.24,KHM
Asia,East and South-East Asia,Cambodia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,1076.76,KHM
Asia,East and South-East Asia,Cambodia,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2022,0.51,KHM
Asia,East and South-East Asia,Cambodia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,13504.49,KHM
Asia,East and South-East Asia,Cambodia,Opioids,Opiates,Heroin,2022,70.8,KHM
Asia,East and South-East Asia,Cambodia,Sedatives and tranquillizers,Benzodiazepines,"Nimetazepam (Erimin, “Happy Five”)",2022,29.54,KHM
Asia,East and South-East Asia,Cambodia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,324.2601,KHM
Asia,East and South-East Asia,Cambodia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,1436.8,KHM
Asia,East and South-East Asia,Cambodia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,5.32998,KHM
Asia,East and South-East Asia,Cambodia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,45.2,KHM
Asia,East and South-East Asia,Cambodia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,1795,KHM
Asia,East and South-East Asia,Cambodia,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,8.7,KHM
Asia,East and South-East Asia,Cambodia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,1040.3,KHM
Asia,East and South-East Asia,Cambodia,Opioids,Opiates,Heroin,2023,166.6,KHM
Asia,East and South-East Asia,Cambodia,Precursors,Non-specified precursors,Non-specified precursors,2023,837,KHM
Asia,East and South-East Asia,Cambodia,Sedatives and tranquillizers,Benzodiazepines,"Nimetazepam (Erimin, “Happy Five”)",2023,6.9,KHM
Asia,East and South-East Asia,Cambodia,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,115,KHM
Asia,East and South-East Asia,Cambodia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,385,KHM
Asia,East and South-East Asia,Cambodia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,44,KHM
Asia,East and South-East Asia,Cambodia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,103,KHM
Asia,East and South-East Asia,Cambodia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,18194,KHM
Asia,East and South-East Asia,Cambodia,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,1,KHM
Asia,East and South-East Asia,Cambodia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,33,KHM
Asia,East and South-East Asia,Cambodia,Opioids,Opiates,Heroin,2019,0,KHM
Asia,East and South-East Asia,China,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,147.2255,CHN
Asia,East and South-East Asia,China,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2020,13236.07,CHN
Asia,East and South-East Asia,China,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,437.8,CHN
Asia,East and South-East Asia,China,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,8300,CHN
Asia,East and South-East Asia,China,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2020,11.26123,CHN
Asia,East and South-East Asia,China,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,406.1,CHN
Asia,East and South-East Asia,China,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,1.118301,CHN
Asia,East and South-East Asia,China,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,406.13036,CHN
Asia,East and South-East Asia,China,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,3,CHN
Asia,East and South-East Asia,China,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,582.2,CHN
Asia,East and South-East Asia,China,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2020,0.00098,CHN
Asia,East and South-East Asia,China,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,1406.8,CHN
Asia,East and South-East Asia,China,Opioids,Opiates,Heroin,2020,3771.5,CHN
Asia,East and South-East Asia,China,Opioids,Opiates,Opium,2020,2770.8,CHN
Asia,East and South-East Asia,China,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.22025,CHN
Asia,East and South-East Asia,China,Opioids,Pharmaceutical opioids,Codeine,2020,29.573776,CHN
Asia,East and South-East Asia,China,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.0371,CHN
Asia,East and South-East Asia,China,Opioids,Pharmaceutical opioids,Methadone,2020,89.274417,CHN
Asia,East and South-East Asia,China,Opioids,Pharmaceutical opioids,Tramadol,2020,25.541455,CHN
Asia,East and South-East Asia,China,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.95898,CHN
Asia,East and South-East Asia,China,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2020,,CHN
Asia,East and South-East Asia,China,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,87.79,CHN
Asia,East and South-East Asia,China,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,16385.59,CHN
Asia,East and South-East Asia,China,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,854.9,CHN
Asia,East and South-East Asia,China,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,9.42,CHN
Asia,East and South-East Asia,China,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,341.35,CHN
Asia,East and South-East Asia,China,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,0.36,CHN
Asia,East and South-East Asia,China,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,690.5,CHN
Asia,East and South-East Asia,China,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,456.6,CHN
Asia,East and South-East Asia,China,Opioids,Opiates,Heroin,2021,1805.6,CHN
Asia,East and South-East Asia,China,Opioids,Opiates,Opium,2021,2031.5,CHN
Asia,East and South-East Asia,China,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,409.4,CHN
Asia,East and South-East Asia,China,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2022,10100,CHN
Asia,East and South-East Asia,China,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,495,CHN
Asia,East and South-East Asia,China,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,1.5,CHN
Asia,East and South-East Asia,China,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,92,CHN
Asia,East and South-East Asia,China,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,176.6,CHN
Asia,East and South-East Asia,China,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,0.7118,CHN
Asia,East and South-East Asia,China,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,1299.6,CHN
Asia,East and South-East Asia,China,Opioids,Opiates,Heroin,2022,1306.6,CHN
Asia,East and South-East Asia,China,Opioids,Opiates,Illicit morphine,2022,40.5,CHN
Asia,East and South-East Asia,China,Opioids,Opiates,Opium,2022,1159.1,CHN
Asia,East and South-East Asia,China,Opioids,Opiates,Poppy plants,2022,306,CHN
Asia,East and South-East Asia,China,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.1203,CHN
Asia,East and South-East Asia,China,Opioids,Pharmaceutical opioids,Codeine,2022,17.7,CHN
Asia,East and South-East Asia,China,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.00003,CHN
Asia,East and South-East Asia,China,Opioids,Pharmaceutical opioids,Methadone,2022,90.1,CHN
Asia,East and South-East Asia,China,Opioids,Pharmaceutical opioids,Oxycodone,2022,0.5194,CHN
Asia,East and South-East Asia,China,Opioids,Pharmaceutical opioids,Tramadol,2022,63.2,CHN
Asia,East and South-East Asia,China,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2022,81.5,CHN
Asia,East and South-East Asia,China,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,,CHN
Asia,East and South-East Asia,China,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2023,14246.225,CHN
Asia,East and South-East Asia,China,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,421.24273,CHN
Asia,East and South-East Asia,China,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,5.5491,CHN
Asia,East and South-East Asia,China,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,99.37681,CHN
Asia,East and South-East Asia,China,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,0.15276,CHN
Asia,East and South-East Asia,China,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,2568.38669,CHN
Asia,East and South-East Asia,China,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.03628,CHN
Asia,East and South-East Asia,China,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,735,CHN
Asia,East and South-East Asia,China,Opioids,Opiates,Heroin,2023,1505.65671,CHN
Asia,East and South-East Asia,China,Opioids,Opiates,Illicit morphine,2023,143.74803,CHN
Asia,East and South-East Asia,China,Opioids,Opiates,Opium,2023,1403.15392,CHN
Asia,East and South-East Asia,China,Opioids,Opiates,Poppy plants,2023,18.32409,CHN
Asia,East and South-East Asia,China,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.34825,CHN
Asia,East and South-East Asia,China,Opioids,Pharmaceutical opioids,Codeine,2023,32.81418,CHN
Asia,East and South-East Asia,China,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.15314,CHN
Asia,East and South-East Asia,China,Opioids,Pharmaceutical opioids,Methadone,2023,23.1767,CHN
Asia,East and South-East Asia,China,Opioids,Pharmaceutical opioids,Oxycodone,2023,2.83552,CHN
Asia,East and South-East Asia,China,Opioids,Pharmaceutical opioids,Tramadol,2023,93.73391,CHN
Asia,East and South-East Asia,China,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.78934,CHN
Asia,East and South-East Asia,China,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2023,2.57851,CHN
Asia,East and South-East Asia,China,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,72,CHN
Asia,East and South-East Asia,China,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2019,1,CHN
Asia,East and South-East Asia,China,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2019,100,CHN
Asia,East and South-East Asia,China,Any other drugs/substances,Other miscellaneous,Caffeine,2019,3907,CHN
Asia,East and South-East Asia,China,Any other drugs/substances,Other miscellaneous,Non-specified,2019,193,CHN
Asia,East and South-East Asia,China,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2019,399,CHN
Asia,East and South-East Asia,China,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,5,CHN
Asia,East and South-East Asia,China,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,250,CHN
Asia,East and South-East Asia,China,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,2560,CHN
Asia,East and South-East Asia,China,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,3354,CHN
Asia,East and South-East Asia,China,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,CHN
Asia,East and South-East Asia,China,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (Spice),2019,6,CHN
Asia,East and South-East Asia,China,Opioids,Opiates,Illicit morphine,2019,218,CHN
Asia,East and South-East Asia,China,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2019,2954,CHN
Asia,East and South-East Asia,China,Opioids,Pharmaceutical opioids,Buprenorphine,2019,0,CHN
Asia,East and South-East Asia,China,Opioids,Pharmaceutical opioids,Codeine,2019,1638,CHN
Asia,East and South-East Asia,China,Opioids,Pharmaceutical opioids,Fentanyl,2019,9,CHN
Asia,East and South-East Asia,China,Opioids,Pharmaceutical opioids,Methadone,2019,32,CHN
Asia,East and South-East Asia,China,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,18,CHN
Asia,East and South-East Asia,China,Opioids,Pharmaceutical opioids,Tramadol,2019,32,CHN
Asia,East and South-East Asia,China,Sedatives and tranquillizers,Barbiturates,Barbiturates,2019,0,CHN
Asia,East and South-East Asia,China,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2019,0,CHN
Asia,East and South-East Asia,China,Sedatives and tranquillizers,Benzodiazepines,"Nimetazepam (Erimin, “Happy Five”)",2019,59,CHN
Asia,East and South-East Asia,China,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,356,CHN
Asia,East and South-East Asia,China,Sedatives and tranquillizers,Methaqualone,Methaqualone,2019,2,CHN
Asia,East and South-East Asia,China,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,12155,CHN
Asia,East and South-East Asia,China,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,12946,CHN
Asia,East and South-East Asia,China,Amphetamine-type stimulants (excluding “ecstasy”),Non-specified amphetamine-type stimulants,Non-specified amphetamine-type stimulants,2019,104,CHN
Asia,East and South-East Asia,China,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Non-specified cannabis-type,2019,8773,CHN
Asia,East and South-East Asia,China,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,155,CHN
Asia,East and South-East Asia,China,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,1762,CHN
Asia,East and South-East Asia,China,Opioids,Opiates,Heroin,2019,6136,CHN
Asia,East and South-East Asia,China,Opioids,Opiates,Opium,2019,2908,CHN
Asia,East and South-East Asia,"China, Hong Kong SAR",“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,1.755,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,98.085,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.0225,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.217,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,1498.6,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,991.237,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,2.706,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,67.7,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,79.529,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,0.952,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,1269.2,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cocaine-type,Cocaine,Cocaine hydrochloride,2020,3.001,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.139,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,0.0034,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,472.9,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,31.73,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,472.87,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,Opiates,Heroin,2020,367.8,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,Opiates,Illicit morphine,2020,0.065,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,Opiates,Opium,2020,15.695,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,Pharmaceutical opioids,Codeine,2020,0.551,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,Pharmaceutical opioids,Methadone,2020,0.024,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,Pharmaceutical opioids,Methadone,2020,0.025,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,Pharmaceutical opioids,Methadone,2020,0.0236,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,1.245,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.11066,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2020,593.63,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2020,0.239,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2020,0.624,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,65,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,19.3644,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2021,1986.9,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,1583.4,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,1.8,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,72.9,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,63.5,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,5,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cocaine-type,Cocaine,"""Crack"" cocaine",2021,26,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cocaine-type,Cocaine,Cocaine hydrochloride,2021,46,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cocaine-type,Cocaine,Cocaine hydrochloride,2021,2731.5,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.0000032,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,20.1,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,3018.7,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,3296,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,Opiates,Heroin,2021,513.8,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,Opiates,Opium,2021,5,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,Pharmaceutical opioids,Methadone,2021,0.01745,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.04902,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.02762,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,45.6,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,1,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,6.3,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,124.6,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,2.7996,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,1796,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,2520.7,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,63.4,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,0.5,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cocaine-type,Cocaine,"""Crack"" cocaine",2022,37,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cocaine-type,Cocaine,Cocaine hydrochloride,2022,2160.9,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,716,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,Opiates,Heroin,2022,307.6,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,Opiates,Opium,2022,0.7,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.03316,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2022,3810.6,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,153.9,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.5112,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,3247,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,3069,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,295.7,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cocaine-type,Cocaine,"""Crack"" cocaine",2023,41,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cocaine-type,Cocaine,Cocaine hydrochloride,2023,3496,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,2672,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,Opiates,Heroin,2023,675,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,Opiates,Opium,2023,131.6,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,Pharmaceutical opioids,Fentanyl,2023,3.2,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.02,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2023,15.1,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,72,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,23,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,570,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,133,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,10,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2019,37,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2019,9,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2019,29,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,187,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,193,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,0,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,24,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,44,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,20,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cocaine-type,Cocaine,"""Crack"" cocaine",2019,24,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cocaine-type,Cocaine,Cocaine hydrochloride,2019,1556,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cocaine-type,Cocaine,Non-specified cocaine,2019,2,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Cocaine-type,Coca-type,Coca leaf,2019,0,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Hallucinogens,Other Hallucinogens,Other hallucinogens,2019,1,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,259,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,2,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",NPS,Plant-based NPS,Khat,2019,116,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",NPS,Synthetic cathinones,Synthetic cathinones,2019,65,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,Opiates,Heroin,2019,47,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,Opiates,Illicit morphine,2019,8,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,Opiates,Illicit morphine,2019,0,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,Opiates,Opium,2019,6,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,Pharmaceutical opioids,Fentanyl,2019,0,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,Pharmaceutical opioids,Methadone,2019,0,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,Pharmaceutical opioids,Methadone,2019,1,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Opioids,Pharmaceutical opioids,Oxycodone,2019,0,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2019,0,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2019,0,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,1,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,10,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,1,HKG
Asia,East and South-East Asia,"China, Hong Kong SAR",Sedatives and tranquillizers,GBL/GHB,GBL,2019,186,HKG
Asia,East and South-East Asia,"China, Macao SAR",“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.003,MAC
Asia,East and South-East Asia,"China, Macao SAR",Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.734666,MAC
Asia,East and South-East Asia,"China, Macao SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,0.210439,MAC
Asia,East and South-East Asia,"China, Macao SAR",Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,3.89197,MAC
Asia,East and South-East Asia,"China, Macao SAR",Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.0000005,MAC
Asia,East and South-East Asia,"China, Macao SAR",NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,0.292987,MAC
Asia,East and South-East Asia,"China, Macao SAR",Opioids,Opiates,Heroin,2020,0.03329,MAC
Asia,East and South-East Asia,"China, Macao SAR",Opioids,Pharmaceutical opioids,Codeine,2020,9.94,MAC
Asia,East and South-East Asia,"China, Macao SAR",Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.00001,MAC
Asia,East and South-East Asia,"China, Macao SAR",Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.04,MAC
Asia,East and South-East Asia,"China, Macao SAR",Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2020,0.001,MAC
Asia,East and South-East Asia,"China, Macao SAR",“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.033722,MAC
Asia,East and South-East Asia,"China, Macao SAR",“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.0264,MAC
Asia,East and South-East Asia,"China, Macao SAR",Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.00045,MAC
Asia,East and South-East Asia,"China, Macao SAR",Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.881436,MAC
Asia,East and South-East Asia,"China, Macao SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,1.869303,MAC
Asia,East and South-East Asia,"China, Macao SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,0.2358,MAC
Asia,East and South-East Asia,"China, Macao SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,1.480258,MAC
Asia,East and South-East Asia,"China, Macao SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,0.5,MAC
Asia,East and South-East Asia,"China, Macao SAR",Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2021,0.025715,MAC
Asia,East and South-East Asia,"China, Macao SAR",Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2021,7.475,MAC
Asia,East and South-East Asia,"China, Macao SAR",Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.00000105,MAC
Asia,East and South-East Asia,"China, Macao SAR",Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2021,0.000281,MAC
Asia,East and South-East Asia,"China, Macao SAR",Opioids,Pharmaceutical opioids,Methadone,2021,0.00005,MAC
Asia,East and South-East Asia,"China, Macao SAR",Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.012,MAC
Asia,East and South-East Asia,"China, Macao SAR",Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.00354,MAC
Asia,East and South-East Asia,"China, Macao SAR",Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,0.024,MAC
Asia,East and South-East Asia,"China, Macao SAR",“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.3429,MAC
Asia,East and South-East Asia,"China, Macao SAR",Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.00045,MAC
Asia,East and South-East Asia,"China, Macao SAR",Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,1.2169,MAC
Asia,East and South-East Asia,"China, Macao SAR",Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,2.9142,MAC
Asia,East and South-East Asia,"China, Macao SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,0.8361,MAC
Asia,East and South-East Asia,"China, Macao SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,1.0395,MAC
Asia,East and South-East Asia,"China, Macao SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,0.055,MAC
Asia,East and South-East Asia,"China, Macao SAR",Cocaine-type,Cocaine,"""Crack"" cocaine",2022,0.164782,MAC
Asia,East and South-East Asia,"China, Macao SAR",Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,0.00992,MAC
Asia,East and South-East Asia,"China, Macao SAR",Opioids,Opiates,Heroin,2022,0.040937,MAC
Asia,East and South-East Asia,"China, Macao SAR",Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,,MAC
Asia,East and South-East Asia,"China, Macao SAR",Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,,MAC
Asia,East and South-East Asia,"China, Macao SAR",Sedatives and tranquillizers,Non-specified sedatives and tranquillizers,Non-specified sedatives and tranquillizers,2022,0.00456,MAC
Asia,East and South-East Asia,"China, Macao SAR",“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.002405,MAC
Asia,East and South-East Asia,"China, Macao SAR",“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.0846,MAC
Asia,East and South-East Asia,"China, Macao SAR",Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.67825,MAC
Asia,East and South-East Asia,"China, Macao SAR",Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Phentermine,2023,0.015,MAC
Asia,East and South-East Asia,"China, Macao SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,0.1712,MAC
Asia,East and South-East Asia,"China, Macao SAR",Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2023,74.83522,MAC
Asia,East and South-East Asia,"China, Macao SAR",Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.00000005,MAC
Asia,East and South-East Asia,"China, Macao SAR",Opioids,Opiates,Heroin,2023,2.518978,MAC
Asia,East and South-East Asia,"China, Macao SAR",Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,0.0009,MAC
Asia,East and South-East Asia,"China, Macao SAR",“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,0,MAC
Asia,East and South-East Asia,"China, Macao SAR",Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2019,0,MAC
Asia,East and South-East Asia,"China, Macao SAR",Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,MAC
Asia,East and South-East Asia,"China, Macao SAR",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,0,MAC
Asia,East and South-East Asia,"China, Macao SAR",Cocaine-type,Cocaine,Non-specified cocaine,2019,5,MAC
Asia,East and South-East Asia,"China, Macao SAR",NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,0,MAC
Asia,East and South-East Asia,"China, Macao SAR",NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (Spice),2019,0,MAC
Asia,East and South-East Asia,"China, Macao SAR",Opioids,Opiates,Heroin,2019,0,MAC
Asia,East and South-East Asia,"China, Macao SAR",Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,MAC
Asia,East and South-East Asia,"China, Taiwan Province of China",“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2019,24,TWN
Asia,East and South-East Asia,"China, Taiwan Province of China",Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,1595,TWN
Asia,East and South-East Asia,"China, Taiwan Province of China",Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,120,TWN
Asia,East and South-East Asia,"China, Taiwan Province of China",NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,4184,TWN
Asia,East and South-East Asia,"China, Taiwan Province of China",Opioids,Opiates,Heroin,2019,536,TWN
Asia,East and South-East Asia,"China, Taiwan Province of China",Precursors,Precursors,Ephedrine,2019,934,TWN
Asia,East and South-East Asia,"China, Taiwan Province of China",Precursors,Precursors,Pseudoephedrine,2019,59,TWN
Asia,East and South-East Asia,Indonesia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,14.4,IDN
Asia,East and South-East Asia,Indonesia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,463.0008,IDN
Asia,East and South-East Asia,Indonesia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,7905.7,IDN
Asia,East and South-East Asia,Indonesia,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2020,492.4,IDN
Asia,East and South-East Asia,Indonesia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,53573,IDN
Asia,East and South-East Asia,Indonesia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,1653.9,IDN
Asia,East and South-East Asia,Indonesia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,0.06459,IDN
Asia,East and South-East Asia,Indonesia,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,0.5,IDN
Asia,East and South-East Asia,Indonesia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,8.2,IDN
Asia,East and South-East Asia,Indonesia,NPS,Synthetic cannabinoids (Spice),ADB-CHMINACA,2020,338.3045,IDN
Asia,East and South-East Asia,Indonesia,Opioids,Opiates,Heroin,2020,44,IDN
Asia,East and South-East Asia,Indonesia,Opioids,Pharmaceutical opioids,Tramadol,2020,0.2999,IDN
Asia,East and South-East Asia,Indonesia,Sedatives and tranquillizers,Barbiturates,Barbiturates,2020,6.5774,IDN
Asia,East and South-East Asia,Indonesia,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2020,0.00006,IDN
Asia,East and South-East Asia,Indonesia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,5.74421,IDN
Asia,East and South-East Asia,Indonesia,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,161.68211,IDN
Asia,East and South-East Asia,Indonesia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,11.73,IDN
Asia,East and South-East Asia,Indonesia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,261.8532,IDN
Asia,East and South-East Asia,Indonesia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,11743.52597,IDN
Asia,East and South-East Asia,Indonesia,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2021,337.91227,IDN
Asia,East and South-East Asia,Indonesia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,115857.6769,IDN
Asia,East and South-East Asia,Indonesia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,14696.3,IDN
Asia,East and South-East Asia,Indonesia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,0.9797,IDN
Asia,East and South-East Asia,Indonesia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,0.60493,IDN
Asia,East and South-East Asia,Indonesia,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,1.41121,IDN
Asia,East and South-East Asia,Indonesia,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2021,1.18526,IDN
Asia,East and South-East Asia,Indonesia,Opioids,Opiates,Heroin,2021,28.09997,IDN
Asia,East and South-East Asia,Indonesia,Sedatives and tranquillizers,Barbiturates,Barbiturates,2021,48.886,IDN
Asia,East and South-East Asia,Indonesia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.88901,IDN
Asia,East and South-East Asia,Indonesia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,482.856675,IDN
Asia,East and South-East Asia,Indonesia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,8560,IDN
Asia,East and South-East Asia,Indonesia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,124320,IDN
Asia,East and South-East Asia,Indonesia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,0.0127,IDN
Asia,East and South-East Asia,Indonesia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,35952.5,IDN
Asia,East and South-East Asia,Indonesia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,0.00926,IDN
Asia,East and South-East Asia,Indonesia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,0.22328,IDN
Asia,East and South-East Asia,Indonesia,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2022,65.11,IDN
Asia,East and South-East Asia,Indonesia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,3.37,IDN
Asia,East and South-East Asia,Indonesia,NPS,Piperazines,Piperazines,2022,1.6586,IDN
Asia,East and South-East Asia,Indonesia,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2022,24,IDN
Asia,East and South-East Asia,Indonesia,Opioids,Opiates,Heroin,2022,0.26849,IDN
Asia,East and South-East Asia,Indonesia,Opioids,Pharmaceutical opioids,Codeine,2022,0.0162,IDN
Asia,East and South-East Asia,Indonesia,Sedatives and tranquillizers,Barbiturates,Barbiturates,2022,22.1475,IDN
Asia,East and South-East Asia,Indonesia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,1.44175,IDN
Asia,East and South-East Asia,Indonesia,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2022,3.65405,IDN
Asia,East and South-East Asia,Indonesia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.35121,IDN
Asia,East and South-East Asia,Indonesia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,618.94695,IDN
Asia,East and South-East Asia,Indonesia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,9280,IDN
Asia,East and South-East Asia,Indonesia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,5.508,IDN
Asia,East and South-East Asia,Indonesia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,IDN
Asia,East and South-East Asia,Indonesia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,9890,IDN
Asia,East and South-East Asia,Indonesia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,3.4,IDN
Asia,East and South-East Asia,Indonesia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,0.63659,IDN
Asia,East and South-East Asia,Indonesia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,0.14894,IDN
Asia,East and South-East Asia,Indonesia,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,13.56,IDN
Asia,East and South-East Asia,Indonesia,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2023,4.82,IDN
Asia,East and South-East Asia,Indonesia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,0.008,IDN
Asia,East and South-East Asia,Indonesia,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2023,223.42,IDN
Asia,East and South-East Asia,Indonesia,Opioids,Opiates,Heroin,2023,1.11,IDN
Asia,East and South-East Asia,Indonesia,Sedatives and tranquillizers,Barbiturates,Barbiturates,2023,11.743,IDN
Asia,East and South-East Asia,Indonesia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,1.56388,IDN
Asia,East and South-East Asia,Indonesia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2019,,IDN
Asia,East and South-East Asia,Indonesia,Any other drugs/substances,Substances not under int. control,Other substances not under int. control,2019,0,IDN
Asia,East and South-East Asia,Indonesia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,2,IDN
Asia,East and South-East Asia,Indonesia,Cocaine-type,Cocaine,Non-specified cocaine,2019,8,IDN
Asia,East and South-East Asia,Indonesia,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (Spice),2019,18,IDN
Asia,East and South-East Asia,Indonesia,NPS,Synthetic cathinones,Synthetic cathinones,2019,134,IDN
Asia,East and South-East Asia,Indonesia,Opioids,Opiates,Illicit morphine,2019,0,IDN
Asia,East and South-East Asia,Indonesia,Opioids,Pharmaceutical opioids,Tramadol,2019,8,IDN
Asia,East and South-East Asia,Indonesia,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2019,0,IDN
Asia,East and South-East Asia,Indonesia,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,143,IDN
Asia,East and South-East Asia,Indonesia,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,461,IDN
Asia,East and South-East Asia,Indonesia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,17928,IDN
Asia,East and South-East Asia,Indonesia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,35087,IDN
Asia,East and South-East Asia,Indonesia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,11470,IDN
Asia,East and South-East Asia,Indonesia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,0,IDN
Asia,East and South-East Asia,Indonesia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,11,IDN
Asia,East and South-East Asia,Indonesia,Opioids,Opiates,Heroin,2019,24,IDN
Asia,East and South-East Asia,Indonesia,Sedatives and tranquillizers,Barbiturates,Barbiturates,2019,7,IDN
Asia,East and South-East Asia,Indonesia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,IDN
Asia,East and South-East Asia,Japan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,3.62,JPN
Asia,East and South-East Asia,Japan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,31.8924,JPN
Asia,East and South-East Asia,Japan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.06751,JPN
Asia,East and South-East Asia,Japan,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2020,0.02475,JPN
Asia,East and South-East Asia,Japan,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2020,824.45,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,299.1,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,2.97,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,31.95,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,37.89,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,1170.5,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,3.6,JPN
Asia,East and South-East Asia,Japan,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,0.0005,JPN
Asia,East and South-East Asia,Japan,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,821.7,JPN
Asia,East and South-East Asia,Japan,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,0.0019,JPN
Asia,East and South-East Asia,Japan,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,0.01995,JPN
Asia,East and South-East Asia,Japan,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,2.4328,JPN
Asia,East and South-East Asia,Japan,Opioids,Opiates,Heroin,2020,14.8,JPN
Asia,East and South-East Asia,Japan,Opioids,Opiates,Illicit morphine,2020,0.00001,JPN
Asia,East and South-East Asia,Japan,Opioids,Opiates,Opium,2020,0.00306,JPN
Asia,East and South-East Asia,Japan,Opioids,Opiates,Poppy plants,2020,28.965,JPN
Asia,East and South-East Asia,Japan,Opioids,Pharmaceutical opioids,Codeine,2020,0.002,JPN
Asia,East and South-East Asia,Japan,Sedatives and tranquillizers,Barbiturates,Barbiturates,2020,0.019,JPN
Asia,East and South-East Asia,Japan,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.048455,JPN
Asia,East and South-East Asia,Japan,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,0.00735,JPN
Asia,East and South-East Asia,Japan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,11.99,JPN
Asia,East and South-East Asia,Japan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,24.1869,JPN
Asia,East and South-East Asia,Japan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,1484.55,JPN
Asia,East and South-East Asia,Japan,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2021,0.8688,JPN
Asia,East and South-East Asia,Japan,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2021,0.75525,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,0.54113,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,88.34,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,115.8,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,2.9,JPN
Asia,East and South-East Asia,Japan,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,15.1,JPN
Asia,East and South-East Asia,Japan,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,1.72,JPN
Asia,East and South-East Asia,Japan,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,0.366,JPN
Asia,East and South-East Asia,Japan,Opioids,Opiates,Heroin,2021,0.00168,JPN
Asia,East and South-East Asia,Japan,Opioids,Opiates,Opium,2021,5.8,JPN
Asia,East and South-East Asia,Japan,Opioids,Opiates,Poppy plants,2021,87.4,JPN
Asia,East and South-East Asia,Japan,Opioids,Pharmaceutical opioids,Codeine,2021,0.0004,JPN
Asia,East and South-East Asia,Japan,Opioids,Pharmaceutical opioids,Codeine,2021,0.08129,JPN
Asia,East and South-East Asia,Japan,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.02011,JPN
Asia,East and South-East Asia,Japan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.286842,JPN
Asia,East and South-East Asia,Japan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,33.114884,JPN
Asia,East and South-East Asia,Japan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,475.315597,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,330.738199,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,89.989198,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,849.2,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,5.585692,JPN
Asia,East and South-East Asia,Japan,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,42.804782,JPN
Asia,East and South-East Asia,Japan,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.024544,JPN
Asia,East and South-East Asia,Japan,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0011535,JPN
Asia,East and South-East Asia,Japan,Opioids,Opiates,Heroin,2022,0.000009,JPN
Asia,East and South-East Asia,Japan,Opioids,Pharmaceutical opioids,Codeine,2022,0.01156,JPN
Asia,East and South-East Asia,Japan,Sedatives and tranquillizers,Barbiturates,Barbiturates,2022,0.001,JPN
Asia,East and South-East Asia,Japan,Sedatives and tranquillizers,Barbiturates,Barbiturates,2022,0.016456,JPN
Asia,East and South-East Asia,Japan,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.466548,JPN
Asia,East and South-East Asia,Japan,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.11214,JPN
Asia,East and South-East Asia,Japan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,35.875,JPN
Asia,East and South-East Asia,Japan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,1603.079,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,849.899,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,28.266,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,1.048,JPN
Asia,East and South-East Asia,Japan,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,56.22,JPN
Asia,East and South-East Asia,Japan,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.037,JPN
Asia,East and South-East Asia,Japan,Opioids,Opiates,Heroin,2023,0.001188,JPN
Asia,East and South-East Asia,Japan,Opioids,Opiates,Illicit morphine,2023,0.014268,JPN
Asia,East and South-East Asia,Japan,Opioids,Opiates,Opium,2023,0.000824,JPN
Asia,East and South-East Asia,Japan,Opioids,Pharmaceutical opioids,Codeine,2023,0.001282,JPN
Asia,East and South-East Asia,Japan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2019,0,JPN
Asia,East and South-East Asia,Japan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2019,22,JPN
Asia,East and South-East Asia,Japan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,2650,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,430,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,0,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,1,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,3,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,38,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,1148,JPN
Asia,East and South-East Asia,Japan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,15,JPN
Asia,East and South-East Asia,Japan,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,640,JPN
Asia,East and South-East Asia,Japan,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,JPN
Asia,East and South-East Asia,Japan,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,JPN
Asia,East and South-East Asia,Japan,Opioids,Opiates,Heroin,2019,17,JPN
Asia,East and South-East Asia,Japan,Opioids,Opiates,Illicit morphine,2019,0,JPN
Asia,East and South-East Asia,Japan,Opioids,Opiates,Opium,2019,0,JPN
Asia,East and South-East Asia,Japan,Sedatives and tranquillizers,Barbiturates,Barbiturates,2019,0,JPN
Asia,East and South-East Asia,Japan,Sedatives and tranquillizers,Barbiturates,Barbiturates,2019,0,JPN
Asia,East and South-East Asia,Japan,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,JPN
Asia,East and South-East Asia,Japan,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,JPN
Asia,East and South-East Asia,Lao People's Democratic Republic,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,1534.32175,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2020,1674.261,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,5564.4,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,5167.6,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Opioids,Opiates,Heroin,2020,537.2,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Opioids,Opiates,Opium,2020,60.3,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2021,12870.693,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,2990.96,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,5846.698,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,4.11,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Opioids,Opiates,Heroin,2021,467.795,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Opioids,Opiates,Opium,2021,18.845,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2022,12959.208,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,2209.9,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,12014.3,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2022,3,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,1930.4,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Opioids,Opiates,Heroin,2022,175.8,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Opioids,Opiates,Opium,2022,251.1,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,4043.1,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,8637.33483,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,1044.8,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,5628.2,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,1044.78,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Opioids,Opiates,Heroin,2023,487.6,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Precursors,Non-specified precursors,Non-specified precursors,2023,26248.4,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,5106,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,1593,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,2577,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,3,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Opioids,Opiates,Heroin,2019,174,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Opioids,Opiates,Opium,2019,89,LAO
Asia,East and South-East Asia,Lao People's Democratic Republic,Precursors,Non-specified precursors,Non-specified precursors,2019,13141,LAO
Asia,East and South-East Asia,Malaysia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,1096,MYS
Asia,East and South-East Asia,Malaysia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2020,207,MYS
Asia,East and South-East Asia,Malaysia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,864.95,MYS
Asia,East and South-East Asia,Malaysia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,13517.2,MYS
Asia,East and South-East Asia,Malaysia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,5426.8,MYS
Asia,East and South-East Asia,Malaysia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,5.9,MYS
Asia,East and South-East Asia,Malaysia,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,11.34,MYS
Asia,East and South-East Asia,Malaysia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,137,MYS
Asia,East and South-East Asia,Malaysia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,493.33,MYS
Asia,East and South-East Asia,Malaysia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,3004.2,MYS
Asia,East and South-East Asia,Malaysia,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2020,296123.14,MYS
Asia,East and South-East Asia,Malaysia,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2020,75545.13,MYS
Asia,East and South-East Asia,Malaysia,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2020,75545.1,MYS
Asia,East and South-East Asia,Malaysia,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2020,148.0604,MYS
Asia,East and South-East Asia,Malaysia,Opioids,Opiates,Heroin,2020,930.3,MYS
Asia,East and South-East Asia,Malaysia,Opioids,Opiates,Opium,2020,0.001,MYS
Asia,East and South-East Asia,Malaysia,Opioids,Pharmaceutical opioids,Codeine,2020,4187.8,MYS
Asia,East and South-East Asia,Malaysia,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,927.38,MYS
Asia,East and South-East Asia,Malaysia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,1058.65,MYS
Asia,East and South-East Asia,Malaysia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,188.52,MYS
Asia,East and South-East Asia,Malaysia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,10039.52,MYS
Asia,East and South-East Asia,Malaysia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,368040.39,MYS
Asia,East and South-East Asia,Malaysia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,76212.79,MYS
Asia,East and South-East Asia,Malaysia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,3728.28,MYS
Asia,East and South-East Asia,Malaysia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,6.4,MYS
Asia,East and South-East Asia,Malaysia,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,5.84,MYS
Asia,East and South-East Asia,Malaysia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,474.61,MYS
Asia,East and South-East Asia,Malaysia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,474.61,MYS
Asia,East and South-East Asia,Malaysia,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2021,76212.79,MYS
Asia,East and South-East Asia,Malaysia,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2021,184.020195,MYS
Asia,East and South-East Asia,Malaysia,Opioids,Opiates,Heroin,2021,2166.49,MYS
Asia,East and South-East Asia,Malaysia,Opioids,Opiates,Opium,2021,0.08,MYS
Asia,East and South-East Asia,Malaysia,Opioids,Pharmaceutical opioids,Codeine,2021,6452.75,MYS
Asia,East and South-East Asia,Malaysia,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,2033.96,MYS
Asia,East and South-East Asia,Malaysia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,335.77,MYS
Asia,East and South-East Asia,Malaysia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2022,383.63,MYS
Asia,East and South-East Asia,Malaysia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,8298.41,MYS
Asia,East and South-East Asia,Malaysia,Amphetamine-type stimulants (excluding “ecstasy”),Non-specified amphetamine-type stimulants,Non-specified amphetamine-type stimulants,2022,49.59,MYS
Asia,East and South-East Asia,Malaysia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,52.41,MYS
Asia,East and South-East Asia,Malaysia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,10.49,MYS
Asia,East and South-East Asia,Malaysia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,8120.89,MYS
Asia,East and South-East Asia,Malaysia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,18.5,MYS
Asia,East and South-East Asia,Malaysia,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,20.07,MYS
Asia,East and South-East Asia,Malaysia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,3007.27,MYS
Asia,East and South-East Asia,Malaysia,Opioids,Opiates,Heroin,2022,717.72,MYS
Asia,East and South-East Asia,Malaysia,Opioids,Opiates,Opium,2022,1.38,MYS
Asia,East and South-East Asia,Malaysia,Opioids,Pharmaceutical opioids,Codeine,2022,3255.4,MYS
Asia,East and South-East Asia,Malaysia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,158.72,MYS
Asia,East and South-East Asia,Malaysia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,6863.33,MYS
Asia,East and South-East Asia,Malaysia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,585.75,MYS
Asia,East and South-East Asia,Malaysia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,10591.6,MYS
Asia,East and South-East Asia,Malaysia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,28.22,MYS
Asia,East and South-East Asia,Malaysia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,4.24,MYS
Asia,East and South-East Asia,Malaysia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,4800.45,MYS
Asia,East and South-East Asia,Malaysia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,18.1,MYS
Asia,East and South-East Asia,Malaysia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,3.9,MYS
Asia,East and South-East Asia,Malaysia,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,293.66,MYS
Asia,East and South-East Asia,Malaysia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,1540.74,MYS
Asia,East and South-East Asia,Malaysia,Opioids,Opiates,Heroin,2023,950.06,MYS
Asia,East and South-East Asia,Malaysia,Opioids,Opiates,Opium,2023,10.21,MYS
Asia,East and South-East Asia,Malaysia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,577.49,MYS
Asia,East and South-East Asia,Malaysia,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,225,MYS
Asia,East and South-East Asia,Malaysia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,5831,MYS
Asia,East and South-East Asia,Malaysia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2019,151,MYS
Asia,East and South-East Asia,Malaysia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2019,308,MYS
Asia,East and South-East Asia,Malaysia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,664,MYS
Asia,East and South-East Asia,Malaysia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,9,MYS
Asia,East and South-East Asia,Malaysia,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,15247,MYS
Asia,East and South-East Asia,Malaysia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,1266,MYS
Asia,East and South-East Asia,Malaysia,NPS,Plant-based NPS,Khat,2019,21,MYS
Asia,East and South-East Asia,Malaysia,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2019,101516,MYS
Asia,East and South-East Asia,Malaysia,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2019,180181,MYS
Asia,East and South-East Asia,Malaysia,Opioids,Opiates,Heroin,2019,710,MYS
Asia,East and South-East Asia,Malaysia,Opioids,Opiates,Opium,2019,0,MYS
Asia,East and South-East Asia,Malaysia,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,13313,MYS
Asia,East and South-East Asia,Malaysia,Sedatives and tranquillizers,Benzodiazepines,"Nimetazepam (Erimin, “Happy Five”)",2019,4052,MYS
Asia,East and South-East Asia,Mongolia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.3352,MNG
Asia,East and South-East Asia,Mongolia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0,MNG
Asia,East and South-East Asia,Mongolia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0.3261,MNG
Asia,East and South-East Asia,Mongolia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0,MNG
Asia,East and South-East Asia,Mongolia,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2022,0.3,MNG
Asia,East and South-East Asia,Mongolia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,106.03,MNG
Asia,East and South-East Asia,Mongolia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,0.372,MNG
Asia,East and South-East Asia,Mongolia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,1.088,MNG
Asia,East and South-East Asia,Mongolia,Opioids,Opiates,Illicit morphine,2022,0.0163,MNG
Asia,East and South-East Asia,Mongolia,Opioids,Pharmaceutical opioids,Tramadol,2022,0.0007,MNG
Asia,East and South-East Asia,Mongolia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.00011,MNG
Asia,East and South-East Asia,Mongolia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,3.46155,MNG
Asia,East and South-East Asia,Mongolia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,121.455,MNG
Asia,East and South-East Asia,Mongolia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,0.07,MNG
Asia,East and South-East Asia,Mongolia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.0000001,MNG
Asia,East and South-East Asia,Mongolia,Opioids,Opiates,Opium,2023,0.0102,MNG
Asia,East and South-East Asia,Myanmar,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.7311,MMR
Asia,East and South-East Asia,Myanmar,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,2145.23,MMR
Asia,East and South-East Asia,Myanmar,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2020,29556.96228,MMR
Asia,East and South-East Asia,Myanmar,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,19509.1,MMR
Asia,East and South-East Asia,Myanmar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,737.6,MMR
Asia,East and South-East Asia,Myanmar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,1.3,MMR
Asia,East and South-East Asia,Myanmar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,5.007,MMR
Asia,East and South-East Asia,Myanmar,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,888.52642,MMR
Asia,East and South-East Asia,Myanmar,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,888.5,MMR
Asia,East and South-East Asia,Myanmar,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2020,2632.7,MMR
Asia,East and South-East Asia,Myanmar,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2020,2632.72,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Opiates,Heroin,2020,1853.4,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Opiates,Illicit morphine,2020,49.06,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Opiates,Opium,2020,3882.9,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.0055,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Pharmaceutical opioids,Methadone,2020,2.322,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Pharmaceutical opioids,Tramadol,2020,5.51255,MMR
Asia,East and South-East Asia,Myanmar,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,46.86,MMR
Asia,East and South-East Asia,Myanmar,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.613,MMR
Asia,East and South-East Asia,Myanmar,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,43.9242,MMR
Asia,East and South-East Asia,Myanmar,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,111.2895,MMR
Asia,East and South-East Asia,Myanmar,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2021,111.28959,MMR
Asia,East and South-East Asia,Myanmar,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2021,17836.9844,MMR
Asia,East and South-East Asia,Myanmar,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,100,MMR
Asia,East and South-East Asia,Myanmar,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,13815.7754,MMR
Asia,East and South-East Asia,Myanmar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,503.7159,MMR
Asia,East and South-East Asia,Myanmar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,10.7,MMR
Asia,East and South-East Asia,Myanmar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,0.01,MMR
Asia,East and South-East Asia,Myanmar,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,762.212,MMR
Asia,East and South-East Asia,Myanmar,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,10,MMR
Asia,East and South-East Asia,Myanmar,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,762.0212,MMR
Asia,East and South-East Asia,Myanmar,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2021,1058.4805,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Opiates,Heroin,2021,1,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Opiates,Heroin,2021,2526.1091,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Opiates,Opium,2021,2632.0097,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.055,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Pharmaceutical opioids,Tramadol,2021,8,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Pharmaceutical opioids,Tramadol,2021,0.30275,MMR
Asia,East and South-East Asia,Myanmar,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,5,MMR
Asia,East and South-East Asia,Myanmar,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,20.7,MMR
Asia,East and South-East Asia,Myanmar,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,18.55316,MMR
Asia,East and South-East Asia,Myanmar,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,202.3626,MMR
Asia,East and South-East Asia,Myanmar,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,279.6371,MMR
Asia,East and South-East Asia,Myanmar,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2022,15216.38181,MMR
Asia,East and South-East Asia,Myanmar,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,23401.92,MMR
Asia,East and South-East Asia,Myanmar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,929.43,MMR
Asia,East and South-East Asia,Myanmar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,9.1,MMR
Asia,East and South-East Asia,Myanmar,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,2328.624,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Opiates,Heroin,2022,1345.498,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Opiates,Opium,2022,1209.771,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Pharmaceutical opioids,Codeine,2022,3.54,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Pharmaceutical opioids,Fentanyl,2022,23.5,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Pharmaceutical opioids,Methadone,2022,0.1,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Pharmaceutical opioids,Tramadol,2022,0.00275,MMR
Asia,East and South-East Asia,Myanmar,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.04,MMR
Asia,East and South-East Asia,Myanmar,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,19.6146,MMR
Asia,East and South-East Asia,Myanmar,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,17829.34476,MMR
Asia,East and South-East Asia,Myanmar,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,22800.69,MMR
Asia,East and South-East Asia,Myanmar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,686.74,MMR
Asia,East and South-East Asia,Myanmar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,1.6,MMR
Asia,East and South-East Asia,Myanmar,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,4053.78,MMR
Asia,East and South-East Asia,Myanmar,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2023,4053.775,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Opiates,Heroin,2023,1873.362993,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Opiates,Opium,2023,518.25268,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.24,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Pharmaceutical opioids,Methadone,2023,0.48,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Pharmaceutical opioids,Tramadol,2023,0.555,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Pharmaceutical opioids,Tramadol,2023,21.35155,MMR
Asia,East and South-East Asia,Myanmar,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,1.27,MMR
Asia,East and South-East Asia,Myanmar,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.01,MMR
Asia,East and South-East Asia,Myanmar,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2019,8,MMR
Asia,East and South-East Asia,Myanmar,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,679,MMR
Asia,East and South-East Asia,Myanmar,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2019,9785,MMR
Asia,East and South-East Asia,Myanmar,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,9426,MMR
Asia,East and South-East Asia,Myanmar,Any other drugs/substances,Substances not under int. control,Other substances not under int. control,2019,2543,MMR
Asia,East and South-East Asia,Myanmar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,365,MMR
Asia,East and South-East Asia,Myanmar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,2,MMR
Asia,East and South-East Asia,Myanmar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,380,MMR
Asia,East and South-East Asia,Myanmar,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,1096,MMR
Asia,East and South-East Asia,Myanmar,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,0,MMR
Asia,East and South-East Asia,Myanmar,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2019,2543,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Opiates,Heroin,2019,690,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Opiates,Opium,2019,1553,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Pharmaceutical opioids,Buprenorphine,2019,0,MMR
Asia,East and South-East Asia,Myanmar,Opioids,Pharmaceutical opioids,Tramadol,2019,0,MMR
Asia,East and South-East Asia,Myanmar,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2019,0,MMR
Asia,East and South-East Asia,Philippines,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,12.8382,PHL
Asia,East and South-East Asia,Philippines,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.7,PHL
Asia,East and South-East Asia,Philippines,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2020,2196.02676,PHL
Asia,East and South-East Asia,Philippines,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,1474.4,PHL
Asia,East and South-East Asia,Philippines,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,237983.5,PHL
Asia,East and South-East Asia,Philippines,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,12.23,PHL
Asia,East and South-East Asia,Philippines,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,1.4,PHL
Asia,East and South-East Asia,Philippines,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2020,3.5,PHL
Asia,East and South-East Asia,Philippines,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,0.26535,PHL
Asia,East and South-East Asia,Philippines,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,22.4358,PHL
Asia,East and South-East Asia,Philippines,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,0.39466,PHL
Asia,East and South-East Asia,Philippines,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.39466,PHL
Asia,East and South-East Asia,Philippines,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,7.87,PHL
Asia,East and South-East Asia,Philippines,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,2302.71276,PHL
Asia,East and South-East Asia,Philippines,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,0.0035,PHL
Asia,East and South-East Asia,Philippines,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,2.649,PHL
Asia,East and South-East Asia,Philippines,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2021,0.02253,PHL
Asia,East and South-East Asia,Philippines,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,620.27182,PHL
Asia,East and South-East Asia,Philippines,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,8.76539,PHL
Asia,East and South-East Asia,Philippines,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,583639.9,PHL
Asia,East and South-East Asia,Philippines,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,2.19558,PHL
Asia,East and South-East Asia,Philippines,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,77.20168,PHL
Asia,East and South-East Asia,Philippines,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,1.16549,PHL
Asia,East and South-East Asia,Philippines,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2021,0.0079,PHL
Asia,East and South-East Asia,Philippines,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.01316,PHL
Asia,East and South-East Asia,Philippines,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,0.78,PHL
Asia,East and South-East Asia,Philippines,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,,PHL
Asia,East and South-East Asia,Philippines,Opioids,Pharmaceutical opioids,Tramadol,2021,0.08795,PHL
Asia,East and South-East Asia,Philippines,Precursors,Precursors,Ephedrine,2021,6.2755,PHL
Asia,East and South-East Asia,Philippines,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.08453,PHL
Asia,East and South-East Asia,Philippines,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.04291,PHL
Asia,East and South-East Asia,Philippines,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,0.54119,PHL
Asia,East and South-East Asia,Philippines,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,9.0639,PHL
Asia,East and South-East Asia,Philippines,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,4260.93563,PHL
Asia,East and South-East Asia,Philippines,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0.02133,PHL
Asia,East and South-East Asia,Philippines,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,3922.54917,PHL
Asia,East and South-East Asia,Philippines,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,6.23449,PHL
Asia,East and South-East Asia,Philippines,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,703093,PHL
Asia,East and South-East Asia,Philippines,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,1.07121,PHL
Asia,East and South-East Asia,Philippines,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,13.49727,PHL
Asia,East and South-East Asia,Philippines,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,1.34659,PHL
Asia,East and South-East Asia,Philippines,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2022,0.00345,PHL
Asia,East and South-East Asia,Philippines,Precursors,Precursors,Ephedrine,2022,6.2755,PHL
Asia,East and South-East Asia,Philippines,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.27561,PHL
Asia,East and South-East Asia,Philippines,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,3.94313,PHL
Asia,East and South-East Asia,Philippines,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,10.5375,PHL
Asia,East and South-East Asia,Philippines,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2023,0.00929,PHL
Asia,East and South-East Asia,Philippines,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.40316,PHL
Asia,East and South-East Asia,Philippines,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,2186.19016,PHL
Asia,East and South-East Asia,Philippines,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,2123.72372,PHL
Asia,East and South-East Asia,Philippines,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,1.32362,PHL
Asia,East and South-East Asia,Philippines,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,402835.7,PHL
Asia,East and South-East Asia,Philippines,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,0.791,PHL
Asia,East and South-East Asia,Philippines,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,1.28594,PHL
Asia,East and South-East Asia,Philippines,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,3.5,PHL
Asia,East and South-East Asia,Philippines,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,40.5552,PHL
Asia,East and South-East Asia,Philippines,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2023,0.00233699,PHL
Asia,East and South-East Asia,Philippines,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,2.39,PHL
Asia,East and South-East Asia,Philippines,Opioids,Opiates,Heroin,2023,4.79029,PHL
Asia,East and South-East Asia,Philippines,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2023,4.9404,PHL
Asia,East and South-East Asia,Philippines,Precursors,Precursors,Acetone,2023,25.3,PHL
Asia,East and South-East Asia,Philippines,Precursors,Precursors,Ephedrine,2023,1.97319,PHL
Asia,East and South-East Asia,Philippines,Precursors,Precursors,Hydrochloric acid,2023,15,PHL
Asia,East and South-East Asia,Philippines,Sedatives and tranquillizers,Benzodiazepines,"Flunitrazepam (Disomnilan, Flumipam, Rohypnol)",2023,0.00004,PHL
Asia,East and South-East Asia,Philippines,Sedatives and tranquillizers,Benzodiazepines,"Nimetazepam (Erimin, “Happy Five”)",2023,0.00018,PHL
Asia,East and South-East Asia,Philippines,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2023,0.697,PHL
Asia,East and South-East Asia,Philippines,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,4,PHL
Asia,East and South-East Asia,Philippines,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,2071,PHL
Asia,East and South-East Asia,Philippines,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,2,PHL
Asia,East and South-East Asia,Philippines,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,1,PHL
Asia,East and South-East Asia,Philippines,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,6,PHL
Asia,East and South-East Asia,Philippines,Sedatives and tranquillizers,GBL/GHB,GBL,2019,2,PHL
Asia,East and South-East Asia,Philippines,Sedatives and tranquillizers,Methaqualone,Methaqualone,2019,0,PHL
Asia,East and South-East Asia,Philippines,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,980,PHL
Asia,East and South-East Asia,Philippines,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,221797,PHL
Asia,East and South-East Asia,Philippines,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,347,PHL
Asia,East and South-East Asia,Philippines,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,0,PHL
Asia,East and South-East Asia,Philippines,Precursors,Precursors,Ephedrine,2019,0,PHL
Asia,East and South-East Asia,Republic of Korea,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,11.914,KOR
Asia,East and South-East Asia,Republic of Korea,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,10.8309,KOR
Asia,East and South-East Asia,Republic of Korea,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2020,2.05065,KOR
Asia,East and South-East Asia,Republic of Korea,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2020,22.786,KOR
Asia,East and South-East Asia,Republic of Korea,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,63.6,KOR
Asia,East and South-East Asia,Republic of Korea,Any other drugs/substances,Synthetic cannabinoids under international control,JWH-018,2020,3.2,KOR
Asia,East and South-East Asia,Republic of Korea,Any other drugs/substances,Synthetic cannabinoids under international control,JWH-018,2020,3.166,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,37.3,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,43.21,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,132.6,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,3,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,5.9,KOR
Asia,East and South-East Asia,Republic of Korea,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,48,KOR
Asia,East and South-East Asia,Republic of Korea,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.023,KOR
Asia,East and South-East Asia,Republic of Korea,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2020,0.119,KOR
Asia,East and South-East Asia,Republic of Korea,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2020,0.06,KOR
Asia,East and South-East Asia,Republic of Korea,Hallucinogens,Other Hallucinogens,Psilocybine,2020,0.093,KOR
Asia,East and South-East Asia,Republic of Korea,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,2.658,KOR
Asia,East and South-East Asia,Republic of Korea,Opioids,Opiates,Heroin,2020,0.0088,KOR
Asia,East and South-East Asia,Republic of Korea,Opioids,Opiates,Opium,2020,0.1873,KOR
Asia,East and South-East Asia,Republic of Korea,Opioids,Opiates,Poppy plants,2020,17425,KOR
Asia,East and South-East Asia,Republic of Korea,Opioids,Pharmaceutical opioids,Codeine,2020,0.001,KOR
Asia,East and South-East Asia,Republic of Korea,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.102,KOR
Asia,East and South-East Asia,Republic of Korea,Opioids,Pharmaceutical opioids,Oxycodone,2020,0.015,KOR
Asia,East and South-East Asia,Republic of Korea,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.058,KOR
Asia,East and South-East Asia,Republic of Korea,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.22,KOR
Asia,East and South-East Asia,Republic of Korea,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2020,29.188,KOR
Asia,East and South-East Asia,Republic of Korea,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,11.984,KOR
Asia,East and South-East Asia,Republic of Korea,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2021,50.137,KOR
Asia,East and South-East Asia,Republic of Korea,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,569.87,KOR
Asia,East and South-East Asia,Republic of Korea,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2021,0.049,KOR
Asia,East and South-East Asia,Republic of Korea,Any other drugs/substances,Synthetic cannabinoids under international control,JWH-018,2021,18.747,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,91.24,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,31.727,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,342.9,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,0.14,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,0.92,KOR
Asia,East and South-East Asia,Republic of Korea,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2021,435.74,KOR
Asia,East and South-East Asia,Republic of Korea,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.052,KOR
Asia,East and South-East Asia,Republic of Korea,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2021,0.434,KOR
Asia,East and South-East Asia,Republic of Korea,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.233,KOR
Asia,East and South-East Asia,Republic of Korea,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,13.307,KOR
Asia,East and South-East Asia,Republic of Korea,Opioids,Opiates,Heroin,2021,1.213,KOR
Asia,East and South-East Asia,Republic of Korea,Opioids,Opiates,Opium,2021,0.0083,KOR
Asia,East and South-East Asia,Republic of Korea,Opioids,Opiates,Poppy plants,2021,11466.7,KOR
Asia,East and South-East Asia,Republic of Korea,Opioids,Pharmaceutical opioids,Fentanyl,2021,0.00305,KOR
Asia,East and South-East Asia,Republic of Korea,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.053,KOR
Asia,East and South-East Asia,Republic of Korea,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.078,KOR
Asia,East and South-East Asia,Republic of Korea,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.624,KOR
Asia,East and South-East Asia,Republic of Korea,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,42.17997,KOR
Asia,East and South-East Asia,Republic of Korea,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2022,167.60222,KOR
Asia,East and South-East Asia,Republic of Korea,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,175.35132,KOR
Asia,East and South-East Asia,Republic of Korea,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2022,0.12036,KOR
Asia,East and South-East Asia,Republic of Korea,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,84.94365,KOR
Asia,East and South-East Asia,Republic of Korea,Any other drugs/substances,Synthetic cannabinoids under international control,JWH-018,2022,55.69348,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,79.3004,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,81.36118,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,1.078,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,1.4125,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,1.5569,KOR
Asia,East and South-East Asia,Republic of Korea,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,0.26122,KOR
Asia,East and South-East Asia,Republic of Korea,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.04754,KOR
Asia,East and South-East Asia,Republic of Korea,Hallucinogens,Other Hallucinogens,Zopiclone,2022,0.00264,KOR
Asia,East and South-East Asia,Republic of Korea,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,30.79456,KOR
Asia,East and South-East Asia,Republic of Korea,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2022,4.65116,KOR
Asia,East and South-East Asia,Republic of Korea,Opioids,Opiates,Heroin,2022,0.03579,KOR
Asia,East and South-East Asia,Republic of Korea,Opioids,Opiates,Illicit morphine,2022,0.40927,KOR
Asia,East and South-East Asia,Republic of Korea,Opioids,Opiates,Poppy plants,2022,118.42,KOR
Asia,East and South-East Asia,Republic of Korea,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.6765,KOR
Asia,East and South-East Asia,Republic of Korea,Opioids,Pharmaceutical opioids,Codeine,2022,0.4654,KOR
Asia,East and South-East Asia,Republic of Korea,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.0154,KOR
Asia,East and South-East Asia,Republic of Korea,Opioids,Pharmaceutical opioids,Oxycodone,2022,0.56911,KOR
Asia,East and South-East Asia,Republic of Korea,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2022,1.7297,KOR
Asia,East and South-East Asia,Republic of Korea,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,6.05693,KOR
Asia,East and South-East Asia,Republic of Korea,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.07524,KOR
Asia,East and South-East Asia,Republic of Korea,Sedatives and tranquillizers,Benzodiazepines,"Lorazepam (Ativan, Temesta)",2022,0.31301,KOR
Asia,East and South-East Asia,Republic of Korea,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,42.17904,KOR
Asia,East and South-East Asia,Republic of Korea,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2023,210.81193,KOR
Asia,East and South-East Asia,Republic of Korea,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,405.00167,KOR
Asia,East and South-East Asia,Republic of Korea,Any other drugs/substances,Synthetic cannabinoids under international control,JWH-018,2023,40.98716,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,114.1547,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,3.30252,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,1195.7,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,3.18359,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,0.62007,KOR
Asia,East and South-East Asia,Republic of Korea,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,11.67179,KOR
Asia,East and South-East Asia,Republic of Korea,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,2.33303,KOR
Asia,East and South-East Asia,Republic of Korea,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,42.57933,KOR
Asia,East and South-East Asia,Republic of Korea,Opioids,Opiates,Heroin,2023,1.36207,KOR
Asia,East and South-East Asia,Republic of Korea,Opioids,Opiates,Illicit morphine,2023,16.3999,KOR
Asia,East and South-East Asia,Republic of Korea,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2019,3,KOR
Asia,East and South-East Asia,Republic of Korea,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2019,17,KOR
Asia,East and South-East Asia,Republic of Korea,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,87,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,82,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,3,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,3,KOR
Asia,East and South-East Asia,Republic of Korea,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,0,KOR
Asia,East and South-East Asia,Republic of Korea,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,107,KOR
Asia,East and South-East Asia,Republic of Korea,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (Spice),2019,2,KOR
Asia,East and South-East Asia,Republic of Korea,Opioids,Opiates,Opium,2019,0,KOR
Asia,East and South-East Asia,Singapore,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.09213,SGP
Asia,East and South-East Asia,Singapore,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,6.9423,SGP
Asia,East and South-East Asia,Singapore,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,46.81,SGP
Asia,East and South-East Asia,Singapore,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.0063,SGP
Asia,East and South-East Asia,Singapore,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2020,0.0435,SGP
Asia,East and South-East Asia,Singapore,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2020,5.55253,SGP
Asia,East and South-East Asia,Singapore,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,43.1,SGP
Asia,East and South-East Asia,Singapore,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,0.02115,SGP
Asia,East and South-East Asia,Singapore,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,3.96,SGP
Asia,East and South-East Asia,Singapore,NPS,Synthetic cathinones,Synthetic cathinones,2020,0.03089,SGP
Asia,East and South-East Asia,Singapore,NPS,Synthetic cathinones,Synthetic cathinones,2020,0.00424,SGP
Asia,East and South-East Asia,Singapore,Opioids,Opiates,Heroin,2020,72.7,SGP
Asia,East and South-East Asia,Singapore,Sedatives and tranquillizers,Benzodiazepines,"Nimetazepam (Erimin, “Happy Five”)",2020,0.64059,SGP
Asia,East and South-East Asia,Singapore,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.25227,SGP
Asia,East and South-East Asia,Singapore,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,2.7939,SGP
Asia,East and South-East Asia,Singapore,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2021,0.00261,SGP
Asia,East and South-East Asia,Singapore,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2021,0.00261,SGP
Asia,East and South-East Asia,Singapore,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,49.95,SGP
Asia,East and South-East Asia,Singapore,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0,SGP
Asia,East and South-East Asia,Singapore,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0.02155,SGP
Asia,East and South-East Asia,Singapore,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,1.225,SGP
Asia,East and South-East Asia,Singapore,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,107.08,SGP
Asia,East and South-East Asia,Singapore,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,0.00098,SGP
Asia,East and South-East Asia,Singapore,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,3.46,SGP
Asia,East and South-East Asia,Singapore,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,0.018675,SGP
Asia,East and South-East Asia,Singapore,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,3.46,SGP
Asia,East and South-East Asia,Singapore,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,0.018675,SGP
Asia,East and South-East Asia,Singapore,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2021,0.02,SGP
Asia,East and South-East Asia,Singapore,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2021,6.21198,SGP
Asia,East and South-East Asia,Singapore,NPS,Synthetic cathinones,Synthetic cathinones,2021,0.44807,SGP
Asia,East and South-East Asia,Singapore,NPS,Synthetic cathinones,Synthetic cathinones,2021,0.0555,SGP
Asia,East and South-East Asia,Singapore,Opioids,Opiates,Heroin,2021,95.43,SGP
Asia,East and South-East Asia,Singapore,Sedatives and tranquillizers,Benzodiazepines,"Nimetazepam (Erimin, “Happy Five”)",2021,0.19938,SGP
Asia,East and South-East Asia,Singapore,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,1.08,SGP
Asia,East and South-East Asia,Singapore,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2022,0.20817,SGP
Asia,East and South-East Asia,Singapore,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,28.15,SGP
Asia,East and South-East Asia,Singapore,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0,SGP
Asia,East and South-East Asia,Singapore,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0.285,SGP
Asia,East and South-East Asia,Singapore,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0.43764,SGP
Asia,East and South-East Asia,Singapore,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2022,0.12477,SGP
Asia,East and South-East Asia,Singapore,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,133.41,SGP
Asia,East and South-East Asia,Singapore,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,0.40522,SGP
Asia,East and South-East Asia,Singapore,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0000394,SGP
Asia,East and South-East Asia,Singapore,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,3.97,SGP
Asia,East and South-East Asia,Singapore,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,0.016025,SGP
Asia,East and South-East Asia,Singapore,NPS,Synthetic cathinones,Synthetic cathinones,2022,0.0087,SGP
Asia,East and South-East Asia,Singapore,NPS,Synthetic cathinones,Synthetic cathinones,2022,0.0034,SGP
Asia,East and South-East Asia,Singapore,Opioids,Opiates,Heroin,2022,68.22,SGP
Asia,East and South-East Asia,Singapore,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.10906,SGP
Asia,East and South-East Asia,Singapore,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,1.235,SGP
Asia,East and South-East Asia,Singapore,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,3.08248,SGP
Asia,East and South-East Asia,Singapore,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,2.3697,SGP
Asia,East and South-East Asia,Singapore,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2023,0.01773,SGP
Asia,East and South-East Asia,Singapore,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.01773,SGP
Asia,East and South-East Asia,Singapore,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,24.37772,SGP
Asia,East and South-East Asia,Singapore,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.285,SGP
Asia,East and South-East Asia,Singapore,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,SGP
Asia,East and South-East Asia,Singapore,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.53748,SGP
Asia,East and South-East Asia,Singapore,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,70.18903,SGP
Asia,East and South-East Asia,Singapore,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,0.11737,SGP
Asia,East and South-East Asia,Singapore,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2023,0.1195,SGP
Asia,East and South-East Asia,Singapore,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,0.031175,SGP
Asia,East and South-East Asia,Singapore,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,5.95909,SGP
Asia,East and South-East Asia,Singapore,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2023,0.00352,SGP
Asia,East and South-East Asia,Singapore,NPS,Synthetic cathinones,Synthetic cathinones,2023,0.07521,SGP
Asia,East and South-East Asia,Singapore,NPS,Synthetic cathinones,Synthetic cathinones,2023,0.06362,SGP
Asia,East and South-East Asia,Singapore,Opioids,Opiates,Heroin,2023,83.00248,SGP
Asia,East and South-East Asia,Singapore,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.0826,SGP
Asia,East and South-East Asia,Singapore,Sedatives and tranquillizers,Benzodiazepines,"Nimetazepam (Erimin, “Happy Five”)",2023,0.1239,SGP
Asia,East and South-East Asia,Singapore,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2023,0.085,SGP
Asia,East and South-East Asia,Singapore,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,0,SGP
Asia,East and South-East Asia,Singapore,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,2,SGP
Asia,East and South-East Asia,Singapore,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2019,0,SGP
Asia,East and South-East Asia,Singapore,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,31,SGP
Asia,East and South-East Asia,Singapore,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,28,SGP
Asia,East and South-East Asia,Singapore,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,0,SGP
Asia,East and South-East Asia,Singapore,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,SGP
Asia,East and South-East Asia,Singapore,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,SGP
Asia,East and South-East Asia,Singapore,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,SGP
Asia,East and South-East Asia,Singapore,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,3,SGP
Asia,East and South-East Asia,Singapore,NPS,Other NPS,Non-specified NPS,2019,0,SGP
Asia,East and South-East Asia,Singapore,NPS,Other NPS,Non-specified NPS,2019,0,SGP
Asia,East and South-East Asia,Singapore,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (Spice),2019,9,SGP
Asia,East and South-East Asia,Singapore,NPS,Synthetic cathinones,Synthetic cathinones,2019,0,SGP
Asia,East and South-East Asia,Singapore,NPS,Synthetic cathinones,Synthetic cathinones,2019,0,SGP
Asia,East and South-East Asia,Singapore,Opioids,Opiates,Heroin,2019,38,SGP
Asia,East and South-East Asia,Singapore,Opioids,Pharmaceutical opioids,Methadone,2019,0,SGP
Asia,East and South-East Asia,Singapore,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,SGP
Asia,East and South-East Asia,Singapore,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,0,SGP
Asia,East and South-East Asia,Thailand,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,121.91269,THA
Asia,East and South-East Asia,Thailand,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,119.6499,THA
Asia,East and South-East Asia,Thailand,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2020,37135.86699,THA
Asia,East and South-East Asia,Thailand,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,25072.6,THA
Asia,East and South-East Asia,Thailand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,41611.6,THA
Asia,East and South-East Asia,Thailand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,7243.98109,THA
Asia,East and South-East Asia,Thailand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,15.75105,THA
Asia,East and South-East Asia,Thailand,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,36.6,THA
Asia,East and South-East Asia,Thailand,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,1926.3,THA
Asia,East and South-East Asia,Thailand,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2020,35307.8,THA
Asia,East and South-East Asia,Thailand,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2020,40.9827,THA
Asia,East and South-East Asia,Thailand,Opioids,Opiates,Heroin,2020,1873.5,THA
Asia,East and South-East Asia,Thailand,Opioids,Opiates,Opium,2020,175.24205,THA
Asia,East and South-East Asia,Thailand,Opioids,Opiates,Poppy plants,2020,250.752,THA
Asia,East and South-East Asia,Thailand,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,178.2087,THA
Asia,East and South-East Asia,Thailand,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2021,53281.52478,THA
Asia,East and South-East Asia,Thailand,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,22126.73,THA
Asia,East and South-East Asia,Thailand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,69711.92,THA
Asia,East and South-East Asia,Thailand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,5863.69096,THA
Asia,East and South-East Asia,Thailand,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,36.11,THA
Asia,East and South-East Asia,Thailand,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,1031.89,THA
Asia,East and South-East Asia,Thailand,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,1031.89,THA
Asia,East and South-East Asia,Thailand,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2021,25408.88797,THA
Asia,East and South-East Asia,Thailand,Opioids,Opiates,Heroin,2021,3370.04,THA
Asia,East and South-East Asia,Thailand,Opioids,Opiates,Opium,2021,106.14305,THA
Asia,East and South-East Asia,Thailand,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2021,0.96135,THA
Asia,East and South-East Asia,Thailand,Sedatives and tranquillizers,Benzodiazepines,"Nimetazepam (Erimin, “Happy Five”)",2021,0.03022,THA
Asia,East and South-East Asia,Thailand,Sedatives and tranquillizers,Benzodiazepines,Valium,2021,0.00865,THA
Asia,East and South-East Asia,Thailand,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,137.3298,THA
Asia,East and South-East Asia,Thailand,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2022,48728.61675,THA
Asia,East and South-East Asia,Thailand,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,9727.13,THA
Asia,East and South-East Asia,Thailand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,5200,THA
Asia,East and South-East Asia,Thailand,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,50.21,THA
Asia,East and South-East Asia,Thailand,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,1867.49,THA
Asia,East and South-East Asia,Thailand,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2022,64.4,THA
Asia,East and South-East Asia,Thailand,Opioids,Opiates,Heroin,2022,849.45,THA
Asia,East and South-East Asia,Thailand,Precursors,Precursors,Pseudoephedrine,2022,128.79,THA
Asia,East and South-East Asia,Thailand,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,47.8818,THA
Asia,East and South-East Asia,Thailand,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2023,40581,THA
Asia,East and South-East Asia,Thailand,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,26391,THA
Asia,East and South-East Asia,Thailand,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,58408.34031,THA
Asia,East and South-East Asia,Thailand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,55.818,THA
Asia,East and South-East Asia,Thailand,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,34.7,THA
Asia,East and South-East Asia,Thailand,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,6385.33,THA
Asia,East and South-East Asia,Thailand,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,0,THA
Asia,East and South-East Asia,Thailand,Opioids,Opiates,Heroin,2023,1098.2,THA
Asia,East and South-East Asia,Thailand,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,66,THA
Asia,East and South-East Asia,Thailand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,26815,THA
Asia,East and South-East Asia,Thailand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,6512,THA
Asia,East and South-East Asia,Thailand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,87,THA
Asia,East and South-East Asia,Thailand,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,42,THA
Asia,East and South-East Asia,Thailand,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,1175,THA
Asia,East and South-East Asia,Thailand,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2019,28525,THA
Asia,East and South-East Asia,Thailand,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2019,85708,THA
Asia,East and South-East Asia,Thailand,Opioids,Opiates,Heroin,2019,723,THA
Asia,East and South-East Asia,Thailand,Opioids,Opiates,Opium,2019,1488,THA
Asia,East and South-East Asia,Thailand,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,17643,THA
Asia,East and South-East Asia,Thailand,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,35550,THA
Asia,East and South-East Asia,Timor-Leste,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,3.323,TLS
Asia,East and South-East Asia,Timor-Leste,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,200,TLS
Asia,East and South-East Asia,Viet Nam,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2020,219.28563,VNM
Asia,East and South-East Asia,Viet Nam,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,3950,VNM
Asia,East and South-East Asia,Viet Nam,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,274.8,VNM
Asia,East and South-East Asia,Viet Nam,Opioids,Opiates,Heroin,2020,841,VNM
Asia,East and South-East Asia,Viet Nam,Opioids,Opiates,Opium,2020,13.4,VNM
Asia,East and South-East Asia,Viet Nam,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2021,230.21694,VNM
Asia,East and South-East Asia,Viet Nam,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,3304,VNM
Asia,East and South-East Asia,Viet Nam,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,1756,VNM
Asia,East and South-East Asia,Viet Nam,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,304,VNM
Asia,East and South-East Asia,Viet Nam,Opioids,Opiates,Heroin,2021,764,VNM
Asia,East and South-East Asia,Viet Nam,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2022,359.8236,VNM
Asia,East and South-East Asia,Viet Nam,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,2147.8,VNM
Asia,East and South-East Asia,Viet Nam,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,467.3,VNM
Asia,East and South-East Asia,Viet Nam,Opioids,Opiates,Heroin,2022,743.7,VNM
Asia,East and South-East Asia,Viet Nam,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,7118.3,VNM
Asia,East and South-East Asia,Viet Nam,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,290.81097,VNM
Asia,East and South-East Asia,Viet Nam,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,726.9,VNM
Asia,East and South-East Asia,Viet Nam,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,335.8,VNM
Asia,East and South-East Asia,Viet Nam,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,1547,VNM
Asia,East and South-East Asia,Viet Nam,Opioids,Opiates,Heroin,2023,682.3,VNM
Asia,East and South-East Asia,Viet Nam,Opioids,Opiates,Opium,2023,125,VNM
Asia,East and South-East Asia,Viet Nam,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,5501,VNM
Asia,East and South-East Asia,Viet Nam,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,89,VNM
Asia,East and South-East Asia,Viet Nam,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,586,VNM
Asia,East and South-East Asia,Viet Nam,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,121,VNM
Asia,East and South-East Asia,Viet Nam,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,508,VNM
Asia,East and South-East Asia,Viet Nam,Opioids,Opiates,Heroin,2019,1494,VNM
Asia,East and South-East Asia,Viet Nam,Opioids,Opiates,Opium,2019,600,VNM
Asia,Near and Middle East/ South-West Asia,Afghanistan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,1198.75,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,422658,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Opioids,Opiates,Heroin,2020,3052,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Opioids,Opiates,Illicit morphine,2020,127.87,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Opioids,Opiates,Opium,2020,6753.64,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,21.57174,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,2656,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,60057,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,158892,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Opioids,Opiates,Heroin,2021,922,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Opioids,Opiates,Illicit morphine,2021,240,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Opioids,Opiates,Opium,2021,5421,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Precursors,Non-specified precursors,Non-specified precursors,2021,14801,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,1244,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,877,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,10691,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Opioids,Opiates,Heroin,2022,488,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Opioids,Opiates,Illicit morphine,2022,148,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Opioids,Opiates,Opium,2022,5685,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Opioids,Pharmaceutical opioids,Methadone,2022,24.0186,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Opioids,Pharmaceutical opioids,Tramadol,2022,12.2825,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Precursors,Non-specified precursors,Non-specified precursors,2022,297200,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,3264,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,18083,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,9.492,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Opioids,Opiates,Heroin,2023,1.002,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Opioids,Opiates,Illicit morphine,2023,72.191,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Opioids,Opiates,Opium,2023,3773,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Opioids,Other illicit opiates,Poppy seed,2023,24507,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Opioids,Pharmaceutical opioids,Methadone,2023,7.8856,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Opioids,Pharmaceutical opioids,Tramadol,2023,1.41015,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Precursors,Non-specified precursors,Non-specified precursors,2023,4509089,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Opioids,Opiates,Heroin,2019,4200,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Opioids,Opiates,Opium,2019,24200,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,1308,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,499545,AFG
Asia,Near and Middle East/ South-West Asia,Afghanistan,Opioids,Opiates,Illicit morphine,2019,11859,AFG
Asia,Near and Middle East/ South-West Asia,Bahrain,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2020,0.47498,BHR
Asia,Near and Middle East/ South-West Asia,Bahrain,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,9.797,BHR
Asia,Near and Middle East/ South-West Asia,Bahrain,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.00999,BHR
Asia,Near and Middle East/ South-West Asia,Bahrain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,17.96,BHR
Asia,Near and Middle East/ South-West Asia,Bahrain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,6.411,BHR
Asia,Near and Middle East/ South-West Asia,Bahrain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,71.54,BHR
Asia,Near and Middle East/ South-West Asia,Bahrain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,0.027,BHR
Asia,Near and Middle East/ South-West Asia,Bahrain,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,0.002,BHR
Asia,Near and Middle East/ South-West Asia,Bahrain,Opioids,Opiates,Heroin,2020,13.432,BHR
Asia,Near and Middle East/ South-West Asia,Bahrain,Opioids,Opiates,Opium,2020,0.022,BHR
Asia,Near and Middle East/ South-West Asia,Bahrain,Opioids,Other illicit opiates,Poppy seed,2020,2.564,BHR
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,20527,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,44326,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,107886,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Opioids,Opiates,Heroin,2020,31133,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Opioids,Opiates,Illicit morphine,2020,26826,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Opioids,Opiates,Opium,2020,916488,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,25170,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,52950,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,124299,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Opioids,Opiates,Heroin,2021,25481,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Opioids,Opiates,Illicit morphine,2021,36583,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Opioids,Opiates,Opium,2021,834865,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,30393,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,45491,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,76667,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Opioids,Opiates,Heroin,2022,17273,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Opioids,Opiates,Illicit morphine,2022,18529,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Opioids,Opiates,Opium,2022,536408,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,37248,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,61534,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,93875,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Opioids,Opiates,Heroin,2023,10275,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Opioids,Opiates,Illicit morphine,2023,14091,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Opioids,Opiates,Opium,2023,445272,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,13570,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,73928,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Opioids,Opiates,Heroin,2019,17414,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Opioids,Opiates,Illicit morphine,2019,18185,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Opioids,Opiates,Opium,2019,656258,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Opioids,Other illicit opioids,Other illicit opioids,2019,35122,IRN
Asia,Near and Middle East/ South-West Asia,Iran (Islamic Republic of),Precursors,Non-specified precursors,Non-specified precursors,2019,15000,IRN
Asia,Near and Middle East/ South-West Asia,Iraq,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2020,352,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2020,16.24656,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,184,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,397,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Opioids,Opiates,Heroin,2020,0.848,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Opioids,Opiates,Opium,2020,18,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Opioids,Pharmaceutical opioids,Codeine,2020,74.4,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Opioids,Pharmaceutical opioids,Methadone,2020,0.0675,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Opioids,Pharmaceutical opioids,Tramadol,2020,1.94,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Sedatives and tranquillizers,Barbiturates,Barbiturates,2020,0.0204,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.24,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.14,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2021,600,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2021,17,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,422,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,372,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Opioids,Opiates,Heroin,2021,20,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Opioids,Opiates,Opium,2021,35,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Opioids,Opiates,Opium,2021,0.6,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Opioids,Pharmaceutical opioids,Codeine,2021,111.6,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Opioids,Pharmaceutical opioids,Methadone,2021,0.32,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Opioids,Pharmaceutical opioids,Methadone,2021,0.0614,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Opioids,Pharmaceutical opioids,Tramadol,2021,5.5,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,0.96187,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,2010.89634,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,587,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,178,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Opioids,Opiates,Heroin,2022,22,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Opioids,Opiates,Opium,2022,20,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.0325,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Opioids,Pharmaceutical opioids,Tramadol,2022,6.5,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.19324,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.14823,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,106,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,118,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,147,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Opioids,Opiates,Heroin,2019,1,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Opioids,Opiates,Opium,2019,27,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Opioids,Pharmaceutical opioids,Methadone,2019,0,IRQ
Asia,Near and Middle East/ South-West Asia,Iraq,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,IRQ
Asia,Near and Middle East/ South-West Asia,Israel,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,33.6,ISR
Asia,Near and Middle East/ South-West Asia,Israel,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,45.642171,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.10659,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,51,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2020,300,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,19200,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,1400,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,821.5,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.932,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.0002876,ISR
Asia,Near and Middle East/ South-West Asia,Israel,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,6.05,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Opioids,Opiates,Heroin,2020,45,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.0164,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Opioids,Pharmaceutical opioids,Methadone,2020,2.7,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2020,38.8,ISR
Asia,Near and Middle East/ South-West Asia,Israel,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,19.925064,ISR
Asia,Near and Middle East/ South-West Asia,Israel,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,208,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,5.00276,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,102,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.38664,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,2.8,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2021,0.20825,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,165,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,11.5,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,581,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2021,125,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.018,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2021,1,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2021,0.011,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,1.546,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Opioids,Opiates,Heroin,2021,7,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Opioids,Opiates,Illicit morphine,2021,0.015,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Opioids,Opiates,Illicit morphine,2021,0.007,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.053,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.04035,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Opioids,Pharmaceutical opioids,Methadone,2021,1.9,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Opioids,Pharmaceutical opioids,Oxycodone,2021,2.4,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.128,ISR
Asia,Near and Middle East/ South-West Asia,Israel,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,16.4,ISR
Asia,Near and Middle East/ South-West Asia,Jordan,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2020,2051.9646,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,31.677,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,273,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,2079.689,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,48.662,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Opioids,Opiates,Heroin,2020,3.6,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2020,13.4997,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2021,5277.18828,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,85.86,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,127,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,3509.982,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,10.59,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Opioids,Opiates,Heroin,2021,0.282,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2021,7.6313,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2022,11800.15849,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,56.689,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,56.68,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,7313.313,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,130.7,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Opioids,Opiates,Heroin,2022,37.55,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2022,11.334,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2023,3216.2487,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,70.437,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,70.47,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,6242.91,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,141.57,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Opioids,Opiates,Heroin,2023,6.46,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2023,7.88845,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,3910,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2019,288,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2019,3,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,67,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,3233,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,4,JOR
Asia,Near and Middle East/ South-West Asia,Jordan,Opioids,Opiates,Heroin,2019,8,JOR
Asia,Near and Middle East/ South-West Asia,Kuwait,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,686,KWT
Asia,Near and Middle East/ South-West Asia,Kuwait,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,70,KWT
Asia,Near and Middle East/ South-West Asia,Kuwait,Any other drugs/substances,Other miscellaneous,Psychotropic substances,2019,0,KWT
Asia,Near and Middle East/ South-West Asia,Kuwait,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,33,KWT
Asia,Near and Middle East/ South-West Asia,Kuwait,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,48,KWT
Asia,Near and Middle East/ South-West Asia,Kuwait,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,0,KWT
Asia,Near and Middle East/ South-West Asia,Kuwait,Opioids,Opiates,Heroin,2019,26,KWT
Asia,Near and Middle East/ South-West Asia,Lebanon,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,0.336777,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2020,174.15667,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,41,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.005,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,3.066,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.425,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,24766.092,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,66.0742,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,0.432525,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Opioids,Opiates,Heroin,2020,5.036,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.0025,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Opioids,Pharmaceutical opioids,Codeine,2020,7.5,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Opioids,Pharmaceutical opioids,Tramadol,2020,0.9394,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.01204,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.0018,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,1.029528,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2021,5135.79741,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,458,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,4.156,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.00328,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,17.859,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,1.964,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,0.7,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,15419.87,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,685,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,29.195,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.0000001,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,0.76,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,NPS,Plant-based NPS,Salvia divinorum,2021,17.959,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Opioids,Opiates,Heroin,2021,1.306,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.00075,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Opioids,Pharmaceutical opioids,Codeine,2021,29.9,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Opioids,Pharmaceutical opioids,Tramadol,2021,2.91265,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.02334,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,0.6,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,0.29065,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,0.828078,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2022,0.01474,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2022,693.13369,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,1.302,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,25.4,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,8100.65,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,23.85,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Opioids,Opiates,Heroin,2022,1.81,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Opioids,Pharmaceutical opioids,Tramadol,2022,0.33455,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.0153,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,0.22623,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2019,0,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2019,0,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,6,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2019,662,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2019,0,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,7,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,1226,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,1,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,3217,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,0,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,1000,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,64,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Hallucinogens,Other Hallucinogens,Other hallucinogens,2019,0,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,0,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Opioids,Opiates,Heroin,2019,11,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Opioids,Pharmaceutical opioids,Tramadol,2019,2,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Precursors,Non-specified precursors,Other precursors,2019,18,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Precursors,Precursors,Acetic anhydride,2019,1,LBN
Asia,Near and Middle East/ South-West Asia,Lebanon,Solvents and Inhalants,Solvents and Inhalants,Solvents and inhalants,2019,0,LBN
Asia,Near and Middle East/ South-West Asia,Oman,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,921.1623,OMN
Asia,Near and Middle East/ South-West Asia,Oman,Opioids,Opiates,Heroin,2020,39.59382,OMN
Asia,Near and Middle East/ South-West Asia,Oman,Opioids,Opiates,Illicit morphine,2020,154.50213,OMN
Asia,Near and Middle East/ South-West Asia,Oman,Opioids,Opiates,Opium,2020,4.982,OMN
Asia,Near and Middle East/ South-West Asia,Oman,Any other drugs/substances,Other miscellaneous,Psychotropic substances,2019,1,OMN
Asia,Near and Middle East/ South-West Asia,Oman,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,11,OMN
Asia,Near and Middle East/ South-West Asia,Oman,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,3794,OMN
Asia,Near and Middle East/ South-West Asia,Oman,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,19,OMN
Asia,Near and Middle East/ South-West Asia,Oman,NPS,Plant-based NPS,Khat,2019,16950,OMN
Asia,Near and Middle East/ South-West Asia,Oman,Opioids,Opiates,Heroin,2019,3,OMN
Asia,Near and Middle East/ South-West Asia,Oman,Opioids,Opiates,Illicit morphine,2019,27,OMN
Asia,Near and Middle East/ South-West Asia,Oman,Opioids,Opiates,Opium,2019,12,OMN
Asia,Near and Middle East/ South-West Asia,Pakistan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,9.08658,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,407.47,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,1864.43,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,46.5,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,6083.85,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,6084.073,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,11044.87,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,354355.16,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,203.264,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,92.65,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,92.65,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Opioids,Opiates,Heroin,2020,27895,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Opioids,Opiates,Illicit morphine,2020,17629.96,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Opioids,Opiates,Opium,2020,47109.8,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2020,10902.99,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Precursors,Precursors,Acetic anhydride,2020,14135,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Precursors,Precursors,Acetic anhydride,2020,14135,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Precursors,Precursors,Ephedrine,2020,5.5,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Precursors,Precursors,Ephedrine,2020,5.5,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Precursors,Precursors,Hydrochloric acid,2020,437,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Precursors,Precursors,Hydrochloric acid,2020,437,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Precursors,Precursors,Sulphuric acid,2020,1175,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Precursors,Precursors,Sulphuric acid,2020,1175,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Sedatives and tranquillizers,Barbiturates,Barbiturates,2020,10.164,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2020,9.793,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2020,69.61,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,9.793,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,2.8577,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Sedatives and tranquillizers,Benzodiazepines,Bromazepam,2020,0.011,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2020,14.774,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,2.6979,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Sedatives and tranquillizers,Benzodiazepines,Valium,2020,2.557,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,5.187456,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,2467.136,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,1735.4,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,29893,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,1129.857,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,164708.383,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,22.213,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,50,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Opioids,Opiates,Heroin,2021,9637.569,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Opioids,Opiates,Illicit morphine,2021,10145.146,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Opioids,Opiates,Opium,2021,35571.398,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2021,29892.275,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Precursors,Precursors,Acetic anhydride,2021,1026,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Precursors,Precursors,Hydrochloric acid,2021,2447.246,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,12.59,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,3.04013,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,282.114,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,1724.277,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,5107.267,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,624.198,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,28.147,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,147873.293,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,28.239,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,2446.16,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Opioids,Opiates,Heroin,2022,11982.41,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Opioids,Opiates,Illicit morphine,2022,2977.192,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Opioids,Opiates,Opium,2022,18927.446,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2022,3139.187,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Precursors,Precursors,Acetic anhydride,2022,9743,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Precursors,Precursors,Hydrochloric acid,2022,16018.72,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,11.132,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,15.128,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,2007.229,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,1281.853,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,19.3,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,14022.358,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,102435.575,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,2.87,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Opioids,Opiates,Heroin,2023,6673.542,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Opioids,Opiates,Illicit morphine,2023,93.074,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Opioids,Opiates,Opium,2023,7092.309,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2023,3110.677,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,2,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,1024,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,870,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,39299,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,162589,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,82,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,151,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Opioids,Opiates,Heroin,2019,8458,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Opioids,Opiates,Illicit morphine,2019,6333,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Opioids,Opiates,Opium,2019,29579,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2019,2104,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2019,1,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2019,1,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2019,1,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Any other drugs/substances,Other miscellaneous,Alcohol,2019,1112,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Precursors,Non-specified precursors,Acetone,2019,20174,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Precursors,Non-specified precursors,Hydrochloric acid,2019,5731,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Precursors,Non-specified precursors,Potassium permanganate,2019,4850,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Precursors,Non-specified precursors,Sulphuric acid,2019,6300,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Precursors,Precursors,Acetic anhydride,2019,19060,PAK
Asia,Near and Middle East/ South-West Asia,Pakistan,Precursors,Precursors,Ephedrine,2019,80,PAK
Asia,Near and Middle East/ South-West Asia,Qatar,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,77.102,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,386.682,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,10.545,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,Opioids,Opiates,Heroin,2020,11.296,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,Opioids,Opiates,Opium,2020,0.794,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.00559,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.373275,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2022,87.06,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,1.279,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2022,603.8555,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,29.016,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,0.05211,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,774.115,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,21.75,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,20.467,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,Opioids,Opiates,Heroin,2022,22.669,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,Opioids,Opiates,Opium,2022,0.18882,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2022,20.552,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.0142,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,Opioids,Pharmaceutical opioids,Codeine,2022,0.0028,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,Opioids,Pharmaceutical opioids,Methadone,2022,0.16615,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,Opioids,Pharmaceutical opioids,Oxycodone,2022,0.0005,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,Opioids,Pharmaceutical opioids,Tramadol,2022,0.27415,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.01534,QAT
Asia,Near and Middle East/ South-West Asia,Qatar,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.00351,QAT
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2020,29027,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,105,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,1107,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,0.148,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,4.7,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,26628,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,785.263,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,444.402,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,NPS,Plant-based NPS,Khat,2020,189903,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Opioids,Opiates,Heroin,2020,18.418,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Opioids,Opiates,Opium,2020,18.002,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2020,7.075,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Opioids,Pharmaceutical opioids,Tramadol,2020,4.432,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.039,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2021,72486.85267,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,140.553,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,316,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,0.1382,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,236,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,4700,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,0.00003,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,0.0015,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,28.056,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Opioids,Opiates,Heroin,2021,1.454,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Opioids,Opiates,Illicit morphine,2021,0.000299,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Opioids,Opiates,Opium,2021,0.09,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Opioids,Opiates,Poppy plants,2021,526.426,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Opioids,Pharmaceutical opioids,Tramadol,2021,21.4399,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,24790,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,199,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2019,204,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,21739,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,0,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,615,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,NPS,Plant-based NPS,Khat,2019,1575453,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Opioids,Opiates,Heroin,2019,29,SAU
Asia,Near and Middle East/ South-West Asia,Saudi Arabia,Opioids,Opiates,Opium,2019,13,SAU
Asia,Near and Middle East/ South-West Asia,State of Palestine,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.0193,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,1.993881,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2020,0.00085,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.036,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,73.804,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,347.8,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,41.692,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Cocaine-type,Cocaine,"""Crack"" cocaine",2020,0.0367,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Opioids,Opiates,Heroin,2020,0.668,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.097,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.834003,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2021,2.93981,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.144,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.471,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,29.33,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,25.55,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2021,1.32,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Opioids,Opiates,Heroin,2021,0.123,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Opioids,Pharmaceutical opioids,Tramadol,2021,0.021,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,0.34316,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,0.999666,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.184,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.228,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.02358,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,32.349,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,0.025,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,51.835,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2023,0.081,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Opioids,Opiates,Heroin,2023,0.25,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Opioids,Pharmaceutical opioids,Methadone,2023,0.004,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Opioids,Pharmaceutical opioids,Methadone,2023,0.174,PSE
Asia,Near and Middle East/ South-West Asia,State of Palestine,Opioids,Pharmaceutical opioids,Tramadol,2023,0.03,PSE
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2021,2608.7163,SYR
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2021,46.2,SYR
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,0.340194,SYR
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,4141,SYR
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,113,SYR
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2021,0.34,SYR
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Opioids,Opiates,Heroin,2021,4.682,SYR
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,2.70862,SYR
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2022,6950,SYR
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,27.229,SYR
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,0.4252425,SYR
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,4964,SYR
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,2.2,SYR
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2022,0.291,SYR
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Opioids,Opiates,Heroin,2022,8.311,SYR
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2022,73,SYR
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2023,1670,SYR
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,4.215,SYR
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,2.951,SYR
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,0.1984465,SYR
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,1230,SYR
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,6.608,SYR
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2023,0.193,SYR
Asia,Near and Middle East/ South-West Asia,Syrian Arab Republic,Opioids,Opiates,Heroin,2023,1.612,SYR
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,0.277527,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2020,12567.25459,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2020,1.15263,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,1730.64,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,357.117,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,2162.989,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,16.58,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Opioids,Opiates,Heroin,2020,190.514,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Opioids,Opiates,Opium,2020,813.358,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Opioids,Pharmaceutical opioids,Codeine,2020,0.0004,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Opioids,Pharmaceutical opioids,Methadone,2020,0.907,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Opioids,Pharmaceutical opioids,Tramadol,2020,16.6022,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2020,26.48272,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,4.78078,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Sedatives and tranquillizers,Benzodiazepines,Bromazepam,2020,0.00048,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2020,0.03981,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,1.02895,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Sedatives and tranquillizers,Benzodiazepines,Oxazepam,2020,0.00066,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.419964,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2021,4989.49167,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,3798.161,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,233.699,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,2737.07,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,625.18,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Opioids,Opiates,Heroin,2021,375.554,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Opioids,Opiates,Opium,2021,11.101,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Opioids,Pharmaceutical opioids,Tramadol,2021,18.30275,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,1.99572,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.555765,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2022,3568.74727,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,1568.35,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,413.859,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,3351.712,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,72.845,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Opioids,Opiates,Heroin,2022,1631.501,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Opioids,Opiates,Opium,2022,1.904,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2022,16.87207,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.277527,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2020,12567.25459,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,1730.64,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,357.117,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,2162.989,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,16.58,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Opioids,Opiates,Heroin,2020,190.514,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Opioids,Opiates,Opium,2020,813.358,ARE
Asia,Near and Middle East/ South-West Asia,United Arab Emirates,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,4.39624,ARE
Asia,South Asia,Bangladesh,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,3274.29153,BGD
Asia,South Asia,Bangladesh,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,50078.54,BGD
Asia,South Asia,Bangladesh,Opioids,Opiates,Heroin,2020,210.438,BGD
Asia,South Asia,Bangladesh,Opioids,Pharmaceutical opioids,Buprenorphine,2020,6.2304,BGD
Asia,South Asia,Bangladesh,Opioids,Pharmaceutical opioids,Codeine,2020,100797.7,BGD
Asia,South Asia,Bangladesh,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,4776.62985,BGD
Asia,South Asia,Bangladesh,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,86696.28,BGD
Asia,South Asia,Bangladesh,Opioids,Opiates,Heroin,2021,441.221,BGD
Asia,South Asia,Bangladesh,Opioids,Pharmaceutical opioids,Buprenorphine,2021,2.4313,BGD
Asia,South Asia,Bangladesh,Opioids,Pharmaceutical opioids,Codeine,2021,57430.1,BGD
Asia,South Asia,Bangladesh,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2022,3935.42703,BGD
Asia,South Asia,Bangladesh,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,104.76,BGD
Asia,South Asia,Bangladesh,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,104308.144,BGD
Asia,South Asia,Bangladesh,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,4.57,BGD
Asia,South Asia,Bangladesh,Opioids,Opiates,Heroin,2022,298.656,BGD
Asia,South Asia,Bangladesh,Opioids,Pharmaceutical opioids,Buprenorphine,2022,9.6442,BGD
Asia,South Asia,Bangladesh,Opioids,Pharmaceutical opioids,Codeine,2022,278.46,BGD
Asia,South Asia,Bangladesh,Opioids,Pharmaceutical opioids,Codeine,2022,67195,BGD
Asia,South Asia,Bangladesh,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,32658,BGD
Asia,South Asia,Bangladesh,Opioids,Opiates,Heroin,2019,323,BGD
Asia,South Asia,Bangladesh,Opioids,Pharmaceutical opioids,Buprenorphine,2019,2,BGD
Asia,South Asia,Bangladesh,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,97666,BGD
Asia,South Asia,Bangladesh,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,“Yaba”,2019,2740,BGD
Asia,South Asia,Bhutan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,459.83,BTN
Asia,South Asia,Bhutan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,5.12,BTN
Asia,South Asia,Bhutan,Opioids,Opiates,Heroin,2020,0.0002,BTN
Asia,South Asia,Bhutan,Opioids,Pharmaceutical opioids,Tramadol,2020,,BTN
Asia,South Asia,Bhutan,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,,BTN
Asia,South Asia,Bhutan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,14.95,BTN
Asia,South Asia,Bhutan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,1.12,BTN
Asia,South Asia,Bhutan,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,0.006,BTN
Asia,South Asia,Bhutan,Opioids,Opiates,Heroin,2023,0.36,BTN
Asia,South Asia,Bhutan,Opioids,Pharmaceutical opioids,Codeine,2023,20.3,BTN
Asia,South Asia,Bhutan,Opioids,Pharmaceutical opioids,Tramadol,2023,12.19245,BTN
Asia,South Asia,Bhutan,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.02401,BTN
Asia,South Asia,Bhutan,Solvents and Inhalants,Solvents and Inhalants,Solvents and inhalants,2023,0.55,BTN
Asia,South Asia,Bhutan,Solvents and Inhalants,Solvents and Inhalants,Solvents and inhalants,2023,148.27,BTN
Asia,South Asia,Bhutan,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,1,BTN
Asia,South Asia,Bhutan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,236,BTN
Asia,South Asia,Bhutan,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,54,BTN
Asia,South Asia,Bhutan,NPS,Plant-based NPS,Khat,2019,4,BTN
Asia,South Asia,Bhutan,Opioids,Pharmaceutical opioids,Codeine,2019,33,BTN
Asia,South Asia,Bhutan,Opioids,Pharmaceutical opioids,Tramadol,2019,4,BTN
Asia,South Asia,Bhutan,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,BTN
Asia,South Asia,India,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,347,IND
Asia,South Asia,India,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,99,IND
Asia,South Asia,India,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,1258,IND
Asia,South Asia,India,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2020,275,IND
Asia,South Asia,India,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2020,0.585,IND
Asia,South Asia,India,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,581644,IND
Asia,South Asia,India,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,17,IND
Asia,South Asia,India,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,1112856.4,IND
Asia,South Asia,India,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,6643,IND
Asia,South Asia,India,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,19,IND
Asia,South Asia,India,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,0.6645,IND
Asia,South Asia,India,Opioids,Opiates,Heroin,2020,3838,IND
Asia,South Asia,India,Opioids,Opiates,Illicit morphine,2020,11,IND
Asia,South Asia,India,Opioids,Opiates,Illicit morphine,2020,684,IND
Asia,South Asia,India,Opioids,Opiates,Opium,2020,5212,IND
Asia,South Asia,India,Opioids,Opiates,Poppy plants,2020,58440.5,IND
Asia,South Asia,India,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2020,383853,IND
Asia,South Asia,India,Opioids,Pharmaceutical opioids,Codeine,2020,2229,IND
Asia,South Asia,India,Opioids,Pharmaceutical opioids,Codeine,2020,6537,IND
Asia,South Asia,India,Opioids,Pharmaceutical opioids,Tramadol,2020,242.9,IND
Asia,South Asia,India,Opioids,Pharmaceutical opioids,Tramadol,2020,933.06785,IND
Asia,South Asia,India,Sedatives and tranquillizers,Barbiturates,Methaqualone,2020,10,IND
Asia,South Asia,India,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.29035,IND
Asia,South Asia,India,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,117,IND
Asia,South Asia,India,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,61,IND
Asia,South Asia,India,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,326,IND
Asia,South Asia,India,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,138,IND
Asia,South Asia,India,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,812545,IND
Asia,South Asia,India,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,112,IND
Asia,South Asia,India,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,3223753.2,IND
Asia,South Asia,India,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,4197,IND
Asia,South Asia,India,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,364,IND
Asia,South Asia,India,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,0.6314,IND
Asia,South Asia,India,Opioids,Opiates,Heroin,2021,7197,IND
Asia,South Asia,India,Opioids,Opiates,Illicit morphine,2021,131,IND
Asia,South Asia,India,Opioids,Opiates,Opium,2021,5161,IND
Asia,South Asia,India,Opioids,Opiates,Poppy plants,2021,18580.6,IND
Asia,South Asia,India,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2021,642609,IND
Asia,South Asia,India,Opioids,Pharmaceutical opioids,Codeine,2021,660,IND
Asia,South Asia,India,Opioids,Pharmaceutical opioids,Codeine,2021,994,IND
Asia,South Asia,India,Opioids,Pharmaceutical opioids,Oxycodone,2021,2.2,IND
Asia,South Asia,India,Opioids,Pharmaceutical opioids,Tramadol,2021,148.88,IND
Asia,South Asia,India,Opioids,Pharmaceutical opioids,Tramadol,2021,209.73105,IND
Asia,South Asia,India,Sedatives and tranquillizers,Barbiturates,Methaqualone,2021,15,IND
Asia,South Asia,India,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,2.198,IND
Asia,South Asia,India,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,6.89724,IND
Asia,South Asia,India,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,63,IND
Asia,South Asia,India,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,496,IND
Asia,South Asia,India,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,727,IND
Asia,South Asia,India,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2022,2872,IND
Asia,South Asia,India,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,718376,IND
Asia,South Asia,India,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,104,IND
Asia,South Asia,India,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,3108804.3,IND
Asia,South Asia,India,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,3495,IND
Asia,South Asia,India,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,218,IND
Asia,South Asia,India,Hallucinogens,Other Hallucinogens,Psilocybine,2022,0.007,IND
Asia,South Asia,India,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,0.115,IND
Asia,South Asia,India,Opioids,Opiates,Heroin,2022,5410,IND
Asia,South Asia,India,Opioids,Opiates,Illicit morphine,2022,129,IND
Asia,South Asia,India,Opioids,Opiates,Opium,2022,3805,IND
Asia,South Asia,India,Opioids,Opiates,Poppy plants,2022,13790.5,IND
Asia,South Asia,India,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2022,398356,IND
Asia,South Asia,India,Opioids,Pharmaceutical opioids,Codeine,2022,48,IND
Asia,South Asia,India,Opioids,Pharmaceutical opioids,Codeine,2022,156,IND
Asia,South Asia,India,Opioids,Pharmaceutical opioids,Tramadol,2022,14.127,IND
Asia,South Asia,India,Opioids,Pharmaceutical opioids,Tramadol,2022,40.76435,IND
Asia,South Asia,India,Sedatives and tranquillizers,Barbiturates,Methaqualone,2022,57,IND
Asia,South Asia,India,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.2185,IND
Asia,South Asia,India,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,89,IND
Asia,South Asia,India,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,177,IND
Asia,South Asia,India,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,3229,IND
Asia,South Asia,India,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,688,IND
Asia,South Asia,India,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,628612,IND
Asia,South Asia,India,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,55,IND
Asia,South Asia,India,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,1848089.2,IND
Asia,South Asia,India,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,3320,IND
Asia,South Asia,India,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,292,IND
Asia,South Asia,India,Hallucinogens,Other Hallucinogens,Psilocybine,2023,1.375,IND
Asia,South Asia,India,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2023,3.572,IND
Asia,South Asia,India,Opioids,Opiates,Heroin,2023,2986,IND
Asia,South Asia,India,Opioids,Opiates,Illicit morphine,2023,210,IND
Asia,South Asia,India,Opioids,Opiates,Opium,2023,8533,IND
Asia,South Asia,India,Opioids,Opiates,Poppy plants,2023,61033.8,IND
Asia,South Asia,India,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2023,541987,IND
Asia,South Asia,India,Opioids,Pharmaceutical opioids,Codeine,2023,59,IND
Asia,South Asia,India,Opioids,Pharmaceutical opioids,Codeine,2023,70,IND
Asia,South Asia,India,Opioids,Pharmaceutical opioids,Tramadol,2023,813,IND
Asia,South Asia,India,Opioids,Pharmaceutical opioids,Tramadol,2023,63.9875,IND
Asia,South Asia,India,Sedatives and tranquillizers,Barbiturates,Methaqualone,2023,26,IND
Asia,South Asia,India,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,94,IND
Asia,South Asia,India,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.04645,IND
Asia,South Asia,India,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,14,IND
Asia,South Asia,India,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,149,IND
Asia,South Asia,India,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,1625,IND
Asia,South Asia,India,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2019,53,IND
Asia,South Asia,India,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2019,7575,IND
Asia,South Asia,India,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,342045,IND
Asia,South Asia,India,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,9,IND
Asia,South Asia,India,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,1151699,IND
Asia,South Asia,India,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,3572,IND
Asia,South Asia,India,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,66,IND
Asia,South Asia,India,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,IND
Asia,South Asia,India,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,IND
Asia,South Asia,India,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,647,IND
Asia,South Asia,India,NPS,Plant-based NPS,Khat,2019,952,IND
Asia,South Asia,India,Opioids,Opiates,Heroin,2019,3231,IND
Asia,South Asia,India,Opioids,Opiates,Illicit morphine,2019,125,IND
Asia,South Asia,India,Opioids,Opiates,Opium,2019,4488,IND
Asia,South Asia,India,Opioids,Opiates,Poppy plants,2019,14963,IND
Asia,South Asia,India,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2019,285506,IND
Asia,South Asia,India,Opioids,Pharmaceutical opioids,Codeine,2019,48136,IND
Asia,South Asia,India,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,500,IND
Asia,South Asia,India,Opioids,Pharmaceutical opioids,Tramadol,2019,14,IND
Asia,South Asia,India,Opioids,Pharmaceutical opioids,Tramadol,2019,130,IND
Asia,South Asia,India,Sedatives and tranquillizers,Methaqualone,Methaqualone,2019,49,IND
Asia,South Asia,India,Precursors,Precursors,Acetic anhydride,2019,218,IND
Asia,South Asia,India,Precursors,Precursors,Ephedrine,2019,684,IND
Asia,South Asia,Maldives,Any other drugs/substances,Other miscellaneous,Non-specified,2019,9,MDV
Asia,South Asia,Maldives,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,147,MDV
Asia,South Asia,Maldives,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,31,MDV
Asia,South Asia,Maldives,Opioids,Opiates,Heroin,2019,222,MDV
Asia,South Asia,Nepal,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,0,NPL
Asia,South Asia,Nepal,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,7,NPL
Asia,South Asia,Nepal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,10320,NPL
Asia,South Asia,Nepal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,2622,NPL
Asia,South Asia,Nepal,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,13,NPL
Asia,South Asia,Nepal,Opioids,Opiates,Heroin,2019,9,NPL
Asia,South Asia,Nepal,Opioids,Opiates,Opium,2019,38,NPL
Asia,South Asia,Nepal,Opioids,Pharmaceutical opioids,Buprenorphine,2019,3,NPL
Asia,South Asia,Nepal,Precursors,Precursors,Ephedrine,2019,4,NPL
Asia,South Asia,Nepal,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2019,1,NPL
Asia,South Asia,Nepal,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2019,4,NPL
Asia,South Asia,Sri Lanka,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,91.077,LKA
Asia,South Asia,Sri Lanka,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,16195.415,LKA
Asia,South Asia,Sri Lanka,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,0.671,LKA
Asia,South Asia,Sri Lanka,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,1.63,LKA
Asia,South Asia,Sri Lanka,Opioids,Opiates,Heroin,2020,1630.156,LKA
Asia,South Asia,Sri Lanka,Opioids,Opiates,Opium,2020,76.91,LKA
Asia,South Asia,Sri Lanka,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2020,9491.021,LKA
Asia,South Asia,Sri Lanka,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2020,4.0073,LKA
Asia,South Asia,Sri Lanka,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,377.293,LKA
Asia,South Asia,Sri Lanka,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,1630,LKA
Asia,South Asia,Sri Lanka,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,93.88469,LKA
Asia,South Asia,Sri Lanka,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,10.303,LKA
Asia,South Asia,Sri Lanka,Opioids,Opiates,Heroin,2021,1630.103,LKA
Asia,South Asia,Sri Lanka,Opioids,Opiates,Opium,2021,0.365376,LKA
Asia,South Asia,Sri Lanka,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,283.873,LKA
Asia,South Asia,Sri Lanka,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,17607.422,LKA
Asia,South Asia,Sri Lanka,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,3.531,LKA
Asia,South Asia,Sri Lanka,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,368.978,LKA
Asia,South Asia,Sri Lanka,Opioids,Opiates,Heroin,2022,1677.102,LKA
Asia,South Asia,Sri Lanka,Opioids,Opiates,Opium,2022,10.809,LKA
Asia,South Asia,Sri Lanka,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,83,LKA
Asia,South Asia,Sri Lanka,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,10220,LKA
Asia,South Asia,Sri Lanka,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,274,LKA
Asia,South Asia,Sri Lanka,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,25,LKA
Asia,South Asia,Sri Lanka,Opioids,Opiates,Heroin,2023,850,LKA
Asia,South Asia,Sri Lanka,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,35,LKA
Asia,South Asia,Sri Lanka,Any other drugs/substances,Other miscellaneous,Other miscellaneous,2019,6,LKA
Asia,South Asia,Sri Lanka,Any other drugs/substances,Other miscellaneous,Other miscellaneous,2019,0,LKA
Asia,South Asia,Sri Lanka,Any other drugs/substances,Other miscellaneous,Other miscellaneous,2019,0,LKA
Asia,South Asia,Sri Lanka,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,7071,LKA
Asia,South Asia,Sri Lanka,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,15,LKA
Asia,South Asia,Sri Lanka,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,11,LKA
Asia,South Asia,Sri Lanka,Opioids,Opiates,Heroin,2019,1742,LKA
Europe,Eastern Europe,Belarus,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.142073,BLR
Europe,Eastern Europe,Belarus,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.00277816,BLR
Europe,Eastern Europe,Belarus,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.142073,BLR
Europe,Eastern Europe,Belarus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,102.488107,BLR
Europe,Eastern Europe,Belarus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.715323,BLR
Europe,Eastern Europe,Belarus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,672.421042,BLR
Europe,Eastern Europe,Belarus,Cocaine-type,Cocaine,"""Crack"" cocaine",2020,0.00314632,BLR
Europe,Eastern Europe,Belarus,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.000374,BLR
Europe,Eastern Europe,Belarus,Hallucinogens,Other Hallucinogens,Psilocybine,2020,0.001464,BLR
Europe,Eastern Europe,Belarus,Opioids,Opiates,Heroin,2020,6.036627,BLR
Europe,Eastern Europe,Belarus,Opioids,Opiates,Illicit morphine,2020,0.00003,BLR
Europe,Eastern Europe,Belarus,Opioids,Opiates,Opium,2020,0.111514,BLR
Europe,Eastern Europe,Belarus,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2020,94.099964,BLR
Europe,Eastern Europe,Belarus,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.00043,BLR
Europe,Eastern Europe,Belarus,Opioids,Pharmaceutical opioids,Methadone,2020,,BLR
Europe,Eastern Europe,Belarus,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.176,BLR
Europe,Eastern Europe,Belarus,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,1.723,BLR
Europe,Eastern Europe,Belarus,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.105,BLR
Europe,Eastern Europe,Belarus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,26.539,BLR
Europe,Eastern Europe,Belarus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,0.043,BLR
Europe,Eastern Europe,Belarus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,2.424,BLR
Europe,Eastern Europe,Belarus,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,0.00203,BLR
Europe,Eastern Europe,Belarus,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.000003,BLR
Europe,Eastern Europe,Belarus,Opioids,Opiates,Heroin,2021,0.00012,BLR
Europe,Eastern Europe,Belarus,Opioids,Opiates,Opium,2021,0.06717,BLR
Europe,Eastern Europe,Belarus,Opioids,Pharmaceutical opioids,Methadone,2021,0.339,BLR
Europe,Eastern Europe,Belarus,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,1.037,BLR
Europe,Eastern Europe,Belarus,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,1.758,BLR
Europe,Eastern Europe,Belarus,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,1.248,BLR
Europe,Eastern Europe,Belarus,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2022,0.054386,BLR
Europe,Eastern Europe,Belarus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,64.008,BLR
Europe,Eastern Europe,Belarus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,0.075,BLR
Europe,Eastern Europe,Belarus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,87.894,BLR
Europe,Eastern Europe,Belarus,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,0.1032,BLR
Europe,Eastern Europe,Belarus,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.000014,BLR
Europe,Eastern Europe,Belarus,Opioids,Opiates,Heroin,2022,0.0059,BLR
Europe,Eastern Europe,Belarus,Opioids,Opiates,Illicit morphine,2022,0.001,BLR
Europe,Eastern Europe,Belarus,Opioids,Opiates,Opium,2022,0.073,BLR
Europe,Eastern Europe,Belarus,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2022,6.168,BLR
Europe,Eastern Europe,Belarus,Opioids,Pharmaceutical opioids,Methadone,2022,1.2759,BLR
Europe,Eastern Europe,Belarus,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,39.0019,BLR
Europe,Eastern Europe,Belarus,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2023,336.9683,BLR
Europe,Eastern Europe,Belarus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,88.1019,BLR
Europe,Eastern Europe,Belarus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,0.3923,BLR
Europe,Eastern Europe,Belarus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,671.2028,BLR
Europe,Eastern Europe,Belarus,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,0.3757,BLR
Europe,Eastern Europe,Belarus,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2023,0.065,BLR
Europe,Eastern Europe,Belarus,Opioids,Opiates,Heroin,2023,0.4919,BLR
Europe,Eastern Europe,Belarus,Opioids,Opiates,Illicit morphine,2023,0.00045,BLR
Europe,Eastern Europe,Belarus,Opioids,Opiates,Opium,2023,0.0167,BLR
Europe,Eastern Europe,Belarus,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2023,11.7242,BLR
Europe,Eastern Europe,Belarus,Opioids,Pharmaceutical opioids,Methadone,2023,0.5828,BLR
Europe,Eastern Europe,Belarus,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,0.505,BLR
Europe,Eastern Europe,Belarus,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,10,BLR
Europe,Eastern Europe,Belarus,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,1,BLR
Europe,Eastern Europe,Belarus,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,BLR
Europe,Eastern Europe,Belarus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,161,BLR
Europe,Eastern Europe,Belarus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,4,BLR
Europe,Eastern Europe,Belarus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,438,BLR
Europe,Eastern Europe,Belarus,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,1,BLR
Europe,Eastern Europe,Belarus,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,BLR
Europe,Eastern Europe,Belarus,NPS,Synthetic cathinones,Alpha-Pyrrolidinohexiophenone (alpha-PHP),2019,38,BLR
Europe,Eastern Europe,Belarus,NPS,Synthetic cathinones,Synthetic cathinones,2019,12,BLR
Europe,Eastern Europe,Belarus,Opioids,Opiates,Heroin,2019,551,BLR
Europe,Eastern Europe,Belarus,Opioids,Opiates,Illicit morphine,2019,0,BLR
Europe,Eastern Europe,Belarus,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2019,40,BLR
Europe,Eastern Europe,Belarus,Opioids,Other illicit opiates,Acetylated opium,2019,0,BLR
Europe,Eastern Europe,Belarus,Opioids,Other illicit opiates,Acetylated opium,2019,0,BLR
Europe,Eastern Europe,Belarus,Opioids,Pharmaceutical opioids,Methadone,2019,0,BLR
Europe,Eastern Europe,Republic of Moldova,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,14.8,MDA
Europe,Eastern Europe,Republic of Moldova,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.295,MDA
Europe,Eastern Europe,Republic of Moldova,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,82,MDA
Europe,Eastern Europe,Republic of Moldova,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,2388.6,MDA
Europe,Eastern Europe,Republic of Moldova,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,0.322,MDA
Europe,Eastern Europe,Republic of Moldova,NPS,Synthetic cathinones,Synthetic cathinones,2020,15.3,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Opiates,Heroin,2020,0.322,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2020,0.093,MDA
Europe,Eastern Europe,Republic of Moldova,Precursors,Precursors,Pseudoephedrine,2020,0.122,MDA
Europe,Eastern Europe,Republic of Moldova,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,2.35,MDA
Europe,Eastern Europe,Republic of Moldova,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,1.2,MDA
Europe,Eastern Europe,Republic of Moldova,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.306,MDA
Europe,Eastern Europe,Republic of Moldova,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,0.3,MDA
Europe,Eastern Europe,Republic of Moldova,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Pyrovalerone,2021,1.31,MDA
Europe,Eastern Europe,Republic of Moldova,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,104,MDA
Europe,Eastern Europe,Republic of Moldova,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,939.1,MDA
Europe,Eastern Europe,Republic of Moldova,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,2.9,MDA
Europe,Eastern Europe,Republic of Moldova,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,0.553,MDA
Europe,Eastern Europe,Republic of Moldova,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.00007395,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Opiates,Heroin,2021,218.4,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Opiates,Poppy plants,2021,789.4,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2021,1.1,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.02352,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Pharmaceutical opioids,Codeine,2021,0.018,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Pharmaceutical opioids,Methadone,2021,0.096,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Pharmaceutical opioids,Tramadol,2021,0.0198,MDA
Europe,Eastern Europe,Republic of Moldova,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.00286,MDA
Europe,Eastern Europe,Republic of Moldova,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,2.8,MDA
Europe,Eastern Europe,Republic of Moldova,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,1.1,MDA
Europe,Eastern Europe,Republic of Moldova,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.0254,MDA
Europe,Eastern Europe,Republic of Moldova,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Pyrovalerone,2022,37.6,MDA
Europe,Eastern Europe,Republic of Moldova,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,90.6,MDA
Europe,Eastern Europe,Republic of Moldova,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,1999.4,MDA
Europe,Eastern Europe,Republic of Moldova,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,0.77,MDA
Europe,Eastern Europe,Republic of Moldova,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,0.414,MDA
Europe,Eastern Europe,Republic of Moldova,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0000473,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Opiates,Heroin,2022,2,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Opiates,Poppy plants,2022,388.2,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2022,2.5,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.00387,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Pharmaceutical opioids,Codeine,2022,0.00145,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Pharmaceutical opioids,Methadone,2022,0.0471,MDA
Europe,Eastern Europe,Republic of Moldova,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,20.186,MDA
Europe,Eastern Europe,Republic of Moldova,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,2.177,MDA
Europe,Eastern Europe,Republic of Moldova,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.001075,MDA
Europe,Eastern Europe,Republic of Moldova,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,4.151,MDA
Europe,Eastern Europe,Republic of Moldova,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.000201,MDA
Europe,Eastern Europe,Republic of Moldova,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,66.379,MDA
Europe,Eastern Europe,Republic of Moldova,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,0.146947,MDA
Europe,Eastern Europe,Republic of Moldova,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,1381,MDA
Europe,Eastern Europe,Republic of Moldova,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,26.078,MDA
Europe,Eastern Europe,Republic of Moldova,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,0.783001,MDA
Europe,Eastern Europe,Republic of Moldova,Cocaine-type,Coca-type,Coca leaf,2023,0.000166,MDA
Europe,Eastern Europe,Republic of Moldova,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.0000172,MDA
Europe,Eastern Europe,Republic of Moldova,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2023,0.000218,MDA
Europe,Eastern Europe,Republic of Moldova,Hallucinogens,Other Hallucinogens,Other hallucinogens,2023,0.016828,MDA
Europe,Eastern Europe,Republic of Moldova,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.480227,MDA
Europe,Eastern Europe,Republic of Moldova,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,0.000606,MDA
Europe,Eastern Europe,Republic of Moldova,NPS,Synthetic cathinones,Synthetic cathinones,2023,19.441277,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Opiates,Heroin,2023,0.099141,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Opiates,Poppy plants,2023,599,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2023,0.429958,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Other illicit opiates,Acetylated opium,2023,0.004723,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.012381,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Pharmaceutical opioids,Codeine,2023,0.015252,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Pharmaceutical opioids,Hydrocodone,2023,0.000055,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Pharmaceutical opioids,Methadone,2023,63.654,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Pharmaceutical opioids,Oxycodone,2023,0.000415,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2023,0.00015,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2023,0.00004,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Pharmaceutical opioids,Tramadol,2023,499.78725,MDA
Europe,Eastern Europe,Republic of Moldova,Precursors,Precursors,Potassium permanganate,2023,0.001304,MDA
Europe,Eastern Europe,Republic of Moldova,Precursors,Precursors,Pseudoephedrine,2023,0.073121,MDA
Europe,Eastern Europe,Republic of Moldova,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2023,0.00139075,MDA
Europe,Eastern Europe,Republic of Moldova,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2023,0.00397,MDA
Europe,Eastern Europe,Republic of Moldova,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.000195,MDA
Europe,Eastern Europe,Republic of Moldova,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2023,0.000022,MDA
Europe,Eastern Europe,Republic of Moldova,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2023,0.00005,MDA
Europe,Eastern Europe,Republic of Moldova,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,3,MDA
Europe,Eastern Europe,Republic of Moldova,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,MDA
Europe,Eastern Europe,Republic of Moldova,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,MDA
Europe,Eastern Europe,Republic of Moldova,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,188,MDA
Europe,Eastern Europe,Republic of Moldova,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,0,MDA
Europe,Eastern Europe,Republic of Moldova,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,2411,MDA
Europe,Eastern Europe,Republic of Moldova,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,3,MDA
Europe,Eastern Europe,Republic of Moldova,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,0,MDA
Europe,Eastern Europe,Republic of Moldova,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Opiates,Heroin,2019,2,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Opiates,Illicit morphine,2019,0,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Opiates,Opium,2019,0,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Pharmaceutical opioids,Methadone,2019,0,MDA
Europe,Eastern Europe,Republic of Moldova,Opioids,Pharmaceutical opioids,Methadone,2019,0,MDA
Europe,Eastern Europe,Russian Federation,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,110.542,RUS
Europe,Eastern Europe,Russian Federation,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Methcathinone,2020,25.109,RUS
Europe,Eastern Europe,Russian Federation,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2020,8586.085,RUS
Europe,Eastern Europe,Russian Federation,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,9379.751,RUS
Europe,Eastern Europe,Russian Federation,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,160.359,RUS
Europe,Eastern Europe,Russian Federation,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,3087.85,RUS
Europe,Eastern Europe,Russian Federation,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,932.025,RUS
Europe,Eastern Europe,Russian Federation,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,862.424,RUS
Europe,Eastern Europe,Russian Federation,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.003,RUS
Europe,Eastern Europe,Russian Federation,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2020,0.057,RUS
Europe,Eastern Europe,Russian Federation,Hallucinogens,Other Hallucinogens,Psilocybine,2020,0.003,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,Heroin,2020,486.427,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,Illicit morphine,2020,1.474,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,Opium,2020,14.148,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,Poppy plants,2020,69.066,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2020,308.557,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Other illicit opioids,Desomorphine,2020,0.256,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.254,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Pharmaceutical opioids,Methadone,2020,87.692,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Pharmaceutical opioids,Tramadol,2020,33.392,RUS
Europe,Eastern Europe,Russian Federation,Precursors,Precursors,Acetic anhydride,2020,52,RUS
Europe,Eastern Europe,Russian Federation,Precursors,Precursors,Hydrochloric acid,2020,310,RUS
Europe,Eastern Europe,Russian Federation,Precursors,Precursors,Phenylacetone (P-2-P),2020,9.655,RUS
Europe,Eastern Europe,Russian Federation,Precursors,Precursors,Sulphuric acid,2020,74,RUS
Europe,Eastern Europe,Russian Federation,Sedatives and tranquillizers,Barbiturates,Barbiturates,2020,0.164,RUS
Europe,Eastern Europe,Russian Federation,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,2.17,RUS
Europe,Eastern Europe,Russian Federation,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2020,165.598,RUS
Europe,Eastern Europe,Russian Federation,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2020,0.16,RUS
Europe,Eastern Europe,Russian Federation,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,422,RUS
Europe,Eastern Europe,Russian Federation,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,276,RUS
Europe,Eastern Europe,Russian Federation,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,1482,RUS
Europe,Eastern Europe,Russian Federation,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,5803.4,RUS
Europe,Eastern Europe,Russian Federation,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Methcathinone,2021,35.7,RUS
Europe,Eastern Europe,Russian Federation,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2021,377.1,RUS
Europe,Eastern Europe,Russian Federation,Any other drugs/substances,Synthetic cannabinoids under international control,JWH-018,2021,13.4,RUS
Europe,Eastern Europe,Russian Federation,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,12175.2,RUS
Europe,Eastern Europe,Russian Federation,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,150.2,RUS
Europe,Eastern Europe,Russian Federation,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,24610,RUS
Europe,Eastern Europe,Russian Federation,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,2213.3,RUS
Europe,Eastern Europe,Russian Federation,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2021,871.5,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,Heroin,2021,1431.5,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,Illicit morphine,2021,9.7,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,Opium,2021,0.576,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,Poppy plants,2021,48.7,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2021,148.9,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Other illicit opioids,"3-Methylfentanyl (3-MF, mefentanyl)",2021,0.014,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Other illicit opioids,Desomorphine,2021,0.032,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Pharmaceutical opioids,Carfentanil,2021,0,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Pharmaceutical opioids,Methadone,2021,59.1,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Pharmaceutical opioids,Tramadol,2021,68.7,RUS
Europe,Eastern Europe,Russian Federation,Precursors,Precursors,Acetic anhydride,2021,3,RUS
Europe,Eastern Europe,Russian Federation,Precursors,Precursors,Ephedrine,2021,0,RUS
Europe,Eastern Europe,Russian Federation,Precursors,Precursors,Hydrochloric acid,2021,395,RUS
Europe,Eastern Europe,Russian Federation,Precursors,Precursors,Sulphuric acid,2021,0,RUS
Europe,Eastern Europe,Russian Federation,Sedatives and tranquillizers,Barbiturates,Barbiturates,2021,0.205,RUS
Europe,Eastern Europe,Russian Federation,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,4.2,RUS
Europe,Eastern Europe,Russian Federation,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,3791.2,RUS
Europe,Eastern Europe,Russian Federation,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,0.057,RUS
Europe,Eastern Europe,Russian Federation,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,55.7,RUS
Europe,Eastern Europe,Russian Federation,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Methcathinone,2022,12,RUS
Europe,Eastern Europe,Russian Federation,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2022,13665.2,RUS
Europe,Eastern Europe,Russian Federation,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2022,337.2,RUS
Europe,Eastern Europe,Russian Federation,Any other drugs/substances,Synthetic cannabinoids under international control,JWH-018,2022,13.4,RUS
Europe,Eastern Europe,Russian Federation,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,9214.9,RUS
Europe,Eastern Europe,Russian Federation,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,126.5,RUS
Europe,Eastern Europe,Russian Federation,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,2768.4,RUS
Europe,Eastern Europe,Russian Federation,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,1759.7,RUS
Europe,Eastern Europe,Russian Federation,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,231.2,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,Heroin,2022,911.7,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,Illicit morphine,2022,1.4,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,Opium,2022,16.6,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,Poppy plants,2022,64.5,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2022,350.7,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Other illicit opioids,"3-Methylfentanyl (3-MF, mefentanyl)",2022,0.023,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Other illicit opioids,Desomorphine,2022,19,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Pharmaceutical opioids,Carfentanil,2022,0.332,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Pharmaceutical opioids,Methadone,2022,214.8,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Pharmaceutical opioids,Tramadol,2022,35,RUS
Europe,Eastern Europe,Russian Federation,Precursors,Precursors,Acetic anhydride,2022,7,RUS
Europe,Eastern Europe,Russian Federation,Precursors,Precursors,Ephedrine,2022,0,RUS
Europe,Eastern Europe,Russian Federation,Precursors,Precursors,Hydrochloric acid,2022,755,RUS
Europe,Eastern Europe,Russian Federation,Precursors,Precursors,Sulphuric acid,2022,11,RUS
Europe,Eastern Europe,Russian Federation,Sedatives and tranquillizers,Barbiturates,Barbiturates,2022,0.412,RUS
Europe,Eastern Europe,Russian Federation,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.426,RUS
Europe,Eastern Europe,Russian Federation,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2022,1.031,RUS
Europe,Eastern Europe,Russian Federation,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,428.1,RUS
Europe,Eastern Europe,Russian Federation,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Methcathinone,2023,312.8,RUS
Europe,Eastern Europe,Russian Federation,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2023,15456.3,RUS
Europe,Eastern Europe,Russian Federation,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2023,178.3,RUS
Europe,Eastern Europe,Russian Federation,Any other drugs/substances,Synthetic cannabinoids under international control,JWH-018,2023,5.415,RUS
Europe,Eastern Europe,Russian Federation,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,7867.6,RUS
Europe,Eastern Europe,Russian Federation,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,122.5,RUS
Europe,Eastern Europe,Russian Federation,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,2794.9,RUS
Europe,Eastern Europe,Russian Federation,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,5314.1,RUS
Europe,Eastern Europe,Russian Federation,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,2072.5,RUS
Europe,Eastern Europe,Russian Federation,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.64,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,Heroin,2023,598.6,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,Illicit morphine,2023,0.153,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,Opium,2023,0.631,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,Poppy plants,2023,34.2,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2023,284,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Other illicit opioids,"3-Methylfentanyl (3-MF, mefentanyl)",2023,0.007,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Other illicit opioids,Desomorphine,2023,0.01,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Pharmaceutical opioids,Carfentanil,2023,8.534,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Pharmaceutical opioids,Methadone,2023,706.3,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Pharmaceutical opioids,Tramadol,2023,30.8,RUS
Europe,Eastern Europe,Russian Federation,Precursors,Precursors,Acetic anhydride,2023,78,RUS
Europe,Eastern Europe,Russian Federation,Precursors,Precursors,Ephedrine,2023,13,RUS
Europe,Eastern Europe,Russian Federation,Precursors,Precursors,Hydrochloric acid,2023,2204,RUS
Europe,Eastern Europe,Russian Federation,Precursors,Precursors,Sulphuric acid,2023,18,RUS
Europe,Eastern Europe,Russian Federation,Sedatives and tranquillizers,Barbiturates,Barbiturates,2023,0.001,RUS
Europe,Eastern Europe,Russian Federation,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.309,RUS
Europe,Eastern Europe,Russian Federation,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2023,0.047,RUS
Europe,Eastern Europe,Russian Federation,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,444,RUS
Europe,Eastern Europe,Russian Federation,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,361,RUS
Europe,Eastern Europe,Russian Federation,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,77,RUS
Europe,Eastern Europe,Russian Federation,Amphetamine-type stimulants (excluding “ecstasy”),Non-specified amphetamine-type stimulants,Non-specified amphetamine-type stimulants,2019,41,RUS
Europe,Eastern Europe,Russian Federation,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2019,785,RUS
Europe,Eastern Europe,Russian Federation,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2019,5,RUS
Europe,Eastern Europe,Russian Federation,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2019,2135,RUS
Europe,Eastern Europe,Russian Federation,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2019,0,RUS
Europe,Eastern Europe,Russian Federation,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,10102,RUS
Europe,Eastern Europe,Russian Federation,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,125,RUS
Europe,Eastern Europe,Russian Federation,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,2409,RUS
Europe,Eastern Europe,Russian Federation,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,2786,RUS
Europe,Eastern Europe,Russian Federation,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (Spice),2019,248,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,Heroin,2019,503,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,Illicit morphine,2019,1,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,Opium,2019,8,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2019,231,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Other illicit opiates,Acetylated opium,2019,0,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Other illicit opioids,Desomorphine,2019,0,RUS
Europe,Eastern Europe,Russian Federation,Opioids,Pharmaceutical opioids,Methadone,2019,1265,RUS
Europe,Eastern Europe,Russian Federation,Precursors,Non-specified precursors,Other precursors,2019,5,RUS
Europe,Eastern Europe,Russian Federation,Sedatives and tranquillizers,GBL/GHB,GBL,2019,1,RUS
Europe,Eastern Europe,Russian Federation,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,516,RUS
Europe,Eastern Europe,Ukraine,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,4.56,UKR
Europe,Eastern Europe,Ukraine,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,24.61,UKR
Europe,Eastern Europe,Ukraine,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,4.8,UKR
Europe,Eastern Europe,Ukraine,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2020,79.48,UKR
Europe,Eastern Europe,Ukraine,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,1296.47,UKR
Europe,Eastern Europe,Ukraine,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,130090.5,UKR
Europe,Eastern Europe,Ukraine,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,2.34,UKR
Europe,Eastern Europe,Ukraine,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,193.99,UKR
Europe,Eastern Europe,Ukraine,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.4,UKR
Europe,Eastern Europe,Ukraine,Opioids,Opiates,Heroin,2020,221.67,UKR
Europe,Eastern Europe,Ukraine,Opioids,Opiates,Opium,2020,0.46,UKR
Europe,Eastern Europe,Ukraine,Opioids,Opiates,Poppy plants,2020,17162.7,UKR
Europe,Eastern Europe,Ukraine,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2020,47.84,UKR
Europe,Eastern Europe,Ukraine,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.23,UKR
Europe,Eastern Europe,Ukraine,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.001,UKR
Europe,Eastern Europe,Ukraine,Opioids,Pharmaceutical opioids,Methadone,2020,33.19,UKR
Europe,Eastern Europe,Ukraine,Opioids,Pharmaceutical opioids,Tramadol,2020,0.09,UKR
Europe,Eastern Europe,Ukraine,Precursors,Non-specified precursors,Other precursors,2020,413,UKR
Europe,Eastern Europe,Ukraine,Precursors,Non-specified precursors,Other precursors,2020,3643,UKR
Europe,Eastern Europe,Ukraine,Precursors,Precursors,Acetic anhydride,2020,395,UKR
Europe,Eastern Europe,Ukraine,Precursors,Precursors,Ephedrine,2020,1,UKR
Europe,Eastern Europe,Ukraine,Precursors,Precursors,Hydrochloric acid,2020,164,UKR
Europe,Eastern Europe,Ukraine,Precursors,Precursors,Potassium permanganate,2020,4,UKR
Europe,Eastern Europe,Ukraine,Precursors,Precursors,Sulphuric acid,2020,6,UKR
Europe,Eastern Europe,Ukraine,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,4.13,UKR
Europe,Eastern Europe,Ukraine,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,169.39,UKR
Europe,Eastern Europe,Ukraine,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,10.32,UKR
Europe,Eastern Europe,Ukraine,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2021,92.79,UKR
Europe,Eastern Europe,Ukraine,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,1605.62,UKR
Europe,Eastern Europe,Ukraine,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,6525.2,UKR
Europe,Eastern Europe,Ukraine,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,0.43,UKR
Europe,Eastern Europe,Ukraine,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,54.49,UKR
Europe,Eastern Europe,Ukraine,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.01,UKR
Europe,Eastern Europe,Ukraine,NPS,Synthetic cathinones,Synthetic cathinones,2021,3545,UKR
Europe,Eastern Europe,Ukraine,Opioids,Opiates,Heroin,2021,505.71,UKR
Europe,Eastern Europe,Ukraine,Opioids,Opiates,Opium,2021,1.81,UKR
Europe,Eastern Europe,Ukraine,Opioids,Opiates,Poppy plants,2021,7571.4,UKR
Europe,Eastern Europe,Ukraine,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2021,44.54,UKR
Europe,Eastern Europe,Ukraine,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.26,UKR
Europe,Eastern Europe,Ukraine,Opioids,Pharmaceutical opioids,Fentanyl,2021,0.02,UKR
Europe,Eastern Europe,Ukraine,Opioids,Pharmaceutical opioids,Methadone,2021,23.64,UKR
Europe,Eastern Europe,Ukraine,Opioids,Pharmaceutical opioids,Tramadol,2021,0.02,UKR
Europe,Eastern Europe,Ukraine,Precursors,Non-specified precursors,Other precursors,2021,108,UKR
Europe,Eastern Europe,Ukraine,Precursors,Non-specified precursors,Other precursors,2021,4403,UKR
Europe,Eastern Europe,Ukraine,Precursors,Precursors,Acetic anhydride,2021,6,UKR
Europe,Eastern Europe,Ukraine,Precursors,Precursors,Ephedrine,2021,0,UKR
Europe,Eastern Europe,Ukraine,Precursors,Precursors,Hydrochloric acid,2021,274,UKR
Europe,Eastern Europe,Ukraine,Precursors,Precursors,Potassium permanganate,2021,3,UKR
Europe,Eastern Europe,Ukraine,Precursors,Precursors,Sulphuric acid,2021,45,UKR
Europe,Eastern Europe,Ukraine,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,1.7,UKR
Europe,Eastern Europe,Ukraine,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,43.8,UKR
Europe,Eastern Europe,Ukraine,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,1.7,UKR
Europe,Eastern Europe,Ukraine,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2022,240,UKR
Europe,Eastern Europe,Ukraine,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,1057.5,UKR
Europe,Eastern Europe,Ukraine,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,6145.4,UKR
Europe,Eastern Europe,Ukraine,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,64.8,UKR
Europe,Eastern Europe,Ukraine,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,7.8,UKR
Europe,Eastern Europe,Ukraine,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.01,UKR
Europe,Eastern Europe,Ukraine,Opioids,Opiates,Heroin,2022,0.9,UKR
Europe,Eastern Europe,Ukraine,Opioids,Opiates,Opium,2022,0.3,UKR
Europe,Eastern Europe,Ukraine,Opioids,Opiates,Poppy plants,2022,7743.2,UKR
Europe,Eastern Europe,Ukraine,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2022,33.5,UKR
Europe,Eastern Europe,Ukraine,Opioids,Pharmaceutical opioids,Methadone,2022,17,UKR
Europe,Eastern Europe,Ukraine,Opioids,Pharmaceutical opioids,Tramadol,2022,0.5,UKR
Europe,Eastern Europe,Ukraine,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,9.882,UKR
Europe,Eastern Europe,Ukraine,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,64.23,UKR
Europe,Eastern Europe,Ukraine,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,6.499,UKR
Europe,Eastern Europe,Ukraine,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2023,0.000025,UKR
Europe,Eastern Europe,Ukraine,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,8.371,UKR
Europe,Eastern Europe,Ukraine,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2023,226.655,UKR
Europe,Eastern Europe,Ukraine,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,1793.504,UKR
Europe,Eastern Europe,Ukraine,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,5683.6,UKR
Europe,Eastern Europe,Ukraine,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,3.124,UKR
Europe,Eastern Europe,Ukraine,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,4.816,UKR
Europe,Eastern Europe,Ukraine,Cocaine-type,Coca-type,Coca leaf,2023,0.0000932,UKR
Europe,Eastern Europe,Ukraine,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.119,UKR
Europe,Eastern Europe,Ukraine,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.015,UKR
Europe,Eastern Europe,Ukraine,Opioids,Opiates,Heroin,2023,0.326,UKR
Europe,Eastern Europe,Ukraine,Opioids,Opiates,Opium,2023,0.13,UKR
Europe,Eastern Europe,Ukraine,Opioids,Opiates,Poppy plants,2023,4956.8,UKR
Europe,Eastern Europe,Ukraine,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2023,783.938,UKR
Europe,Eastern Europe,Ukraine,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.107,UKR
Europe,Eastern Europe,Ukraine,Opioids,Pharmaceutical opioids,Codeine,2023,0.025,UKR
Europe,Eastern Europe,Ukraine,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.000005,UKR
Europe,Eastern Europe,Ukraine,Opioids,Pharmaceutical opioids,Methadone,2023,9.563,UKR
Europe,Eastern Europe,Ukraine,Opioids,Pharmaceutical opioids,Tramadol,2023,0.797,UKR
Europe,Eastern Europe,Ukraine,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,3,UKR
Europe,Eastern Europe,Ukraine,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,49,UKR
Europe,Eastern Europe,Ukraine,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,16,UKR
Europe,Eastern Europe,Ukraine,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2019,1,UKR
Europe,Eastern Europe,Ukraine,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,3397,UKR
Europe,Eastern Europe,Ukraine,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,18314,UKR
Europe,Eastern Europe,Ukraine,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,1,UKR
Europe,Eastern Europe,Ukraine,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,837,UKR
Europe,Eastern Europe,Ukraine,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,UKR
Europe,Eastern Europe,Ukraine,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (Spice),2019,3,UKR
Europe,Eastern Europe,Ukraine,Opioids,Opiates,Heroin,2019,1049,UKR
Europe,Eastern Europe,Ukraine,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2019,4780,UKR
Europe,Eastern Europe,Ukraine,Opioids,Other illicit opioids,Other illicit opioids,2019,2,UKR
Europe,Eastern Europe,Ukraine,Opioids,Pharmaceutical opioids,Tramadol,2019,0,UKR
Europe,South-Eastern Europe,Albania,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,0.11867,ALB
Europe,South-Eastern Europe,Albania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,3601.735665,ALB
Europe,South-Eastern Europe,Albania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,13.807,ALB
Europe,South-Eastern Europe,Albania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,16621.2,ALB
Europe,South-Eastern Europe,Albania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,208.1182,ALB
Europe,South-Eastern Europe,Albania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,3.70475,ALB
Europe,South-Eastern Europe,Albania,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,725.10937,ALB
Europe,South-Eastern Europe,Albania,Opioids,Opiates,Heroin,2021,81.25319,ALB
Europe,South-Eastern Europe,Albania,Opioids,Pharmaceutical opioids,Methadone,2021,0.0844,ALB
Europe,South-Eastern Europe,Albania,Opioids,Pharmaceutical opioids,Methadone,2021,0.0127,ALB
Europe,South-Eastern Europe,Albania,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,2.23163,ALB
Europe,South-Eastern Europe,Albania,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.1289,ALB
Europe,South-Eastern Europe,Albania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,3764.806919,ALB
Europe,South-Eastern Europe,Albania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,4251.5,ALB
Europe,South-Eastern Europe,Albania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,11447.8,ALB
Europe,South-Eastern Europe,Albania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,0.0374,ALB
Europe,South-Eastern Europe,Albania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,2.28111,ALB
Europe,South-Eastern Europe,Albania,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2022,578.59216,ALB
Europe,South-Eastern Europe,Albania,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0002,ALB
Europe,South-Eastern Europe,Albania,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,0.04423,ALB
Europe,South-Eastern Europe,Albania,Opioids,Opiates,Heroin,2022,7.45617,ALB
Europe,South-Eastern Europe,Albania,Opioids,Opiates,Poppy plants,2022,7.5,ALB
Europe,South-Eastern Europe,Albania,Opioids,Pharmaceutical opioids,Methadone,2022,0.0313,ALB
Europe,South-Eastern Europe,Albania,Opioids,Pharmaceutical opioids,Methadone,2022,0.00475,ALB
Europe,South-Eastern Europe,Albania,Precursors,Non-specified precursors,Non-specified precursors,2022,0.4534,ALB
Europe,South-Eastern Europe,Albania,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,5.27336,ALB
Europe,South-Eastern Europe,Albania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,2229.017,ALB
Europe,South-Eastern Europe,Albania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,29.3047,ALB
Europe,South-Eastern Europe,Albania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,0.0015,ALB
Europe,South-Eastern Europe,Albania,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,23.07702,ALB
Europe,South-Eastern Europe,Albania,Opioids,Opiates,Heroin,2023,61.986,ALB
Europe,South-Eastern Europe,Albania,Opioids,Opiates,Poppy plants,2023,8.8,ALB
Europe,South-Eastern Europe,Albania,Opioids,Pharmaceutical opioids,Methadone,2023,0.52547,ALB
Europe,South-Eastern Europe,Albania,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,0,ALB
Europe,South-Eastern Europe,Albania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,6331,ALB
Europe,South-Eastern Europe,Albania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,1,ALB
Europe,South-Eastern Europe,Albania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,75037,ALB
Europe,South-Eastern Europe,Albania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,1102,ALB
Europe,South-Eastern Europe,Albania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,1,ALB
Europe,South-Eastern Europe,Albania,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,145,ALB
Europe,South-Eastern Europe,Albania,Opioids,Opiates,Heroin,2019,38,ALB
Europe,South-Eastern Europe,Albania,Opioids,Pharmaceutical opioids,Methadone,2019,0,ALB
Europe,South-Eastern Europe,Bosnia and Herzegovina,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.00926,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.030081,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,13.8705,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.0008,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2021,0.0045,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,672.40216,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,42.6,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,1.1449,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,0.138,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,0.296,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.00031,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,0.0006,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Opioids,Opiates,Heroin,2021,0.55608,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.0155,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Opioids,Pharmaceutical opioids,Methadone,2021,0.00235,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Opioids,Pharmaceutical opioids,Tramadol,2021,0.006,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,0.02622,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.00103816,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.850398,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.005,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,13.106,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,21.021,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,327.762,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,0.05718,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,0.1906,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,1589.8,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,1.339,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2022,75.047,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.00000005,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Hallucinogens,Other Hallucinogens,Psilocybine,2022,0.04116,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Opioids,Opiates,Heroin,2022,0.25474666,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.0134,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Opioids,Pharmaceutical opioids,Buprenorphine,2022,2.586,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Opioids,Pharmaceutical opioids,Methadone,2022,0.0425,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Opioids,Pharmaceutical opioids,Methadone,2022,0.00905,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Opioids,Pharmaceutical opioids,Tramadol,2022,0.01585,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2022,0.00271,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.024,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.07453,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.414088,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,7.8,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.18,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.024,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.024,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2023,0.20875,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,681.91,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,0.053,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,94,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,254.01,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,0.33,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,275.07,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.0198,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2023,0.0201,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Opioids,Opiates,Heroin,2023,0.48288,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.00745,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Opioids,Pharmaceutical opioids,Methadone,2023,0.0531,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Opioids,Pharmaceutical opioids,Tramadol,2023,0.0103,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,0.024,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,0.07364,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,0,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,6,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Amphetamine-type stimulants (excluding “ecstasy”),Non-specified amphetamine-type stimulants,Non-specified amphetamine-type stimulants,2019,93,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,0,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,1948,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,3,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,235,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,5,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,4,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,0,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,4,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,0,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,3,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Opioids,Opiates,Heroin,2019,0,BIH
Europe,South-Eastern Europe,Bosnia and Herzegovina,Opioids,Opiates,Heroin,2019,3,BIH
Europe,South-Eastern Europe,Bulgaria,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,11.811,BGR
Europe,South-Eastern Europe,Bulgaria,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,38.962,BGR
Europe,South-Eastern Europe,Bulgaria,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,11.78,BGR
Europe,South-Eastern Europe,Bulgaria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,2230.423,BGR
Europe,South-Eastern Europe,Bulgaria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.129,BGR
Europe,South-Eastern Europe,Bulgaria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,0.01,BGR
Europe,South-Eastern Europe,Bulgaria,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,225.338,BGR
Europe,South-Eastern Europe,Bulgaria,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,0.0057,BGR
Europe,South-Eastern Europe,Bulgaria,Opioids,Opiates,Heroin,2020,251.112,BGR
Europe,South-Eastern Europe,Bulgaria,Opioids,Opiates,Opium,2020,0.06,BGR
Europe,South-Eastern Europe,Bulgaria,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.2072,BGR
Europe,South-Eastern Europe,Bulgaria,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2020,9,BGR
Europe,South-Eastern Europe,Bulgaria,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.670725,BGR
Europe,South-Eastern Europe,Bulgaria,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,259.727,BGR
Europe,South-Eastern Europe,Bulgaria,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,262.639,BGR
Europe,South-Eastern Europe,Bulgaria,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,450,BGR
Europe,South-Eastern Europe,Bulgaria,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,169.799,BGR
Europe,South-Eastern Europe,Bulgaria,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2021,0.23675,BGR
Europe,South-Eastern Europe,Bulgaria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,10404.007,BGR
Europe,South-Eastern Europe,Bulgaria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,2426.5,BGR
Europe,South-Eastern Europe,Bulgaria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,28466.879,BGR
Europe,South-Eastern Europe,Bulgaria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,1.628,BGR
Europe,South-Eastern Europe,Bulgaria,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,0.011633,BGR
Europe,South-Eastern Europe,Bulgaria,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,1263,BGR
Europe,South-Eastern Europe,Bulgaria,Opioids,Opiates,Heroin,2021,1107.228,BGR
Europe,South-Eastern Europe,Bulgaria,Opioids,Opiates,Opium,2021,27,BGR
Europe,South-Eastern Europe,Bulgaria,Opioids,Pharmaceutical opioids,Methadone,2021,0.001,BGR
Europe,South-Eastern Europe,Bulgaria,Opioids,Pharmaceutical opioids,Methadone,2021,0.56,BGR
Europe,South-Eastern Europe,Bulgaria,Sedatives and tranquillizers,Barbiturates,Barbiturates,2021,21.007,BGR
Europe,South-Eastern Europe,Bulgaria,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,0.68295,BGR
Europe,South-Eastern Europe,Bulgaria,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,4.449,BGR
Europe,South-Eastern Europe,Bulgaria,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.360972,BGR
Europe,South-Eastern Europe,Bulgaria,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,28.91,BGR
Europe,South-Eastern Europe,Bulgaria,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.111826,BGR
Europe,South-Eastern Europe,Bulgaria,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,45.874,BGR
Europe,South-Eastern Europe,Bulgaria,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.191925,BGR
Europe,South-Eastern Europe,Bulgaria,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2022,0.035,BGR
Europe,South-Eastern Europe,Bulgaria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,15224.008,BGR
Europe,South-Eastern Europe,Bulgaria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,2526.2,BGR
Europe,South-Eastern Europe,Bulgaria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,3.985,BGR
Europe,South-Eastern Europe,Bulgaria,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,32.836,BGR
Europe,South-Eastern Europe,Bulgaria,Hallucinogens,Other Hallucinogens,Psilocybine,2022,0.022,BGR
Europe,South-Eastern Europe,Bulgaria,Opioids,Opiates,Heroin,2022,334.941,BGR
Europe,South-Eastern Europe,Bulgaria,Opioids,Opiates,Illicit morphine,2022,0.1,BGR
Europe,South-Eastern Europe,Bulgaria,Opioids,Opiates,Illicit morphine,2022,0.0116,BGR
Europe,South-Eastern Europe,Bulgaria,Opioids,Opiates,Opium,2022,34.606,BGR
Europe,South-Eastern Europe,Bulgaria,Opioids,Pharmaceutical opioids,Codeine,2022,0.0115,BGR
Europe,South-Eastern Europe,Bulgaria,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.0042,BGR
Europe,South-Eastern Europe,Bulgaria,Opioids,Pharmaceutical opioids,Fentanyl,2022,168,BGR
Europe,South-Eastern Europe,Bulgaria,Opioids,Pharmaceutical opioids,Oxycodone,2022,0.0782,BGR
Europe,South-Eastern Europe,Bulgaria,Opioids,Pharmaceutical opioids,Tramadol,2022,0.04575,BGR
Europe,South-Eastern Europe,Bulgaria,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,3.97824,BGR
Europe,South-Eastern Europe,Bulgaria,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.02,BGR
Europe,South-Eastern Europe,Bulgaria,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.57589,BGR
Europe,South-Eastern Europe,Bulgaria,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,71.5959,BGR
Europe,South-Eastern Europe,Bulgaria,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,16.41989,BGR
Europe,South-Eastern Europe,Bulgaria,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,48.989,BGR
Europe,South-Eastern Europe,Bulgaria,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.059455,BGR
Europe,South-Eastern Europe,Bulgaria,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,75.007,BGR
Europe,South-Eastern Europe,Bulgaria,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.027675,BGR
Europe,South-Eastern Europe,Bulgaria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,9784.1105,BGR
Europe,South-Eastern Europe,Bulgaria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,8283.9268,BGR
Europe,South-Eastern Europe,Bulgaria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,5065.5,BGR
Europe,South-Eastern Europe,Bulgaria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,19.4781,BGR
Europe,South-Eastern Europe,Bulgaria,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,48.9095,BGR
Europe,South-Eastern Europe,Bulgaria,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.151,BGR
Europe,South-Eastern Europe,Bulgaria,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,71.7,BGR
Europe,South-Eastern Europe,Bulgaria,NPS,Synthetic cannabinoids (Spice),ADB-CHMINACA,2023,0.04,BGR
Europe,South-Eastern Europe,Bulgaria,Opioids,Opiates,Heroin,2023,10.9129,BGR
Europe,South-Eastern Europe,Bulgaria,Opioids,Opiates,Opium,2023,8.856,BGR
Europe,South-Eastern Europe,Bulgaria,Opioids,Pharmaceutical opioids,Fentanyl,2023,5.754,BGR
Europe,South-Eastern Europe,Bulgaria,Opioids,Pharmaceutical opioids,Oxycodone,2023,0.00095,BGR
Europe,South-Eastern Europe,Bulgaria,Opioids,Pharmaceutical opioids,Tramadol,2023,5.252,BGR
Europe,South-Eastern Europe,Bulgaria,Sedatives and tranquillizers,Barbiturates,Barbiturates,2023,10.0073,BGR
Europe,South-Eastern Europe,Bulgaria,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.0105,BGR
Europe,South-Eastern Europe,Bulgaria,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.0021,BGR
Europe,South-Eastern Europe,Bulgaria,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,129,BGR
Europe,South-Eastern Europe,Bulgaria,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,1,BGR
Europe,South-Eastern Europe,Bulgaria,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,72,BGR
Europe,South-Eastern Europe,Bulgaria,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,BGR
Europe,South-Eastern Europe,Bulgaria,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,24,BGR
Europe,South-Eastern Europe,Bulgaria,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,BGR
Europe,South-Eastern Europe,Bulgaria,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2019,0,BGR
Europe,South-Eastern Europe,Bulgaria,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Phenmetrazine,2019,0,BGR
Europe,South-Eastern Europe,Bulgaria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,2939,BGR
Europe,South-Eastern Europe,Bulgaria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,2570,BGR
Europe,South-Eastern Europe,Bulgaria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,1,BGR
Europe,South-Eastern Europe,Bulgaria,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,297,BGR
Europe,South-Eastern Europe,Bulgaria,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2019,2,BGR
Europe,South-Eastern Europe,Bulgaria,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2019,1,BGR
Europe,South-Eastern Europe,Bulgaria,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2019,0,BGR
Europe,South-Eastern Europe,Bulgaria,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2019,0,BGR
Europe,South-Eastern Europe,Bulgaria,Opioids,Opiates,Heroin,2019,677,BGR
Europe,South-Eastern Europe,Bulgaria,Opioids,Opiates,Opium,2019,2,BGR
Europe,South-Eastern Europe,Bulgaria,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,2,BGR
Europe,South-Eastern Europe,Bulgaria,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,3,BGR
Europe,South-Eastern Europe,Bulgaria,Sedatives and tranquillizers,GBL/GHB,GBL,2019,6,BGR
Europe,South-Eastern Europe,Croatia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,3.646,HRV
Europe,South-Eastern Europe,Croatia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,45.677,HRV
Europe,South-Eastern Europe,Croatia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.021,HRV
Europe,South-Eastern Europe,Croatia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,1683.069,HRV
Europe,South-Eastern Europe,Croatia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,2.647,HRV
Europe,South-Eastern Europe,Croatia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,0.02783,HRV
Europe,South-Eastern Europe,Croatia,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,60.049,HRV
Europe,South-Eastern Europe,Croatia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.00002345,HRV
Europe,South-Eastern Europe,Croatia,Opioids,Opiates,Heroin,2020,12.821,HRV
Europe,South-Eastern Europe,Croatia,Opioids,Pharmaceutical opioids,Codeine,2020,0.04175,HRV
Europe,South-Eastern Europe,Croatia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,1.3743,HRV
Europe,South-Eastern Europe,Croatia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,7.13,HRV
Europe,South-Eastern Europe,Croatia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,110,HRV
Europe,South-Eastern Europe,Croatia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.0998,HRV
Europe,South-Eastern Europe,Croatia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,1190,HRV
Europe,South-Eastern Europe,Croatia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,1477.6,HRV
Europe,South-Eastern Europe,Croatia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,3.52,HRV
Europe,South-Eastern Europe,Croatia,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,745.04,HRV
Europe,South-Eastern Europe,Croatia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.0000476,HRV
Europe,South-Eastern Europe,Croatia,Opioids,Opiates,Heroin,2021,249.7,HRV
Europe,South-Eastern Europe,Croatia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,4.98916,HRV
Europe,South-Eastern Europe,Croatia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,11.35,HRV
Europe,South-Eastern Europe,Croatia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,95.5,HRV
Europe,South-Eastern Europe,Croatia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,1140.4,HRV
Europe,South-Eastern Europe,Croatia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,1165.8,HRV
Europe,South-Eastern Europe,Croatia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,38.1,HRV
Europe,South-Eastern Europe,Croatia,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,329.35,HRV
Europe,South-Eastern Europe,Croatia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.00003215,HRV
Europe,South-Eastern Europe,Croatia,Opioids,Opiates,Heroin,2022,28.3,HRV
Europe,South-Eastern Europe,Croatia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.0004,HRV
Europe,South-Eastern Europe,Croatia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,16.34425,HRV
Europe,South-Eastern Europe,Croatia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,99.2,HRV
Europe,South-Eastern Europe,Croatia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,242,HRV
Europe,South-Eastern Europe,Croatia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,6030,HRV
Europe,South-Eastern Europe,Croatia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,1692.1,HRV
Europe,South-Eastern Europe,Croatia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,71,HRV
Europe,South-Eastern Europe,Croatia,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2023,780.4,HRV
Europe,South-Eastern Europe,Croatia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.00004655,HRV
Europe,South-Eastern Europe,Croatia,Opioids,Opiates,Heroin,2023,43.9,HRV
Europe,South-Eastern Europe,Croatia,Opioids,Pharmaceutical opioids,Methadone,2023,0.0012,HRV
Europe,South-Eastern Europe,Croatia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,2.27621,HRV
Europe,South-Eastern Europe,Croatia,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,16,HRV
Europe,South-Eastern Europe,Croatia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,41,HRV
Europe,South-Eastern Europe,Croatia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,2231,HRV
Europe,South-Eastern Europe,Croatia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,304,HRV
Europe,South-Eastern Europe,Croatia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,148,HRV
Europe,South-Eastern Europe,Croatia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,0,HRV
Europe,South-Eastern Europe,Croatia,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,16,HRV
Europe,South-Eastern Europe,Croatia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,HRV
Europe,South-Eastern Europe,Croatia,Opioids,Opiates,Heroin,2019,12,HRV
Europe,South-Eastern Europe,Croatia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,2,HRV
Europe,South-Eastern Europe,Montenegro,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.1135,MNE
Europe,South-Eastern Europe,Montenegro,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.079403,MNE
Europe,South-Eastern Europe,Montenegro,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.2212,MNE
Europe,South-Eastern Europe,Montenegro,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.0045,MNE
Europe,South-Eastern Europe,Montenegro,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,3103.998,MNE
Europe,South-Eastern Europe,Montenegro,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.0148,MNE
Europe,South-Eastern Europe,Montenegro,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,0.9462,MNE
Europe,South-Eastern Europe,Montenegro,Cocaine-type,Cocaine,"""Crack"" cocaine",2020,1.08259,MNE
Europe,South-Eastern Europe,Montenegro,Opioids,Opiates,Heroin,2020,13.15707,MNE
Europe,South-Eastern Europe,Montenegro,Opioids,Other illicit opioids,Other illicit opioids,2020,0.073975,MNE
Europe,South-Eastern Europe,Montenegro,Opioids,Pharmaceutical opioids,Methadone,2020,0.00015,MNE
Europe,South-Eastern Europe,Montenegro,Opioids,Pharmaceutical opioids,Tramadol,2020,0.0024,MNE
Europe,South-Eastern Europe,Montenegro,Sedatives and tranquillizers,Benzodiazepines,Bromazepam,2020,0.0031,MNE
Europe,South-Eastern Europe,Montenegro,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.00193,MNE
Europe,South-Eastern Europe,Montenegro,Sedatives and tranquillizers,Benzodiazepines,"Lorazepam (Ativan, Temesta)",2020,0.0016,MNE
Europe,South-Eastern Europe,Montenegro,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2020,0.02998,MNE
Europe,South-Eastern Europe,Montenegro,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.028997,MNE
Europe,South-Eastern Europe,Montenegro,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,2.37646,MNE
Europe,South-Eastern Europe,Montenegro,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.92851,MNE
Europe,South-Eastern Europe,Montenegro,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.0041,MNE
Europe,South-Eastern Europe,Montenegro,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,3465.09403,MNE
Europe,South-Eastern Europe,Montenegro,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,0.07531,MNE
Europe,South-Eastern Europe,Montenegro,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,734.7,MNE
Europe,South-Eastern Europe,Montenegro,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,0.1068,MNE
Europe,South-Eastern Europe,Montenegro,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,1244.18061,MNE
Europe,South-Eastern Europe,Montenegro,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.00000005,MNE
Europe,South-Eastern Europe,Montenegro,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2021,0.0008,MNE
Europe,South-Eastern Europe,Montenegro,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2021,0.0626,MNE
Europe,South-Eastern Europe,Montenegro,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.0022,MNE
Europe,South-Eastern Europe,Montenegro,Opioids,Opiates,Heroin,2021,2.05905,MNE
Europe,South-Eastern Europe,Montenegro,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.03705,MNE
Europe,South-Eastern Europe,Montenegro,Opioids,Pharmaceutical opioids,Methadone,2021,0.0399,MNE
Europe,South-Eastern Europe,Montenegro,Sedatives and tranquillizers,Barbiturates,Barbiturates,2021,0.1846,MNE
Europe,South-Eastern Europe,Montenegro,Sedatives and tranquillizers,Barbiturates,Methaqualone,2021,0.03,MNE
Europe,South-Eastern Europe,Montenegro,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.00014,MNE
Europe,South-Eastern Europe,Montenegro,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.00469,MNE
Europe,South-Eastern Europe,Montenegro,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,0.1139,MNE
Europe,South-Eastern Europe,Montenegro,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,0.0355,MNE
Europe,South-Eastern Europe,Montenegro,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.112465,MNE
Europe,South-Eastern Europe,Montenegro,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,2.66999,MNE
Europe,South-Eastern Europe,Montenegro,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.0153,MNE
Europe,South-Eastern Europe,Montenegro,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,1803.8929,MNE
Europe,South-Eastern Europe,Montenegro,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,0.0246,MNE
Europe,South-Eastern Europe,Montenegro,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,119.2,MNE
Europe,South-Eastern Europe,Montenegro,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,20.0324,MNE
Europe,South-Eastern Europe,Montenegro,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,500.55755,MNE
Europe,South-Eastern Europe,Montenegro,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0000005,MNE
Europe,South-Eastern Europe,Montenegro,Opioids,Opiates,Heroin,2022,3.01748,MNE
Europe,South-Eastern Europe,Montenegro,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.026975,MNE
Europe,South-Eastern Europe,Montenegro,Opioids,Pharmaceutical opioids,Methadone,2022,0.00025,MNE
Europe,South-Eastern Europe,Montenegro,Opioids,Pharmaceutical opioids,Tramadol,2022,0.001,MNE
Europe,South-Eastern Europe,Montenegro,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2022,0.01198,MNE
Europe,South-Eastern Europe,Montenegro,Sedatives and tranquillizers,Benzodiazepines,Bromazepam,2022,0.00395,MNE
Europe,South-Eastern Europe,Montenegro,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.00207,MNE
Europe,South-Eastern Europe,Montenegro,Sedatives and tranquillizers,Benzodiazepines,Diazepam (Stesolid),2022,0.00207,MNE
Europe,South-Eastern Europe,Montenegro,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2022,0.00285,MNE
Europe,South-Eastern Europe,Montenegro,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,3.32297,MNE
Europe,South-Eastern Europe,Montenegro,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,1.873694,MNE
Europe,South-Eastern Europe,Montenegro,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,1.92876,MNE
Europe,South-Eastern Europe,Montenegro,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.1599,MNE
Europe,South-Eastern Europe,Montenegro,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,932.71931,MNE
Europe,South-Eastern Europe,Montenegro,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,0.852,MNE
Europe,South-Eastern Europe,Montenegro,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,82.3,MNE
Europe,South-Eastern Europe,Montenegro,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,0.55629,MNE
Europe,South-Eastern Europe,Montenegro,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,25.12374,MNE
Europe,South-Eastern Europe,Montenegro,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.0264,MNE
Europe,South-Eastern Europe,Montenegro,Opioids,Opiates,Heroin,2023,1.55405,MNE
Europe,South-Eastern Europe,Montenegro,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.01825,MNE
Europe,South-Eastern Europe,Montenegro,Opioids,Pharmaceutical opioids,Tramadol,2023,0.0002,MNE
Europe,South-Eastern Europe,Montenegro,Sedatives and tranquillizers,Benzodiazepines,Bromazepam,2023,0.00262,MNE
Europe,South-Eastern Europe,Montenegro,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.00158,MNE
Europe,South-Eastern Europe,Montenegro,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,0,MNE
Europe,South-Eastern Europe,Montenegro,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,0,MNE
Europe,South-Eastern Europe,Montenegro,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2019,1,MNE
Europe,South-Eastern Europe,Montenegro,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2019,0,MNE
Europe,South-Eastern Europe,Montenegro,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2019,0,MNE
Europe,South-Eastern Europe,Montenegro,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2019,0,MNE
Europe,South-Eastern Europe,Montenegro,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,2290,MNE
Europe,South-Eastern Europe,Montenegro,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,0,MNE
Europe,South-Eastern Europe,Montenegro,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,93,MNE
Europe,South-Eastern Europe,Montenegro,Opioids,Opiates,Heroin,2019,23,MNE
Europe,South-Eastern Europe,North Macedonia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,0.018,MKD
Europe,South-Eastern Europe,North Macedonia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,0.094579,MKD
Europe,South-Eastern Europe,North Macedonia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,9.06,MKD
Europe,South-Eastern Europe,North Macedonia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.003036,MKD
Europe,South-Eastern Europe,North Macedonia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.0036,MKD
Europe,South-Eastern Europe,North Macedonia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.126,MKD
Europe,South-Eastern Europe,North Macedonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,2973.7,MKD
Europe,South-Eastern Europe,North Macedonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,0.594,MKD
Europe,South-Eastern Europe,North Macedonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,2037.3,MKD
Europe,South-Eastern Europe,North Macedonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,0.75,MKD
Europe,South-Eastern Europe,North Macedonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,4.33,MKD
Europe,South-Eastern Europe,North Macedonia,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,2.72,MKD
Europe,South-Eastern Europe,North Macedonia,Opioids,Opiates,Heroin,2022,2.36,MKD
Europe,South-Eastern Europe,North Macedonia,Opioids,Opiates,Opium,2022,0.02,MKD
Europe,South-Eastern Europe,North Macedonia,Precursors,Non-specified precursors,Non-specified precursors,2022,1002.52,MKD
Europe,South-Eastern Europe,North Macedonia,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,0,MKD
Europe,South-Eastern Europe,North Macedonia,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,0,MKD
Europe,South-Eastern Europe,North Macedonia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,1,MKD
Europe,South-Eastern Europe,North Macedonia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,MKD
Europe,South-Eastern Europe,North Macedonia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,MKD
Europe,South-Eastern Europe,North Macedonia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,MKD
Europe,South-Eastern Europe,North Macedonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,977,MKD
Europe,South-Eastern Europe,North Macedonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,0,MKD
Europe,South-Eastern Europe,North Macedonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,13,MKD
Europe,South-Eastern Europe,North Macedonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,5,MKD
Europe,South-Eastern Europe,North Macedonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,1,MKD
Europe,South-Eastern Europe,North Macedonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,0,MKD
Europe,South-Eastern Europe,North Macedonia,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,1,MKD
Europe,South-Eastern Europe,North Macedonia,Hallucinogens,Non-specified hallucinogens,Non-specified hallucinogens,2019,0,MKD
Europe,South-Eastern Europe,North Macedonia,Opioids,Opiates,Heroin,2019,1,MKD
Europe,South-Eastern Europe,Romania,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,2.411,ROU
Europe,South-Eastern Europe,Romania,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,8.200731,ROU
Europe,South-Eastern Europe,Romania,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2020,1568.146624,ROU
Europe,South-Eastern Europe,Romania,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2020,0.138,ROU
Europe,South-Eastern Europe,Romania,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2020,0.00017,ROU
Europe,South-Eastern Europe,Romania,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2020,0.0065,ROU
Europe,South-Eastern Europe,Romania,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2020,4.81134,ROU
Europe,South-Eastern Europe,Romania,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2020,0.03769,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,929.321,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.0537,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,627.806,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,1385.084,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,0.00706,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,3.385,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,40.315,ROU
Europe,South-Eastern Europe,Romania,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,43.496,ROU
Europe,South-Eastern Europe,Romania,Cocaine-type,Coca-type,Coca leaf,2020,0.2692,ROU
Europe,South-Eastern Europe,Romania,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.0038,ROU
Europe,South-Eastern Europe,Romania,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.0000202,ROU
Europe,South-Eastern Europe,Romania,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2020,0.0023,ROU
Europe,South-Eastern Europe,Romania,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2020,3.85,ROU
Europe,South-Eastern Europe,Romania,Hallucinogens,Other Hallucinogens,Other hallucinogens,2020,0.00037,ROU
Europe,South-Eastern Europe,Romania,Hallucinogens,Other Hallucinogens,Other hallucinogens,2020,0.0041,ROU
Europe,South-Eastern Europe,Romania,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,0.64607,ROU
Europe,South-Eastern Europe,Romania,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,0.11833,ROU
Europe,South-Eastern Europe,Romania,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,0.49899,ROU
Europe,South-Eastern Europe,Romania,NPS,Synthetic cannabinoids (Spice),MDMB-CHMICA,2020,0.002,ROU
Europe,South-Eastern Europe,Romania,Opioids,Opiates,Heroin,2020,0.0001,ROU
Europe,South-Eastern Europe,Romania,Opioids,Opiates,Heroin,2020,63.808,ROU
Europe,South-Eastern Europe,Romania,Opioids,Opiates,Illicit morphine,2020,0.115,ROU
Europe,South-Eastern Europe,Romania,Opioids,Opiates,Opium,2020,0.00006,ROU
Europe,South-Eastern Europe,Romania,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2020,7.3,ROU
Europe,South-Eastern Europe,Romania,Opioids,Other illicit opioids,Other illicit opioids,2020,0.0001,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.00025,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Codeine,2020,0.00476,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Codeine,2020,0.01945,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.00046,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Methadone,2020,0.01239,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Methadone,2020,0.0813,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Methadone,2020,0.0473,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Oxycodone,2020,0.00005,ROU
Europe,South-Eastern Europe,Romania,Precursors,Precursors,Ephedrine,2020,0.03,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Barbiturates,Barbiturates,2020,0.00012,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Barbiturates,Barbiturates,2020,0.004,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.00092,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.02,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.03423,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.00011,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.008,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.02044,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2020,0.01862,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2020,0.02517,ROU
Europe,South-Eastern Europe,Romania,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,2.677,ROU
Europe,South-Eastern Europe,Romania,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,13.168974,ROU
Europe,South-Eastern Europe,Romania,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.0026,ROU
Europe,South-Eastern Europe,Romania,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,8.375,ROU
Europe,South-Eastern Europe,Romania,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,1.384,ROU
Europe,South-Eastern Europe,Romania,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2021,0.11244,ROU
Europe,South-Eastern Europe,Romania,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2021,0.0015,ROU
Europe,South-Eastern Europe,Romania,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2021,0.61,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,498.009,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,0.0143,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,3586.348,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,6.136,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,0.02115,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,0.05336,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,0.299,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,1341.89,ROU
Europe,South-Eastern Europe,Romania,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,874.727,ROU
Europe,South-Eastern Europe,Romania,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.00362,ROU
Europe,South-Eastern Europe,Romania,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.0047,ROU
Europe,South-Eastern Europe,Romania,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2021,0.00241,ROU
Europe,South-Eastern Europe,Romania,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2021,0.04789,ROU
Europe,South-Eastern Europe,Romania,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2021,0.65725,ROU
Europe,South-Eastern Europe,Romania,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,0.0524,ROU
Europe,South-Eastern Europe,Romania,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,,ROU
Europe,South-Eastern Europe,Romania,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,1.90515,ROU
Europe,South-Eastern Europe,Romania,NPS,Synthetic cannabinoids (Spice),JWH-210,2021,0.86,ROU
Europe,South-Eastern Europe,Romania,NPS,Synthetic cannabinoids (Spice),MDMB-CHMICA,2021,0.0002,ROU
Europe,South-Eastern Europe,Romania,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2021,0.00102,ROU
Europe,South-Eastern Europe,Romania,NPS,Synthetic cathinones,Pentedrone,2021,0.0055,ROU
Europe,South-Eastern Europe,Romania,NPS,Synthetic cathinones,Synthetic cathinones,2021,0.10694,ROU
Europe,South-Eastern Europe,Romania,Opioids,Opiates,Heroin,2021,1437.392,ROU
Europe,South-Eastern Europe,Romania,Opioids,Opiates,Illicit morphine,2021,0.05,ROU
Europe,South-Eastern Europe,Romania,Opioids,Opiates,Illicit morphine,2021,0.05086,ROU
Europe,South-Eastern Europe,Romania,Opioids,Opiates,Illicit morphine,2021,0.0066,ROU
Europe,South-Eastern Europe,Romania,Opioids,Other illicit opioids,Other illicit opioids,2021,0.002,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.00005,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Codeine,2021,0.00406,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Codeine,2021,0.01075,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Fentanyl,2021,0.04,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Methadone,2021,0.01534,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Methadone,2021,0.254,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Methadone,2021,0.04805,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.00005,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.0305,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Barbiturates,Barbiturates,2021,0.001,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.00343,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.03004,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.0001,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.033,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.00936,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,3.694,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2021,0.00147,ROU
Europe,South-Eastern Europe,Romania,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,2.37216,ROU
Europe,South-Eastern Europe,Romania,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,12.291205,ROU
Europe,South-Eastern Europe,Romania,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,13.96068,ROU
Europe,South-Eastern Europe,Romania,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.2,ROU
Europe,South-Eastern Europe,Romania,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.73214,ROU
Europe,South-Eastern Europe,Romania,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2022,16.96863,ROU
Europe,South-Eastern Europe,Romania,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2022,2.04025,ROU
Europe,South-Eastern Europe,Romania,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2022,0.26946,ROU
Europe,South-Eastern Europe,Romania,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2022,0.0001,ROU
Europe,South-Eastern Europe,Romania,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2022,0.00332,ROU
Europe,South-Eastern Europe,Romania,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2022,0.008,ROU
Europe,South-Eastern Europe,Romania,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2022,0.00185,ROU
Europe,South-Eastern Europe,Romania,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2022,0.001,ROU
Europe,South-Eastern Europe,Romania,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2022,0.02933,ROU
Europe,South-Eastern Europe,Romania,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2022,0.00015,ROU
Europe,South-Eastern Europe,Romania,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2022,0.09859,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,608.3882,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,0.22048,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,652.57672,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,12.58784,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,0,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,60.0456,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,0.1189,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,176.92809,ROU
Europe,South-Eastern Europe,Romania,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,80.11756,ROU
Europe,South-Eastern Europe,Romania,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0019,ROU
Europe,South-Eastern Europe,Romania,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0000707,ROU
Europe,South-Eastern Europe,Romania,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2022,0.00146,ROU
Europe,South-Eastern Europe,Romania,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2022,0.007,ROU
Europe,South-Eastern Europe,Romania,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2022,0.41442,ROU
Europe,South-Eastern Europe,Romania,Hallucinogens,Other Hallucinogens,Other hallucinogens,2022,0.75264,ROU
Europe,South-Eastern Europe,Romania,Hallucinogens,Other Hallucinogens,Other hallucinogens,2022,0.0001,ROU
Europe,South-Eastern Europe,Romania,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,1.65049,ROU
Europe,South-Eastern Europe,Romania,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,0.36992,ROU
Europe,South-Eastern Europe,Romania,NPS,Piperazines,Piperazines,2022,0.0001,ROU
Europe,South-Eastern Europe,Romania,NPS,Synthetic cannabinoids (Spice),JWH-210,2022,0.17849,ROU
Europe,South-Eastern Europe,Romania,NPS,Synthetic cannabinoids (Spice),MDMB-CHMICA,2022,0.00999,ROU
Europe,South-Eastern Europe,Romania,NPS,Synthetic cannabinoids (Spice),UR-144,2022,0.00246,ROU
Europe,South-Eastern Europe,Romania,Opioids,Opiates,Heroin,2022,0.001,ROU
Europe,South-Eastern Europe,Romania,Opioids,Opiates,Heroin,2022,191.28896,ROU
Europe,South-Eastern Europe,Romania,Opioids,Opiates,Illicit morphine,2022,0.00003,ROU
Europe,South-Eastern Europe,Romania,Opioids,Opiates,Illicit morphine,2022,1.049,ROU
Europe,South-Eastern Europe,Romania,Opioids,Opiates,Illicit morphine,2022,0.3941,ROU
Europe,South-Eastern Europe,Romania,Opioids,Opiates,Opium,2022,119.3656,ROU
Europe,South-Eastern Europe,Romania,Opioids,Other illicit opioids,Other illicit opioids,2022,0.01025,ROU
Europe,South-Eastern Europe,Romania,Opioids,Other illicit opioids,Other illicit opioids,2022,0.42,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Codeine,2022,0.00255,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Codeine,2022,0.004,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.02,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.4071,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Methadone,2022,0.00326,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Methadone,2022,0.055,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Methadone,2022,0.05785,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Oxycodone,2022,0.001,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Oxycodone,2022,0.5053,ROU
Europe,South-Eastern Europe,Romania,Precursors,Precursors,Acetone,2022,0.01,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Barbiturates,Barbiturates,2022,0.001,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Barbiturates,Barbiturates,2022,0.016,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.01333,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.06,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,4.41642,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.00029,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.0264,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.0042,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,0.043,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2022,0.00069,ROU
Europe,South-Eastern Europe,Romania,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,4,ROU
Europe,South-Eastern Europe,Romania,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,13,ROU
Europe,South-Eastern Europe,Romania,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,7,ROU
Europe,South-Eastern Europe,Romania,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,ROU
Europe,South-Eastern Europe,Romania,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,ROU
Europe,South-Eastern Europe,Romania,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,ROU
Europe,South-Eastern Europe,Romania,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,ROU
Europe,South-Eastern Europe,Romania,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2019,0,ROU
Europe,South-Eastern Europe,Romania,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Pyrovalerone,2019,0,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,1207,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,0,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,21,ROU
Europe,South-Eastern Europe,Romania,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,555,ROU
Europe,South-Eastern Europe,Romania,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,1616,ROU
Europe,South-Eastern Europe,Romania,Cocaine-type,Coca-type,Coca leaf,2019,0,ROU
Europe,South-Eastern Europe,Romania,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,ROU
Europe,South-Eastern Europe,Romania,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,0,ROU
Europe,South-Eastern Europe,Romania,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,1,ROU
Europe,South-Eastern Europe,Romania,NPS,Phenethylamines,2C (psychedelics),2019,0,ROU
Europe,South-Eastern Europe,Romania,NPS,Plant-based NPS,Mushrooms (hallucinogenic),2019,0,ROU
Europe,South-Eastern Europe,Romania,NPS,Plant-based NPS,Other hallucinogens,2019,0,ROU
Europe,South-Eastern Europe,Romania,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (Spice),2019,0,ROU
Europe,South-Eastern Europe,Romania,NPS,Synthetic cathinones,Synthetic cathinones,2019,0,ROU
Europe,South-Eastern Europe,Romania,NPS,Tryptamines,Tryptamines,2019,2,ROU
Europe,South-Eastern Europe,Romania,Opioids,Opiates,Heroin,2019,138,ROU
Europe,South-Eastern Europe,Romania,Opioids,Opiates,Illicit morphine,2019,0,ROU
Europe,South-Eastern Europe,Romania,Opioids,Opiates,Illicit morphine,2019,0,ROU
Europe,South-Eastern Europe,Romania,Opioids,Opiates,Opium,2019,3,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Buprenorphine,2019,0,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Codeine,2019,0,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Codeine,2019,0,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Methadone,2019,1,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Methadone,2019,0,ROU
Europe,South-Eastern Europe,Romania,Opioids,Pharmaceutical opioids,Oxycodone,2019,0,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Barbiturates,Barbiturates,2019,0,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Non-specified sedatives and tranquillizers,Non-specified sedatives and tranquillizers,2019,0,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2019,0,ROU
Europe,South-Eastern Europe,Romania,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2019,0,ROU
Europe,South-Eastern Europe,Serbia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,11.2,SRB
Europe,South-Eastern Europe,Serbia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,1.312182,SRB
Europe,South-Eastern Europe,Serbia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,167.6,SRB
Europe,South-Eastern Europe,Serbia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,6768.56,SRB
Europe,South-Eastern Europe,Serbia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,5.2,SRB
Europe,South-Eastern Europe,Serbia,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,10.6,SRB
Europe,South-Eastern Europe,Serbia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.01057,SRB
Europe,South-Eastern Europe,Serbia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.0000259,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Opiates,Heroin,2020,84.5,SRB
Europe,South-Eastern Europe,Serbia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,128.62912,SRB
Europe,South-Eastern Europe,Serbia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2021,186.8179,SRB
Europe,South-Eastern Europe,Serbia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,8219.43937,SRB
Europe,South-Eastern Europe,Serbia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,5090.44751,SRB
Europe,South-Eastern Europe,Serbia,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2021,32.08544,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Opiates,Heroin,2021,66.66359,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Opiates,Illicit morphine,2021,2.72762,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Pharmaceutical opioids,Buprenorphine,2021,,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Pharmaceutical opioids,Codeine,2021,,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Pharmaceutical opioids,Fentanyl,2021,,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Pharmaceutical opioids,Methadone,2021,,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Pharmaceutical opioids,Oxycodone,2021,,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Pharmaceutical opioids,Tramadol,2021,,SRB
Europe,South-Eastern Europe,Serbia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.58667,SRB
Europe,South-Eastern Europe,Serbia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,50.35118,SRB
Europe,South-Eastern Europe,Serbia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,72.91653,SRB
Europe,South-Eastern Europe,Serbia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,1.00463,SRB
Europe,South-Eastern Europe,Serbia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,3293.3777,SRB
Europe,South-Eastern Europe,Serbia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,3417.17899,SRB
Europe,South-Eastern Europe,Serbia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,73.71856,SRB
Europe,South-Eastern Europe,Serbia,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,45.99902,SRB
Europe,South-Eastern Europe,Serbia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,,SRB
Europe,South-Eastern Europe,Serbia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,1.06126,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Opiates,Heroin,2022,61.22591,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Opiates,Illicit morphine,2022,3.9423,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2022,2913.617,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.13175,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Pharmaceutical opioids,Codeine,2022,0.00665,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.00005,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Pharmaceutical opioids,Methadone,2022,1.34649,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Pharmaceutical opioids,Tramadol,2022,0.171575,SRB
Europe,South-Eastern Europe,Serbia,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2022,0.423775,SRB
Europe,South-Eastern Europe,Serbia,Sedatives and tranquillizers,Benzodiazepines,Bromazepam,2022,0.107055,SRB
Europe,South-Eastern Europe,Serbia,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2022,0.0072,SRB
Europe,South-Eastern Europe,Serbia,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2022,1.129325,SRB
Europe,South-Eastern Europe,Serbia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,5.65116,SRB
Europe,South-Eastern Europe,Serbia,Sedatives and tranquillizers,Benzodiazepines,Midazolam,2022,0.00861,SRB
Europe,South-Eastern Europe,Serbia,Sedatives and tranquillizers,Benzodiazepines,Oxazepam,2022,0.00159,SRB
Europe,South-Eastern Europe,Serbia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,9.47885,SRB
Europe,South-Eastern Europe,Serbia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.00506,SRB
Europe,South-Eastern Europe,Serbia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,11.41,SRB
Europe,South-Eastern Europe,Serbia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,259.46857,SRB
Europe,South-Eastern Europe,Serbia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.001,SRB
Europe,South-Eastern Europe,Serbia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.11575,SRB
Europe,South-Eastern Europe,Serbia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,0.001,SRB
Europe,South-Eastern Europe,Serbia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,0.00453,SRB
Europe,South-Eastern Europe,Serbia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2023,0.00025,SRB
Europe,South-Eastern Europe,Serbia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,6792.16781,SRB
Europe,South-Eastern Europe,Serbia,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,52.3554,SRB
Europe,South-Eastern Europe,Serbia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.00012,SRB
Europe,South-Eastern Europe,Serbia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.006,SRB
Europe,South-Eastern Europe,Serbia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.0001315,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Opiates,Heroin,2023,19.47914,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Opiates,Illicit morphine,2023,0.0001704,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.00423,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.0058,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Pharmaceutical opioids,Buprenorphine,2023,33.52685,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Pharmaceutical opioids,Methadone,2023,1.15314,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Pharmaceutical opioids,Oxycodone,2023,0.0002,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Pharmaceutical opioids,Tramadol,2023,0.0003,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Pharmaceutical opioids,Tramadol,2023,0.0237,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Pharmaceutical opioids,Tramadol,2023,3.528,SRB
Europe,South-Eastern Europe,Serbia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.01737,SRB
Europe,South-Eastern Europe,Serbia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.022,SRB
Europe,South-Eastern Europe,Serbia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,3.59386,SRB
Europe,South-Eastern Europe,Serbia,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,3,SRB
Europe,South-Eastern Europe,Serbia,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,31,SRB
Europe,South-Eastern Europe,Serbia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,SRB
Europe,South-Eastern Europe,Serbia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,SRB
Europe,South-Eastern Europe,Serbia,Amphetamine-type stimulants (excluding “ecstasy”),Non-specified amphetamine-type stimulants,Non-specified amphetamine-type stimulants,2019,0,SRB
Europe,South-Eastern Europe,Serbia,Amphetamine-type stimulants (excluding “ecstasy”),Non-specified amphetamine-type stimulants,Non-specified amphetamine-type stimulants,2019,71,SRB
Europe,South-Eastern Europe,Serbia,Any other drugs/substances,Other miscellaneous,Other miscellaneous,2019,0,SRB
Europe,South-Eastern Europe,Serbia,Any other drugs/substances,Substances not under int. control,Other substances not under int. control,2019,40,SRB
Europe,South-Eastern Europe,Serbia,Any other drugs/substances,Substances not under int. control,Other substances not under int. control,2019,8,SRB
Europe,South-Eastern Europe,Serbia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,7059,SRB
Europe,South-Eastern Europe,Serbia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,1,SRB
Europe,South-Eastern Europe,Serbia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,2,SRB
Europe,South-Eastern Europe,Serbia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,4,SRB
Europe,South-Eastern Europe,Serbia,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,14,SRB
Europe,South-Eastern Europe,Serbia,Hallucinogens,Non-specified hallucinogens,Non-specified hallucinogens,2019,0,SRB
Europe,South-Eastern Europe,Serbia,Hallucinogens,Non-specified hallucinogens,Non-specified hallucinogens,2019,0,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Opiates,Heroin,2019,172,SRB
Europe,South-Eastern Europe,Serbia,Opioids,Pharmaceutical opioids,Methadone,2019,0,SRB
Europe,South-Eastern Europe,Türkiye,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,3007.082124,TUR
Europe,South-Eastern Europe,Türkiye,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2020,727.421046,TUR
Europe,South-Eastern Europe,Türkiye,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2020,4757,TUR
Europe,South-Eastern Europe,Türkiye,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,50450,TUR
Europe,South-Eastern Europe,Türkiye,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,8.32,TUR
Europe,South-Eastern Europe,Türkiye,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,11496580.1,TUR
Europe,South-Eastern Europe,Türkiye,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,37489,TUR
Europe,South-Eastern Europe,Türkiye,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,5794,TUR
Europe,South-Eastern Europe,Türkiye,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,1961,TUR
Europe,South-Eastern Europe,Türkiye,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,2.08,TUR
Europe,South-Eastern Europe,Türkiye,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2020,0.06,TUR
Europe,South-Eastern Europe,Türkiye,NPS,Plant-based NPS,Khat,2020,1368,TUR
Europe,South-Eastern Europe,Türkiye,NPS,Plant-based NPS,Salvia divinorum,2020,0.71,TUR
Europe,South-Eastern Europe,Türkiye,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2020,1700,TUR
Europe,South-Eastern Europe,Türkiye,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2020,36.5,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Opiates,Heroin,2020,407,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Opiates,Heroin,2020,13376,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Opiates,Illicit morphine,2020,25.2,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Opiates,Opium,2020,796,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Pharmaceutical opioids,Codeine,2020,0.649,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Pharmaceutical opioids,Methadone,2020,1.0145,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2020,200.6122,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2020,0.6066,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Pharmaceutical opioids,Tramadol,2020,10.8901,TUR
Europe,South-Eastern Europe,Türkiye,Precursors,Precursors,Acetic anhydride,2020,12136,TUR
Europe,South-Eastern Europe,Türkiye,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2020,0.7,TUR
Europe,South-Eastern Europe,Türkiye,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,2064.481523,TUR
Europe,South-Eastern Europe,Türkiye,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2021,3489.033944,TUR
Europe,South-Eastern Europe,Türkiye,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,71.6,TUR
Europe,South-Eastern Europe,Türkiye,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,5528,TUR
Europe,South-Eastern Europe,Türkiye,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,31048.24,TUR
Europe,South-Eastern Europe,Türkiye,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,8.67,TUR
Europe,South-Eastern Europe,Türkiye,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,7570215.5,TUR
Europe,South-Eastern Europe,Türkiye,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,33068,TUR
Europe,South-Eastern Europe,Türkiye,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,2841,TUR
Europe,South-Eastern Europe,Türkiye,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,1.6,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Opiates,Heroin,2021,22202,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Opiates,Illicit morphine,2021,0.23,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Opiates,Opium,2021,976,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Pharmaceutical opioids,Codeine,2021,49.5,TUR
Europe,South-Eastern Europe,Türkiye,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,0.64,TUR
Europe,South-Eastern Europe,Türkiye,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,1368.638075,TUR
Europe,South-Eastern Europe,Türkiye,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2022,6058.091578,TUR
Europe,South-Eastern Europe,Türkiye,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,8.4,TUR
Europe,South-Eastern Europe,Türkiye,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,16210,TUR
Europe,South-Eastern Europe,Türkiye,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,42519,TUR
Europe,South-Eastern Europe,Türkiye,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,116,TUR
Europe,South-Eastern Europe,Türkiye,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,10957245.9,TUR
Europe,South-Eastern Europe,Türkiye,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,29331,TUR
Europe,South-Eastern Europe,Türkiye,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,2276,TUR
Europe,South-Eastern Europe,Türkiye,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,0.2415,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Opiates,Heroin,2022,7956,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Opiates,Illicit morphine,2022,48.5,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Opiates,Opium,2022,720,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Pharmaceutical opioids,Codeine,2022,0.0024,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Pharmaceutical opioids,Methadone,2022,2.40395,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Pharmaceutical opioids,Tramadol,2022,3.85535,TUR
Europe,South-Eastern Europe,Türkiye,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,1416.748163,TUR
Europe,South-Eastern Europe,Türkiye,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2023,3481.365261,TUR
Europe,South-Eastern Europe,Türkiye,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,19.1,TUR
Europe,South-Eastern Europe,Türkiye,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,21912,TUR
Europe,South-Eastern Europe,Türkiye,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,71429,TUR
Europe,South-Eastern Europe,Türkiye,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,29.5,TUR
Europe,South-Eastern Europe,Türkiye,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,15734375.8,TUR
Europe,South-Eastern Europe,Türkiye,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,27836,TUR
Europe,South-Eastern Europe,Türkiye,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,2502,TUR
Europe,South-Eastern Europe,Türkiye,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2023,0.3619,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Opiates,Heroin,2023,3314,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Opiates,Illicit morphine,2023,191,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Opiates,Opium,2023,691,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Pharmaceutical opioids,Methadone,2023,4.12655,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Pharmaceutical opioids,Tramadol,2023,7.7876,TUR
Europe,South-Eastern Europe,Türkiye,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2023,1.6,TUR
Europe,South-Eastern Europe,Türkiye,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,2357,TUR
Europe,South-Eastern Europe,Türkiye,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2019,2804,TUR
Europe,South-Eastern Europe,Türkiye,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,18,TUR
Europe,South-Eastern Europe,Türkiye,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,1042,TUR
Europe,South-Eastern Europe,Türkiye,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,36294,TUR
Europe,South-Eastern Europe,Türkiye,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,26291,TUR
Europe,South-Eastern Europe,Türkiye,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,5,TUR
Europe,South-Eastern Europe,Türkiye,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,4227669,TUR
Europe,South-Eastern Europe,Türkiye,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,27889,TUR
Europe,South-Eastern Europe,Türkiye,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,1634,TUR
Europe,South-Eastern Europe,Türkiye,Cocaine-type,Cocaine,Non-specified cocaine,2019,4,TUR
Europe,South-Eastern Europe,Türkiye,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,TUR
Europe,South-Eastern Europe,Türkiye,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,TUR
Europe,South-Eastern Europe,Türkiye,NPS,Plant-based NPS,Khat,2019,38,TUR
Europe,South-Eastern Europe,Türkiye,NPS,Plant-based NPS,Mushrooms (hallucinogenic),2019,0,TUR
Europe,South-Eastern Europe,Türkiye,NPS,Plant-based NPS,Salvia divinorum,2019,5,TUR
Europe,South-Eastern Europe,Türkiye,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2019,13,TUR
Europe,South-Eastern Europe,Türkiye,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (Spice),2019,710,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Opiates,Heroin,2019,19963,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Opiates,Heroin,2019,202,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Opiates,Illicit morphine,2019,28,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Opiates,Opium,2019,1314,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Pharmaceutical opioids,Buprenorphine,2019,0,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Pharmaceutical opioids,Methadone,2019,6,TUR
Europe,South-Eastern Europe,Türkiye,Opioids,Pharmaceutical opioids,Tramadol,2019,3,TUR
Europe,South-Eastern Europe,Türkiye,Precursors,Precursors,Acetic anhydride,2019,803,TUR
Europe,South-Eastern Europe,Türkiye,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,19,TUR
Europe,South-Eastern Europe,Türkiye,Sedatives and tranquillizers,GBL/GHB,GBL,2019,2,TUR
Europe,Western and Central Europe,Andorra,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.001,AND
Europe,Western and Central Europe,Andorra,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.006,AND
Europe,Western and Central Europe,Andorra,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,5.597,AND
Europe,Western and Central Europe,Andorra,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,0.702,AND
Europe,Western and Central Europe,Andorra,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,0.172,AND
Europe,Western and Central Europe,Andorra,Opioids,Opiates,Heroin,2020,0.001,AND
Europe,Western and Central Europe,Andorra,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.019,AND
Europe,Western and Central Europe,Andorra,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.036,AND
Europe,Western and Central Europe,Andorra,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,4.544,AND
Europe,Western and Central Europe,Andorra,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,2.189,AND
Europe,Western and Central Europe,Andorra,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,0.142,AND
Europe,Western and Central Europe,Andorra,Opioids,Opiates,Heroin,2022,0.041,AND
Europe,Western and Central Europe,Andorra,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.002,AND
Europe,Western and Central Europe,Andorra,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.044,AND
Europe,Western and Central Europe,Andorra,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,3.492,AND
Europe,Western and Central Europe,Andorra,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,5.854,AND
Europe,Western and Central Europe,Andorra,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,0.63,AND
Europe,Western and Central Europe,Andorra,Opioids,Opiates,Heroin,2023,0.009,AND
Europe,Western and Central Europe,Andorra,“Ecstasy”-type substances,“Ecstasy”-type substances,Tenamfetamine (MDA),2019,0,AND
Europe,Western and Central Europe,Andorra,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,0,AND
Europe,Western and Central Europe,Andorra,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,0,AND
Europe,Western and Central Europe,Andorra,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,AND
Europe,Western and Central Europe,Andorra,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,AND
Europe,Western and Central Europe,Andorra,Any other drugs/substances,Other miscellaneous,Psychotropic substances,2019,0,AND
Europe,Western and Central Europe,Andorra,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,0,AND
Europe,Western and Central Europe,Andorra,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,14,AND
Europe,Western and Central Europe,Andorra,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,0,AND
Europe,Western and Central Europe,Andorra,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,7,AND
Europe,Western and Central Europe,Andorra,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,0,AND
Europe,Western and Central Europe,Andorra,Cocaine-type,Other/non-specified coca/cocaine-type drugs OR Miscellaneous coca/cocaine-type drugs,Other coca/cocaine-type drugs,2019,0,AND
Europe,Western and Central Europe,Andorra,Opioids,Opiates,Heroin,2019,0,AND
Europe,Western and Central Europe,Austria,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,14.94403,AUT
Europe,Western and Central Europe,Austria,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,24.159108,AUT
Europe,Western and Central Europe,Austria,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,36.83786,AUT
Europe,Western and Central Europe,Austria,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,9.23771,AUT
Europe,Western and Central Europe,Austria,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2020,0.14928,AUT
Europe,Western and Central Europe,Austria,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2020,0.2,AUT
Europe,Western and Central Europe,Austria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,2031.85214,AUT
Europe,Western and Central Europe,Austria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,3.19937,AUT
Europe,Western and Central Europe,Austria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,1788.1,AUT
Europe,Western and Central Europe,Austria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,21.72477,AUT
Europe,Western and Central Europe,Austria,Cocaine-type,Cocaine,"""Crack"" cocaine",2020,0.0016,AUT
Europe,Western and Central Europe,Austria,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,62.98496,AUT
Europe,Western and Central Europe,Austria,Hallucinogens,Other Hallucinogens,Psilocybine,2020,7.41888,AUT
Europe,Western and Central Europe,Austria,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,0.7066,AUT
Europe,Western and Central Europe,Austria,NPS,Plant-based NPS,Khat,2020,1094.77015,AUT
Europe,Western and Central Europe,Austria,Opioids,Opiates,Heroin,2020,104.27223,AUT
Europe,Western and Central Europe,Austria,Opioids,Opiates,Opium,2020,18.49122,AUT
Europe,Western and Central Europe,Austria,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2020,94.3622,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.0286,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Codeine,2020,0.03335,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.0017,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.07951,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Methadone,2020,0.0056,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Oxycodone,2020,0.0047,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Tramadol,2020,0.03455,AUT
Europe,Western and Central Europe,Austria,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,1.30491,AUT
Europe,Western and Central Europe,Austria,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,0.68404,AUT
Europe,Western and Central Europe,Austria,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,8.81468,AUT
Europe,Western and Central Europe,Austria,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,14.395791,AUT
Europe,Western and Central Europe,Austria,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2021,0.214,AUT
Europe,Western and Central Europe,Austria,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2021,116.48244,AUT
Europe,Western and Central Europe,Austria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,1739.03608,AUT
Europe,Western and Central Europe,Austria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,7.80258,AUT
Europe,Western and Central Europe,Austria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,4123,AUT
Europe,Western and Central Europe,Austria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,366.50661,AUT
Europe,Western and Central Europe,Austria,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,0.00174,AUT
Europe,Western and Central Europe,Austria,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,80.52867,AUT
Europe,Western and Central Europe,Austria,Hallucinogens,Other Hallucinogens,Psilocybine,2021,4.09634,AUT
Europe,Western and Central Europe,Austria,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,0.6546,AUT
Europe,Western and Central Europe,Austria,NPS,Plant-based NPS,Khat,2021,180.46,AUT
Europe,Western and Central Europe,Austria,Opioids,Opiates,Heroin,2021,71.52548,AUT
Europe,Western and Central Europe,Austria,Opioids,Opiates,Illicit morphine,2021,0.91517,AUT
Europe,Western and Central Europe,Austria,Opioids,Opiates,Opium,2021,17.2587,AUT
Europe,Western and Central Europe,Austria,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2021,24.283,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.11915,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Codeine,2021,0.00865,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Fentanyl,2021,0.00185,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Fentanyl,2021,0.04205,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Methadone,2021,0.0298,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.01825,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Tramadol,2021,0.18205,AUT
Europe,Western and Central Europe,Austria,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.15752,AUT
Europe,Western and Central Europe,Austria,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.00574,AUT
Europe,Western and Central Europe,Austria,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,2.95761,AUT
Europe,Western and Central Europe,Austria,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,8.14903,AUT
Europe,Western and Central Europe,Austria,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,5.686122,AUT
Europe,Western and Central Europe,Austria,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,29.26172,AUT
Europe,Western and Central Europe,Austria,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,9.73049,AUT
Europe,Western and Central Europe,Austria,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2022,0.0621,AUT
Europe,Western and Central Europe,Austria,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2022,0.2421,AUT
Europe,Western and Central Europe,Austria,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2022,0.12675,AUT
Europe,Western and Central Europe,Austria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,1685.01103,AUT
Europe,Western and Central Europe,Austria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,3.43241,AUT
Europe,Western and Central Europe,Austria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,2422.4,AUT
Europe,Western and Central Europe,Austria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,69.6425,AUT
Europe,Western and Central Europe,Austria,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2022,119.19616,AUT
Europe,Western and Central Europe,Austria,Hallucinogens,Other Hallucinogens,Psilocybine,2022,3.03929,AUT
Europe,Western and Central Europe,Austria,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,0.2494,AUT
Europe,Western and Central Europe,Austria,NPS,Plant-based NPS,Khat,2022,419.3835,AUT
Europe,Western and Central Europe,Austria,Opioids,Opiates,Heroin,2022,102.4259,AUT
Europe,Western and Central Europe,Austria,Opioids,Opiates,Illicit morphine,2022,0.41069,AUT
Europe,Western and Central Europe,Austria,Opioids,Opiates,Opium,2022,3.03978,AUT
Europe,Western and Central Europe,Austria,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2022,0.0169,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.11915,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Codeine,2022,0.00865,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.00185,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.04205,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Methadone,2022,0.0298,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Oxycodone,2022,0.01825,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Tramadol,2022,0.18205,AUT
Europe,Western and Central Europe,Austria,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.5348,AUT
Europe,Western and Central Europe,Austria,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.17503,AUT
Europe,Western and Central Europe,Austria,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.03112,AUT
Europe,Western and Central Europe,Austria,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.00409,AUT
Europe,Western and Central Europe,Austria,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,0.6346,AUT
Europe,Western and Central Europe,Austria,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,25.36168,AUT
Europe,Western and Central Europe,Austria,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,8.2282375,AUT
Europe,Western and Central Europe,Austria,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,94.06789,AUT
Europe,Western and Central Europe,Austria,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,8.89707,AUT
Europe,Western and Central Europe,Austria,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2023,0.1499,AUT
Europe,Western and Central Europe,Austria,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,0.15496,AUT
Europe,Western and Central Europe,Austria,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2023,0.24,AUT
Europe,Western and Central Europe,Austria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,2469.8173,AUT
Europe,Western and Central Europe,Austria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,7.17274,AUT
Europe,Western and Central Europe,Austria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,2212.3,AUT
Europe,Western and Central Europe,Austria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,183.18883,AUT
Europe,Western and Central Europe,Austria,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,0.00736,AUT
Europe,Western and Central Europe,Austria,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,153.60991,AUT
Europe,Western and Central Europe,Austria,Hallucinogens,Other Hallucinogens,Psilocybine,2023,6.97307,AUT
Europe,Western and Central Europe,Austria,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2023,0.405,AUT
Europe,Western and Central Europe,Austria,NPS,Plant-based NPS,Khat,2023,25,AUT
Europe,Western and Central Europe,Austria,Opioids,Opiates,Heroin,2023,57.01207,AUT
Europe,Western and Central Europe,Austria,Opioids,Opiates,Illicit morphine,2023,0.24763,AUT
Europe,Western and Central Europe,Austria,Opioids,Opiates,Opium,2023,16.13577,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.0145,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Codeine,2023,0.01445,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.0031,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.0041,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Methadone,2023,0.0128,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Oxycodone,2023,0.0462,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Tramadol,2023,0.0383,AUT
Europe,Western and Central Europe,Austria,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.59957,AUT
Europe,Western and Central Europe,Austria,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.2089,AUT
Europe,Western and Central Europe,Austria,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2023,0.7274,AUT
Europe,Western and Central Europe,Austria,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,0.19842,AUT
Europe,Western and Central Europe,Austria,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,9,AUT
Europe,Western and Central Europe,Austria,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,21,AUT
Europe,Western and Central Europe,Austria,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,122,AUT
Europe,Western and Central Europe,Austria,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,31,AUT
Europe,Western and Central Europe,Austria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,1216,AUT
Europe,Western and Central Europe,Austria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,4,AUT
Europe,Western and Central Europe,Austria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,2657,AUT
Europe,Western and Central Europe,Austria,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,147,AUT
Europe,Western and Central Europe,Austria,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,3,AUT
Europe,Western and Central Europe,Austria,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,87,AUT
Europe,Western and Central Europe,Austria,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,AUT
Europe,Western and Central Europe,Austria,NPS,Plant-based NPS,Mushrooms (hallucinogenic),2019,37,AUT
Europe,Western and Central Europe,Austria,Opioids,Opiates,Heroin,2019,95,AUT
Europe,Western and Central Europe,Austria,Opioids,Opiates,Illicit morphine,2019,0,AUT
Europe,Western and Central Europe,Austria,Opioids,Opiates,Opium,2019,22,AUT
Europe,Western and Central Europe,Austria,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2019,21,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Buprenorphine,2019,0,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Codeine,2019,0,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Fentanyl,2019,0,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Methadone,2019,0,AUT
Europe,Western and Central Europe,Austria,Opioids,Pharmaceutical opioids,Tramadol,2019,2,AUT
Europe,Western and Central Europe,Austria,Sedatives and tranquillizers,Methaqualone,Methaqualone,2019,1,AUT
Europe,Western and Central Europe,Austria,Sedatives and tranquillizers,Non-specified sedatives and tranquillizers,Non-specified sedatives and tranquillizers,2019,0,AUT
Europe,Western and Central Europe,Belgium,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,349.6,BEL
Europe,Western and Central Europe,Belgium,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,350.75,BEL
Europe,Western and Central Europe,Belgium,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,66.179013,BEL
Europe,Western and Central Europe,Belgium,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,164.337,BEL
Europe,Western and Central Europe,Belgium,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.064262,BEL
Europe,Western and Central Europe,Belgium,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,968.75,BEL
Europe,Western and Central Europe,Belgium,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,9.039,BEL
Europe,Western and Central Europe,Belgium,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,77,BEL
Europe,Western and Central Europe,Belgium,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2020,0.002,BEL
Europe,Western and Central Europe,Belgium,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2020,0.11475,BEL
Europe,Western and Central Europe,Belgium,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,2.25,BEL
Europe,Western and Central Europe,Belgium,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,18.62,BEL
Europe,Western and Central Europe,Belgium,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0,BEL
Europe,Western and Central Europe,Belgium,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,67.94,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,0.4945,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,1135.32,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.235,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.0063,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,29.568,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,13924.011,BEL
Europe,Western and Central Europe,Belgium,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,70254.476,BEL
Europe,Western and Central Europe,Belgium,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,0.451,BEL
Europe,Western and Central Europe,Belgium,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,1.7933,BEL
Europe,Western and Central Europe,Belgium,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,0.75,BEL
Europe,Western and Central Europe,Belgium,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,154.514,BEL
Europe,Western and Central Europe,Belgium,NPS,Plant-based NPS,Ayahuasca,2020,11,BEL
Europe,Western and Central Europe,Belgium,NPS,Plant-based NPS,Khat,2020,4452.647,BEL
Europe,Western and Central Europe,Belgium,Opioids,Opiates,Heroin,2020,684.44,BEL
Europe,Western and Central Europe,Belgium,Opioids,Opiates,Illicit morphine,2020,0.01857,BEL
Europe,Western and Central Europe,Belgium,Opioids,Opiates,Illicit morphine,2020,0.0102,BEL
Europe,Western and Central Europe,Belgium,Opioids,Pharmaceutical opioids,Methadone,2020,0.0031,BEL
Europe,Western and Central Europe,Belgium,Opioids,Pharmaceutical opioids,Methadone,2020,12.38001,BEL
Europe,Western and Central Europe,Belgium,Opioids,Pharmaceutical opioids,Oxycodone,2020,0.091,BEL
Europe,Western and Central Europe,Belgium,Precursors,Precursors,Acetic anhydride,2020,10,BEL
Europe,Western and Central Europe,Belgium,Precursors,Precursors,Acetone,2020,1948,BEL
Europe,Western and Central Europe,Belgium,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,51.32,BEL
Europe,Western and Central Europe,Belgium,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,1.88237,BEL
Europe,Western and Central Europe,Belgium,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,0.04581,BEL
Europe,Western and Central Europe,Belgium,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,248.88,BEL
Europe,Western and Central Europe,Belgium,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,123.772475,BEL
Europe,Western and Central Europe,Belgium,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,277,BEL
Europe,Western and Central Europe,Belgium,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,110,BEL
Europe,Western and Central Europe,Belgium,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,0.165,BEL
Europe,Western and Central Europe,Belgium,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2021,0.025,BEL
Europe,Western and Central Europe,Belgium,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2021,279.38,BEL
Europe,Western and Central Europe,Belgium,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,0.167,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,639.09,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,13451.13,BEL
Europe,Western and Central Europe,Belgium,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2021,96320.8,BEL
Europe,Western and Central Europe,Belgium,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.71,BEL
Europe,Western and Central Europe,Belgium,Hallucinogens,Other Hallucinogens,Zopiclone,2021,0.045,BEL
Europe,Western and Central Europe,Belgium,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,1.4021,BEL
Europe,Western and Central Europe,Belgium,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,218.65,BEL
Europe,Western and Central Europe,Belgium,NPS,Plant-based NPS,Khat,2021,9473,BEL
Europe,Western and Central Europe,Belgium,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2021,14.4,BEL
Europe,Western and Central Europe,Belgium,NPS,Synthetic cathinones,Synthetic cathinones,2021,9.6,BEL
Europe,Western and Central Europe,Belgium,Opioids,Opiates,Heroin,2021,1554.39,BEL
Europe,Western and Central Europe,Belgium,Opioids,Opiates,Illicit morphine,2021,0.001,BEL
Europe,Western and Central Europe,Belgium,Opioids,Opiates,Illicit morphine,2021,0.05,BEL
Europe,Western and Central Europe,Belgium,Opioids,Pharmaceutical opioids,Methadone,2021,0.204,BEL
Europe,Western and Central Europe,Belgium,Opioids,Pharmaceutical opioids,Methadone,2021,0.0025,BEL
Europe,Western and Central Europe,Belgium,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.02505,BEL
Europe,Western and Central Europe,Belgium,Opioids,Pharmaceutical opioids,Tramadol,2021,0.006,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2021,665,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2021,2209.6,BEL
Europe,Western and Central Europe,Belgium,Precursors,Precursors,Acetic anhydride,2021,120,BEL
Europe,Western and Central Europe,Belgium,Precursors,Precursors,Pseudoephedrine,2021,3.5,BEL
Europe,Western and Central Europe,Belgium,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.077,BEL
Europe,Western and Central Europe,Belgium,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.09599,BEL
Europe,Western and Central Europe,Belgium,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.02408,BEL
Europe,Western and Central Europe,Belgium,Sedatives and tranquillizers,Benzodiazepines,Midazolam,2021,0.25,BEL
Europe,Western and Central Europe,Belgium,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,0.04,BEL
Europe,Western and Central Europe,Belgium,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,0.75,BEL
Europe,Western and Central Europe,Belgium,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,73.455,BEL
Europe,Western and Central Europe,Belgium,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,20.288686,BEL
Europe,Western and Central Europe,Belgium,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2022,0.02025,BEL
Europe,Western and Central Europe,Belgium,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2022,0.1215,BEL
Europe,Western and Central Europe,Belgium,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2022,20.968,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,0.002,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,2990.424,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,0.52,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,0.17,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,2832.963,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,20.47,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,0,BEL
Europe,Western and Central Europe,Belgium,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,110910.532,BEL
Europe,Western and Central Europe,Belgium,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,,BEL
Europe,Western and Central Europe,Belgium,Hallucinogens,Other Hallucinogens,Psilocybine,2022,,BEL
Europe,Western and Central Europe,Belgium,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,23.932,BEL
Europe,Western and Central Europe,Belgium,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,1.028,BEL
Europe,Western and Central Europe,Belgium,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,150.736,BEL
Europe,Western and Central Europe,Belgium,NPS,Phenethylamines,Phenethylamines,2022,0.031065,BEL
Europe,Western and Central Europe,Belgium,NPS,Plant-based NPS,Khat,2022,5023.05,BEL
Europe,Western and Central Europe,Belgium,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2022,2.783,BEL
Europe,Western and Central Europe,Belgium,NPS,Synthetic cathinones,Synthetic cathinones,2022,0.03,BEL
Europe,Western and Central Europe,Belgium,Opioids,Opiates,Heroin,2022,,BEL
Europe,Western and Central Europe,Belgium,Opioids,Opiates,Heroin,2022,1282.703,BEL
Europe,Western and Central Europe,Belgium,Opioids,Opiates,Illicit morphine,2022,0.001,BEL
Europe,Western and Central Europe,Belgium,Opioids,Pharmaceutical opioids,Fentanyl,2022,,BEL
Europe,Western and Central Europe,Belgium,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.04,BEL
Europe,Western and Central Europe,Belgium,Opioids,Pharmaceutical opioids,Oxycodone,2022,,BEL
Europe,Western and Central Europe,Belgium,Opioids,Pharmaceutical opioids,Oxycodone,2022,0.012,BEL
Europe,Western and Central Europe,Belgium,Opioids,Pharmaceutical opioids,Tramadol,2022,0.014,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2022,5,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2022,440,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2022,20.02,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2022,1.04,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2022,2500,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2022,2,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2022,2285.56,BEL
Europe,Western and Central Europe,Belgium,Precursors,Precursors,"3,4-Methylenedioxyphenyl-2-propanone (3,4-MDP-2-P, PMK)",2022,120,BEL
Europe,Western and Central Europe,Belgium,Precursors,Precursors,"3,4-Methylenedioxyphenyl-2-propanone (3,4-MDP-2-P, PMK)",2022,553.32,BEL
Europe,Western and Central Europe,Belgium,Precursors,Precursors,Phenylacetone (P-2-P),2022,345,BEL
Europe,Western and Central Europe,Belgium,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,4.187,BEL
Europe,Western and Central Europe,Belgium,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.00765,BEL
Europe,Western and Central Europe,Belgium,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,0.14,BEL
Europe,Western and Central Europe,Belgium,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,1,BEL
Europe,Western and Central Europe,Belgium,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,24.37103,BEL
Europe,Western and Central Europe,Belgium,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,298.295,BEL
Europe,Western and Central Europe,Belgium,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.097,BEL
Europe,Western and Central Europe,Belgium,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,8.11,BEL
Europe,Western and Central Europe,Belgium,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2023,2.34,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,0.254,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,849.805,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,0.467,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,0.039,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,0.00513,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,4514.515,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,0.00066,BEL
Europe,Western and Central Europe,Belgium,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,0.03,BEL
Europe,Western and Central Europe,Belgium,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,123026.367,BEL
Europe,Western and Central Europe,Belgium,Cocaine-type,Coca-type,Coca leaf,2023,1.99,BEL
Europe,Western and Central Europe,Belgium,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2023,67.434,BEL
Europe,Western and Central Europe,Belgium,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2023,0.0666,BEL
Europe,Western and Central Europe,Belgium,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,159.87,BEL
Europe,Western and Central Europe,Belgium,NPS,Phenethylamines,Phenethylamines,2023,0.42,BEL
Europe,Western and Central Europe,Belgium,NPS,Plant-based NPS,Khat,2023,276.53,BEL
Europe,Western and Central Europe,Belgium,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2023,0.07,BEL
Europe,Western and Central Europe,Belgium,NPS,Synthetic cathinones,Synthetic cathinones,2023,0.58,BEL
Europe,Western and Central Europe,Belgium,Opioids,Opiates,Heroin,2023,0.00003,BEL
Europe,Western and Central Europe,Belgium,Opioids,Opiates,Heroin,2023,2918.976,BEL
Europe,Western and Central Europe,Belgium,Opioids,Opiates,Illicit morphine,2023,0.004,BEL
Europe,Western and Central Europe,Belgium,Opioids,Pharmaceutical opioids,Oxycodone,2023,0.005,BEL
Europe,Western and Central Europe,Belgium,Opioids,Pharmaceutical opioids,Tramadol,2023,0.025,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,20,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,10,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,980,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,460,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,225,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,40,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,6540,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,50,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,460,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,460,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,2800,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,3880,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,3550,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,2635,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,950,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,630,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,560,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,12.5,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,750,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,630,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,20,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,6775,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,1295,BEL
Europe,Western and Central Europe,Belgium,Precursors,Non-specified precursors,Other precursors,2023,1185,BEL
Europe,Western and Central Europe,Belgium,Precursors,Precursors,Acetone,2023,10277,BEL
Europe,Western and Central Europe,Belgium,Precursors,Precursors,Hydrochloric acid,2023,7830,BEL
Europe,Western and Central Europe,Belgium,Precursors,Precursors,Methylamine,2023,8981,BEL
Europe,Western and Central Europe,Belgium,Precursors,Precursors,Methylamine,2023,4,BEL
Europe,Western and Central Europe,Belgium,Precursors,Precursors,Sulphuric acid,2023,697,BEL
Europe,Western and Central Europe,Belgium,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.189,BEL
Europe,Western and Central Europe,Belgium,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.02988,BEL
Europe,Western and Central Europe,Belgium,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,250,BEL
Europe,Western and Central Europe,Belgium,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,111,BEL
Europe,Western and Central Europe,Belgium,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,1027,BEL
Europe,Western and Central Europe,Belgium,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,25,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,1154,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,8,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,174,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,0,BEL
Europe,Western and Central Europe,Belgium,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Non-specified cannabis-type,2019,35,BEL
Europe,Western and Central Europe,Belgium,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,65248,BEL
Europe,Western and Central Europe,Belgium,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,BEL
Europe,Western and Central Europe,Belgium,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,165,BEL
Europe,Western and Central Europe,Belgium,NPS,Other NPS,Non-specified NPS,2019,12,BEL
Europe,Western and Central Europe,Belgium,NPS,Plant-based NPS,Ayahuasca,2019,8,BEL
Europe,Western and Central Europe,Belgium,NPS,Plant-based NPS,Khat,2019,3573,BEL
Europe,Western and Central Europe,Belgium,NPS,Plant-based NPS,Mushrooms (hallucinogenic),2019,1,BEL
Europe,Western and Central Europe,Belgium,Opioids,Opiates,Heroin,2019,1929,BEL
Europe,Western and Central Europe,Belgium,Opioids,Opiates,Illicit morphine,2019,0,BEL
Europe,Western and Central Europe,Belgium,Opioids,Opiates,Illicit morphine,2019,0,BEL
Europe,Western and Central Europe,Belgium,Opioids,Opiates,Opium,2019,1,BEL
Europe,Western and Central Europe,Belgium,Opioids,Opioids,Non-specified opioids,2019,24,BEL
Europe,Western and Central Europe,Belgium,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,1,BEL
Europe,Western and Central Europe,Belgium,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,BEL
Europe,Western and Central Europe,Belgium,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,2,BEL
Europe,Western and Central Europe,Belgium,Sedatives and tranquillizers,GBL/GHB,GBL,2019,7,BEL
Europe,Western and Central Europe,Belgium,Sedatives and tranquillizers,GBL/GHB,GBL,2019,10000,BEL
Europe,Western and Central Europe,Cyprus,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.034,CYP
Europe,Western and Central Europe,Cyprus,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.018157,CYP
Europe,Western and Central Europe,Cyprus,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.005175,CYP
Europe,Western and Central Europe,Cyprus,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.277,CYP
Europe,Western and Central Europe,Cyprus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,212.215,CYP
Europe,Western and Central Europe,Cyprus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,7,CYP
Europe,Western and Central Europe,Cyprus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,0.349,CYP
Europe,Western and Central Europe,Cyprus,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,4.942,CYP
Europe,Western and Central Europe,Cyprus,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.00000305,CYP
Europe,Western and Central Europe,Cyprus,Opioids,Opiates,Heroin,2020,0.007,CYP
Europe,Western and Central Europe,Cyprus,Opioids,Pharmaceutical opioids,Methadone,2020,0.075,CYP
Europe,Western and Central Europe,Cyprus,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.005,CYP
Europe,Western and Central Europe,Cyprus,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.016802,CYP
Europe,Western and Central Europe,Cyprus,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,3.742,CYP
Europe,Western and Central Europe,Cyprus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,240.646,CYP
Europe,Western and Central Europe,Cyprus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,19,CYP
Europe,Western and Central Europe,Cyprus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,0.059,CYP
Europe,Western and Central Europe,Cyprus,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,5.51,CYP
Europe,Western and Central Europe,Cyprus,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.00000065,CYP
Europe,Western and Central Europe,Cyprus,Opioids,Opiates,Heroin,2021,0.004,CYP
Europe,Western and Central Europe,Cyprus,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2021,1.682,CYP
Europe,Western and Central Europe,Cyprus,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,3.5,CYP
Europe,Western and Central Europe,Cyprus,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,0.044986,CYP
Europe,Western and Central Europe,Cyprus,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.000506,CYP
Europe,Western and Central Europe,Cyprus,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,4.3,CYP
Europe,Western and Central Europe,Cyprus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,348.2,CYP
Europe,Western and Central Europe,Cyprus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,13.6,CYP
Europe,Western and Central Europe,Cyprus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,38.6,CYP
Europe,Western and Central Europe,Cyprus,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,38,CYP
Europe,Western and Central Europe,Cyprus,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.00000075,CYP
Europe,Western and Central Europe,Cyprus,Opioids,Opiates,Heroin,2022,0.069,CYP
Europe,Western and Central Europe,Cyprus,Opioids,Opiates,Opium,2022,0.002,CYP
Europe,Western and Central Europe,Cyprus,Opioids,Opiates,Poppy plants,2022,1.6,CYP
Europe,Western and Central Europe,Cyprus,Opioids,Opiates,Poppy plants,2022,3,CYP
Europe,Western and Central Europe,Cyprus,Precursors,Non-specified precursors,Other precursors,2022,4.2,CYP
Europe,Western and Central Europe,Cyprus,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.291,CYP
Europe,Western and Central Europe,Cyprus,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.475063,CYP
Europe,Western and Central Europe,Cyprus,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.253,CYP
Europe,Western and Central Europe,Cyprus,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,8.5,CYP
Europe,Western and Central Europe,Cyprus,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,500,CYP
Europe,Western and Central Europe,Cyprus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,554,CYP
Europe,Western and Central Europe,Cyprus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,4.8,CYP
Europe,Western and Central Europe,Cyprus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,16,CYP
Europe,Western and Central Europe,Cyprus,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,24.5,CYP
Europe,Western and Central Europe,Cyprus,Opioids,Opiates,Heroin,2023,1,CYP
Europe,Western and Central Europe,Cyprus,Opioids,Pharmaceutical opioids,Tramadol,2023,0.00525,CYP
Europe,Western and Central Europe,Cyprus,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,0,CYP
Europe,Western and Central Europe,Cyprus,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,1,CYP
Europe,Western and Central Europe,Cyprus,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,CYP
Europe,Western and Central Europe,Cyprus,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,1,CYP
Europe,Western and Central Europe,Cyprus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,227,CYP
Europe,Western and Central Europe,Cyprus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,16,CYP
Europe,Western and Central Europe,Cyprus,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,60,CYP
Europe,Western and Central Europe,Cyprus,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,49,CYP
Europe,Western and Central Europe,Cyprus,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,CYP
Europe,Western and Central Europe,Cyprus,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2019,5,CYP
Europe,Western and Central Europe,Cyprus,Opioids,Opiates,Heroin,2019,13,CYP
Europe,Western and Central Europe,Cyprus,Opioids,Opiates,Opium,2019,0,CYP
Europe,Western and Central Europe,Czechia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,20.65,CZE
Europe,Western and Central Europe,Czechia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,24.063174,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.028083,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,1.85866,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,29.6015,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2020,0.0025,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2020,30.176,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2020,0.0088,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2020,0.0054,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2020,0.0035,CZE
Europe,Western and Central Europe,Czechia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,655.13,CZE
Europe,Western and Central Europe,Czechia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,1599,CZE
Europe,Western and Central Europe,Czechia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,1.1857,CZE
Europe,Western and Central Europe,Czechia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,0.1694,CZE
Europe,Western and Central Europe,Czechia,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,2.642,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.01,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.0001771,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2020,0.022,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,Psilocybine,2020,0.383,CZE
Europe,Western and Central Europe,Czechia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,0.0641,CZE
Europe,Western and Central Europe,Czechia,NPS,Phenethylamines,"2,5-Dimethoxy-4-chloroamphetamine (DOC)",2020,0.000075,CZE
Europe,Western and Central Europe,Czechia,NPS,Plant-based NPS,Khat,2020,113.467,CZE
Europe,Western and Central Europe,Czechia,Opioids,Opiates,Heroin,2020,0.2861,CZE
Europe,Western and Central Europe,Czechia,Opioids,Opiates,Illicit morphine,2020,0.0289,CZE
Europe,Western and Central Europe,Czechia,Opioids,Opiates,Opium,2020,0.0717,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.0068,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.00685,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Codeine,2020,0.0014,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Codeine,2020,0.0567,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.00135,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Oxycodone,2020,0.0002,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Tramadol,2020,0.0199,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Tramadol,2020,0.0485,CZE
Europe,Western and Central Europe,Czechia,Precursors,Precursors,Ephedrine,2020,0.0009,CZE
Europe,Western and Central Europe,Czechia,Precursors,Precursors,Ephedrine,2020,0.632,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.05198,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.014,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.00356,CZE
Europe,Western and Central Europe,Czechia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,4.23,CZE
Europe,Western and Central Europe,Czechia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,2.522468,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,1.25,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.0045,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,33.4,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.3972,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2021,0.02649,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,0.00097,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Dextroamphetamine (Dexedrine),2021,0.00625,CZE
Europe,Western and Central Europe,Czechia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,1370,CZE
Europe,Western and Central Europe,Czechia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,0.04,CZE
Europe,Western and Central Europe,Czechia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,0.6171,CZE
Europe,Western and Central Europe,Czechia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,1723.7,CZE
Europe,Western and Central Europe,Czechia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,1.0418,CZE
Europe,Western and Central Europe,Czechia,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,180.66,CZE
Europe,Western and Central Europe,Czechia,Cocaine-type,Coca-type,Coca leaf,2021,0.002088,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.0014,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.0001493,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2021,0.0065,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2021,0.0044,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2021,5.63,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.4835,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.0542,CZE
Europe,Western and Central Europe,Czechia,NPS,Plant-based NPS,Khat,2021,62.6,CZE
Europe,Western and Central Europe,Czechia,Opioids,Opiates,Heroin,2021,107.199,CZE
Europe,Western and Central Europe,Czechia,Opioids,Opiates,Heroin,2021,0.02193,CZE
Europe,Western and Central Europe,Czechia,Opioids,Opiates,Illicit morphine,2021,0.003,CZE
Europe,Western and Central Europe,Czechia,Opioids,Opiates,Illicit morphine,2021,0.0108,CZE
Europe,Western and Central Europe,Czechia,Opioids,Opiates,Opium,2021,0.018,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.0117,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.00375,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Codeine,2021,0.02665,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Fentanyl,2021,0.00125,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.0242,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Tramadol,2021,0.0074,CZE
Europe,Western and Central Europe,Czechia,Precursors,Precursors,Ephedrine,2021,1.4,CZE
Europe,Western and Central Europe,Czechia,Precursors,Precursors,Ephedrine,2021,1.724145,CZE
Europe,Western and Central Europe,Czechia,Precursors,Precursors,Pseudoephedrine,2021,11.9,CZE
Europe,Western and Central Europe,Czechia,Precursors,Precursors,Pseudoephedrine,2021,49.4054,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,Barbiturates,Barbiturates,2021,0.5908,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.041176,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.13324,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.00092,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.00128,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,0.108,CZE
Europe,Western and Central Europe,Czechia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,1.833,CZE
Europe,Western and Central Europe,Czechia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,5.109434,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,2.526,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.016951,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,41.916,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2022,0.03213,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2022,0.0055,CZE
Europe,Western and Central Europe,Czechia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,926.74,CZE
Europe,Western and Central Europe,Czechia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,0.093,CZE
Europe,Western and Central Europe,Czechia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,1567.1,CZE
Europe,Western and Central Europe,Czechia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,2.36,CZE
Europe,Western and Central Europe,Czechia,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,1194.635,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0687,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0001703,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2022,0.0384,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2022,0.01,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2022,16.7,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2022,0.0029,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,Mescaline,2022,0.1,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,Psilocybine,2022,1.0626,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,Psilocybine,2022,0.0523,CZE
Europe,Western and Central Europe,Czechia,NPS,Plant-based NPS,Salvia divinorum,2022,0.168,CZE
Europe,Western and Central Europe,Czechia,Opioids,Opiates,Heroin,2022,0.00219,CZE
Europe,Western and Central Europe,Czechia,Opioids,Opiates,Heroin,2022,0.1016,CZE
Europe,Western and Central Europe,Czechia,Opioids,Opiates,Illicit morphine,2022,0.0001,CZE
Europe,Western and Central Europe,Czechia,Opioids,Opiates,Illicit morphine,2022,0.004,CZE
Europe,Western and Central Europe,Czechia,Opioids,Opiates,Opium,2022,0.0059,CZE
Europe,Western and Central Europe,Czechia,Opioids,Opiates,Opium,2022,0.0183,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.02082,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.011,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Codeine,2022,0.0012,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Codeine,2022,0.0284,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.0002,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.00265,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Methadone,2022,0.002,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Oxycodone,2022,0.07845,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Tramadol,2022,0.0152,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,Barbiturates,Barbiturates,2022,0.01,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.0056,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.891,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.1106,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.00603,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2022,0.0135,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,0.0263,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,0.128,CZE
Europe,Western and Central Europe,Czechia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,2.75561,CZE
Europe,Western and Central Europe,Czechia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,2.763658,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.004554,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,1.32292,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,34.03345,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,1.00285,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2023,0.07375,CZE
Europe,Western and Central Europe,Czechia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,648.76637,CZE
Europe,Western and Central Europe,Czechia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,0.00815,CZE
Europe,Western and Central Europe,Czechia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,0.009615,CZE
Europe,Western and Central Europe,Czechia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,1323.6,CZE
Europe,Western and Central Europe,Czechia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,1.88691,CZE
Europe,Western and Central Europe,Czechia,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,677.52304,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.0027992,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.0000769,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2023,0.00584,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2023,0.015,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2023,5.01881,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.02,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.80823,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.207,CZE
Europe,Western and Central Europe,Czechia,Opioids,Opiates,Heroin,2023,0.90576,CZE
Europe,Western and Central Europe,Czechia,Opioids,Opiates,Illicit morphine,2023,0.00205,CZE
Europe,Western and Central Europe,Czechia,Opioids,Opiates,Illicit morphine,2023,0.026,CZE
Europe,Western and Central Europe,Czechia,Opioids,Opiates,Illicit morphine,2023,0.0376,CZE
Europe,Western and Central Europe,Czechia,Opioids,Opiates,Opium,2023,0.0016,CZE
Europe,Western and Central Europe,Czechia,Opioids,Opiates,Opium,2023,0.01576,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.04419,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.0203,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Codeine,2023,0.0041,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.00045,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.0045,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Oxycodone,2023,0.19035,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Tramadol,2023,0.01565,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Tramadol,2023,1.3,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Tramadol,2023,1.309,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,1.93623,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.73715,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2023,0.07795,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2023,0.17,CZE
Europe,Western and Central Europe,Czechia,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,37,CZE
Europe,Western and Central Europe,Czechia,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,20,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,1,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,28,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2019,0,CZE
Europe,Western and Central Europe,Czechia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2019,4,CZE
Europe,Western and Central Europe,Czechia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,546,CZE
Europe,Western and Central Europe,Czechia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,2693,CZE
Europe,Western and Central Europe,Czechia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,2,CZE
Europe,Western and Central Europe,Czechia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,0,CZE
Europe,Western and Central Europe,Czechia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,0,CZE
Europe,Western and Central Europe,Czechia,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,187,CZE
Europe,Western and Central Europe,Czechia,Cocaine-type,Coca-type,Coca leaf,2019,2,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,Lysergic acid diethylamide (LSD),2019,0,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,Other hallucinogens,2019,0,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,Phencyclidine (PCP),2019,0,CZE
Europe,Western and Central Europe,Czechia,Hallucinogens,Other Hallucinogens,Phencyclidine (PCP),2019,0,CZE
Europe,Western and Central Europe,Czechia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,1,CZE
Europe,Western and Central Europe,Czechia,NPS,Phenethylamines,Phenethylamine,2019,0,CZE
Europe,Western and Central Europe,Czechia,NPS,Phenethylamines,Phenethylamine,2019,0,CZE
Europe,Western and Central Europe,Czechia,NPS,Piperazines,Piperazines,2019,0,CZE
Europe,Western and Central Europe,Czechia,NPS,Plant-based NPS,Khat,2019,564,CZE
Europe,Western and Central Europe,Czechia,NPS,Plant-based NPS,Mushrooms (hallucinogenic),2019,1,CZE
Europe,Western and Central Europe,Czechia,NPS,Plant-based NPS,Mushrooms (hallucinogenic),2019,1,CZE
Europe,Western and Central Europe,Czechia,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2019,1,CZE
Europe,Western and Central Europe,Czechia,NPS,Synthetic cannabinoids (Spice),UR-144,2019,0,CZE
Europe,Western and Central Europe,Czechia,Opioids,Opiates,Heroin,2019,9,CZE
Europe,Western and Central Europe,Czechia,Opioids,Opiates,Illicit morphine,2019,0,CZE
Europe,Western and Central Europe,Czechia,Opioids,Opiates,Opium,2019,0,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Buprenorphine,2019,0,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Buprenorphine,2019,0,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Codeine,2019,0,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Fentanyl,2019,0,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Oxycodone,2019,0,CZE
Europe,Western and Central Europe,Czechia,Opioids,Pharmaceutical opioids,Tramadol,2019,0,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,0,CZE
Europe,Western and Central Europe,Czechia,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2019,0,CZE
Europe,Western and Central Europe,Denmark,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,25.15,DNK
Europe,Western and Central Europe,Denmark,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,539.43,DNK
Europe,Western and Central Europe,Denmark,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,12.83,DNK
Europe,Western and Central Europe,Denmark,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,439.43,DNK
Europe,Western and Central Europe,Denmark,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,53.517,DNK
Europe,Western and Central Europe,Denmark,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,254.82,DNK
Europe,Western and Central Europe,Denmark,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,5469.69,DNK
Europe,Western and Central Europe,Denmark,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,374.67,DNK
Europe,Western and Central Europe,Denmark,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.0003104,DNK
Europe,Western and Central Europe,Denmark,Hallucinogens,Other Hallucinogens,Psilocybine,2020,,DNK
Europe,Western and Central Europe,Denmark,Opioids,Opiates,Heroin,2020,7.85,DNK
Europe,Western and Central Europe,Denmark,Opioids,Opiates,Opium,2020,10.29,DNK
Europe,Western and Central Europe,Denmark,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2020,36.517,DNK
Europe,Western and Central Europe,Denmark,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,8.42,DNK
Europe,Western and Central Europe,Denmark,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,1.718953,DNK
Europe,Western and Central Europe,Denmark,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,160.04,DNK
Europe,Western and Central Europe,Denmark,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,3.33,DNK
Europe,Western and Central Europe,Denmark,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,392.25,DNK
Europe,Western and Central Europe,Denmark,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,5.26282,DNK
Europe,Western and Central Europe,Denmark,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,81.2,DNK
Europe,Western and Central Europe,Denmark,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,939.1,DNK
Europe,Western and Central Europe,Denmark,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,3034.55,DNK
Europe,Western and Central Europe,Denmark,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,397.14,DNK
Europe,Western and Central Europe,Denmark,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.00036145,DNK
Europe,Western and Central Europe,Denmark,Hallucinogens,Other Hallucinogens,Psilocybine,2021,17.15,DNK
Europe,Western and Central Europe,Denmark,NPS,Plant-based NPS,Khat,2021,450.13,DNK
Europe,Western and Central Europe,Denmark,Opioids,Opiates,Heroin,2021,14.14,DNK
Europe,Western and Central Europe,Denmark,Opioids,Opiates,Opium,2021,1.39,DNK
Europe,Western and Central Europe,Denmark,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,9.57705,DNK
Europe,Western and Central Europe,Denmark,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,71.29201,DNK
Europe,Western and Central Europe,Denmark,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,7.643284,DNK
Europe,Western and Central Europe,Denmark,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,8.34,DNK
Europe,Western and Central Europe,Denmark,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,365.16,DNK
Europe,Western and Central Europe,Denmark,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,12.9,DNK
Europe,Western and Central Europe,Denmark,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,497.3,DNK
Europe,Western and Central Europe,Denmark,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,5.28741,DNK
Europe,Western and Central Europe,Denmark,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,294.5,DNK
Europe,Western and Central Europe,Denmark,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,658.5,DNK
Europe,Western and Central Europe,Denmark,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,5073.22,DNK
Europe,Western and Central Europe,Denmark,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2022,351.84,DNK
Europe,Western and Central Europe,Denmark,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.00024285,DNK
Europe,Western and Central Europe,Denmark,Hallucinogens,Other Hallucinogens,Psilocybine,2022,74.24,DNK
Europe,Western and Central Europe,Denmark,Hallucinogens,Other Hallucinogens,Psilocybine,2022,0.0133,DNK
Europe,Western and Central Europe,Denmark,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,548.82,DNK
Europe,Western and Central Europe,Denmark,NPS,Plant-based NPS,Khat,2022,509.41,DNK
Europe,Western and Central Europe,Denmark,Opioids,Opiates,Opium,2022,120,DNK
Europe,Western and Central Europe,Denmark,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2022,20.8,DNK
Europe,Western and Central Europe,Denmark,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,10.09,DNK
Europe,Western and Central Europe,Denmark,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,8.17,DNK
Europe,Western and Central Europe,Denmark,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,9.047877,DNK
Europe,Western and Central Europe,Denmark,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,313.81,DNK
Europe,Western and Central Europe,Denmark,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,6.57,DNK
Europe,Western and Central Europe,Denmark,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,383,DNK
Europe,Western and Central Europe,Denmark,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,12.89,DNK
Europe,Western and Central Europe,Denmark,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,3062,DNK
Europe,Western and Central Europe,Denmark,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,3965,DNK
Europe,Western and Central Europe,Denmark,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,192.46,DNK
Europe,Western and Central Europe,Denmark,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.00006785,DNK
Europe,Western and Central Europe,Denmark,Hallucinogens,Other Hallucinogens,Psilocybine,2023,163.84,DNK
Europe,Western and Central Europe,Denmark,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,63.72,DNK
Europe,Western and Central Europe,Denmark,NPS,Plant-based NPS,Khat,2023,678.62,DNK
Europe,Western and Central Europe,Denmark,Opioids,Opiates,Heroin,2023,20.19,DNK
Europe,Western and Central Europe,Denmark,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2023,75.12,DNK
Europe,Western and Central Europe,Denmark,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,66,DNK
Europe,Western and Central Europe,Denmark,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,10,DNK
Europe,Western and Central Europe,Denmark,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,214,DNK
Europe,Western and Central Europe,Denmark,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,11,DNK
Europe,Western and Central Europe,Denmark,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,556,DNK
Europe,Western and Central Europe,Denmark,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,37,DNK
Europe,Western and Central Europe,Denmark,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,121,DNK
Europe,Western and Central Europe,Denmark,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,1434,DNK
Europe,Western and Central Europe,Denmark,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,2399,DNK
Europe,Western and Central Europe,Denmark,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,190,DNK
Europe,Western and Central Europe,Denmark,Hallucinogens,Non-specified hallucinogens,Non-specified hallucinogens,2019,0,DNK
Europe,Western and Central Europe,Denmark,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,7,DNK
Europe,Western and Central Europe,Denmark,Opioids,Opiates,Heroin,2019,46,DNK
Europe,Western and Central Europe,Denmark,Opioids,Opiates,Opium,2019,11,DNK
Europe,Western and Central Europe,Denmark,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,7,DNK
Europe,Western and Central Europe,Denmark,Sedatives and tranquillizers,GBL/GHB,GBL,2019,24,DNK
Europe,Western and Central Europe,Estonia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,67.482,EST
Europe,Western and Central Europe,Estonia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,42.374373,EST
Europe,Western and Central Europe,Estonia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,128.469,EST
Europe,Western and Central Europe,Estonia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,27.06,EST
Europe,Western and Central Europe,Estonia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2020,0.424,EST
Europe,Western and Central Europe,Estonia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2020,0.002,EST
Europe,Western and Central Europe,Estonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,57.382,EST
Europe,Western and Central Europe,Estonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.164,EST
Europe,Western and Central Europe,Estonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,36.28,EST
Europe,Western and Central Europe,Estonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,1.452,EST
Europe,Western and Central Europe,Estonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,0.164,EST
Europe,Western and Central Europe,Estonia,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,413.044,EST
Europe,Western and Central Europe,Estonia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.086,EST
Europe,Western and Central Europe,Estonia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,,EST
Europe,Western and Central Europe,Estonia,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2020,0.013,EST
Europe,Western and Central Europe,Estonia,Hallucinogens,Other Hallucinogens,Psilocybine,2020,0.266,EST
Europe,Western and Central Europe,Estonia,Opioids,Opiates,Illicit morphine,2020,0.001,EST
Europe,Western and Central Europe,Estonia,Opioids,Opiates,Opium,2020,0.001,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.004,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Carfentanil,2020,0.158,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Codeine,2020,0.002,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Methadone,2020,0.884,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Tramadol,2020,0.003,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Tramadol,2020,0.0004,EST
Europe,Western and Central Europe,Estonia,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2020,0.04,EST
Europe,Western and Central Europe,Estonia,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2020,0.007,EST
Europe,Western and Central Europe,Estonia,Sedatives and tranquillizers,Benzodiazepines,"Lorazepam (Ativan, Temesta)",2020,0.001,EST
Europe,Western and Central Europe,Estonia,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,40.865,EST
Europe,Western and Central Europe,Estonia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,30.1,EST
Europe,Western and Central Europe,Estonia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,17.0188,EST
Europe,Western and Central Europe,Estonia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2021,52.1,EST
Europe,Western and Central Europe,Estonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,117,EST
Europe,Western and Central Europe,Estonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,0.00072,EST
Europe,Western and Central Europe,Estonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,75,EST
Europe,Western and Central Europe,Estonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,105,EST
Europe,Western and Central Europe,Estonia,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,16.3,EST
Europe,Western and Central Europe,Estonia,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,2.05,EST
Europe,Western and Central Europe,Estonia,Opioids,Opiates,Heroin,2021,0.047,EST
Europe,Western and Central Europe,Estonia,Opioids,Opiates,Illicit morphine,2021,0.0096,EST
Europe,Western and Central Europe,Estonia,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2021,0.04914,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Buprenorphine,2021,4.9,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Codeine,2021,0.0135,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Fentanyl,2021,0.582,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Methadone,2021,0.001175,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Methadone,2021,1.13,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Methadone,2021,1.138,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.00896,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.0014,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Tramadol,2021,0.094,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Tramadol,2021,0.0077,EST
Europe,Western and Central Europe,Estonia,Sedatives and tranquillizers,Barbiturates,Barbiturates,2021,0.00126,EST
Europe,Western and Central Europe,Estonia,Sedatives and tranquillizers,Barbiturates,Barbiturates,2021,0.0009,EST
Europe,Western and Central Europe,Estonia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.45,EST
Europe,Western and Central Europe,Estonia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.0211,EST
Europe,Western and Central Europe,Estonia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.116,EST
Europe,Western and Central Europe,Estonia,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,45.1,EST
Europe,Western and Central Europe,Estonia,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,2.14,EST
Europe,Western and Central Europe,Estonia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,1.25,EST
Europe,Western and Central Europe,Estonia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2022,79,EST
Europe,Western and Central Europe,Estonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,68.4,EST
Europe,Western and Central Europe,Estonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,38.7,EST
Europe,Western and Central Europe,Estonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,38.6,EST
Europe,Western and Central Europe,Estonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,0.00021,EST
Europe,Western and Central Europe,Estonia,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,3100,EST
Europe,Western and Central Europe,Estonia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.028,EST
Europe,Western and Central Europe,Estonia,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2022,0.0053,EST
Europe,Western and Central Europe,Estonia,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2022,3.1,EST
Europe,Western and Central Europe,Estonia,Hallucinogens,Other Hallucinogens,Psilocybine,2022,0.38,EST
Europe,Western and Central Europe,Estonia,Opioids,Opiates,Heroin,2022,0.0014,EST
Europe,Western and Central Europe,Estonia,Opioids,Opiates,Illicit morphine,2022,0.0065,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Buprenorphine,2022,3,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.0007,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Methadone,2022,0.72,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Oxycodone,2022,0.047,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Tramadol,2022,0.04,EST
Europe,Western and Central Europe,Estonia,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2022,95,EST
Europe,Western and Central Europe,Estonia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,14.8,EST
Europe,Western and Central Europe,Estonia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2023,473,EST
Europe,Western and Central Europe,Estonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,69.4,EST
Europe,Western and Central Europe,Estonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,94.2,EST
Europe,Western and Central Europe,Estonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,67.5,EST
Europe,Western and Central Europe,Estonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,0.006,EST
Europe,Western and Central Europe,Estonia,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,335,EST
Europe,Western and Central Europe,Estonia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.054,EST
Europe,Western and Central Europe,Estonia,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2023,0.021,EST
Europe,Western and Central Europe,Estonia,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2023,3.5,EST
Europe,Western and Central Europe,Estonia,Hallucinogens,Other Hallucinogens,Psilocybine,2023,1.18,EST
Europe,Western and Central Europe,Estonia,Opioids,Opiates,Heroin,2023,0.002,EST
Europe,Western and Central Europe,Estonia,Opioids,Opiates,Illicit morphine,2023,0.001,EST
Europe,Western and Central Europe,Estonia,Opioids,Opiates,Opium,2023,0.338,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Buprenorphine,2023,5.4,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Methadone,2023,0.845,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Oxycodone,2023,0.023,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Tramadol,2023,0.08,EST
Europe,Western and Central Europe,Estonia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.19,EST
Europe,Western and Central Europe,Estonia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.068,EST
Europe,Western and Central Europe,Estonia,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2023,35.8,EST
Europe,Western and Central Europe,Estonia,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2023,0.295,EST
Europe,Western and Central Europe,Estonia,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,33,EST
Europe,Western and Central Europe,Estonia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,111,EST
Europe,Western and Central Europe,Estonia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,4,EST
Europe,Western and Central Europe,Estonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,97,EST
Europe,Western and Central Europe,Estonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,3,EST
Europe,Western and Central Europe,Estonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,75,EST
Europe,Western and Central Europe,Estonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,2,EST
Europe,Western and Central Europe,Estonia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,2,EST
Europe,Western and Central Europe,Estonia,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,17,EST
Europe,Western and Central Europe,Estonia,Cocaine-type,Coca-type,Coca leaf,2019,2,EST
Europe,Western and Central Europe,Estonia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,EST
Europe,Western and Central Europe,Estonia,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2019,0,EST
Europe,Western and Central Europe,Estonia,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2019,0,EST
Europe,Western and Central Europe,Estonia,Hallucinogens,Other Hallucinogens,Lysergic acid diethylamide (LSD),2019,0,EST
Europe,Western and Central Europe,Estonia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,1,EST
Europe,Western and Central Europe,Estonia,NPS,Other NPS,Non-specified NPS,2019,50,EST
Europe,Western and Central Europe,Estonia,NPS,Phenethylamines,4-Fluoromethamphetamine (4-FMA),2019,5,EST
Europe,Western and Central Europe,Estonia,NPS,Plant-based NPS,Khat,2019,4,EST
Europe,Western and Central Europe,Estonia,NPS,Synthetic cannabinoids (Spice),AB-FUBINACA,2019,0,EST
Europe,Western and Central Europe,Estonia,NPS,Synthetic cathinones,Alpha-Pyrrolidinohexiophenone (alpha-PHP),2019,1,EST
Europe,Western and Central Europe,Estonia,Opioids,Opiates,Heroin,2019,0,EST
Europe,Western and Central Europe,Estonia,Opioids,Opiates,Illicit morphine,2019,0,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Buprenorphine,2019,0,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Carfentanil,2019,0,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Fentanyl,2019,11,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Fentanyl,2019,0,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Methadone,2019,0,EST
Europe,Western and Central Europe,Estonia,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,0,EST
Europe,Western and Central Europe,Estonia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,1,EST
Europe,Western and Central Europe,Estonia,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,3,EST
Europe,Western and Central Europe,Estonia,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2019,127,EST
Europe,Western and Central Europe,Finland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,14.8,FIN
Europe,Western and Central Europe,Finland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,37.351388,FIN
Europe,Western and Central Europe,Finland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,256,FIN
Europe,Western and Central Europe,Finland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,5.8,FIN
Europe,Western and Central Europe,Finland,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0.47,FIN
Europe,Western and Central Europe,Finland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,458,FIN
Europe,Western and Central Europe,Finland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,1930,FIN
Europe,Western and Central Europe,Finland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,12,FIN
Europe,Western and Central Europe,Finland,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,52.2,FIN
Europe,Western and Central Europe,Finland,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,0.3295,FIN
Europe,Western and Central Europe,Finland,NPS,Plant-based NPS,Khat,2020,427,FIN
Europe,Western and Central Europe,Finland,Opioids,Opiates,Heroin,2020,0.3,FIN
Europe,Western and Central Europe,Finland,Opioids,Opiates,Opium,2020,0.95,FIN
Europe,Western and Central Europe,Finland,Opioids,Other illicit opioids,Other illicit opioids,2020,1.93855,FIN
Europe,Western and Central Europe,Finland,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,5.30034,FIN
Europe,Western and Central Europe,Finland,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2020,333.3,FIN
Europe,Western and Central Europe,Finland,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2020,0.58,FIN
Europe,Western and Central Europe,Finland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,5.2,FIN
Europe,Western and Central Europe,Finland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,22.7911,FIN
Europe,Western and Central Europe,Finland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,393,FIN
Europe,Western and Central Europe,Finland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,1.7,FIN
Europe,Western and Central Europe,Finland,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0.22,FIN
Europe,Western and Central Europe,Finland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,677,FIN
Europe,Western and Central Europe,Finland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,1710,FIN
Europe,Western and Central Europe,Finland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,19.5,FIN
Europe,Western and Central Europe,Finland,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,63,FIN
Europe,Western and Central Europe,Finland,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.0005725,FIN
Europe,Western and Central Europe,Finland,NPS,Plant-based NPS,Khat,2021,276,FIN
Europe,Western and Central Europe,Finland,NPS,Synthetic cathinones,Alpha-Pyrrolidinohexiophenone (alpha-PHP),2021,1.94,FIN
Europe,Western and Central Europe,Finland,Opioids,Opiates,Heroin,2021,0.11,FIN
Europe,Western and Central Europe,Finland,Opioids,Pharmaceutical opioids,Buprenorphine,2021,3.4045,FIN
Europe,Western and Central Europe,Finland,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,5.1673,FIN
Europe,Western and Central Europe,Finland,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,198,FIN
Europe,Western and Central Europe,Finland,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,0.27,FIN
Europe,Western and Central Europe,Finland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,8.8,FIN
Europe,Western and Central Europe,Finland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,16.445093,FIN
Europe,Western and Central Europe,Finland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,304.3,FIN
Europe,Western and Central Europe,Finland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,8.8,FIN
Europe,Western and Central Europe,Finland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,753.4,FIN
Europe,Western and Central Europe,Finland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,1270.3,FIN
Europe,Western and Central Europe,Finland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,286.1,FIN
Europe,Western and Central Europe,Finland,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,56.4,FIN
Europe,Western and Central Europe,Finland,Cocaine-type,Coca-type,Coca leaf,2022,0.071,FIN
Europe,Western and Central Europe,Finland,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,0.43555,FIN
Europe,Western and Central Europe,Finland,NPS,Plant-based NPS,Khat,2022,926,FIN
Europe,Western and Central Europe,Finland,NPS,Synthetic cathinones,Alpha-Pyrrolidinohexiophenone (alpha-PHP),2022,1.19,FIN
Europe,Western and Central Europe,Finland,NPS,Synthetic cathinones,Synthetic cathinones,2022,0.277,FIN
Europe,Western and Central Europe,Finland,Opioids,Opiates,Heroin,2022,0.102,FIN
Europe,Western and Central Europe,Finland,Opioids,Opiates,Opium,2022,0.21,FIN
Europe,Western and Central Europe,Finland,Opioids,Pharmaceutical opioids,Buprenorphine,2022,1.15465,FIN
Europe,Western and Central Europe,Finland,Precursors,Non-specified precursors,Other precursors,2022,0.307,FIN
Europe,Western and Central Europe,Finland,Precursors,Non-specified precursors,Other precursors,2022,0.15,FIN
Europe,Western and Central Europe,Finland,Precursors,Precursors,Ephedrine,2022,0.136,FIN
Europe,Western and Central Europe,Finland,Precursors,Precursors,Pseudoephedrine,2022,108.053,FIN
Europe,Western and Central Europe,Finland,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,6.41803,FIN
Europe,Western and Central Europe,Finland,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2022,413.97,FIN
Europe,Western and Central Europe,Finland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,19.3,FIN
Europe,Western and Central Europe,Finland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,55.86936,FIN
Europe,Western and Central Europe,Finland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,838,FIN
Europe,Western and Central Europe,Finland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,3.4,FIN
Europe,Western and Central Europe,Finland,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,3.258,FIN
Europe,Western and Central Europe,Finland,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,9,FIN
Europe,Western and Central Europe,Finland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,1018,FIN
Europe,Western and Central Europe,Finland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,1017.8,FIN
Europe,Western and Central Europe,Finland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,211,FIN
Europe,Western and Central Europe,Finland,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,106.4,FIN
Europe,Western and Central Europe,Finland,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2023,0.2813,FIN
Europe,Western and Central Europe,Finland,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,27.8,FIN
Europe,Western and Central Europe,Finland,NPS,Plant-based NPS,Khat,2023,563,FIN
Europe,Western and Central Europe,Finland,NPS,Synthetic cathinones,Alpha-Pyrrolidinohexiophenone (alpha-PHP),2023,3,FIN
Europe,Western and Central Europe,Finland,Opioids,Opiates,Heroin,2023,0.0908,FIN
Europe,Western and Central Europe,Finland,Opioids,Opiates,Opium,2023,0.8,FIN
Europe,Western and Central Europe,Finland,Opioids,Pharmaceutical opioids,Buprenorphine,2023,2.8406,FIN
Europe,Western and Central Europe,Finland,Precursors,Non-specified precursors,Other precursors,2023,0.002,FIN
Europe,Western and Central Europe,Finland,Precursors,Non-specified precursors,Other precursors,2023,1,FIN
Europe,Western and Central Europe,Finland,Precursors,Non-specified precursors,Other precursors,2023,0.01,FIN
Europe,Western and Central Europe,Finland,Precursors,Non-specified precursors,Other precursors,2023,0.025,FIN
Europe,Western and Central Europe,Finland,Precursors,Non-specified precursors,Other precursors,2023,50.4,FIN
Europe,Western and Central Europe,Finland,Precursors,Non-specified precursors,Other precursors,2023,1,FIN
Europe,Western and Central Europe,Finland,Precursors,Non-specified precursors,Other precursors,2023,0.089,FIN
Europe,Western and Central Europe,Finland,Precursors,Non-specified precursors,Other precursors,2023,0.004,FIN
Europe,Western and Central Europe,Finland,Precursors,Precursors,Pseudoephedrine,2023,0.0001,FIN
Europe,Western and Central Europe,Finland,Precursors,Precursors,Sulphuric acid,2023,0.35,FIN
Europe,Western and Central Europe,Finland,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,12.96219,FIN
Europe,Western and Central Europe,Finland,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2023,79,FIN
Europe,Western and Central Europe,Finland,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,29,FIN
Europe,Western and Central Europe,Finland,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,72,FIN
Europe,Western and Central Europe,Finland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,180,FIN
Europe,Western and Central Europe,Finland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,10,FIN
Europe,Western and Central Europe,Finland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,397,FIN
Europe,Western and Central Europe,Finland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,1590,FIN
Europe,Western and Central Europe,Finland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,215,FIN
Europe,Western and Central Europe,Finland,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,223,FIN
Europe,Western and Central Europe,Finland,Cocaine-type,Coca-type,Coca leaf,2019,2,FIN
Europe,Western and Central Europe,Finland,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,FIN
Europe,Western and Central Europe,Finland,NPS,Plant-based NPS,Khat,2019,1313,FIN
Europe,Western and Central Europe,Finland,NPS,Synthetic cathinones,Alpha-Pyrrolidinohexiophenone (alpha-PHP),2019,0,FIN
Europe,Western and Central Europe,Finland,Opioids,Opiates,Heroin,2019,8,FIN
Europe,Western and Central Europe,Finland,Opioids,Opiates,Opium,2019,0,FIN
Europe,Western and Central Europe,Finland,Opioids,Pharmaceutical opioids,Buprenorphine,2019,3,FIN
Europe,Western and Central Europe,Finland,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,8,FIN
Europe,Western and Central Europe,Finland,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,1,FIN
Europe,Western and Central Europe,Finland,Sedatives and tranquillizers,GBL/GHB,GBL,2019,54,FIN
Europe,Western and Central Europe,France,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,309.969,FRA
Europe,Western and Central Europe,France,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2020,697,FRA
Europe,Western and Central Europe,France,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,46277,FRA
Europe,Western and Central Europe,France,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,11536.5,FRA
Europe,Western and Central Europe,France,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,58248,FRA
Europe,Western and Central Europe,France,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,13145,FRA
Europe,Western and Central Europe,France,Opioids,Opiates,Heroin,2020,1132,FRA
Europe,Western and Central Europe,France,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,394.057035,FRA
Europe,Western and Central Europe,France,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2021,226,FRA
Europe,Western and Central Europe,France,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,39500,FRA
Europe,Western and Central Europe,France,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,10177.1,FRA
Europe,Western and Central Europe,France,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,72400,FRA
Europe,Western and Central Europe,France,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,26500,FRA
Europe,Western and Central Europe,France,Opioids,Opiates,Heroin,2021,1312,FRA
Europe,Western and Central Europe,France,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,418.267091,FRA
Europe,Western and Central Europe,France,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2022,273,FRA
Europe,Western and Central Europe,France,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,41000,FRA
Europe,Western and Central Europe,France,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,7680.7,FRA
Europe,Western and Central Europe,France,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,87600,FRA
Europe,Western and Central Europe,France,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,27700,FRA
Europe,Western and Central Europe,France,Opioids,Opiates,Heroin,2022,1400,FRA
Europe,Western and Central Europe,France,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,1103.702784,FRA
Europe,Western and Central Europe,France,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2023,265,FRA
Europe,Western and Central Europe,France,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,37700,FRA
Europe,Western and Central Europe,France,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,11202.8,FRA
Europe,Western and Central Europe,France,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,87000,FRA
Europe,Western and Central Europe,France,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,23200,FRA
Europe,Western and Central Europe,France,Opioids,Opiates,Heroin,2023,1100,FRA
Europe,Western and Central Europe,France,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,319,FRA
Europe,Western and Central Europe,France,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,92,FRA
Europe,Western and Central Europe,France,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,562,FRA
Europe,Western and Central Europe,France,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,21949,FRA
Europe,Western and Central Europe,France,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,18300,FRA
Europe,Western and Central Europe,France,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,73462,FRA
Europe,Western and Central Europe,France,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,14599,FRA
Europe,Western and Central Europe,France,Opioids,Opiates,Heroin,2019,1012,FRA
Europe,Western and Central Europe,Germany,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,292.5,DEU
Europe,Western and Central Europe,Germany,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,11000,DEU
Europe,Western and Central Europe,Germany,Opioids,Opiates,Heroin,2020,570,DEU
Europe,Western and Central Europe,Germany,Precursors,Precursors,Acetone,2020,1510,DEU
Europe,Western and Central Europe,Germany,Precursors,Precursors,Ephedrine,2020,1.1,DEU
Europe,Western and Central Europe,Germany,Precursors,Precursors,Hydrochloric acid,2020,2301.5,DEU
Europe,Western and Central Europe,Germany,Precursors,Precursors,Methylamine,2020,125,DEU
Europe,Western and Central Europe,Germany,Precursors,Precursors,Pseudoephedrine,2020,4.3,DEU
Europe,Western and Central Europe,Germany,Precursors,Precursors,Sulphuric acid,2020,224,DEU
Europe,Western and Central Europe,Germany,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,346,DEU
Europe,Western and Central Europe,Germany,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,23000,DEU
Europe,Western and Central Europe,Germany,Opioids,Opiates,Heroin,2021,430,DEU
Europe,Western and Central Europe,Germany,Precursors,Non-specified precursors,Other precursors,2021,1136.6,DEU
Europe,Western and Central Europe,Germany,Precursors,Precursors,Acetone,2021,30.5,DEU
Europe,Western and Central Europe,Germany,Precursors,Precursors,Ephedrine,2021,0.8,DEU
Europe,Western and Central Europe,Germany,Precursors,Precursors,Hydrochloric acid,2021,122.75,DEU
Europe,Western and Central Europe,Germany,Precursors,Precursors,Pseudoephedrine,2021,1.08,DEU
Europe,Western and Central Europe,Germany,Precursors,Precursors,Sulphuric acid,2021,58.75,DEU
Europe,Western and Central Europe,Germany,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,236,DEU
Europe,Western and Central Europe,Germany,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,276.837882,DEU
Europe,Western and Central Europe,Germany,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,1631,DEU
Europe,Western and Central Europe,Germany,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,785,DEU
Europe,Western and Central Europe,Germany,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,16914,DEU
Europe,Western and Central Europe,Germany,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,15240.9,DEU
Europe,Western and Central Europe,Germany,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,2845,DEU
Europe,Western and Central Europe,Germany,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,2.433,DEU
Europe,Western and Central Europe,Germany,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,20047,DEU
Europe,Western and Central Europe,Germany,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0008788,DEU
Europe,Western and Central Europe,Germany,Hallucinogens,Other Hallucinogens,Psilocybine,2022,28,DEU
Europe,Western and Central Europe,Germany,Opioids,Opiates,Heroin,2022,1023,DEU
Europe,Western and Central Europe,Germany,Opioids,Opiates,Opium,2022,81,DEU
Europe,Western and Central Europe,Germany,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.02,DEU
Europe,Western and Central Europe,Germany,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.02745,DEU
Europe,Western and Central Europe,Germany,Precursors,Non-specified precursors,Other precursors,2022,8.828,DEU
Europe,Western and Central Europe,Germany,Precursors,Non-specified precursors,Other precursors,2022,1478,DEU
Europe,Western and Central Europe,Germany,Precursors,Non-specified precursors,Other precursors,2022,1509,DEU
Europe,Western and Central Europe,Germany,Precursors,Non-specified precursors,Other precursors,2022,2.653,DEU
Europe,Western and Central Europe,Germany,Precursors,Non-specified precursors,Other precursors,2022,25,DEU
Europe,Western and Central Europe,Germany,Precursors,Non-specified precursors,Other precursors,2022,0.273,DEU
Europe,Western and Central Europe,Germany,Precursors,Non-specified precursors,Other precursors,2022,10,DEU
Europe,Western and Central Europe,Germany,Precursors,Precursors,Acetic anhydride,2022,5,DEU
Europe,Western and Central Europe,Germany,Precursors,Precursors,Acetone,2022,149,DEU
Europe,Western and Central Europe,Germany,Precursors,Precursors,Hydrochloric acid,2022,408,DEU
Europe,Western and Central Europe,Germany,Precursors,Precursors,Methylamine,2022,1180,DEU
Europe,Western and Central Europe,Germany,Precursors,Precursors,Pseudoephedrine,2022,0.908,DEU
Europe,Western and Central Europe,Germany,Precursors,Precursors,Sulphuric acid,2022,251,DEU
Europe,Western and Central Europe,Germany,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,12,DEU
Europe,Western and Central Europe,Germany,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,272,DEU
Europe,Western and Central Europe,Germany,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,313.087655,DEU
Europe,Western and Central Europe,Germany,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2023,913.47674,DEU
Europe,Western and Central Europe,Germany,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,136,DEU
Europe,Western and Central Europe,Germany,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,1934,DEU
Europe,Western and Central Europe,Germany,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,451,DEU
Europe,Western and Central Europe,Germany,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,20887,DEU
Europe,Western and Central Europe,Germany,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,6,DEU
Europe,Western and Central Europe,Germany,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,12797.3,DEU
Europe,Western and Central Europe,Germany,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,3741,DEU
Europe,Western and Central Europe,Germany,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,2.08,DEU
Europe,Western and Central Europe,Germany,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,43070,DEU
Europe,Western and Central Europe,Germany,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.00340595,DEU
Europe,Western and Central Europe,Germany,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2023,5,DEU
Europe,Western and Central Europe,Germany,Hallucinogens,Other Hallucinogens,Psilocybine,2023,26,DEU
Europe,Western and Central Europe,Germany,Opioids,Opiates,Heroin,2023,171,DEU
Europe,Western and Central Europe,Germany,Opioids,Opiates,Illicit morphine,2023,0.3551,DEU
Europe,Western and Central Europe,Germany,Opioids,Opiates,Opium,2023,251,DEU
Europe,Western and Central Europe,Germany,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.2013,DEU
Europe,Western and Central Europe,Germany,Opioids,Pharmaceutical opioids,Codeine,2023,10,DEU
Europe,Western and Central Europe,Germany,Opioids,Pharmaceutical opioids,Codeine,2023,0.0179,DEU
Europe,Western and Central Europe,Germany,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.05575,DEU
Europe,Western and Central Europe,Germany,Opioids,Pharmaceutical opioids,Methadone,2023,0.1232,DEU
Europe,Western and Central Europe,Germany,Opioids,Pharmaceutical opioids,Oxycodone,2023,0.2738,DEU
Europe,Western and Central Europe,Germany,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2023,11,DEU
Europe,Western and Central Europe,Germany,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2023,37,DEU
Europe,Western and Central Europe,Germany,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,211,DEU
Europe,Western and Central Europe,Germany,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,10000,DEU
Europe,Western and Central Europe,Germany,Opioids,Opiates,Heroin,2019,900,DEU
Europe,Western and Central Europe,Gibraltar,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.2601,GIB
Europe,Western and Central Europe,Gibraltar,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.10168,GIB
Europe,Western and Central Europe,Gibraltar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,3.8,GIB
Europe,Western and Central Europe,Gibraltar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,1.5,GIB
Europe,Western and Central Europe,Gibraltar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,4877.68,GIB
Europe,Western and Central Europe,Gibraltar,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,25.8,GIB
Europe,Western and Central Europe,Gibraltar,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2020,0.001,GIB
Europe,Western and Central Europe,Gibraltar,Hallucinogens,Other Hallucinogens,Psilocybine,2020,0.068,GIB
Europe,Western and Central Europe,Gibraltar,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.00108,GIB
Europe,Western and Central Europe,Gibraltar,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,,GIB
Europe,Western and Central Europe,Gibraltar,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.0026,GIB
Europe,Western and Central Europe,Gibraltar,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.03,GIB
Europe,Western and Central Europe,Gibraltar,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.652,GIB
Europe,Western and Central Europe,Gibraltar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,0.5,GIB
Europe,Western and Central Europe,Gibraltar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,9223.1,GIB
Europe,Western and Central Europe,Gibraltar,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,0.1615,GIB
Europe,Western and Central Europe,Gibraltar,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,20.6,GIB
Europe,Western and Central Europe,Gibraltar,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.0009,GIB
Europe,Western and Central Europe,Gibraltar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,21.1,GIB
Europe,Western and Central Europe,Gibraltar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,44.1,GIB
Europe,Western and Central Europe,Gibraltar,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2022,220.11,GIB
Europe,Western and Central Europe,Gibraltar,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2022,25.4,GIB
Europe,Western and Central Europe,Gibraltar,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2022,0.00063,GIB
Europe,Western and Central Europe,Gibraltar,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.0016,GIB
Europe,Western and Central Europe,Gibraltar,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.000542,GIB
Europe,Western and Central Europe,Gibraltar,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.0278,GIB
Europe,Western and Central Europe,Gibraltar,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.00171,GIB
Europe,Western and Central Europe,Gibraltar,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.0185,GIB
Europe,Western and Central Europe,Gibraltar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,0.03215,GIB
Europe,Western and Central Europe,Gibraltar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,4.23573,GIB
Europe,Western and Central Europe,Gibraltar,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2023,0.48156,GIB
Europe,Western and Central Europe,Gibraltar,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,0.0314,GIB
Europe,Western and Central Europe,Gibraltar,Opioids,Opiates,Heroin,2023,0.00009,GIB
Europe,Western and Central Europe,Gibraltar,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.0185,GIB
Europe,Western and Central Europe,Gibraltar,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,0,GIB
Europe,Western and Central Europe,Gibraltar,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,GIB
Europe,Western and Central Europe,Gibraltar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,0,GIB
Europe,Western and Central Europe,Gibraltar,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,3043,GIB
Europe,Western and Central Europe,Gibraltar,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,0,GIB
Europe,Western and Central Europe,Gibraltar,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,1,GIB
Europe,Western and Central Europe,Gibraltar,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,0,GIB
Europe,Western and Central Europe,Gibraltar,Opioids,Pharmaceutical opioids,Methadone,2019,0,GIB
Europe,Western and Central Europe,Gibraltar,Opioids,Pharmaceutical opioids,Tramadol,2019,0,GIB
Europe,Western and Central Europe,Gibraltar,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,GIB
Europe,Western and Central Europe,Greece,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,1.946,GRC
Europe,Western and Central Europe,Greece,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,140.731926,GRC
Europe,Western and Central Europe,Greece,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2020,3.362623,GRC
Europe,Western and Central Europe,Greece,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.001265,GRC
Europe,Western and Central Europe,Greece,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.358,GRC
Europe,Western and Central Europe,Greece,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,9.581,GRC
Europe,Western and Central Europe,Greece,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2020,0.283,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,7794.297,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,9.521,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,5114.9,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,2113.809,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,0.431,GRC
Europe,Western and Central Europe,Greece,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,1787.283,GRC
Europe,Western and Central Europe,Greece,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2020,0.0011,GRC
Europe,Western and Central Europe,Greece,Hallucinogens,Other Hallucinogens,Psilocybine,2020,0.0005,GRC
Europe,Western and Central Europe,Greece,Hallucinogens,Other Hallucinogens,Psilocybine,2020,0.552,GRC
Europe,Western and Central Europe,Greece,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,0.0198,GRC
Europe,Western and Central Europe,Greece,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,0.177,GRC
Europe,Western and Central Europe,Greece,NPS,Plant-based NPS,Khat,2020,166.961,GRC
Europe,Western and Central Europe,Greece,Opioids,Opiates,Heroin,2020,299.855,GRC
Europe,Western and Central Europe,Greece,Opioids,Opiates,Opium,2020,10.549,GRC
Europe,Western and Central Europe,Greece,Opioids,Opiates,Poppy plants,2020,12.9,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.083,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.07915,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Codeine,2020,0.04945,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.00065,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Methadone,2020,0.00955,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Methadone,2020,24.305,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Tramadol,2020,1.29735,GRC
Europe,Western and Central Europe,Greece,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,0.459,GRC
Europe,Western and Central Europe,Greece,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,0.47567,GRC
Europe,Western and Central Europe,Greece,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.238,GRC
Europe,Western and Central Europe,Greece,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,0.15989,GRC
Europe,Western and Central Europe,Greece,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2021,0.008855,GRC
Europe,Western and Central Europe,Greece,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.014674,GRC
Europe,Western and Central Europe,Greece,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.304,GRC
Europe,Western and Central Europe,Greece,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,2.083,GRC
Europe,Western and Central Europe,Greece,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2021,51.91,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,5899.364,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,1.534,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,8794.6,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,4463.496,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,1.126,GRC
Europe,Western and Central Europe,Greece,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,1085.848,GRC
Europe,Western and Central Europe,Greece,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.347,GRC
Europe,Western and Central Europe,Greece,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2021,0.048,GRC
Europe,Western and Central Europe,Greece,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2021,0.028,GRC
Europe,Western and Central Europe,Greece,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,0.2089,GRC
Europe,Western and Central Europe,Greece,Opioids,Opiates,Heroin,2021,364.402,GRC
Europe,Western and Central Europe,Greece,Opioids,Opiates,Illicit morphine,2021,0.004,GRC
Europe,Western and Central Europe,Greece,Opioids,Opiates,Opium,2021,0.223,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.002,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.0038,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Codeine,2021,0.012,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Codeine,2021,3.601,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Fentanyl,2021,0.0012,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Methadone,2021,0.0048,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Methadone,2021,38.834,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Tramadol,2021,6.9853,GRC
Europe,Western and Central Europe,Greece,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,1.087,GRC
Europe,Western and Central Europe,Greece,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,7.38656,GRC
Europe,Western and Central Europe,Greece,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,2.137106,GRC
Europe,Western and Central Europe,Greece,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,20.948,GRC
Europe,Western and Central Europe,Greece,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2022,88.92444,GRC
Europe,Western and Central Europe,Greece,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.002024,GRC
Europe,Western and Central Europe,Greece,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.000675,GRC
Europe,Western and Central Europe,Greece,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2022,96.612,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,6186.182,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,432.576,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,5179,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,78.396,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,12.967,GRC
Europe,Western and Central Europe,Greece,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,899.689,GRC
Europe,Western and Central Europe,Greece,Hallucinogens,Other Hallucinogens,Psilocybine,2022,0.0034,GRC
Europe,Western and Central Europe,Greece,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,0.0248,GRC
Europe,Western and Central Europe,Greece,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,11.1,GRC
Europe,Western and Central Europe,Greece,Opioids,Opiates,Heroin,2022,139.71,GRC
Europe,Western and Central Europe,Greece,Opioids,Opiates,Opium,2022,3.207,GRC
Europe,Western and Central Europe,Greece,Opioids,Opiates,Poppy plants,2022,0.007,GRC
Europe,Western and Central Europe,Greece,Opioids,Opiates,Poppy plants,2022,6,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.04,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.0339,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Codeine,2022,0.004,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Codeine,2022,0.00155,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.00095,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Methadone,2022,0.0003,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Methadone,2022,8.949,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Tramadol,2022,0.002,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Tramadol,2022,0.05195,GRC
Europe,Western and Central Europe,Greece,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2022,1.4,GRC
Europe,Western and Central Europe,Greece,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2022,0.38493,GRC
Europe,Western and Central Europe,Greece,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,2.006,GRC
Europe,Western and Central Europe,Greece,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,4.640062,GRC
Europe,Western and Central Europe,Greece,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2023,0.03475,GRC
Europe,Western and Central Europe,Greece,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2023,28.495,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,6115.776,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,11.259,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,3020.8,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,348.799,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,34.314,GRC
Europe,Western and Central Europe,Greece,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,1789.151,GRC
Europe,Western and Central Europe,Greece,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.0053,GRC
Europe,Western and Central Europe,Greece,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2023,1.2,GRC
Europe,Western and Central Europe,Greece,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2023,0.1988,GRC
Europe,Western and Central Europe,Greece,Opioids,Opiates,Heroin,2023,199.903,GRC
Europe,Western and Central Europe,Greece,Opioids,Opiates,Illicit morphine,2023,0.001,GRC
Europe,Western and Central Europe,Greece,Opioids,Opiates,Opium,2023,0.036,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.015,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.02805,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Codeine,2023,0.02785,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Codeine,2023,1.011,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.01585,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Methadone,2023,0.00165,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Methadone,2023,7.107,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Tramadol,2023,0.03265,GRC
Europe,Western and Central Europe,Greece,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,0.99,GRC
Europe,Western and Central Europe,Greece,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,0.38691,GRC
Europe,Western and Central Europe,Greece,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,2,GRC
Europe,Western and Central Europe,Greece,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,46,GRC
Europe,Western and Central Europe,Greece,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,"""Captagon""",2019,9739,GRC
Europe,Western and Central Europe,Greece,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,GRC
Europe,Western and Central Europe,Greece,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,GRC
Europe,Western and Central Europe,Greece,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,5,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,12508,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,0,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,4,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,5696,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,6587,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,2,GRC
Europe,Western and Central Europe,Greece,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,0,GRC
Europe,Western and Central Europe,Greece,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,953,GRC
Europe,Western and Central Europe,Greece,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,GRC
Europe,Western and Central Europe,Greece,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,GRC
Europe,Western and Central Europe,Greece,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,0,GRC
Europe,Western and Central Europe,Greece,NPS,Plant-based NPS,Khat,2019,27,GRC
Europe,Western and Central Europe,Greece,NPS,Plant-based NPS,Mushrooms (hallucinogenic),2019,0,GRC
Europe,Western and Central Europe,Greece,NPS,Plant-based NPS,Mushrooms (hallucinogenic),2019,0,GRC
Europe,Western and Central Europe,Greece,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2019,0,GRC
Europe,Western and Central Europe,Greece,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (Spice),2019,0,GRC
Europe,Western and Central Europe,Greece,NPS,Synthetic cathinones,Synthetic cathinones,2019,0,GRC
Europe,Western and Central Europe,Greece,NPS,Synthetic cathinones,Synthetic cathinones,2019,2,GRC
Europe,Western and Central Europe,Greece,Opioids,Opiates,Heroin,2019,403,GRC
Europe,Western and Central Europe,Greece,Opioids,Opiates,Illicit morphine,2019,7,GRC
Europe,Western and Central Europe,Greece,Opioids,Opiates,Opium,2019,0,GRC
Europe,Western and Central Europe,Greece,Opioids,Opiates,Poppy plants,2019,21,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Buprenorphine,2019,0,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Buprenorphine,2019,0,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Codeine,2019,0,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Fentanyl,2019,0,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Methadone,2019,8,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Methadone,2019,0,GRC
Europe,Western and Central Europe,Greece,Opioids,Pharmaceutical opioids,Tramadol,2019,0,GRC
Europe,Western and Central Europe,Greece,Sedatives and tranquillizers,Non-specified sedatives and tranquillizers,Non-specified sedatives and tranquillizers,2019,0,GRC
Europe,Western and Central Europe,Greece,Sedatives and tranquillizers,Non-specified sedatives and tranquillizers,Non-specified sedatives and tranquillizers,2019,0,GRC
Europe,Western and Central Europe,Holy See,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,0.016,VAT
Europe,Western and Central Europe,Hungary,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,3.6,HUN
Europe,Western and Central Europe,Hungary,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,13.649728,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.017963,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,3-Fluoroethamphetamine (3-FEA),2020,0.0002,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2020,0.05625,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,"Methylphenidate (Ritalin, Concerta)",2020,0.05625,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2020,83.3,HUN
Europe,Western and Central Europe,Hungary,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2020,0.043,HUN
Europe,Western and Central Europe,Hungary,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2020,0,HUN
Europe,Western and Central Europe,Hungary,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,632.2,HUN
Europe,Western and Central Europe,Hungary,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,364.9,HUN
Europe,Western and Central Europe,Hungary,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,43.19,HUN
Europe,Western and Central Europe,Hungary,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,0.222,HUN
Europe,Western and Central Europe,Hungary,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,11.73,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Other Hallucinogens,25B-NBOMe (2C-B-NBOMe),2020,0.0001,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Other Hallucinogens,"25C-NBOMe (NBOMe-2C-C, 2C-C-NBOMe, Cimbi-82)",2020,0.0001,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Other Hallucinogens,Mescaline,2020,0.075,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Other Hallucinogens,Other hallucinogens,2020,0.0177,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,0.868,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,0.1693,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,5.3,HUN
Europe,Western and Central Europe,Hungary,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,5.3,HUN
Europe,Western and Central Europe,Hungary,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,0.168,HUN
Europe,Western and Central Europe,Hungary,NPS,Plant-based NPS,Khat,2020,67.1,HUN
Europe,Western and Central Europe,Hungary,NPS,Synthetic cathinones,Pentedrone,2020,0.00022,HUN
Europe,Western and Central Europe,Hungary,Opioids,Opiates,Heroin,2020,41.04,HUN
Europe,Western and Central Europe,Hungary,Opioids,Opiates,Illicit morphine,2020,0.0024,HUN
Europe,Western and Central Europe,Hungary,Opioids,Opiates,Opium,2020,0.0023,HUN
Europe,Western and Central Europe,Hungary,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2020,13.29,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.02,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Methadone,2020,0.281,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Tramadol,2020,0.01955,HUN
Europe,Western and Central Europe,Hungary,Precursors,Non-specified precursors,Other precursors,2020,1,HUN
Europe,Western and Central Europe,Hungary,Precursors,Non-specified precursors,Other precursors,2020,2240,HUN
Europe,Western and Central Europe,Hungary,Precursors,Non-specified precursors,Other precursors,2020,1.1,HUN
Europe,Western and Central Europe,Hungary,Precursors,Precursors,Acetone,2020,7,HUN
Europe,Western and Central Europe,Hungary,Precursors,Precursors,Ephedrine,2020,0.063,HUN
Europe,Western and Central Europe,Hungary,Precursors,Precursors,Ephedrine,2020,1.455,HUN
Europe,Western and Central Europe,Hungary,Precursors,Precursors,Hydrochloric acid,2020,1.5,HUN
Europe,Western and Central Europe,Hungary,Precursors,Precursors,Sulphuric acid,2020,89.5,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2020,0.00708,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.00086,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2020,0.00847,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2020,31.2,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,0.01884,HUN
Europe,Western and Central Europe,Hungary,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.852,HUN
Europe,Western and Central Europe,Hungary,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,5.633548,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,20,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,54,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,1.9,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,0.067,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,"Methylphenidate (Ritalin, Concerta)",2021,0.06275,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2021,0.06275,HUN
Europe,Western and Central Europe,Hungary,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2021,0.0017,HUN
Europe,Western and Central Europe,Hungary,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2021,0.264,HUN
Europe,Western and Central Europe,Hungary,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2021,0,HUN
Europe,Western and Central Europe,Hungary,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,847,HUN
Europe,Western and Central Europe,Hungary,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,7.592,HUN
Europe,Western and Central Europe,Hungary,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,470.1,HUN
Europe,Western and Central Europe,Hungary,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,3.3,HUN
Europe,Western and Central Europe,Hungary,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,26,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.000078,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2021,0.024,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2021,0.0188,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Other Hallucinogens,"Brolamfetamine (DOB, dimethoxybromoamphetamine, bromo-DMA)",2021,0.0001,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2021,0.312,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Other Hallucinogens,Phencyclidine (PCP),2021,0.022,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.208,HUN
Europe,Western and Central Europe,Hungary,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,0.441,HUN
Europe,Western and Central Europe,Hungary,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,4.89,HUN
Europe,Western and Central Europe,Hungary,NPS,Phenethylamines,"2,5-Dimethoxy-4-chloroamphetamine (DOC)",2021,0.00003,HUN
Europe,Western and Central Europe,Hungary,NPS,Phenethylamines,4-Fluoromethamphetamine (4-FMA),2021,0.0087,HUN
Europe,Western and Central Europe,Hungary,NPS,Phenethylamines,4-Fluoromethamphetamine (4-FMA),2021,0.013,HUN
Europe,Western and Central Europe,Hungary,NPS,Plant-based NPS,Salvia divinorum,2021,0.0023,HUN
Europe,Western and Central Europe,Hungary,NPS,Synthetic cannabinoids (Spice),JWH-210,2021,0.0015,HUN
Europe,Western and Central Europe,Hungary,NPS,Synthetic cannabinoids (Spice),MDMB-CHMICA,2021,0.0011,HUN
Europe,Western and Central Europe,Hungary,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2021,34.1,HUN
Europe,Western and Central Europe,Hungary,NPS,Synthetic cathinones,Alpha-Pyrrolidinohexiophenone (alpha-PHP),2021,0.01,HUN
Europe,Western and Central Europe,Hungary,NPS,Synthetic cathinones,Synthetic cathinones,2021,20.4,HUN
Europe,Western and Central Europe,Hungary,NPS,Synthetic cathinones,Synthetic cathinones,2021,0.00644,HUN
Europe,Western and Central Europe,Hungary,Opioids,Opiates,Heroin,2021,13,HUN
Europe,Western and Central Europe,Hungary,Opioids,Opiates,Illicit morphine,2021,0.0001,HUN
Europe,Western and Central Europe,Hungary,Opioids,Opiates,Opium,2021,0.001,HUN
Europe,Western and Central Europe,Hungary,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2021,5.1,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.00018,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Codeine,2021,0.001,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Codeine,2021,0.014,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Methadone,2021,0.0088,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Methadone,2021,0.414,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Tramadol,2021,0.0019,HUN
Europe,Western and Central Europe,Hungary,Precursors,Non-specified precursors,Other precursors,2021,2000,HUN
Europe,Western and Central Europe,Hungary,Precursors,Precursors,Acetone,2021,0.489,HUN
Europe,Western and Central Europe,Hungary,Precursors,Precursors,Ephedrine,2021,0.0000495,HUN
Europe,Western and Central Europe,Hungary,Precursors,Precursors,Ephedrine,2021,0.103,HUN
Europe,Western and Central Europe,Hungary,Precursors,Precursors,Sulphuric acid,2021,2.6,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2021,0.00125,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2021,0.00245,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2021,0.00275,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,4.175,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,0.235,HUN
Europe,Western and Central Europe,Hungary,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,3.621,HUN
Europe,Western and Central Europe,Hungary,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,12.635917,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,29.57,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.218845,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,1.386,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.867,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2022,0.021,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2022,3.255,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,3-Fluoroethamphetamine (3-FEA),2022,0.0015,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,3-Fluoroethamphetamine (3-FEA),2022,0.00606,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2022,0.0119,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2022,0.29925,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,"Methylphenidate (Ritalin, Concerta)",2022,0.0119,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,"Methylphenidate (Ritalin, Concerta)",2022,0.29925,HUN
Europe,Western and Central Europe,Hungary,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2022,0,HUN
Europe,Western and Central Europe,Hungary,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2022,0,HUN
Europe,Western and Central Europe,Hungary,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2022,0.136,HUN
Europe,Western and Central Europe,Hungary,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,522,HUN
Europe,Western and Central Europe,Hungary,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,4.778,HUN
Europe,Western and Central Europe,Hungary,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,636.6,HUN
Europe,Western and Central Europe,Hungary,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,18.2,HUN
Europe,Western and Central Europe,Hungary,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,85.3,HUN
Europe,Western and Central Europe,Hungary,Cocaine-type,Coca-type,Coca leaf,2022,0.045,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.012,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.00024515,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2022,0.0344,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2022,0.041,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2022,0.03,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2022,0.42,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Other Hallucinogens,Psilocybine,2022,0.42,HUN
Europe,Western and Central Europe,Hungary,NPS,Aminoindanes,Aminoindanes,2022,0.0256,HUN
Europe,Western and Central Europe,Hungary,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,1.115,HUN
Europe,Western and Central Europe,Hungary,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,12.731,HUN
Europe,Western and Central Europe,Hungary,NPS,Phenethylamines,4-Fluoromethamphetamine (4-FMA),2022,0.0031,HUN
Europe,Western and Central Europe,Hungary,NPS,Phenethylamines,Phenethylamines,2022,0.0344,HUN
Europe,Western and Central Europe,Hungary,NPS,Phenethylamines,Phenethylamines,2022,0.00615,HUN
Europe,Western and Central Europe,Hungary,NPS,Phenethylamines,Phenethylamines,2022,0.000255,HUN
Europe,Western and Central Europe,Hungary,NPS,Phenethylamines,Phenethylamines,2022,0.0186,HUN
Europe,Western and Central Europe,Hungary,NPS,Phenethylamines,Phenethylamines,2022,0.00042,HUN
Europe,Western and Central Europe,Hungary,NPS,Phenethylamines,Phenethylamines,2022,0.0031,HUN
Europe,Western and Central Europe,Hungary,NPS,Synthetic cannabinoids (Spice),JWH-210,2022,0.04,HUN
Europe,Western and Central Europe,Hungary,NPS,Synthetic cannabinoids (Spice),JWH-210,2022,0.0015,HUN
Europe,Western and Central Europe,Hungary,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2022,8.636,HUN
Europe,Western and Central Europe,Hungary,NPS,Synthetic cathinones,4-MEC,2022,0.0118,HUN
Europe,Western and Central Europe,Hungary,NPS,Synthetic cathinones,Pentedrone,2022,0.0118,HUN
Europe,Western and Central Europe,Hungary,NPS,Synthetic cathinones,Synthetic cathinones,2022,175.8,HUN
Europe,Western and Central Europe,Hungary,NPS,Synthetic cathinones,Synthetic cathinones,2022,0.33988,HUN
Europe,Western and Central Europe,Hungary,Opioids,Opiates,Heroin,2022,5.736,HUN
Europe,Western and Central Europe,Hungary,Opioids,Opiates,Illicit morphine,2022,0.0005,HUN
Europe,Western and Central Europe,Hungary,Opioids,Opiates,Illicit morphine,2022,0.0013,HUN
Europe,Western and Central Europe,Hungary,Opioids,Opiates,Opium,2022,5.454,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.00025,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Codeine,2022,0.0235,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Codeine,2022,0.002,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Methadone,2022,0.0031,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Methadone,2022,0.306,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Oxycodone,2022,0.0025,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2022,0.00025,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2022,0.0005,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2022,0.00065,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2022,0.0025,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Tramadol,2022,0.0019,HUN
Europe,Western and Central Europe,Hungary,Precursors,Precursors,Acetone,2022,1.038,HUN
Europe,Western and Central Europe,Hungary,Precursors,Precursors,Ephedrine,2022,0.033,HUN
Europe,Western and Central Europe,Hungary,Precursors,Precursors,Hydrochloric acid,2022,0.424,HUN
Europe,Western and Central Europe,Hungary,Precursors,Precursors,Sulphuric acid,2022,4.462,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2022,0.00716,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.0001,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.0032,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.00086,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.0001,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.00025,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2022,0.00152,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.00003,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,Benzodiazepines,Diazepam (Stesolid),2022,0.00003,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2022,5.269,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,0.0663,HUN
Europe,Western and Central Europe,Hungary,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.889,HUN
Europe,Western and Central Europe,Hungary,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,15.41177,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.001771,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,21,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,41.739,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,1.52,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,0.651,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2023,0.105,HUN
Europe,Western and Central Europe,Hungary,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,484.249,HUN
Europe,Western and Central Europe,Hungary,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,466,HUN
Europe,Western and Central Europe,Hungary,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,5.613,HUN
Europe,Western and Central Europe,Hungary,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,167.4,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.012,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.0000704,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2023,0.0189,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2023,0.0508,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2023,0.07688,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Other Hallucinogens,Mescaline,2023,0.3767,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.0022,HUN
Europe,Western and Central Europe,Hungary,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.9893,HUN
Europe,Western and Central Europe,Hungary,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,0.436,HUN
Europe,Western and Central Europe,Hungary,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,6.602,HUN
Europe,Western and Central Europe,Hungary,NPS,Phenethylamines,Phenethylamines,2023,0.13355,HUN
Europe,Western and Central Europe,Hungary,NPS,Phenethylamines,Phenethylamines,2023,0.007695,HUN
Europe,Western and Central Europe,Hungary,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2023,0.183,HUN
Europe,Western and Central Europe,Hungary,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2023,12.76,HUN
Europe,Western and Central Europe,Hungary,NPS,Synthetic cathinones,Synthetic cathinones,2023,0.0347,HUN
Europe,Western and Central Europe,Hungary,NPS,Synthetic cathinones,Synthetic cathinones,2023,47.399,HUN
Europe,Western and Central Europe,Hungary,Opioids,Opiates,Heroin,2023,1.676,HUN
Europe,Western and Central Europe,Hungary,Opioids,Opiates,Illicit morphine,2023,0.0005,HUN
Europe,Western and Central Europe,Hungary,Opioids,Opiates,Opium,2023,0.00096,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Codeine,2023,0.00003,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Methadone,2023,0.06,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Methadone,2023,0.00635,HUN
Europe,Western and Central Europe,Hungary,Opioids,Pharmaceutical opioids,Tramadol,2023,0.01268,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2023,0.00902,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.0018,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.0013,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2023,0.0017,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.00002,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2023,16.042,HUN
Europe,Western and Central Europe,Hungary,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2023,0.048,HUN
Europe,Western and Central Europe,Hungary,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,13,HUN
Europe,Western and Central Europe,Hungary,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,65,HUN
Europe,Western and Central Europe,Hungary,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2019,10,HUN
Europe,Western and Central Europe,Hungary,Opioids,Opiates,Heroin,2019,75,HUN
Europe,Western and Central Europe,Iceland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.224,ISL
Europe,Western and Central Europe,Iceland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.993,ISL
Europe,Western and Central Europe,Iceland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,14.098,ISL
Europe,Western and Central Europe,Iceland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,2.321,ISL
Europe,Western and Central Europe,Iceland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,141.323,ISL
Europe,Western and Central Europe,Iceland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,468.7,ISL
Europe,Western and Central Europe,Iceland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,52.406,ISL
Europe,Western and Central Europe,Iceland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,0.201,ISL
Europe,Western and Central Europe,Iceland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,0.00067,ISL
Europe,Western and Central Europe,Iceland,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,2.125,ISL
Europe,Western and Central Europe,Iceland,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,11.89,ISL
Europe,Western and Central Europe,Iceland,Opioids,Opiates,Heroin,2021,0.016,ISL
Europe,Western and Central Europe,Iceland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.473,ISL
Europe,Western and Central Europe,Iceland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.44986,ISL
Europe,Western and Central Europe,Iceland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.01,ISL
Europe,Western and Central Europe,Iceland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,1.805914,ISL
Europe,Western and Central Europe,Iceland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,12.81,ISL
Europe,Western and Central Europe,Iceland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,1.303,ISL
Europe,Western and Central Europe,Iceland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,210.371,ISL
Europe,Western and Central Europe,Iceland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,0.0003,ISL
Europe,Western and Central Europe,Iceland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,3.381,ISL
Europe,Western and Central Europe,Iceland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,26.629,ISL
Europe,Western and Central Europe,Iceland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,53.751,ISL
Europe,Western and Central Europe,Iceland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,174.818,ISL
Europe,Western and Central Europe,Iceland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,0.00021,ISL
Europe,Western and Central Europe,Iceland,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,56.248,ISL
Europe,Western and Central Europe,Iceland,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.0001332,ISL
Europe,Western and Central Europe,Iceland,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,1,ISL
Europe,Western and Central Europe,Iceland,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,0,ISL
Europe,Western and Central Europe,Iceland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,9,ISL
Europe,Western and Central Europe,Iceland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,55,ISL
Europe,Western and Central Europe,Iceland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,2,ISL
Europe,Western and Central Europe,Iceland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,45,ISL
Europe,Western and Central Europe,Iceland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,0,ISL
Europe,Western and Central Europe,Iceland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,4,ISL
Europe,Western and Central Europe,Iceland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,551,ISL
Europe,Western and Central Europe,Iceland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,12,ISL
Europe,Western and Central Europe,Iceland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,24,ISL
Europe,Western and Central Europe,Iceland,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,83544,ISL
Europe,Western and Central Europe,Iceland,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,41,ISL
Europe,Western and Central Europe,Iceland,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,ISL
Europe,Western and Central Europe,Iceland,Opioids,Opiates,Illicit morphine,2019,,ISL
Europe,Western and Central Europe,Ireland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,15.04,IRL
Europe,Western and Central Europe,Ireland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,8.632976,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,19.88,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2020,0.386,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2020,0.70325,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2020,0.0225,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2020,0.0195,IRL
Europe,Western and Central Europe,Ireland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,577.2,IRL
Europe,Western and Central Europe,Ireland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,70.3,IRL
Europe,Western and Central Europe,Ireland,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,227.6,IRL
Europe,Western and Central Europe,Ireland,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,0.2821,IRL
Europe,Western and Central Europe,Ireland,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,6.372,IRL
Europe,Western and Central Europe,Ireland,Opioids,Opiates,Heroin,2020,41.4,IRL
Europe,Western and Central Europe,Ireland,Opioids,Opiates,Illicit morphine,2020,7.1,IRL
Europe,Western and Central Europe,Ireland,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.00145,IRL
Europe,Western and Central Europe,Ireland,Opioids,Pharmaceutical opioids,Codeine,2020,0.012,IRL
Europe,Western and Central Europe,Ireland,Opioids,Pharmaceutical opioids,Codeine,2020,0.0062,IRL
Europe,Western and Central Europe,Ireland,Opioids,Pharmaceutical opioids,Methadone,2020,3.567,IRL
Europe,Western and Central Europe,Ireland,Opioids,Pharmaceutical opioids,Oxycodone,2020,0.0035,IRL
Europe,Western and Central Europe,Ireland,Opioids,Pharmaceutical opioids,Tramadol,2020,0.00635,IRL
Europe,Western and Central Europe,Ireland,Sedatives and tranquillizers,Barbiturates,Barbiturates,2020,7.0712,IRL
Europe,Western and Central Europe,Ireland,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,1.2,IRL
Europe,Western and Central Europe,Ireland,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,4.71403,IRL
Europe,Western and Central Europe,Ireland,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.251,IRL
Europe,Western and Central Europe,Ireland,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.19559,IRL
Europe,Western and Central Europe,Ireland,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2020,3.966,IRL
Europe,Western and Central Europe,Ireland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,19.4,IRL
Europe,Western and Central Europe,Ireland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,56.578567,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,6.2,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.023023,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,2.7,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2021,4.2,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2021,3.0785,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,0.00525,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,0.687,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2021,0.00275,IRL
Europe,Western and Central Europe,Ireland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,1054.9,IRL
Europe,Western and Central Europe,Ireland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,706.4,IRL
Europe,Western and Central Europe,Ireland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,15.7,IRL
Europe,Western and Central Europe,Ireland,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,109.8,IRL
Europe,Western and Central Europe,Ireland,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,26.2,IRL
Europe,Western and Central Europe,Ireland,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,0.1671,IRL
Europe,Western and Central Europe,Ireland,Opioids,Opiates,Heroin,2021,9.7,IRL
Europe,Western and Central Europe,Ireland,Opioids,Opiates,Heroin,2021,0.00123,IRL
Europe,Western and Central Europe,Ireland,Opioids,Opiates,Illicit morphine,2021,0.0015,IRL
Europe,Western and Central Europe,Ireland,Opioids,Opiates,Illicit morphine,2021,0.461,IRL
Europe,Western and Central Europe,Ireland,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.0009,IRL
Europe,Western and Central Europe,Ireland,Opioids,Pharmaceutical opioids,Codeine,2021,0.01275,IRL
Europe,Western and Central Europe,Ireland,Opioids,Pharmaceutical opioids,Methadone,2021,4.065,IRL
Europe,Western and Central Europe,Ireland,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.01425,IRL
Europe,Western and Central Europe,Ireland,Opioids,Pharmaceutical opioids,Tramadol,2021,0.02975,IRL
Europe,Western and Central Europe,Ireland,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,5.5,IRL
Europe,Western and Central Europe,Ireland,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,4.70983,IRL
Europe,Western and Central Europe,Ireland,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.000929,IRL
Europe,Western and Central Europe,Ireland,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.04836,IRL
Europe,Western and Central Europe,Ireland,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,0.1195,IRL
Europe,Western and Central Europe,Ireland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,14.95,IRL
Europe,Western and Central Europe,Ireland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,17.362699,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,20.7,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.010626,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.2468,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2022,4.2,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2022,0.0505,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2022,0.0125,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2022,0.00275,IRL
Europe,Western and Central Europe,Ireland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,1557,IRL
Europe,Western and Central Europe,Ireland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,559.2,IRL
Europe,Western and Central Europe,Ireland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,294,IRL
Europe,Western and Central Europe,Ireland,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2022,402.28,IRL
Europe,Western and Central Europe,Ireland,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,11.58,IRL
Europe,Western and Central Europe,Ireland,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,0.8162,IRL
Europe,Western and Central Europe,Ireland,Opioids,Opiates,Heroin,2022,75.2,IRL
Europe,Western and Central Europe,Ireland,Opioids,Opiates,Illicit morphine,2022,0.04,IRL
Europe,Western and Central Europe,Ireland,Opioids,Opiates,Illicit morphine,2022,0.0048,IRL
Europe,Western and Central Europe,Ireland,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.00105,IRL
Europe,Western and Central Europe,Ireland,Opioids,Pharmaceutical opioids,Codeine,2022,0.0039,IRL
Europe,Western and Central Europe,Ireland,Opioids,Pharmaceutical opioids,Codeine,2022,0.68888,IRL
Europe,Western and Central Europe,Ireland,Opioids,Pharmaceutical opioids,Methadone,2022,4.373,IRL
Europe,Western and Central Europe,Ireland,Opioids,Pharmaceutical opioids,Oxycodone,2022,0.0094,IRL
Europe,Western and Central Europe,Ireland,Opioids,Pharmaceutical opioids,Tramadol,2022,0.01975,IRL
Europe,Western and Central Europe,Ireland,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2022,8.43,IRL
Europe,Western and Central Europe,Ireland,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2022,1.15,IRL
Europe,Western and Central Europe,Ireland,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2022,7.04884,IRL
Europe,Western and Central Europe,Ireland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,19.67,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.27,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.7,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,0.48,IRL
Europe,Western and Central Europe,Ireland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,3278.01,IRL
Europe,Western and Central Europe,Ireland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,103.06,IRL
Europe,Western and Central Europe,Ireland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,64.28,IRL
Europe,Western and Central Europe,Ireland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,206.8,IRL
Europe,Western and Central Europe,Ireland,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,0.006,IRL
Europe,Western and Central Europe,Ireland,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,3153.09,IRL
Europe,Western and Central Europe,Ireland,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2023,0.0025,IRL
Europe,Western and Central Europe,Ireland,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2023,88.27,IRL
Europe,Western and Central Europe,Ireland,Opioids,Opiates,Heroin,2023,60.06,IRL
Europe,Western and Central Europe,Ireland,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,533.84,IRL
Europe,Western and Central Europe,Ireland,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,29,IRL
Europe,Western and Central Europe,Ireland,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,9,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,10,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,1,IRL
Europe,Western and Central Europe,Ireland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,IRL
Europe,Western and Central Europe,Ireland,Any other drugs/substances,Other miscellaneous,Psychotropic substances,2019,0,IRL
Europe,Western and Central Europe,Ireland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,981,IRL
Europe,Western and Central Europe,Ireland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,16,IRL
Europe,Western and Central Europe,Ireland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,941,IRL
Europe,Western and Central Europe,Ireland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,1,IRL
Europe,Western and Central Europe,Ireland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,858,IRL
Europe,Western and Central Europe,Ireland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,68,IRL
Europe,Western and Central Europe,Ireland,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,0,IRL
Europe,Western and Central Europe,Ireland,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,16,IRL
Europe,Western and Central Europe,Ireland,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,0,IRL
Europe,Western and Central Europe,Ireland,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,168,IRL
Europe,Western and Central Europe,Ireland,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,IRL
Europe,Western and Central Europe,Ireland,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,IRL
Europe,Western and Central Europe,Ireland,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2019,31,IRL
Europe,Western and Central Europe,Ireland,Hallucinogens,Other Hallucinogens,Other hallucinogens,2019,3,IRL
Europe,Western and Central Europe,Ireland,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,5,IRL
Europe,Western and Central Europe,Ireland,NPS,Plant-based NPS,Khat,2019,508,IRL
Europe,Western and Central Europe,Ireland,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2019,5,IRL
Europe,Western and Central Europe,Ireland,NPS,Plant-based NPS,Mushrooms (hallucinogenic),2019,3,IRL
Europe,Western and Central Europe,Ireland,NPS,Plant-based NPS,Mushrooms (hallucinogenic),2019,0,IRL
Europe,Western and Central Europe,Ireland,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (Spice),2019,9,IRL
Europe,Western and Central Europe,Ireland,Opioids,Opiates,Heroin,2019,305,IRL
Europe,Western and Central Europe,Ireland,Opioids,Pharmaceutical opioids,Methadone,2019,0,IRL
Europe,Western and Central Europe,Ireland,Opioids,Pharmaceutical opioids,Methadone,2019,13,IRL
Europe,Western and Central Europe,Ireland,Precursors,Precursors,Ephedrine,2019,0,IRL
Europe,Western and Central Europe,Ireland,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,25,IRL
Europe,Western and Central Europe,Ireland,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,2,IRL
Europe,Western and Central Europe,Italy,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,11.1,ITA
Europe,Western and Central Europe,Italy,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,3.082354,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,14213.19,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,43.23,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2020,0.49,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2020,1.89,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2020,1.51175,ITA
Europe,Western and Central Europe,Italy,Any other drugs/substances,Synthetic cannabinoids under international control,JWH-018,2020,1.09,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,0.668,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,19862.89,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.0015,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,15.61,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.13,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,41439.6,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,0.05967,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,9731.81,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2020,0.02,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,0.1957,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,13426.04,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2020,6.7,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2020,0.0381,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Coca-type,Coca leaf,2020,0.02,ITA
Europe,Western and Central Europe,Italy,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,21.42,ITA
Europe,Western and Central Europe,Italy,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,0.0409,ITA
Europe,Western and Central Europe,Italy,NPS,Phenethylamines,"2,5-Dimethoxy-4-chloroamphetamine (DOC)",2020,0.058725,ITA
Europe,Western and Central Europe,Italy,NPS,Synthetic cathinones,4-MEC,2020,0.065,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Heroin,2020,0.002,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Heroin,2020,0.01047,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Heroin,2020,512.39,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Illicit morphine,2020,7.27,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Illicit morphine,2020,0.001,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Opium,2020,2.27,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Poppy plants,2020,1.2,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Poppy plants,2020,10.3,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Poppy plants,2020,22665,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.005,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Codeine,2020,0.32,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.0002,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Methadone,2020,3.81,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Methadone,2020,0.0373,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Methadone,2020,10.601,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Oxycodone,2020,0.08,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Oxycodone,2020,0.211,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.0061,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2020,57.57,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2020,0.18,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,11.35,ITA
Europe,Western and Central Europe,Italy,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,8.43,ITA
Europe,Western and Central Europe,Italy,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,1.696189,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,9.01,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.062491,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.0008,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,25.95,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,1.81665,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,0.45,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,0.01175,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2021,0.02,ITA
Europe,Western and Central Europe,Italy,Any other drugs/substances,Synthetic cannabinoids under international control,JWH-018,2021,0.36,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,46853.01,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,25.6995,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,20.54,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,0.0345,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,29.1,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,30044.8,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,0.02,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,0.185085,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,20838.89,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,6.93,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,0.0775,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2021,0.07,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,0.1271,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,3.35,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,20068.47,ITA
Europe,Western and Central Europe,Italy,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,1.1,ITA
Europe,Western and Central Europe,Italy,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2021,75.85,ITA
Europe,Western and Central Europe,Italy,Hallucinogens,Other Hallucinogens,Psilocybine,2021,1.91,ITA
Europe,Western and Central Europe,Italy,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,0.0107,ITA
Europe,Western and Central Europe,Italy,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,0.51,ITA
Europe,Western and Central Europe,Italy,NPS,Plant-based NPS,Khat,2021,2293.96,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Heroin,2021,0.00435,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Heroin,2021,567.52,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Illicit morphine,2021,1.32,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Illicit morphine,2021,0.0024,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Opium,2021,3.19,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Opium,2021,0.0054,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Opium,2021,0.03,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Poppy plants,2021,4,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2021,0.048,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2021,263.63,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.0004,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Codeine,2021,0.35,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Fentanyl,2021,0.0004,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Methadone,2021,12.98,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Methadone,2021,0.0335,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Methadone,2021,12.983,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.02,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.06035,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.01,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.0034,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,0.0003,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,12.95,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,89.472,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,3.34,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,0.0361,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,5.6,ITA
Europe,Western and Central Europe,Italy,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,10.6,ITA
Europe,Western and Central Europe,Italy,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,2.494013,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,9.1,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.252494,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,44.38,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.0216,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2022,0.21,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2022,0.00025,ITA
Europe,Western and Central Europe,Italy,Any other drugs/substances,Synthetic cannabinoids under international control,JWH-018,2022,0.001,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,0.9575,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,33105.49,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,18.32,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,0.0207,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,10.425,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,20905.7,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,0.120015,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,13900.05,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,10.5,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,0.0355,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,1,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,0.239,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,26088.85,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,"Other smokable forms of cocaine (consumer products such as basuco, merla, paco, pasta base, etc.) (please specify)",2022,0.12,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Coca-type,Coca leaf,2022,0.92,ITA
Europe,Western and Central Europe,Italy,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,32.04,ITA
Europe,Western and Central Europe,Italy,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,0.0376,ITA
Europe,Western and Central Europe,Italy,NPS,Plant-based NPS,Ayahuasca,2022,25.18,ITA
Europe,Western and Central Europe,Italy,NPS,Plant-based NPS,Khat,2022,979.5,ITA
Europe,Western and Central Europe,Italy,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2022,0.33,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Heroin,2022,0.015,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Heroin,2022,548.08,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Heroin,2022,0.0426,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Illicit morphine,2022,0.69,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Illicit morphine,2022,0.0022,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Opium,2022,1.06,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Opium,2022,0.0264,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Poppy plants,2022,79.5,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2022,68.25,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2022,1.074,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.02,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.0004,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Codeine,2022,0.0001,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Codeine,2022,11.03,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.0002,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Methadone,2022,1.6,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Methadone,2022,0.0009,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Methadone,2022,30.598,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Oxycodone,2022,0.0069,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Tramadol,2022,0.00095,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,Barbiturates,Methaqualone,2022,0.0047,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2022,9.01,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2022,37.5267,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,4.03,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,0.68,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2022,0.01552,ITA
Europe,Western and Central Europe,Italy,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,69.63,ITA
Europe,Western and Central Europe,Italy,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,2.800514,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,5.26,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,1.929125,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,53.78,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.23445,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,0.01275,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,0.34,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2023,0.004,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,0.9195,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,40225.15,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,13.14,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,0.9003,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,13.2425,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,15657.5,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,0.18873,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,27074.56,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,16.57,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,0.1147,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2023,8.49,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,0.1696,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,19787.56,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,92.125,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Coca-type,Coca leaf,2023,12.68,ITA
Europe,Western and Central Europe,Italy,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.206,ITA
Europe,Western and Central Europe,Italy,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.0000147,ITA
Europe,Western and Central Europe,Italy,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2023,0.0044,ITA
Europe,Western and Central Europe,Italy,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2023,0.379,ITA
Europe,Western and Central Europe,Italy,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2023,0.249,ITA
Europe,Western and Central Europe,Italy,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.0002,ITA
Europe,Western and Central Europe,Italy,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.483,ITA
Europe,Western and Central Europe,Italy,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,0.00165,ITA
Europe,Western and Central Europe,Italy,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,126.33,ITA
Europe,Western and Central Europe,Italy,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,3,ITA
Europe,Western and Central Europe,Italy,NPS,Plant-based NPS,Khat,2023,854.38,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Heroin,2023,259.58,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Heroin,2023,0.01134,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Illicit morphine,2023,0.002,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Illicit morphine,2023,0.0472,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Opium,2023,0.0012,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Opium,2023,50.31,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Poppy plants,2023,14.9,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2023,118.36,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.0013,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.144,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Codeine,2023,4.78,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.0012,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Methadone,2023,8.4,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Methadone,2023,0.0221,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Methadone,2023,23.10655,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Oxycodone,2023,0.069,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Oxycodone,2023,0.0091,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Tramadol,2023,0.1673,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2023,3.7,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2023,8.72,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2023,0.09,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2023,0.52,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,0.01739,ITA
Europe,Western and Central Europe,Italy,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,37,ITA
Europe,Western and Central Europe,Italy,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,5,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,10,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,23,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,7,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,8,ITA
Europe,Western and Central Europe,Italy,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2019,1,ITA
Europe,Western and Central Europe,Italy,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2019,1,ITA
Europe,Western and Central Europe,Italy,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2019,0,ITA
Europe,Western and Central Europe,Italy,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2019,0,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,1,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,23632,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,19,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,6,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,22354,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,0,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,20986,ITA
Europe,Western and Central Europe,Italy,Cannabis-type drugs (excluding synthetic cannabinoids),Synthetic cannabinoids under international control,JWH-018,2019,0,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,7,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,0,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2019,0,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,0,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,8263,ITA
Europe,Western and Central Europe,Italy,Cocaine-type,Coca-type,Coca leaf,2019,0,ITA
Europe,Western and Central Europe,Italy,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,ITA
Europe,Western and Central Europe,Italy,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,ITA
Europe,Western and Central Europe,Italy,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2019,17,ITA
Europe,Western and Central Europe,Italy,Hallucinogens,Other Hallucinogens,Psilocybine,2019,2,ITA
Europe,Western and Central Europe,Italy,Hallucinogens,Other Hallucinogens,Psilocybine,2019,0,ITA
Europe,Western and Central Europe,Italy,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,20,ITA
Europe,Western and Central Europe,Italy,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,0,ITA
Europe,Western and Central Europe,Italy,NPS,Plant-based NPS,Khat,2019,805,ITA
Europe,Western and Central Europe,Italy,NPS,Synthetic cathinones,4-MEC,2019,0,ITA
Europe,Western and Central Europe,Italy,NPS,Synthetic cathinones,Synthetic cathinones,2019,0,ITA
Europe,Western and Central Europe,Italy,NPS,Synthetic cathinones,Synthetic cathinones,2019,0,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Heroin,2019,0,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Heroin,2019,615,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Illicit morphine,2019,18,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Illicit morphine,2019,0,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Opium,2019,2,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,Opium,2019,0,ITA
Europe,Western and Central Europe,Italy,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2019,194,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Buprenorphine,2019,0,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Buprenorphine,2019,0,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Buprenorphine,2019,0,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Fentanyl,2019,0,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Fentanyl,2019,0,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Methadone,2019,4,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Methadone,2019,22,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Oxycodone,2019,0,ITA
Europe,Western and Central Europe,Italy,Opioids,Pharmaceutical opioids,Oxycodone,2019,0,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2019,0,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2019,0,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2019,0,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2019,0,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,1,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,7,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,GBL/GHB,GBL,2019,4,ITA
Europe,Western and Central Europe,Italy,Sedatives and tranquillizers,GBL/GHB,GBL,2019,7,ITA
Europe,Western and Central Europe,Latvia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,12.009,LVA
Europe,Western and Central Europe,Latvia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,85.885049,LVA
Europe,Western and Central Europe,Latvia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2020,0.0761,LVA
Europe,Western and Central Europe,Latvia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2020,26.4296,LVA
Europe,Western and Central Europe,Latvia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2020,79.44025,LVA
Europe,Western and Central Europe,Latvia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0,LVA
Europe,Western and Central Europe,Latvia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,1.03589,LVA
Europe,Western and Central Europe,Latvia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,138.38,LVA
Europe,Western and Central Europe,Latvia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.08675,LVA
Europe,Western and Central Europe,Latvia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,234.63,LVA
Europe,Western and Central Europe,Latvia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,271.64,LVA
Europe,Western and Central Europe,Latvia,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,67.68,LVA
Europe,Western and Central Europe,Latvia,Cocaine-type,Coca-type,Coca leaf,2020,0.00013,LVA
Europe,Western and Central Europe,Latvia,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,0.3574,LVA
Europe,Western and Central Europe,Latvia,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,4.48241,LVA
Europe,Western and Central Europe,Latvia,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2020,0.0049,LVA
Europe,Western and Central Europe,Latvia,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2020,0.181,LVA
Europe,Western and Central Europe,Latvia,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2020,0.792,LVA
Europe,Western and Central Europe,Latvia,NPS,Tryptamines,Tryptamines,2020,0.00336,LVA
Europe,Western and Central Europe,Latvia,Opioids,Opiates,Heroin,2020,0.0038,LVA
Europe,Western and Central Europe,Latvia,Opioids,Opiates,Illicit morphine,2020,0.000026,LVA
Europe,Western and Central Europe,Latvia,Opioids,Opiates,Opium,2020,0.0001,LVA
Europe,Western and Central Europe,Latvia,Opioids,Opiates,Poppy plants,2020,37,LVA
Europe,Western and Central Europe,Latvia,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2020,4,LVA
Europe,Western and Central Europe,Latvia,Opioids,Other illicit opioids,Other illicit opioids,2020,0.00156,LVA
Europe,Western and Central Europe,Latvia,Opioids,Other illicit opioids,Other illicit opioids,2020,3.83695,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.00144,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.16,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.05255,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Carfentanil,2020,0.00141,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Carfentanil,2020,0.29276,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Codeine,2020,0.00255,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Codeine,2020,0.053,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Codeine,2020,0.3596,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.11012,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Methadone,2020,0.00105,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Methadone,2020,22.95,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Methadone,2020,0.2699,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Oxycodone,2020,0.001,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Tramadol,2020,0.044,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Tramadol,2020,0.2167,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Tramadol,2020,0.0492,LVA
Europe,Western and Central Europe,Latvia,Precursors,Non-specified precursors,Non-specified precursors,2020,24.3312,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Barbiturates,Barbiturates,2020,0.02,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.13,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.88121,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.05597,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.00011,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.01618,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.00211,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2020,0.243,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2020,0.32341,LVA
Europe,Western and Central Europe,Latvia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,4.76,LVA
Europe,Western and Central Europe,Latvia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,51.244474,LVA
Europe,Western and Central Europe,Latvia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2021,32.14,LVA
Europe,Western and Central Europe,Latvia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,139.9,LVA
Europe,Western and Central Europe,Latvia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,0.00048246,LVA
Europe,Western and Central Europe,Latvia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,269.5,LVA
Europe,Western and Central Europe,Latvia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,1082.9,LVA
Europe,Western and Central Europe,Latvia,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,2.88,LVA
Europe,Western and Central Europe,Latvia,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2021,0.0266,LVA
Europe,Western and Central Europe,Latvia,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2021,0.00074,LVA
Europe,Western and Central Europe,Latvia,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,0.2734,LVA
Europe,Western and Central Europe,Latvia,Opioids,Opiates,Heroin,2021,0.00297,LVA
Europe,Western and Central Europe,Latvia,Opioids,Opiates,Illicit morphine,2021,0.00124,LVA
Europe,Western and Central Europe,Latvia,Opioids,Opiates,Illicit morphine,2021,0.0002,LVA
Europe,Western and Central Europe,Latvia,Opioids,Opiates,Opium,2021,0.00989,LVA
Europe,Western and Central Europe,Latvia,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2021,0.39,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.734,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.22915,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Codeine,2021,0.00155,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Fentanyl,2021,0.00005,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Fentanyl,2021,0.50146,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Methadone,2021,0.06943,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Methadone,2021,6.4513,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.0001,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Tramadol,2021,0.19678,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Tramadol,2021,0.0757,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.05671,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.00269,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,1.4263,LVA
Europe,Western and Central Europe,Latvia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,8.47,LVA
Europe,Western and Central Europe,Latvia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,1.085897,LVA
Europe,Western and Central Europe,Latvia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.01903,LVA
Europe,Western and Central Europe,Latvia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.00959,LVA
Europe,Western and Central Europe,Latvia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2022,20.73,LVA
Europe,Western and Central Europe,Latvia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2022,0.0235,LVA
Europe,Western and Central Europe,Latvia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,170.2,LVA
Europe,Western and Central Europe,Latvia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,0.00000039,LVA
Europe,Western and Central Europe,Latvia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,64.6,LVA
Europe,Western and Central Europe,Latvia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,40.3,LVA
Europe,Western and Central Europe,Latvia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,584.1,LVA
Europe,Western and Central Europe,Latvia,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,174.8,LVA
Europe,Western and Central Europe,Latvia,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2022,0.12,LVA
Europe,Western and Central Europe,Latvia,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2022,0.00568,LVA
Europe,Western and Central Europe,Latvia,Hallucinogens,Other Hallucinogens,Zopiclone,2022,0.0014,LVA
Europe,Western and Central Europe,Latvia,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,1.0588,LVA
Europe,Western and Central Europe,Latvia,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2022,0.00003175,LVA
Europe,Western and Central Europe,Latvia,NPS,Synthetic cathinones,Synthetic cathinones,2022,78.24,LVA
Europe,Western and Central Europe,Latvia,Opioids,Opiates,Heroin,2022,0.00747,LVA
Europe,Western and Central Europe,Latvia,Opioids,Opiates,Illicit morphine,2022,0.086,LVA
Europe,Western and Central Europe,Latvia,Opioids,Opiates,Opium,2022,0.00012,LVA
Europe,Western and Central Europe,Latvia,Opioids,Opiates,Poppy plants,2022,0.3,LVA
Europe,Western and Central Europe,Latvia,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2022,0.36,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.28,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.00135,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.2267,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Carfentanil,2022,0.04,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Codeine,2022,0.0012,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.00662,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.0005,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.0199,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Methadone,2022,0.00027,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Methadone,2022,0.0001,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Methadone,2022,0.4285,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Oxycodone,2022,0.00115,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Barbiturates,Barbiturates,2022,0.22,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Barbiturates,Barbiturates,2022,0.0165,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Barbiturates,Barbiturates,2022,1.3234,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.28,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.06385,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.04914,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Benzodiazepines,Bromazepam,2022,0.00000068,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Benzodiazepines,Bromazepam,2022,0.00068,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Benzodiazepines,Phenazepam,2022,0.00000304,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Benzodiazepines,Phenazepam,2022,0.00224,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2022,1.381,LVA
Europe,Western and Central Europe,Latvia,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,4,LVA
Europe,Western and Central Europe,Latvia,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,26,LVA
Europe,Western and Central Europe,Latvia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,104,LVA
Europe,Western and Central Europe,Latvia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,4,LVA
Europe,Western and Central Europe,Latvia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,LVA
Europe,Western and Central Europe,Latvia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,4,LVA
Europe,Western and Central Europe,Latvia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2019,130,LVA
Europe,Western and Central Europe,Latvia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2019,0,LVA
Europe,Western and Central Europe,Latvia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2019,0,LVA
Europe,Western and Central Europe,Latvia,Any other drugs/substances,Substances not under int. control,Other drugs/substances,2019,0,LVA
Europe,Western and Central Europe,Latvia,Any other drugs/substances,Substances not under int. control,Other drugs/substances,2019,0,LVA
Europe,Western and Central Europe,Latvia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,64,LVA
Europe,Western and Central Europe,Latvia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,0,LVA
Europe,Western and Central Europe,Latvia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,100,LVA
Europe,Western and Central Europe,Latvia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,372,LVA
Europe,Western and Central Europe,Latvia,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,0,LVA
Europe,Western and Central Europe,Latvia,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,2202,LVA
Europe,Western and Central Europe,Latvia,Cocaine-type,Coca-type,Coca leaf,2019,0,LVA
Europe,Western and Central Europe,Latvia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,LVA
Europe,Western and Central Europe,Latvia,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2019,0,LVA
Europe,Western and Central Europe,Latvia,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2019,0,LVA
Europe,Western and Central Europe,Latvia,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2019,0,LVA
Europe,Western and Central Europe,Latvia,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2019,2,LVA
Europe,Western and Central Europe,Latvia,NPS,Plant-based NPS,Mushrooms (hallucinogenic),2019,1,LVA
Europe,Western and Central Europe,Latvia,NPS,Plant-based NPS,Mushrooms (hallucinogenic),2019,0,LVA
Europe,Western and Central Europe,Latvia,Opioids,Opiates,Heroin,2019,0,LVA
Europe,Western and Central Europe,Latvia,Opioids,Opiates,Illicit morphine,2019,0,LVA
Europe,Western and Central Europe,Latvia,Opioids,Opiates,Illicit morphine,2019,0,LVA
Europe,Western and Central Europe,Latvia,Opioids,Opiates,Opium,2019,0,LVA
Europe,Western and Central Europe,Latvia,Opioids,Opiates,Poppy plants,2019,2,LVA
Europe,Western and Central Europe,Latvia,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2019,2,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Buprenorphine,2019,0,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Buprenorphine,2019,0,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Carfentanil,2019,0,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Fentanyl,2019,0,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Fentanyl,2019,0,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Methadone,2019,0,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Methadone,2019,3,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Oxycodone,2019,0,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Tramadol,2019,0,LVA
Europe,Western and Central Europe,Latvia,Opioids,Pharmaceutical opioids,Tramadol,2019,0,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Barbiturates,Barbiturates,2019,0,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,0,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,0,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,GBL/GHB,GBL,2019,11,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,GBL/GHB,GBL,2019,0,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2019,0,LVA
Europe,Western and Central Europe,Latvia,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2019,0,LVA
Europe,Western and Central Europe,Lithuania,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,50,LTU
Europe,Western and Central Europe,Lithuania,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,3-Fluoroethamphetamine (3-FEA),2020,0.002,LTU
Europe,Western and Central Europe,Lithuania,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2020,203.248,LTU
Europe,Western and Central Europe,Lithuania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,70.8,LTU
Europe,Western and Central Europe,Lithuania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,3.8,LTU
Europe,Western and Central Europe,Lithuania,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,43.4,LTU
Europe,Western and Central Europe,Lithuania,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.0012,LTU
Europe,Western and Central Europe,Lithuania,NPS,Phenethylamines,4-MA (4-methylamphetamine),2020,0.024,LTU
Europe,Western and Central Europe,Lithuania,NPS,Piperazines,Piperazines,2020,0.0018,LTU
Europe,Western and Central Europe,Lithuania,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2020,3.4,LTU
Europe,Western and Central Europe,Lithuania,NPS,Synthetic cathinones,Synthetic cathinones,2020,0.0078,LTU
Europe,Western and Central Europe,Lithuania,NPS,Tryptamines,Tryptamines,2020,0.2073,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Opiates,Heroin,2020,0.87,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Opiates,Poppy plants,2020,0.1335,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Carfentanil,2020,4,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.0004,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Methadone,2020,0.673,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Tramadol,2020,0.0001,LTU
Europe,Western and Central Europe,Lithuania,Precursors,Precursors,Phenylacetone (P-2-P),2020,0.03,LTU
Europe,Western and Central Europe,Lithuania,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.00662,LTU
Europe,Western and Central Europe,Lithuania,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.00026,LTU
Europe,Western and Central Europe,Lithuania,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,8.4,LTU
Europe,Western and Central Europe,Lithuania,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.028455,LTU
Europe,Western and Central Europe,Lithuania,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,25,LTU
Europe,Western and Central Europe,Lithuania,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,41,LTU
Europe,Western and Central Europe,Lithuania,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,109,LTU
Europe,Western and Central Europe,Lithuania,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,323,LTU
Europe,Western and Central Europe,Lithuania,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,0.103,LTU
Europe,Western and Central Europe,Lithuania,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2021,0.006,LTU
Europe,Western and Central Europe,Lithuania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,312,LTU
Europe,Western and Central Europe,Lithuania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,0.064,LTU
Europe,Western and Central Europe,Lithuania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,178,LTU
Europe,Western and Central Europe,Lithuania,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,5.75,LTU
Europe,Western and Central Europe,Lithuania,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.012,LTU
Europe,Western and Central Europe,Lithuania,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.0012754,LTU
Europe,Western and Central Europe,Lithuania,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2021,0.106,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Opiates,Heroin,2021,1.9,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Opiates,Illicit morphine,2021,0.000087,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Opiates,Illicit morphine,2021,0.0308,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.47315,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Codeine,2021,0.00045,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Fentanyl,2021,0.063,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Methadone,2021,0.005,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.00065,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Tramadol,2021,0.11455,LTU
Europe,Western and Central Europe,Lithuania,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,0.000171,LTU
Europe,Western and Central Europe,Lithuania,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.014092,LTU
Europe,Western and Central Europe,Lithuania,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,52.967,LTU
Europe,Western and Central Europe,Lithuania,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.088,LTU
Europe,Western and Central Europe,Lithuania,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,101,LTU
Europe,Western and Central Europe,Lithuania,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,1.87,LTU
Europe,Western and Central Europe,Lithuania,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2022,0.0015,LTU
Europe,Western and Central Europe,Lithuania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,262,LTU
Europe,Western and Central Europe,Lithuania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,1.7,LTU
Europe,Western and Central Europe,Lithuania,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,26.5,LTU
Europe,Western and Central Europe,Lithuania,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,0.036,LTU
Europe,Western and Central Europe,Lithuania,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.002,LTU
Europe,Western and Central Europe,Lithuania,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0000136,LTU
Europe,Western and Central Europe,Lithuania,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2022,0.342,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Opiates,Heroin,2022,1.5,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Opiates,Illicit morphine,2022,0.001,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Opiates,Illicit morphine,2022,0.012,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Opiates,Poppy plants,2022,0.157,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.001,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.01,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.0047,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Methadone,2022,1.9,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Methadone,2022,5,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Tramadol,2022,0.002,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Tramadol,2022,0.02075,LTU
Europe,Western and Central Europe,Lithuania,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.002,LTU
Europe,Western and Central Europe,Lithuania,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.00099,LTU
Europe,Western and Central Europe,Lithuania,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2022,0.295,LTU
Europe,Western and Central Europe,Lithuania,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,131,LTU
Europe,Western and Central Europe,Lithuania,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.240919,LTU
Europe,Western and Central Europe,Lithuania,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,21.2,LTU
Europe,Western and Central Europe,Lithuania,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.7136,LTU
Europe,Western and Central Europe,Lithuania,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,1.7,LTU
Europe,Western and Central Europe,Lithuania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,198.3,LTU
Europe,Western and Central Europe,Lithuania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,3.7,LTU
Europe,Western and Central Europe,Lithuania,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,1372,LTU
Europe,Western and Central Europe,Lithuania,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.0018,LTU
Europe,Western and Central Europe,Lithuania,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.0108,LTU
Europe,Western and Central Europe,Lithuania,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.0003109,LTU
Europe,Western and Central Europe,Lithuania,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2023,0.0133,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Opiates,Heroin,2023,2.2,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.0012,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.00015,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.0000192,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.0169,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Methadone,2023,1.2,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Methadone,2023,0.00355,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Methadone,2023,0.8446,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Oxycodone,2023,0.0009,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Oxycodone,2023,0.00025,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Tramadol,2023,0.0004,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Tramadol,2023,0.002,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Tramadol,2023,0.0314,LTU
Europe,Western and Central Europe,Lithuania,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.002,LTU
Europe,Western and Central Europe,Lithuania,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.00079,LTU
Europe,Western and Central Europe,Lithuania,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,283,LTU
Europe,Western and Central Europe,Lithuania,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,24,LTU
Europe,Western and Central Europe,Lithuania,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,4,LTU
Europe,Western and Central Europe,Lithuania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,220,LTU
Europe,Western and Central Europe,Lithuania,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,1775,LTU
Europe,Western and Central Europe,Lithuania,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,16,LTU
Europe,Western and Central Europe,Lithuania,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Opiates,Heroin,2019,2,LTU
Europe,Western and Central Europe,Lithuania,Opioids,Pharmaceutical opioids,Carfentanil,2019,3,LTU
Europe,Western and Central Europe,Luxembourg,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,7.8507345,LUX
Europe,Western and Central Europe,Luxembourg,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2020,0.001,LUX
Europe,Western and Central Europe,Luxembourg,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2020,0.003,LUX
Europe,Western and Central Europe,Luxembourg,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2020,0.001,LUX
Europe,Western and Central Europe,Luxembourg,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,3-Fluoroethamphetamine (3-FEA),2020,0.003,LUX
Europe,Western and Central Europe,Luxembourg,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2020,0.028538,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0.004,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0.005,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0.002,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0.002,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0.0005,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0.004,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0.05,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0.005,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0.014,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0.52,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,89.713673,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,0.0007,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,0.7,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,11.89107,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,0.00003,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,0.192,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,0,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,0,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,0.039,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,0,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,0.02484,LUX
Europe,Western and Central Europe,Luxembourg,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,11.23406,LUX
Europe,Western and Central Europe,Luxembourg,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2020,0.1058,LUX
Europe,Western and Central Europe,Luxembourg,Hallucinogens,Other Hallucinogens,Other hallucinogens,2020,0.000017,LUX
Europe,Western and Central Europe,Luxembourg,Hallucinogens,Other Hallucinogens,Phencyclidine (PCP),2020,0.0001,LUX
Europe,Western and Central Europe,Luxembourg,Hallucinogens,Other Hallucinogens,Phencyclidine (PCP),2020,0.0015,LUX
Europe,Western and Central Europe,Luxembourg,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,0.0003,LUX
Europe,Western and Central Europe,Luxembourg,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,0.0019,LUX
Europe,Western and Central Europe,Luxembourg,NPS,Phenethylamines,2C (psychedelics),2020,0.000075,LUX
Europe,Western and Central Europe,Luxembourg,NPS,Plant-based NPS,Khat,2020,18.2,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Opiates,Heroin,2020,1.47236,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Other illicit opiates,Other illicit opiates,2020,0.0024,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Other illicit opiates,Other illicit opiates,2020,0.00325,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Other illicit opioids,Other illicit opioids,2020,0.0005,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Other illicit opioids,Other illicit opioids,2020,0.00075,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Pharmaceutical opioids,Codeine,2020,0.0015,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Pharmaceutical opioids,Methadone,2020,0.2862,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Pharmaceutical opioids,Oxycodone,2020,0.0001,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2020,1.368,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Pharmaceutical opioids,Tramadol,2020,0.00795,LUX
Europe,Western and Central Europe,Luxembourg,Precursors,Non-specified precursors,Other precursors,2020,0.0102,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.0043,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.0005,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.002,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.0035,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Benzodiazepines,Bromazepam,2020,0.00012,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.00005,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2020,0.0005,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2020,0.001,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2020,0.0005,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2020,0.00001,LUX
Europe,Western and Central Europe,Luxembourg,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.004331,LUX
Europe,Western and Central Europe,Luxembourg,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,,LUX
Europe,Western and Central Europe,Luxembourg,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,1.94877,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2021,,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2021,,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2021,,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0.0009,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0.000125,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,33.75,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,1.205,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0.0026,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,13.9933,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,0.1039,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,7.6,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,39.26374,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,0.0169,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,0.007,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,0.0112,LUX
Europe,Western and Central Europe,Luxembourg,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,3.66514,LUX
Europe,Western and Central Europe,Luxembourg,Cocaine-type,Other coca/cocaine-type drugs,Other coca/cocaine-type drugs,2021,0.0157,LUX
Europe,Western and Central Europe,Luxembourg,Cocaine-type,Other coca/cocaine-type drugs,Other coca/cocaine-type drugs,2021,,LUX
Europe,Western and Central Europe,Luxembourg,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.089,LUX
Europe,Western and Central Europe,Luxembourg,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.00371,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Opiates,Heroin,2021,2.21339,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Pharmaceutical opioids,Methadone,2021,0.011,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Pharmaceutical opioids,Methadone,2021,0.195,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2021,,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2021,,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Benzodiazepines,Bromazepam,2021,,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2021,,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Benzodiazepines,Valium,2021,,LUX
Europe,Western and Central Europe,Luxembourg,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.005149,LUX
Europe,Western and Central Europe,Luxembourg,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.0353,LUX
Europe,Western and Central Europe,Luxembourg,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.14066,LUX
Europe,Western and Central Europe,Luxembourg,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.0028,LUX
Europe,Western and Central Europe,Luxembourg,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.006525,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,9.06467,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,36.7,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,12.01887,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,0.1313,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,0.0028,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,0,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,29.9086,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,0,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,0.9941,LUX
Europe,Western and Central Europe,Luxembourg,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,0.0003,LUX
Europe,Western and Central Europe,Luxembourg,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,1.290371,LUX
Europe,Western and Central Europe,Luxembourg,Cocaine-type,Other coca/cocaine-type drugs,Other coca/cocaine-type drugs,2022,0.00016,LUX
Europe,Western and Central Europe,Luxembourg,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0000008,LUX
Europe,Western and Central Europe,Luxembourg,Hallucinogens,Other Hallucinogens,Psilocybine,2022,0.0373,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Opiates,Heroin,2022,3.86728,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Other illicit opioids,Other illicit opioids,2022,0.0039,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Pharmaceutical opioids,Methadone,2022,0.00165,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Pharmaceutical opioids,Methadone,2022,0.035,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Pharmaceutical opioids,Methadone,2022,0.692,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Pharmaceutical opioids,Tramadol,2022,0.0002,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2022,0.00092,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Benzodiazepines,Bromazepam,2022,0.00033,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2022,0.00015,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2022,0.071,LUX
Europe,Western and Central Europe,Luxembourg,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.0109,LUX
Europe,Western and Central Europe,Luxembourg,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.144714,LUX
Europe,Western and Central Europe,Luxembourg,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.001518,LUX
Europe,Western and Central Europe,Luxembourg,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.15985,LUX
Europe,Western and Central Europe,Luxembourg,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.0168,LUX
Europe,Western and Central Europe,Luxembourg,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,3-Fluoroethamphetamine (3-FEA),2023,0.0059,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.0042,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,LUX
Europe,Western and Central Europe,Luxembourg,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,3.47446,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,98.96143,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,3.8,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,426.0642,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,0.2018,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,0.00938,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,0,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,0.0029,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,0.0055,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,0.0321,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,0.0328,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,0,LUX
Europe,Western and Central Europe,Luxembourg,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2023,5.03427,LUX
Europe,Western and Central Europe,Luxembourg,Cocaine-type,Other coca/cocaine-type drugs,Other coca/cocaine-type drugs,2023,0.00003,LUX
Europe,Western and Central Europe,Luxembourg,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.00242,LUX
Europe,Western and Central Europe,Luxembourg,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2023,0.17787,LUX
Europe,Western and Central Europe,Luxembourg,Hallucinogens,Other Hallucinogens,Other hallucinogens,2023,0.0002,LUX
Europe,Western and Central Europe,Luxembourg,Hallucinogens,Other Hallucinogens,Other hallucinogens,2023,0.0001,LUX
Europe,Western and Central Europe,Luxembourg,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,0.0026,LUX
Europe,Western and Central Europe,Luxembourg,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2023,0.5276,LUX
Europe,Western and Central Europe,Luxembourg,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2023,0.0108,LUX
Europe,Western and Central Europe,Luxembourg,NPS,Synthetic cathinones,Synthetic cathinones,2023,0.0033,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Opiates,Heroin,2023,1.0646,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Opiates,Illicit morphine,2023,0.0002,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Pharmaceutical opioids,Methadone,2023,0.9156,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2023,0.0004,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2023,0.007,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2023,0.0003,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2023,0.00058,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.0063,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Benzodiazepines,Bromazepam,2023,0.0005,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Benzodiazepines,Bromazepam,2023,0.00003,LUX
Europe,Western and Central Europe,Luxembourg,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.00057,LUX
Europe,Western and Central Europe,Luxembourg,Solvents and Inhalants,Solvents and Inhalants,Solvents and inhalants,2023,0,LUX
Europe,Western and Central Europe,Luxembourg,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,12,LUX
Europe,Western and Central Europe,Luxembourg,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,98,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,2,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,0,LUX
Europe,Western and Central Europe,Luxembourg,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,0,LUX
Europe,Western and Central Europe,Luxembourg,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,2,LUX
Europe,Western and Central Europe,Luxembourg,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,LUX
Europe,Western and Central Europe,Luxembourg,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,LUX
Europe,Western and Central Europe,Luxembourg,NPS,Plant-based NPS,Khat,2019,9,LUX
Europe,Western and Central Europe,Luxembourg,NPS,Plant-based NPS,Mushrooms (hallucinogenic),2019,1,LUX
Europe,Western and Central Europe,Luxembourg,Opioids,Opiates,Heroin,2019,6,LUX
Europe,Western and Central Europe,Malta,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.004065,MLT
Europe,Western and Central Europe,Malta,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,0.004012,MLT
Europe,Western and Central Europe,Malta,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,151.1245508,MLT
Europe,Western and Central Europe,Malta,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,0.4,MLT
Europe,Western and Central Europe,Malta,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,0.361601,MLT
Europe,Western and Central Europe,Malta,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,524.540869,MLT
Europe,Western and Central Europe,Malta,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2020,2.028766,MLT
Europe,Western and Central Europe,Malta,Opioids,Opiates,Heroin,2020,1.848908,MLT
Europe,Western and Central Europe,Malta,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,0.092,MLT
Europe,Western and Central Europe,Malta,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.031,MLT
Europe,Western and Central Europe,Malta,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.04,MLT
Europe,Western and Central Europe,Malta,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,188,MLT
Europe,Western and Central Europe,Malta,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,7.2,MLT
Europe,Western and Central Europe,Malta,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,5.6,MLT
Europe,Western and Central Europe,Malta,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,27,MLT
Europe,Western and Central Europe,Malta,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,0.023,MLT
Europe,Western and Central Europe,Malta,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,762.4,MLT
Europe,Western and Central Europe,Malta,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2021,0.403,MLT
Europe,Western and Central Europe,Malta,NPS,Plant-based NPS,Khat,2021,118,MLT
Europe,Western and Central Europe,Malta,Opioids,Opiates,Heroin,2021,0.064,MLT
Europe,Western and Central Europe,Malta,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.006775,MLT
Europe,Western and Central Europe,Malta,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.13695,MLT
Europe,Western and Central Europe,Malta,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,156.7,MLT
Europe,Western and Central Europe,Malta,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,7,MLT
Europe,Western and Central Europe,Malta,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,0.223,MLT
Europe,Western and Central Europe,Malta,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,0.93378,MLT
Europe,Western and Central Europe,Malta,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,2970.4,MLT
Europe,Western and Central Europe,Malta,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.00000005,MLT
Europe,Western and Central Europe,Malta,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2022,0.00015,MLT
Europe,Western and Central Europe,Malta,Opioids,Opiates,Heroin,2022,19.6,MLT
Europe,Western and Central Europe,Malta,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.18428,MLT
Europe,Western and Central Europe,Malta,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.022,MLT
Europe,Western and Central Europe,Malta,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2023,4.7,MLT
Europe,Western and Central Europe,Malta,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,154.3,MLT
Europe,Western and Central Europe,Malta,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,7.3,MLT
Europe,Western and Central Europe,Malta,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,1.497,MLT
Europe,Western and Central Europe,Malta,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,0.0301,MLT
Europe,Western and Central Europe,Malta,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,493,MLT
Europe,Western and Central Europe,Malta,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2023,0.174,MLT
Europe,Western and Central Europe,Malta,NPS,Plant-based NPS,Khat,2023,10,MLT
Europe,Western and Central Europe,Malta,Opioids,Opiates,Heroin,2023,7.84,MLT
Europe,Western and Central Europe,Malta,Opioids,Pharmaceutical opioids,Methadone,2023,0.5,MLT
Europe,Western and Central Europe,Malta,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2019,60,MLT
Europe,Western and Central Europe,Malta,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,690,MLT
Europe,Western and Central Europe,Netherlands,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,519,NLD
Europe,Western and Central Europe,Netherlands,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,34,NLD
Europe,Western and Central Europe,Netherlands,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,17,NLD
Europe,Western and Central Europe,Netherlands,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2020,9137,NLD
Europe,Western and Central Europe,Netherlands,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,514,NLD
Europe,Western and Central Europe,Netherlands,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,1010,NLD
Europe,Western and Central Europe,Netherlands,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,48891,NLD
Europe,Western and Central Europe,Netherlands,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2020,1408,NLD
Europe,Western and Central Europe,Netherlands,Opioids,Opiates,Heroin,2020,105,NLD
Europe,Western and Central Europe,Netherlands,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,259,NLD
Europe,Western and Central Europe,Netherlands,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,19,NLD
Europe,Western and Central Europe,Netherlands,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,20,NLD
Europe,Western and Central Europe,Netherlands,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,734,NLD
Europe,Western and Central Europe,Netherlands,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,172,NLD
Europe,Western and Central Europe,Netherlands,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2021,72808,NLD
Europe,Western and Central Europe,Netherlands,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,4,NLD
Europe,Western and Central Europe,Netherlands,Opioids,Opiates,Heroin,2021,1734,NLD
Europe,Western and Central Europe,Netherlands,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,363,NLD
Europe,Western and Central Europe,Netherlands,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,32,NLD
Europe,Western and Central Europe,Netherlands,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,82,NLD
Europe,Western and Central Europe,Netherlands,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,5492,NLD
Europe,Western and Central Europe,Netherlands,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,293,NLD
Europe,Western and Central Europe,Netherlands,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,51447,NLD
Europe,Western and Central Europe,Netherlands,Opioids,Opiates,Heroin,2022,2611,NLD
Europe,Western and Central Europe,Netherlands,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,377,NLD
Europe,Western and Central Europe,Netherlands,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,25,NLD
Europe,Western and Central Europe,Netherlands,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,474,NLD
Europe,Western and Central Europe,Netherlands,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,3832,NLD
Europe,Western and Central Europe,Netherlands,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,253,NLD
Europe,Western and Central Europe,Netherlands,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2023,59116,NLD
Europe,Western and Central Europe,Netherlands,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,37,NLD
Europe,Western and Central Europe,Netherlands,Opioids,Opiates,Heroin,2023,19,NLD
Europe,Western and Central Europe,Netherlands,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,600,NLD
Europe,Western and Central Europe,Netherlands,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,207,NLD
Europe,Western and Central Europe,Netherlands,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,476,NLD
Europe,Western and Central Europe,Netherlands,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,NLD
Europe,Western and Central Europe,Netherlands,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,837,NLD
Europe,Western and Central Europe,Netherlands,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,5378,NLD
Europe,Western and Central Europe,Netherlands,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,55680,NLD
Europe,Western and Central Europe,Netherlands,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,1552,NLD
Europe,Western and Central Europe,Netherlands,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,43836,NLD
Europe,Western and Central Europe,Netherlands,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,NLD
Europe,Western and Central Europe,Netherlands,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,NLD
Europe,Western and Central Europe,Netherlands,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2019,51,NLD
Europe,Western and Central Europe,Netherlands,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,20,NLD
Europe,Western and Central Europe,Netherlands,NPS,Phenethylamines,4-Fluoroamphetamine (4-FA),2019,6,NLD
Europe,Western and Central Europe,Netherlands,NPS,Plant-based NPS,Khat,2019,2273,NLD
Europe,Western and Central Europe,Netherlands,Opioids,Opiates,Heroin,2019,1326,NLD
Europe,Western and Central Europe,Netherlands,Opioids,Opiates,Opium,2019,93,NLD
Europe,Western and Central Europe,Netherlands,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,2,NLD
Europe,Western and Central Europe,Netherlands,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,,NLD
Europe,Western and Central Europe,Netherlands,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,10,NLD
Europe,Western and Central Europe,Netherlands,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2019,496,NLD
Europe,Western and Central Europe,Netherlands,Cocaine-type,Coca-type,Coca leaf,2019,10,NLD
Europe,Western and Central Europe,Netherlands,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,0,NLD
Europe,Western and Central Europe,Netherlands,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,NLD
Europe,Western and Central Europe,Netherlands,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,NLD
Europe,Western and Central Europe,Netherlands,Sedatives and tranquillizers,GBL/GHB,GBL,2019,9,NLD
Europe,Western and Central Europe,Netherlands,Precursors,Non-specified precursors,Non-specified precursors,2019,17500,NLD
Europe,Western and Central Europe,Norway,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,21,NOR
Europe,Western and Central Europe,Norway,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,20.440446,NOR
Europe,Western and Central Europe,Norway,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,530,NOR
Europe,Western and Central Europe,Norway,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,4.8,NOR
Europe,Western and Central Europe,Norway,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2020,0.0083,NOR
Europe,Western and Central Europe,Norway,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2020,0.2545,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,819,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.481,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.601,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,1785,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,2.814,NOR
Europe,Western and Central Europe,Norway,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,48.7,NOR
Europe,Western and Central Europe,Norway,Cocaine-type,Coca-type,Coca leaf,2020,0.008,NOR
Europe,Western and Central Europe,Norway,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.00081865,NOR
Europe,Western and Central Europe,Norway,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2020,0.0069,NOR
Europe,Western and Central Europe,Norway,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2020,0.041,NOR
Europe,Western and Central Europe,Norway,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2020,9.9,NOR
Europe,Western and Central Europe,Norway,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2020,53.4,NOR
Europe,Western and Central Europe,Norway,Opioids,Opiates,Heroin,2020,24.4,NOR
Europe,Western and Central Europe,Norway,Opioids,Opiates,Illicit morphine,2020,0.0007,NOR
Europe,Western and Central Europe,Norway,Opioids,Opiates,Illicit morphine,2020,0.316,NOR
Europe,Western and Central Europe,Norway,Opioids,Opiates,Illicit morphine,2020,0.1246,NOR
Europe,Western and Central Europe,Norway,Opioids,Opiates,Opium,2020,1.16,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.026,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.0708,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Codeine,2020,0.067,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Codeine,2020,2,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Codeine,2020,0.39815,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.004,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.008,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.0031,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Methadone,2020,0.027,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Methadone,2020,1.128,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Methadone,2020,0.14595,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Oxycodone,2020,0.1,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Oxycodone,2020,0.07375,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Tramadol,2020,0.053,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Tramadol,2020,0.2,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Tramadol,2020,0.80855,NOR
Europe,Western and Central Europe,Norway,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.267,NOR
Europe,Western and Central Europe,Norway,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,1.653,NOR
Europe,Western and Central Europe,Norway,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,12.89247,NOR
Europe,Western and Central Europe,Norway,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2020,80,NOR
Europe,Western and Central Europe,Norway,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2020,260.3,NOR
Europe,Western and Central Europe,Norway,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,10.5,NOR
Europe,Western and Central Europe,Norway,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,5.096426,NOR
Europe,Western and Central Europe,Norway,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,756,NOR
Europe,Western and Central Europe,Norway,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,4,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,737,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,1.74,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,3.23,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,1513,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,0.395,NOR
Europe,Western and Central Europe,Norway,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,160.3,NOR
Europe,Western and Central Europe,Norway,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.00078275,NOR
Europe,Western and Central Europe,Norway,Opioids,Opiates,Heroin,2021,33,NOR
Europe,Western and Central Europe,Norway,Opioids,Opiates,Opium,2021,6.999,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.0045,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.0334,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Codeine,2021,0.0054,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Codeine,2021,0.10605,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Fentanyl,2021,0.012,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Fentanyl,2021,0.00245,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Methadone,2021,0.0236,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Methadone,2021,1.313,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.205,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Tramadol,2021,1.85645,NOR
Europe,Western and Central Europe,Norway,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,10.65,NOR
Europe,Western and Central Europe,Norway,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,133.7,NOR
Europe,Western and Central Europe,Norway,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,107.2,NOR
Europe,Western and Central Europe,Norway,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,13.7,NOR
Europe,Western and Central Europe,Norway,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,11.831318,NOR
Europe,Western and Central Europe,Norway,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,237,NOR
Europe,Western and Central Europe,Norway,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,21,NOR
Europe,Western and Central Europe,Norway,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2022,0.00109,NOR
Europe,Western and Central Europe,Norway,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2022,0.00224,NOR
Europe,Western and Central Europe,Norway,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2022,0.06575,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,1173,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,1.363,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,4.827,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,3971,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,0.058,NOR
Europe,Western and Central Europe,Norway,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,116.6,NOR
Europe,Western and Central Europe,Norway,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.07458,NOR
Europe,Western and Central Europe,Norway,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0001623,NOR
Europe,Western and Central Europe,Norway,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2022,0.03355,NOR
Europe,Western and Central Europe,Norway,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2022,0.1429,NOR
Europe,Western and Central Europe,Norway,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2022,0.0006,NOR
Europe,Western and Central Europe,Norway,Opioids,Opiates,Heroin,2022,84.3,NOR
Europe,Western and Central Europe,Norway,Opioids,Opiates,Opium,2022,1.98121,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.0555,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Codeine,2022,0.11325,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.0013,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.38681,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Methadone,2022,0.0118,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Methadone,2022,0.5915,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Oxycodone,2022,0.0569,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Tramadol,2022,0.82915,NOR
Europe,Western and Central Europe,Norway,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,24.7445,NOR
Europe,Western and Central Europe,Norway,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2022,118.4,NOR
Europe,Western and Central Europe,Norway,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,163,NOR
Europe,Western and Central Europe,Norway,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,89.27,NOR
Europe,Western and Central Europe,Norway,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,9.901527,NOR
Europe,Western and Central Europe,Norway,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,597,NOR
Europe,Western and Central Europe,Norway,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,28.51,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,533,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,2.478,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,2.719,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,3281,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,0.47336,NOR
Europe,Western and Central Europe,Norway,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,2292,NOR
Europe,Western and Central Europe,Norway,Cocaine-type,Coca-type,Coca leaf,2023,0.00149,NOR
Europe,Western and Central Europe,Norway,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.0435,NOR
Europe,Western and Central Europe,Norway,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.1477,NOR
Europe,Western and Central Europe,Norway,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.0011158,NOR
Europe,Western and Central Europe,Norway,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2023,0.09446,NOR
Europe,Western and Central Europe,Norway,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2023,0.24,NOR
Europe,Western and Central Europe,Norway,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2023,0.01081,NOR
Europe,Western and Central Europe,Norway,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,43,NOR
Europe,Western and Central Europe,Norway,Opioids,Opiates,Heroin,2023,63.23,NOR
Europe,Western and Central Europe,Norway,Opioids,Opiates,Opium,2023,4.316,NOR
Europe,Western and Central Europe,Norway,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2023,1.936,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.0435,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Codeine,2023,0.00917,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Codeine,2023,3.996,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Codeine,2023,0.25585,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.01014,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.003,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Methadone,2023,0.02145,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Methadone,2023,1.802,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Oxycodone,2023,0.16025,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Tramadol,2023,0.92935,NOR
Europe,Western and Central Europe,Norway,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2023,96.76,NOR
Europe,Western and Central Europe,Norway,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2023,137.15,NOR
Europe,Western and Central Europe,Norway,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,16.56024,NOR
Europe,Western and Central Europe,Norway,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,44,NOR
Europe,Western and Central Europe,Norway,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,33,NOR
Europe,Western and Central Europe,Norway,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,454,NOR
Europe,Western and Central Europe,Norway,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,13,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,458,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,2244,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,2,NOR
Europe,Western and Central Europe,Norway,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,0,NOR
Europe,Western and Central Europe,Norway,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,136,NOR
Europe,Western and Central Europe,Norway,Opioids,Opiates,Heroin,2019,88,NOR
Europe,Western and Central Europe,Norway,Opioids,Opiates,Opium,2019,1,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Buprenorphine,2019,0,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Fentanyl,2019,0,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Fentanyl,2019,0,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Oxycodone,2019,0,NOR
Europe,Western and Central Europe,Norway,Opioids,Pharmaceutical opioids,Tramadol,2019,44,NOR
Europe,Western and Central Europe,Norway,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,18,NOR
Europe,Western and Central Europe,Norway,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,2,NOR
Europe,Western and Central Europe,Norway,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,154,NOR
Europe,Western and Central Europe,Norway,Sedatives and tranquillizers,GBL/GHB,GBL,2019,199,NOR
Europe,Western and Central Europe,Poland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,40,POL
Europe,Western and Central Europe,Poland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,138.619,POL
Europe,Western and Central Europe,Poland,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,44.587088,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,1921.343,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,4.8,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,303.14,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2020,0.03,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2020,120.456,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2020,0.0045,POL
Europe,Western and Central Europe,Poland,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0,POL
Europe,Western and Central Europe,Poland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,5315.641,POL
Europe,Western and Central Europe,Poland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.0732,POL
Europe,Western and Central Europe,Poland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.0011934,POL
Europe,Western and Central Europe,Poland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,11860,POL
Europe,Western and Central Europe,Poland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,1994.474,POL
Europe,Western and Central Europe,Poland,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,3886.844,POL
Europe,Western and Central Europe,Poland,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.0000988,POL
Europe,Western and Central Europe,Poland,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2020,1.0945,POL
Europe,Western and Central Europe,Poland,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2020,12.1316,POL
Europe,Western and Central Europe,Poland,Hallucinogens,Other Hallucinogens,Psilocybine,2020,3.735,POL
Europe,Western and Central Europe,Poland,Opioids,Opiates,Heroin,2020,426.9,POL
Europe,Western and Central Europe,Poland,Opioids,Opiates,Illicit morphine,2020,0.1052,POL
Europe,Western and Central Europe,Poland,Opioids,Opiates,Opium,2020,19.518,POL
Europe,Western and Central Europe,Poland,Opioids,Pharmaceutical opioids,Codeine,2020,0.0347,POL
Europe,Western and Central Europe,Poland,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.7253,POL
Europe,Western and Central Europe,Poland,Opioids,Pharmaceutical opioids,Methadone,2020,0.1171,POL
Europe,Western and Central Europe,Poland,Opioids,Pharmaceutical opioids,Oxycodone,2020,0.0156,POL
Europe,Western and Central Europe,Poland,Precursors,Non-specified precursors,Other precursors,2020,0,POL
Europe,Western and Central Europe,Poland,Precursors,Precursors,Acetic anhydride,2020,4000,POL
Europe,Western and Central Europe,Poland,Precursors,Precursors,Pseudoephedrine,2020,1.1,POL
Europe,Western and Central Europe,Poland,Precursors,Precursors,Pseudoephedrine,2020,6.0404,POL
Europe,Western and Central Europe,Poland,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.3621,POL
Europe,Western and Central Europe,Poland,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.0495,POL
Europe,Western and Central Europe,Poland,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2020,2440.01,POL
Europe,Western and Central Europe,Poland,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2020,0.62,POL
Europe,Western and Central Europe,Poland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,185.39,POL
Europe,Western and Central Europe,Poland,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,19.908473,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,42.809,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,2083.88436,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,162.5687,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,1298.7438,POL
Europe,Western and Central Europe,Poland,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0.0034,POL
Europe,Western and Central Europe,Poland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,9167.3438,POL
Europe,Western and Central Europe,Poland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,5336.3,POL
Europe,Western and Central Europe,Poland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,681.63488,POL
Europe,Western and Central Europe,Poland,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,2133.45799,POL
Europe,Western and Central Europe,Poland,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.000188875,POL
Europe,Western and Central Europe,Poland,NPS,Synthetic cathinones,Alpha-Pyrrolidinohexiophenone (alpha-PHP),2021,0.00886,POL
Europe,Western and Central Europe,Poland,Opioids,Opiates,Heroin,2021,119.5,POL
Europe,Western and Central Europe,Poland,Opioids,Pharmaceutical opioids,Fentanyl,2021,1.26249,POL
Europe,Western and Central Europe,Poland,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2021,0.00014,POL
Europe,Western and Central Europe,Poland,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2021,0.0085,POL
Europe,Western and Central Europe,Poland,Precursors,Precursors,Pseudoephedrine,2021,0.3052,POL
Europe,Western and Central Europe,Poland,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,8.1255,POL
Europe,Western and Central Europe,Poland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,64.15412,POL
Europe,Western and Central Europe,Poland,“Ecstasy”-type substances,“Ecstasy”-type substances,MDEA,2022,0.6147,POL
Europe,Western and Central Europe,Poland,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,18.405778,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,1822.74146,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,106.55423,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2022,428.83618,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Methcathinone,2022,1.3382,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,"Methylphenidate (Ritalin, Concerta)",2022,0.0236,POL
Europe,Western and Central Europe,Poland,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0,POL
Europe,Western and Central Europe,Poland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,7280.412,POL
Europe,Western and Central Europe,Poland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,4670.2,POL
Europe,Western and Central Europe,Poland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,379.85945,POL
Europe,Western and Central Europe,Poland,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,309.18853,POL
Europe,Western and Central Europe,Poland,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0003194,POL
Europe,Western and Central Europe,Poland,Hallucinogens,Other Hallucinogens,25B-NBOMe (2C-B-NBOMe),2022,0.1057,POL
Europe,Western and Central Europe,Poland,Hallucinogens,Other Hallucinogens,"25C-NBOMe (NBOMe-2C-C, 2C-C-NBOMe, Cimbi-82)",2022,0.004,POL
Europe,Western and Central Europe,Poland,Hallucinogens,Other Hallucinogens,Mescaline,2022,0.0003,POL
Europe,Western and Central Europe,Poland,Hallucinogens,Other Hallucinogens,Phencyclidine (PCP),2022,0.1003,POL
Europe,Western and Central Europe,Poland,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,0.4949,POL
Europe,Western and Central Europe,Poland,NPS,Phenethylamines,4-Fluoroamphetamine (4-FA),2022,0.0082,POL
Europe,Western and Central Europe,Poland,NPS,Synthetic cannabinoids (Spice),AB-FUBINACA,2022,0.566,POL
Europe,Western and Central Europe,Poland,NPS,Synthetic cannabinoids (Spice),MDMB-CHMICA,2022,0.0148,POL
Europe,Western and Central Europe,Poland,NPS,Synthetic cathinones,4-MEC,2022,0.0944,POL
Europe,Western and Central Europe,Poland,NPS,Synthetic cathinones,Alpha-Pyrrolidinohexiophenone (alpha-PHP),2022,0.6136,POL
Europe,Western and Central Europe,Poland,NPS,Synthetic cathinones,Pentedrone,2022,1.6274,POL
Europe,Western and Central Europe,Poland,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.07495,POL
Europe,Western and Central Europe,Poland,Sedatives and tranquillizers,Barbiturates,Chlordiazepoxide,2022,0.0011,POL
Europe,Western and Central Europe,Poland,Sedatives and tranquillizers,Benzodiazepines,Diazepam (Stesolid),2022,0.1392,POL
Europe,Western and Central Europe,Poland,Sedatives and tranquillizers,Benzodiazepines,Estazolam (desmethylalprazolam),2022,0.001,POL
Europe,Western and Central Europe,Poland,Sedatives and tranquillizers,Benzodiazepines,"Lorazepam (Ativan, Temesta)",2022,6.385,POL
Europe,Western and Central Europe,Poland,Sedatives and tranquillizers,Benzodiazepines,Midazolam,2022,0.0016,POL
Europe,Western and Central Europe,Poland,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2022,3.4328,POL
Europe,Western and Central Europe,Poland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,151.02386,POL
Europe,Western and Central Europe,Poland,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,33.803998,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,2054.98437,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,250.16101,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,883.30827,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2023,0.09424,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2023,0.03515,POL
Europe,Western and Central Europe,Poland,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,28.05854,POL
Europe,Western and Central Europe,Poland,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,POL
Europe,Western and Central Europe,Poland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,4251.26137,POL
Europe,Western and Central Europe,Poland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,3954.5,POL
Europe,Western and Central Europe,Poland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,782.77829,POL
Europe,Western and Central Europe,Poland,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,2153.2028,POL
Europe,Western and Central Europe,Poland,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.0002215,POL
Europe,Western and Central Europe,Poland,Opioids,Opiates,Heroin,2023,12.60397,POL
Europe,Western and Central Europe,Poland,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.0015,POL
Europe,Western and Central Europe,Poland,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,203.6317,POL
Europe,Western and Central Europe,Poland,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,537.3086,POL
Europe,Western and Central Europe,Poland,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2019,272,POL
Europe,Western and Central Europe,Poland,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,36,POL
Europe,Western and Central Europe,Poland,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,70,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,1677,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,538,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2019,29,POL
Europe,Western and Central Europe,Poland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2019,0,POL
Europe,Western and Central Europe,Poland,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2019,0,POL
Europe,Western and Central Europe,Poland,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2019,47,POL
Europe,Western and Central Europe,Poland,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2019,0,POL
Europe,Western and Central Europe,Poland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,1,POL
Europe,Western and Central Europe,Poland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,2990,POL
Europe,Western and Central Europe,Poland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,0,POL
Europe,Western and Central Europe,Poland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,35,POL
Europe,Western and Central Europe,Poland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,9571,POL
Europe,Western and Central Europe,Poland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,436,POL
Europe,Western and Central Europe,Poland,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,600,POL
Europe,Western and Central Europe,Poland,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,5481,POL
Europe,Western and Central Europe,Poland,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,POL
Europe,Western and Central Europe,Poland,NPS,Other NPS,Non-specified NPS,2019,48,POL
Europe,Western and Central Europe,Poland,NPS,Other NPS,Non-specified NPS,2019,0,POL
Europe,Western and Central Europe,Poland,NPS,Other NPS,Non-specified NPS,2019,2,POL
Europe,Western and Central Europe,Poland,NPS,Other NPS,Non-specified NPS,2019,0,POL
Europe,Western and Central Europe,Poland,NPS,Plant-based NPS,Khat,2019,16,POL
Europe,Western and Central Europe,Poland,NPS,Plant-based NPS,Mushrooms (hallucinogenic),2019,0,POL
Europe,Western and Central Europe,Poland,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (Spice),2019,1,POL
Europe,Western and Central Europe,Poland,Opioids,Opiates,Heroin,2019,21,POL
Europe,Western and Central Europe,Poland,Opioids,Opiates,Illicit morphine,2019,8,POL
Europe,Western and Central Europe,Poland,Opioids,Other illicit opioids,Other illicit opioids,2019,0,POL
Europe,Western and Central Europe,Poland,Opioids,Pharmaceutical opioids,Buprenorphine,2019,0,POL
Europe,Western and Central Europe,Poland,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,1,POL
Europe,Western and Central Europe,Poland,Precursors,Non-specified precursors,Other precursors,2019,28,POL
Europe,Western and Central Europe,Poland,Precursors,Non-specified precursors,Other precursors,2019,1,POL
Europe,Western and Central Europe,Poland,Precursors,Non-specified precursors,Sulphuric acid,2019,1,POL
Europe,Western and Central Europe,Poland,Precursors,Precursors,Ephedrine,2019,0,POL
Europe,Western and Central Europe,Poland,Sedatives and tranquillizers,Barbiturates,Barbiturates,2019,0,POL
Europe,Western and Central Europe,Poland,Sedatives and tranquillizers,Barbiturates,Barbiturates,2019,0,POL
Europe,Western and Central Europe,Poland,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,1,POL
Europe,Western and Central Europe,Poland,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,POL
Europe,Western and Central Europe,Poland,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,2,POL
Europe,Western and Central Europe,Poland,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,1,POL
Europe,Western and Central Europe,Poland,Sedatives and tranquillizers,GBL/GHB,GBL,2019,160,POL
Europe,Western and Central Europe,Portugal,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,1.075,PRT
Europe,Western and Central Europe,Portugal,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.098373,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.121,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.07337,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.029,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2020,0.042,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2020,0.03775,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,821.388,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.346,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.0018,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,13.8,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,2869.2,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,33551.541,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,12.135,PRT
Europe,Western and Central Europe,Portugal,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,0.0003,PRT
Europe,Western and Central Europe,Portugal,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,10066.343,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.004,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.0000191,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2020,15.973,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Other Hallucinogens,Psilocybine,2020,0.027,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Other Hallucinogens,Psilocybine,2020,0.0002,PRT
Europe,Western and Central Europe,Portugal,NPS,Plant-based NPS,Khat,2020,374.6,PRT
Europe,Western and Central Europe,Portugal,Opioids,Opiates,Heroin,2020,23.196,PRT
Europe,Western and Central Europe,Portugal,Opioids,Opiates,Poppy plants,2020,131,PRT
Europe,Western and Central Europe,Portugal,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.00085,PRT
Europe,Western and Central Europe,Portugal,Opioids,Pharmaceutical opioids,Methadone,2020,0.03,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.00188,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.003,PRT
Europe,Western and Central Europe,Portugal,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,1.973151,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.878,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.025047,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.0028,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.05625,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,3.895,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,0.004,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,1289.23,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,5.15,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,0.0129,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,3,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,2652,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,14821.12,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,39.79,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,0.11628,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,22.77,PRT
Europe,Western and Central Europe,Portugal,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,0.036651,PRT
Europe,Western and Central Europe,Portugal,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,9916.244,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.0000121,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2021,18.859,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2021,0.017,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2021,0.036529,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Other Hallucinogens,Other hallucinogens,2021,0.0034,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Other Hallucinogens,Other hallucinogens,2021,0.0005,PRT
Europe,Western and Central Europe,Portugal,NPS,Plant-based NPS,Khat,2021,267.521,PRT
Europe,Western and Central Europe,Portugal,NPS,Synthetic cathinones,Alpha-Pyrrolidinohexiophenone (alpha-PHP),2021,1.562,PRT
Europe,Western and Central Europe,Portugal,Opioids,Opiates,Heroin,2021,22.875,PRT
Europe,Western and Central Europe,Portugal,Opioids,Opiates,Opium,2021,1540.003,PRT
Europe,Western and Central Europe,Portugal,Opioids,Opiates,Opium,2021,0.675,PRT
Europe,Western and Central Europe,Portugal,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.00015,PRT
Europe,Western and Central Europe,Portugal,Opioids,Pharmaceutical opioids,Methadone,2021,0.00019,PRT
Europe,Western and Central Europe,Portugal,Opioids,Pharmaceutical opioids,Methadone,2021,0.0042,PRT
Europe,Western and Central Europe,Portugal,Opioids,Pharmaceutical opioids,Methadone,2021,8.6,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2021,0.017461,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2021,0.00172,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,Benzodiazepines,Bromazepam,2021,0.004026,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2021,0.004755,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.001526,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,Benzodiazepines,"Lorazepam (Ativan, Temesta)",2021,0.00008,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,Benzodiazepines,"Lorazepam (Ativan, Temesta)",2021,0.00005,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,Benzodiazepines,Oxazepam,2021,0.03,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,0.017,PRT
Europe,Western and Central Europe,Portugal,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,16.751594,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,1.26,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.01,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.147752,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.09,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,2.10465,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Non-specified amphetamine-type stimulants,Non-specified amphetamine-type stimulants,2022,0.02,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Non-specified amphetamine-type stimulants,Non-specified amphetamine-type stimulants,2022,0.0003,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2022,0.05,PRT
Europe,Western and Central Europe,Portugal,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0.01,PRT
Europe,Western and Central Europe,Portugal,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0.001,PRT
Europe,Western and Central Europe,Portugal,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,1157.27,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,0.01,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,0.81,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,0.0084,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,0.09,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,927.3,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,23375.5,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,10.45,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,0.01439,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,0.15,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,0.06,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,0,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,0,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,15.6,PRT
Europe,Western and Central Europe,Portugal,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,4.93,PRT
Europe,Western and Central Europe,Portugal,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,1,PRT
Europe,Western and Central Europe,Portugal,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,16533.22,PRT
Europe,Western and Central Europe,Portugal,Cocaine-type,Coca-type,Coca leaf,2022,1.27,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.52,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0002347,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2022,0.0134,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2022,0.09,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2022,3.14,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2022,0.0055,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,0.07,PRT
Europe,Western and Central Europe,Portugal,NPS,Phenethylamines,"2,5-Dimethoxy-4-chloroamphetamine (DOC)",2022,0.001,PRT
Europe,Western and Central Europe,Portugal,NPS,Plant-based NPS,Khat,2022,520.61,PRT
Europe,Western and Central Europe,Portugal,Opioids,Opiates,Heroin,2022,72.56,PRT
Europe,Western and Central Europe,Portugal,Opioids,Opiates,Opium,2022,2.15,PRT
Europe,Western and Central Europe,Portugal,Opioids,Opiates,Opium,2022,0.6765,PRT
Europe,Western and Central Europe,Portugal,Opioids,Other illicit opiates,Other illicit opiates,2022,0.0004,PRT
Europe,Western and Central Europe,Portugal,Opioids,Other illicit opioids,Other illicit opioids,2022,0.010775,PRT
Europe,Western and Central Europe,Portugal,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.00035,PRT
Europe,Western and Central Europe,Portugal,Opioids,Pharmaceutical opioids,Codeine,2022,0.86,PRT
Europe,Western and Central Europe,Portugal,Opioids,Pharmaceutical opioids,Codeine,2022,0.005,PRT
Europe,Western and Central Europe,Portugal,Opioids,Pharmaceutical opioids,Methadone,2022,0.415,PRT
Europe,Western and Central Europe,Portugal,Opioids,Pharmaceutical opioids,Methadone,2022,0.0049,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.00081,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2022,0.00058,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.00004,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,Benzodiazepines,"Lorazepam (Ativan, Temesta)",2022,0.0002,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,Benzodiazepines,Midazolam,2022,0.00013,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,0.37,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,Non-specified sedatives and tranquillizers,Non-specified sedatives and tranquillizers,2022,,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2022,0.00003,PRT
Europe,Western and Central Europe,Portugal,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,24.675634,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.052877,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,4.132633,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.00045,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,1.73672,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,0.00078,PRT
Europe,Western and Central Europe,Portugal,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2023,0.415588,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,1553.917497,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,1.1241,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,0.079167,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,889.8,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,37946.85542,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,15.15654,PRT
Europe,Western and Central Europe,Portugal,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,7.113356,PRT
Europe,Western and Central Europe,Portugal,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,21720.81666,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.03313,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.00008865,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2023,0.00583,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2023,0.01,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2023,16.013,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2023,26.68576,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Other Hallucinogens,Mescaline,2023,0.0018,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Other Hallucinogens,Mescaline,2023,0.063,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.0078,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Other Hallucinogens,Psilocybine,2023,2.39768,PRT
Europe,Western and Central Europe,Portugal,NPS,Plant-based NPS,Khat,2023,138.13547,PRT
Europe,Western and Central Europe,Portugal,NPS,Synthetic cathinones,Alpha-Pyrrolidinohexiophenone (alpha-PHP),2023,0.0011,PRT
Europe,Western and Central Europe,Portugal,NPS,Synthetic cathinones,Synthetic cathinones,2023,1157.57744,PRT
Europe,Western and Central Europe,Portugal,Opioids,Opiates,Heroin,2023,41.390431,PRT
Europe,Western and Central Europe,Portugal,Opioids,Opiates,Illicit morphine,2023,0.00015,PRT
Europe,Western and Central Europe,Portugal,Opioids,Opiates,Opium,2023,0.1776,PRT
Europe,Western and Central Europe,Portugal,Opioids,Opiates,Poppy plants,2023,14.8,PRT
Europe,Western and Central Europe,Portugal,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2023,0.008,PRT
Europe,Western and Central Europe,Portugal,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.000475,PRT
Europe,Western and Central Europe,Portugal,Opioids,Pharmaceutical opioids,Codeine,2023,1.37254,PRT
Europe,Western and Central Europe,Portugal,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.0002,PRT
Europe,Western and Central Europe,Portugal,Opioids,Pharmaceutical opioids,Methadone,2023,0.0027,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.00462,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.00107,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.00067,PRT
Europe,Western and Central Europe,Portugal,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,2,PRT
Europe,Western and Central Europe,Portugal,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,4,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,3,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,PRT
Europe,Western and Central Europe,Portugal,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2019,0,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,492,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,5,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,1208,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,3235,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,4,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,0,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,4,PRT
Europe,Western and Central Europe,Portugal,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,0,PRT
Europe,Western and Central Europe,Portugal,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,9,PRT
Europe,Western and Central Europe,Portugal,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,10567,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2019,0,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2019,14,PRT
Europe,Western and Central Europe,Portugal,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2019,0,PRT
Europe,Western and Central Europe,Portugal,NPS,Plant-based NPS,Khat,2019,485,PRT
Europe,Western and Central Europe,Portugal,NPS,Plant-based NPS,Mushrooms (hallucinogenic),2019,0,PRT
Europe,Western and Central Europe,Portugal,NPS,Synthetic cathinones,Synthetic cathinones,2019,0,PRT
Europe,Western and Central Europe,Portugal,Opioids,Opiates,Heroin,2019,15,PRT
Europe,Western and Central Europe,Portugal,Opioids,Opiates,Opium,2019,0,PRT
Europe,Western and Central Europe,Portugal,Opioids,Pharmaceutical opioids,Fentanyl,2019,0,PRT
Europe,Western and Central Europe,Portugal,Opioids,Pharmaceutical opioids,Methadone,2019,0,PRT
Europe,Western and Central Europe,Portugal,Opioids,Pharmaceutical opioids,Methadone,2019,0,PRT
Europe,Western and Central Europe,Portugal,Opioids,Pharmaceutical opioids,Methadone,2019,0,PRT
Europe,Western and Central Europe,Portugal,Opioids,Pharmaceutical opioids,Methadone,2019,0,PRT
Europe,Western and Central Europe,Portugal,Opioids,Pharmaceutical opioids,Methadone,2019,0,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,PRT
Europe,Western and Central Europe,Portugal,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,0,PRT
Europe,Western and Central Europe,Slovakia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,0.785358,SVK
Europe,Western and Central Europe,Slovakia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.02,SVK
Europe,Western and Central Europe,Slovakia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,1518.114,SVK
Europe,Western and Central Europe,Slovakia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,63.3,SVK
Europe,Western and Central Europe,Slovakia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,0.0337,SVK
Europe,Western and Central Europe,Slovakia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.0000003,SVK
Europe,Western and Central Europe,Slovakia,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2020,0.00096,SVK
Europe,Western and Central Europe,Slovakia,Hallucinogens,Other Hallucinogens,Psilocybine,2020,0.222171,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Opiates,Heroin,2020,0.308,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Opiates,Illicit morphine,2020,0.0006,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.0009,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.00045,SVK
Europe,Western and Central Europe,Slovakia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.00103,SVK
Europe,Western and Central Europe,Slovakia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.151,SVK
Europe,Western and Central Europe,Slovakia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.254469,SVK
Europe,Western and Central Europe,Slovakia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.001,SVK
Europe,Western and Central Europe,Slovakia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.00315,SVK
Europe,Western and Central Europe,Slovakia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,23.247,SVK
Europe,Western and Central Europe,Slovakia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.25,SVK
Europe,Western and Central Europe,Slovakia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,3-Fluoroethamphetamine (3-FEA),2021,0.00175,SVK
Europe,Western and Central Europe,Slovakia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,146.402,SVK
Europe,Western and Central Europe,Slovakia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,28.4,SVK
Europe,Western and Central Europe,Slovakia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,0.168,SVK
Europe,Western and Central Europe,Slovakia,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,0.543,SVK
Europe,Western and Central Europe,Slovakia,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2021,0.0005,SVK
Europe,Western and Central Europe,Slovakia,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.139,SVK
Europe,Western and Central Europe,Slovakia,NPS,Plant-based NPS,Khat,2021,19.427,SVK
Europe,Western and Central Europe,Slovakia,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2021,0.13745,SVK
Europe,Western and Central Europe,Slovakia,NPS,Synthetic cathinones,Alpha-PHpP (PV8),2021,0.00216,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Opiates,Heroin,2021,35.495,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Opiates,Opium,2021,0.026,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.001,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.0038,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Pharmaceutical opioids,Codeine,2021,0.0003,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Pharmaceutical opioids,Fentanyl,2021,0.898,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Pharmaceutical opioids,Fentanyl,2021,0.00098,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Pharmaceutical opioids,Methadone,2021,0.071,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Pharmaceutical opioids,Tramadol,2021,0.0126,SVK
Europe,Western and Central Europe,Slovakia,Sedatives and tranquillizers,Benzodiazepines,Bromazepam,2021,0.00076,SVK
Europe,Western and Central Europe,Slovakia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.002,SVK
Europe,Western and Central Europe,Slovakia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.00025,SVK
Europe,Western and Central Europe,Slovakia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.05,SVK
Europe,Western and Central Europe,Slovakia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.0572,SVK
Europe,Western and Central Europe,Slovakia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.106503,SVK
Europe,Western and Central Europe,Slovakia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.00103,SVK
Europe,Western and Central Europe,Slovakia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,5.9,SVK
Europe,Western and Central Europe,Slovakia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2022,0.005,SVK
Europe,Western and Central Europe,Slovakia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,3-Fluoroethamphetamine (3-FEA),2022,0.000122,SVK
Europe,Western and Central Europe,Slovakia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,3-Fluoroethamphetamine (3-FEA),2022,0.0015,SVK
Europe,Western and Central Europe,Slovakia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,103.545,SVK
Europe,Western and Central Europe,Slovakia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,7.6,SVK
Europe,Western and Central Europe,Slovakia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,0.26583,SVK
Europe,Western and Central Europe,Slovakia,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,6.23,SVK
Europe,Western and Central Europe,Slovakia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0000037,SVK
Europe,Western and Central Europe,Slovakia,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2022,0.00093,SVK
Europe,Western and Central Europe,Slovakia,Hallucinogens,Other Hallucinogens,Psilocybine,2022,0.0005,SVK
Europe,Western and Central Europe,Slovakia,Hallucinogens,Other Hallucinogens,Psilocybine,2022,0.12878,SVK
Europe,Western and Central Europe,Slovakia,Hallucinogens,Other Hallucinogens,Zopiclone,2022,0.0001,SVK
Europe,Western and Central Europe,Slovakia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,0.000181,SVK
Europe,Western and Central Europe,Slovakia,NPS,Plant-based NPS,Khat,2022,500,SVK
Europe,Western and Central Europe,Slovakia,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2022,28.77,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Opiates,Heroin,2022,0.413643,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Opiates,Illicit morphine,2022,0.0004,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Opiates,Illicit morphine,2022,0.033,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.000076,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.00215,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.00085,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Pharmaceutical opioids,Methadone,2022,0.005,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Pharmaceutical opioids,Oxycodone,2022,0.046,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Pharmaceutical opioids,Tramadol,2022,0.0109,SVK
Europe,Western and Central Europe,Slovakia,Sedatives and tranquillizers,Benzodiazepines,Bromazepam,2022,0.00384,SVK
Europe,Western and Central Europe,Slovakia,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2022,0.00026,SVK
Europe,Western and Central Europe,Slovakia,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2022,0.0035,SVK
Europe,Western and Central Europe,Slovakia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.0026,SVK
Europe,Western and Central Europe,Slovakia,Sedatives and tranquillizers,Benzodiazepines,Diazepam (Stesolid),2022,0.0026,SVK
Europe,Western and Central Europe,Slovakia,Sedatives and tranquillizers,Benzodiazepines,Midazolam,2022,0.0006,SVK
Europe,Western and Central Europe,Slovakia,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2022,2.62,SVK
Europe,Western and Central Europe,Slovakia,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,0.019,SVK
Europe,Western and Central Europe,Slovakia,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2022,0.00675,SVK
Europe,Western and Central Europe,Slovakia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.4128,SVK
Europe,Western and Central Europe,Slovakia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,4.776646,SVK
Europe,Western and Central Europe,Slovakia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.0256,SVK
Europe,Western and Central Europe,Slovakia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.030107,SVK
Europe,Western and Central Europe,Slovakia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,8.3,SVK
Europe,Western and Central Europe,Slovakia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,0.336,SVK
Europe,Western and Central Europe,Slovakia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,107.7,SVK
Europe,Western and Central Europe,Slovakia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,4.9,SVK
Europe,Western and Central Europe,Slovakia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,9.5,SVK
Europe,Western and Central Europe,Slovakia,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,3.7,SVK
Europe,Western and Central Europe,Slovakia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.00000285,SVK
Europe,Western and Central Europe,Slovakia,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2023,0.0055,SVK
Europe,Western and Central Europe,Slovakia,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.2321,SVK
Europe,Western and Central Europe,Slovakia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,0.0074,SVK
Europe,Western and Central Europe,Slovakia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,0.0786,SVK
Europe,Western and Central Europe,Slovakia,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2023,0.1629,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Opiates,Heroin,2023,1.46,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.00055,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.00265,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Pharmaceutical opioids,Tramadol,2023,0.0017,SVK
Europe,Western and Central Europe,Slovakia,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2023,0.02265,SVK
Europe,Western and Central Europe,Slovakia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.0051,SVK
Europe,Western and Central Europe,Slovakia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.00023,SVK
Europe,Western and Central Europe,Slovakia,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2023,1000,SVK
Europe,Western and Central Europe,Slovakia,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,0,SVK
Europe,Western and Central Europe,Slovakia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,SVK
Europe,Western and Central Europe,Slovakia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,9,SVK
Europe,Western and Central Europe,Slovakia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,1,SVK
Europe,Western and Central Europe,Slovakia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,131,SVK
Europe,Western and Central Europe,Slovakia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,0,SVK
Europe,Western and Central Europe,Slovakia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,161,SVK
Europe,Western and Central Europe,Slovakia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,0,SVK
Europe,Western and Central Europe,Slovakia,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,1,SVK
Europe,Western and Central Europe,Slovakia,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,0,SVK
Europe,Western and Central Europe,Slovakia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,SVK
Europe,Western and Central Europe,Slovakia,Hallucinogens,Other Hallucinogens,Psilocybine,2019,0,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Opiates,Heroin,2019,2,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Opiates,Illicit morphine,2019,0,SVK
Europe,Western and Central Europe,Slovakia,Opioids,Pharmaceutical opioids,Fentanyl,2019,0,SVK
Europe,Western and Central Europe,Slovenia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,3.530859,SVN
Europe,Western and Central Europe,Slovenia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,0.9787,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.00506,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,1.059,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,107.8062,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.0846,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.219825,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,1412.9189,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,2334.4,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,0.7037,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,3.2948,SVN
Europe,Western and Central Europe,Slovenia,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,0.0016,SVN
Europe,Western and Central Europe,Slovenia,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,8.565,SVN
Europe,Western and Central Europe,Slovenia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.0001,SVN
Europe,Western and Central Europe,Slovenia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.0000032,SVN
Europe,Western and Central Europe,Slovenia,Hallucinogens,Other Hallucinogens,Psilocybine,2020,0.0225,SVN
Europe,Western and Central Europe,Slovenia,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2020,0.00014,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Opiates,Heroin,2020,0.0726,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Opiates,Heroin,2020,4.8866,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Opiates,Illicit morphine,2020,0.0086,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.0001,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.0007,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Pharmaceutical opioids,Methadone,2020,2.1224,SVN
Europe,Western and Central Europe,Slovenia,Precursors,Precursors,Sulphuric acid,2020,0.0025,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.087205,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.0026,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.01135,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Midazolam,2020,0.01398,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2020,12720,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2020,0.109,SVN
Europe,Western and Central Europe,Slovenia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,66.48985,SVN
Europe,Western and Central Europe,Slovenia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,123.4779,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.0709,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.9741765,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,96.9222,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.005,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.006075,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,6.6385,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,9.715,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2021,0.0021,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2021,0.0025,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,"Methylphenidate (Ritalin, Concerta)",2021,0.0021,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,"Methylphenidate (Ritalin, Concerta)",2021,0.0025,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2021,0.0364,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2021,1.3553,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2021,0,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0.0191,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0.0746,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0.247,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0.6688,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2021,0.0003,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2021,0.0227,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2021,0.002,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,1205.0767,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,2285.2,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,0.2714,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,0.4455,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,1.5792,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2021,20.6595,SVN
Europe,Western and Central Europe,Slovenia,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,0.0008,SVN
Europe,Western and Central Europe,Slovenia,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,827.9119,SVN
Europe,Western and Central Europe,Slovenia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.0315,SVN
Europe,Western and Central Europe,Slovenia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.00039085,SVN
Europe,Western and Central Europe,Slovenia,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2021,10.1296,SVN
Europe,Western and Central Europe,Slovenia,Hallucinogens,Other Hallucinogens,Mushrooms (hallucinogenic),2021,0.001,SVN
Europe,Western and Central Europe,Slovenia,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.001,SVN
Europe,Western and Central Europe,Slovenia,NPS,Phenethylamines,4-Fluoroamphetamine (4-FA),2021,0.179055,SVN
Europe,Western and Central Europe,Slovenia,NPS,Phenethylamines,4-Fluoromethamphetamine (4-FMA),2021,0.08772,SVN
Europe,Western and Central Europe,Slovenia,NPS,Plant-based NPS,Kratom (Mitragyna speciosa),2021,0.018,SVN
Europe,Western and Central Europe,Slovenia,NPS,Synthetic cannabinoids (Spice),MDMB-CHMICA,2021,0.0207,SVN
Europe,Western and Central Europe,Slovenia,NPS,Synthetic cathinones,Synthetic cathinones,2021,0.0003,SVN
Europe,Western and Central Europe,Slovenia,NPS,Synthetic cathinones,Synthetic cathinones,2021,0.007,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Opiates,Heroin,2021,0.0073,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Opiates,Heroin,2021,226.1483,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Opiates,Illicit morphine,2021,0.0005,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Opiates,Illicit morphine,2021,0.0164,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Opiates,Opium,2021,0.0056,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Opiates,Opium,2021,0.0503,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Other illicit opioids,Other illicit opioids,2021,0.0034,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Other illicit opioids,Other illicit opioids,2021,0.004,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Other illicit opioids,Other illicit opioids,2021,0.0005,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Other illicit opioids,Other illicit opioids,2021,0.000225,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.0002,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.00255,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Pharmaceutical opioids,Methadone,2021,0.0001,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Pharmaceutical opioids,Methadone,2021,1.4591,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.0001,SVN
Europe,Western and Central Europe,Slovenia,Precursors,Precursors,Acetone,2021,2470,SVN
Europe,Western and Central Europe,Slovenia,Precursors,Precursors,Pseudoephedrine,2021,0.045,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2021,0.03232,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.0263,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.0834,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.025055,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.0776,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.00182,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Bromazepam,2021,0.00098,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2021,0.0059,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2021,0.00056,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.0002,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.00117,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Midazolam,2021,0.2151,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Midazolam,2021,0.01478,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,0.1614,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,1.5118,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,0.7,SVN
Europe,Western and Central Europe,Slovenia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.0736,SVN
Europe,Western and Central Europe,Slovenia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.0277775,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.027577,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.7216,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.00855,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.0706,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.5388,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2022,0.0186,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2022,0.0198,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2022,1.0804,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2022,0,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2022,0.0016,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2022,0.0042,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2022,0.0554,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2022,0.0321,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,688.408,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,88.1106,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,1511.9,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,1.7355,SVN
Europe,Western and Central Europe,Slovenia,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,678.3451,SVN
Europe,Western and Central Europe,Slovenia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0001,SVN
Europe,Western and Central Europe,Slovenia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0000083,SVN
Europe,Western and Central Europe,Slovenia,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2022,0.0003,SVN
Europe,Western and Central Europe,Slovenia,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2022,0.7775,SVN
Europe,Western and Central Europe,Slovenia,Hallucinogens,Other Hallucinogens,Other hallucinogens,2022,0.7444,SVN
Europe,Western and Central Europe,Slovenia,NPS,Synthetic cannabinoids (Spice),JWH-210,2022,0.0077,SVN
Europe,Western and Central Europe,Slovenia,NPS,Synthetic cathinones,Synthetic cathinones,2022,0.0959,SVN
Europe,Western and Central Europe,Slovenia,NPS,Synthetic cathinones,Synthetic cathinones,2022,0.0126,SVN
Europe,Western and Central Europe,Slovenia,NPS,Synthetic cathinones,Synthetic cathinones,2022,0.0074,SVN
Europe,Western and Central Europe,Slovenia,NPS,Synthetic cathinones,Synthetic cathinones,2022,0.0002,SVN
Europe,Western and Central Europe,Slovenia,NPS,Tryptamines,Tryptamines,2022,0.0008,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Opiates,Heroin,2022,0.0077,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Opiates,Heroin,2022,5.8014,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Opiates,Illicit morphine,2022,0.02,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Opiates,Illicit morphine,2022,0.2843,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Other illicit opioids,Other illicit opioids,2022,0.000125,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.0004,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.00415,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Pharmaceutical opioids,Codeine,2022,0.002,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Pharmaceutical opioids,Methadone,2022,0.5029,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Pharmaceutical opioids,Oxycodone,2022,0.101,SVN
Europe,Western and Central Europe,Slovenia,Precursors,Non-specified precursors,Non-specified precursors,2022,0.006,SVN
Europe,Western and Central Europe,Slovenia,Precursors,Non-specified precursors,Non-specified precursors,2022,0.015,SVN
Europe,Western and Central Europe,Slovenia,Precursors,Non-specified precursors,Other precursors,2022,1518.19,SVN
Europe,Western and Central Europe,Slovenia,Precursors,Non-specified precursors,Other precursors,2022,0.2817,SVN
Europe,Western and Central Europe,Slovenia,Precursors,Non-specified precursors,Other precursors,2022,7.757,SVN
Europe,Western and Central Europe,Slovenia,Precursors,Precursors,Acetone,2022,0.52,SVN
Europe,Western and Central Europe,Slovenia,Precursors,Precursors,Ephedrine,2022,0.45,SVN
Europe,Western and Central Europe,Slovenia,Precursors,Precursors,Hydrochloric acid,2022,1.3,SVN
Europe,Western and Central Europe,Slovenia,Precursors,Precursors,Hydrochloric acid,2022,1.3,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2022,0.0004,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2022,0.01676,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.0924,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.2098,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.074515,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.0078,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.0394,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.007875,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Bromazepam,2022,0.00019,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2022,0.0036,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2022,0.00043,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.00557,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,"Lorazepam (Ativan, Temesta)",2022,0.0085,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,"Lorazepam (Ativan, Temesta)",2022,0.00122,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Midazolam,2022,0.045,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Midazolam,2022,0.1567,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Midazolam,2022,0.03027,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Nitrazepam,2022,0.00096,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2022,0.0041,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2022,0.119,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,0.765,SVN
Europe,Western and Central Europe,Slovenia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.1769,SVN
Europe,Western and Central Europe,Slovenia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,1.004055,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.016,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.03795,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,63.3578,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.0006,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.001125,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,10.5735,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,0.0011,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2023,0.06075,SVN
Europe,Western and Central Europe,Slovenia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2023,0.00375,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2023,0.05,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2023,0,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2023,0.0408,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2023,0,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2023,0.753,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.0159,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.02,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.172,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.0903,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.1625,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.0215,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.012,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.0185,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.02,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2023,0.0114,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2023,0.0097,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2023,0.0087,SVN
Europe,Western and Central Europe,Slovenia,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2023,0.0623,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,794.4314,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,0.0004,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,1205.9,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,0.7998,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,10.6114,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,3.3917,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,12.672,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,0.0269,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,0.185,SVN
Europe,Western and Central Europe,Slovenia,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,0.0036,SVN
Europe,Western and Central Europe,Slovenia,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,44.0677,SVN
Europe,Western and Central Europe,Slovenia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.0368,SVN
Europe,Western and Central Europe,Slovenia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.00000605,SVN
Europe,Western and Central Europe,Slovenia,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2023,0.0085,SVN
Europe,Western and Central Europe,Slovenia,Hallucinogens,Other Hallucinogens,Other hallucinogens,2023,0.068,SVN
Europe,Western and Central Europe,Slovenia,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.0327,SVN
Europe,Western and Central Europe,Slovenia,NPS,Synthetic cannabinoids (Spice),JWH-210,2023,0.0065,SVN
Europe,Western and Central Europe,Slovenia,NPS,Synthetic cathinones,Alpha-Pyrrolidinohexiophenone (alpha-PHP),2023,0.0116,SVN
Europe,Western and Central Europe,Slovenia,NPS,Synthetic cathinones,Synthetic cathinones,2023,0.1475,SVN
Europe,Western and Central Europe,Slovenia,NPS,Synthetic cathinones,Synthetic cathinones,2023,0.0021,SVN
Europe,Western and Central Europe,Slovenia,NPS,Synthetic cathinones,Synthetic cathinones,2023,0.0004,SVN
Europe,Western and Central Europe,Slovenia,NPS,Synthetic cathinones,Synthetic cathinones,2023,0.0227,SVN
Europe,Western and Central Europe,Slovenia,NPS,Synthetic cathinones,Synthetic cathinones,2023,0.0039,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Opiates,Heroin,2023,0.0979,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Opiates,Heroin,2023,2.9602,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Opiates,Illicit morphine,2023,0.002,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Opiates,Illicit morphine,2023,0.007,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Opiates,Opium,2023,0.0361,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.0042,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.00515,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Pharmaceutical opioids,Codeine,2023,0.171,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Pharmaceutical opioids,Methadone,2023,0.7263,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Pharmaceutical opioids,Oxycodone,2023,0.0035,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Pharmaceutical opioids,Tramadol,2023,0.00005,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2023,0.0007,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,"Alprazolam (Xanax, Pranax, Ksalol)",2023,0.00495,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.0138,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.019,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.008505,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.0247,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.00386,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Bromazepam,2023,0.00115,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2023,0.002,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2023,0.00045,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.0002,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.00429,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Midazolam,2023,0.0199,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Benzodiazepines,Midazolam,2023,0.006225,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2023,0.0554,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2023,7.74,SVN
Europe,Western and Central Europe,Slovenia,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2023,0.0009,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,7,SVN
Europe,Western and Central Europe,Slovenia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,1,SVN
Europe,Western and Central Europe,Slovenia,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2019,1,SVN
Europe,Western and Central Europe,Slovenia,Opioids,Opiates,Heroin,2019,749,SVN
Europe,Western and Central Europe,Spain,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,432.618438,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2020,0.012,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2020,0.654,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2020,79.808,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,70073,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,24,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,170227.3,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,473925,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,418,ESP
Europe,Western and Central Europe,Spain,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,36950,ESP
Europe,Western and Central Europe,Spain,Cocaine-type,Coca-type,Coca leaf,2020,301,ESP
Europe,Western and Central Europe,Spain,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,3.8991,ESP
Europe,Western and Central Europe,Spain,Opioids,Opiates,Heroin,2020,178,ESP
Europe,Western and Central Europe,Spain,Opioids,Opiates,Opium,2020,12,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.00215,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Codeine,2020,0.043,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.015,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Methadone,2020,3.57,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Oxycodone,2020,0.00005,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,Barbiturates,Barbiturates,2020,0.0845,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,1.72747,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.17341,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2020,1.042,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2020,100.898,ESP
Europe,Western and Central Europe,Spain,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,172.585537,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,35.992033,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,76.3587,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2021,0.016,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,5.213,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2021,0.07975,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,139711,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,87.846,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,7.1,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,333516.7,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,676182,ESP
Europe,Western and Central Europe,Spain,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2021,49159.178,ESP
Europe,Western and Central Europe,Spain,Cocaine-type,Coca-type,Coca leaf,2021,382.103,ESP
Europe,Western and Central Europe,Spain,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.00050215,ESP
Europe,Western and Central Europe,Spain,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2021,1.6409,ESP
Europe,Western and Central Europe,Spain,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2021,0.0055,ESP
Europe,Western and Central Europe,Spain,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.006,ESP
Europe,Western and Central Europe,Spain,Opioids,Opiates,Heroin,2021,238,ESP
Europe,Western and Central Europe,Spain,Opioids,Opiates,Illicit morphine,2021,3.352,ESP
Europe,Western and Central Europe,Spain,Opioids,Opiates,Opium,2021,15.631,ESP
Europe,Western and Central Europe,Spain,Opioids,Opiates,Poppy plants,2021,0.005,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.0008,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Codeine,2021,0.864,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Fentanyl,2021,0.021,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Methadone,2021,193.141,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Oxycodone,2021,,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.06027,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.01703,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,4.337,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,36.304,ESP
Europe,Western and Central Europe,Spain,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,125.524761,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,14.160157,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,60.11235,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2022,0.313,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,144803,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,8.826,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,335096.9,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,324709,ESP
Europe,Western and Central Europe,Spain,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2022,58334,ESP
Europe,Western and Central Europe,Spain,Cocaine-type,Coca-type,Coca leaf,2022,258.302,ESP
Europe,Western and Central Europe,Spain,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.00083765,ESP
Europe,Western and Central Europe,Spain,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2022,5.731,ESP
Europe,Western and Central Europe,Spain,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2022,0.8423,ESP
Europe,Western and Central Europe,Spain,Hallucinogens,Other Hallucinogens,Psilocybine,2022,0.2884,ESP
Europe,Western and Central Europe,Spain,Opioids,Opiates,Heroin,2022,189,ESP
Europe,Western and Central Europe,Spain,Opioids,Opiates,Illicit morphine,2022,0.032,ESP
Europe,Western and Central Europe,Spain,Opioids,Opiates,Opium,2022,0.176,ESP
Europe,Western and Central Europe,Spain,Opioids,Opiates,Poppy plants,2022,42245,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Codeine,2022,13.864,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.04,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Methadone,2022,2.891,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Oxycodone,2022,0.013,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,1.00756,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.02657,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2022,0.046,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,31.531,ESP
Europe,Western and Central Europe,Spain,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,232.101,ESP
Europe,Western and Central Europe,Spain,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,227.096374,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,26.822554,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,430.193,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,270.137,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,94.302,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,5.586,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,59235,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,303.333,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,170429.4,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,375290,ESP
Europe,Western and Central Europe,Spain,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2023,118324,ESP
Europe,Western and Central Europe,Spain,Cocaine-type,Coca-type,Coca leaf,2023,480.263,ESP
Europe,Western and Central Europe,Spain,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.00521445,ESP
Europe,Western and Central Europe,Spain,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2023,9.797,ESP
Europe,Western and Central Europe,Spain,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2023,0.006,ESP
Europe,Western and Central Europe,Spain,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,201.102,ESP
Europe,Western and Central Europe,Spain,NPS,Plant-based NPS,Ayahuasca,2023,23.439,ESP
Europe,Western and Central Europe,Spain,NPS,Plant-based NPS,Khat,2023,66.415,ESP
Europe,Western and Central Europe,Spain,Opioids,Opiates,Heroin,2023,321,ESP
Europe,Western and Central Europe,Spain,Opioids,Opiates,Illicit morphine,2023,0.086,ESP
Europe,Western and Central Europe,Spain,Opioids,Opiates,Opium,2023,0.459,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.002,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Codeine,2023,0.069,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.002,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Methadone,2023,3.224,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Oxycodone,2023,0.004,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Tramadol,2023,0.02735,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,3.46091,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,Benzodiazepines,Clonazepam (Rivotril),2023,1.31006,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2023,0.06543,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2023,9.258,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2023,13.598,ESP
Europe,Western and Central Europe,Spain,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,340,ESP
Europe,Western and Central Europe,Spain,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,73,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,437,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,23,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,1559,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,51,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2019,1,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2019,0,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2019,0,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2019,1,ESP
Europe,Western and Central Europe,Spain,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2019,3,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,39861,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,27,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,153900,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,349489,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,25,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,32,ESP
Europe,Western and Central Europe,Spain,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,30,ESP
Europe,Western and Central Europe,Spain,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,1,ESP
Europe,Western and Central Europe,Spain,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2019,30,ESP
Europe,Western and Central Europe,Spain,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,37868,ESP
Europe,Western and Central Europe,Spain,Cocaine-type,Coca-type,Coca leaf,2019,276,ESP
Europe,Western and Central Europe,Spain,Cocaine-type,Other/non-specified coca/cocaine-type drugs OR Miscellaneous coca/cocaine-type drugs,Other coca/cocaine-type drugs,2019,1,ESP
Europe,Western and Central Europe,Spain,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,ESP
Europe,Western and Central Europe,Spain,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2019,0,ESP
Europe,Western and Central Europe,Spain,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2019,7,ESP
Europe,Western and Central Europe,Spain,Hallucinogens,Other Hallucinogens,Other hallucinogens,2019,0,ESP
Europe,Western and Central Europe,Spain,Hallucinogens,Other Hallucinogens,Other hallucinogens,2019,0,ESP
Europe,Western and Central Europe,Spain,Hallucinogens,Other Hallucinogens,Phencyclidine (PCP),2019,1,ESP
Europe,Western and Central Europe,Spain,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,7,ESP
Europe,Western and Central Europe,Spain,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,10,ESP
Europe,Western and Central Europe,Spain,NPS,Phenethylamines,4-MA (4-methylamphetamine),2019,0,ESP
Europe,Western and Central Europe,Spain,NPS,Plant-based NPS,Ayahuasca,2019,254,ESP
Europe,Western and Central Europe,Spain,NPS,Plant-based NPS,Khat,2019,1324,ESP
Europe,Western and Central Europe,Spain,NPS,Plant-based NPS,Mushrooms (hallucinogenic),2019,1,ESP
Europe,Western and Central Europe,Spain,Opioids,Opiates,Heroin,2019,234,ESP
Europe,Western and Central Europe,Spain,Opioids,Opiates,Illicit morphine,2019,0,ESP
Europe,Western and Central Europe,Spain,Opioids,Opiates,Opium,2019,2,ESP
Europe,Western and Central Europe,Spain,Opioids,Other illicit opiates,Other illicit opiates,2019,6,ESP
Europe,Western and Central Europe,Spain,Opioids,Other illicit opioids,Other illicit opioids,2019,0,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Codeine,2019,0,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Fentanyl,2019,0,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Methadone,2019,2,ESP
Europe,Western and Central Europe,Spain,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,0,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,Barbiturates,Barbiturates,2019,0,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,2,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,18,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,GBL/GHB,GBL,2019,0,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,Methaqualone,Methaqualone,2019,0,ESP
Europe,Western and Central Europe,Spain,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2019,0,ESP
Europe,Western and Central Europe,Spain,Solvents and Inhalants,Solvents and Inhalants,Solvents and inhalants,2019,10,ESP
Europe,Western and Central Europe,Sweden,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,24.793,SWE
Europe,Western and Central Europe,Sweden,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,0.241,SWE
Europe,Western and Central Europe,Sweden,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,58.425432,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.954063,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,166.174,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,1115.324,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.04725,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,4.158,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,22.619,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2020,0.003,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2020,5.202,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2020,0.003,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2020,0.04,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2020,1.2215,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,2112,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,1.1,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,8.1,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,4510,SWE
Europe,Western and Central Europe,Sweden,Cocaine-type,Cocaine,Coca paste/refined cocaine base (intermediate products) (please specify),2020,216.2,SWE
Europe,Western and Central Europe,Sweden,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,367,SWE
Europe,Western and Central Europe,Sweden,Cocaine-type,Coca-type,Coca leaf,2020,0.2,SWE
Europe,Western and Central Europe,Sweden,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,0.6457,SWE
Europe,Western and Central Europe,Sweden,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,7.929,SWE
Europe,Western and Central Europe,Sweden,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,9.584,SWE
Europe,Western and Central Europe,Sweden,NPS,Plant-based NPS,Khat,2020,104.8,SWE
Europe,Western and Central Europe,Sweden,NPS,Plant-based NPS,Khat,2020,2268.1,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Heroin,2020,37.115,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Illicit morphine,2020,0.08,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Illicit morphine,2020,0.526,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Illicit morphine,2020,0.3408,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Opium,2020,11.56,SWE
Europe,Western and Central Europe,Sweden,Opioids,Other illicit opioids,Other illicit opioids,2020,0.004825,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.112,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Buprenorphine,2020,5.548,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Codeine,2020,0.642,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Codeine,2020,1.711,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Codeine,2020,0.6893,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Fentanyl,2020,1,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.11365,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Methadone,2020,0.026,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Methadone,2020,0.03755,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Methadone,2020,5.847,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Oxycodone,2020,0.7,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Oxycodone,2020,1.0617,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Tramadol,2020,49.129,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Barbiturates,Barbiturates,2020,0.007,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Barbiturates,Barbiturates,2020,0.0203,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.168,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,18.44912,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.01,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,3.01,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2020,0.023,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,5.925,SWE
Europe,Western and Central Europe,Sweden,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.029,SWE
Europe,Western and Central Europe,Sweden,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,63.476,SWE
Europe,Western and Central Europe,Sweden,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,40.005833,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,50.887,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,1553.9,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,14.546235,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.000225,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,2.668,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,7.377,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,7.589,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2021,0.017,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2021,0.045,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2021,1.96625,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,2199.76,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,55.37,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,61.6,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,4467.76,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,125,SWE
Europe,Western and Central Europe,Sweden,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,395.55,SWE
Europe,Western and Central Europe,Sweden,Cocaine-type,Coca-type,Coca leaf,2021,1.981,SWE
Europe,Western and Central Europe,Sweden,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.013,SWE
Europe,Western and Central Europe,Sweden,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.05,SWE
Europe,Western and Central Europe,Sweden,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.0003104,SWE
Europe,Western and Central Europe,Sweden,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2021,0.008,SWE
Europe,Western and Central Europe,Sweden,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2021,0.0487,SWE
Europe,Western and Central Europe,Sweden,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2021,3.131,SWE
Europe,Western and Central Europe,Sweden,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2021,6.495,SWE
Europe,Western and Central Europe,Sweden,Hallucinogens,Other Hallucinogens,Psilocybine,2021,2.155,SWE
Europe,Western and Central Europe,Sweden,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.242,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Heroin,2021,11.37,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Heroin,2021,0.013,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Illicit morphine,2021,0.449,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Illicit morphine,2021,0.092001,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Illicit morphine,2021,0.6774,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Opium,2021,12.57,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Opium,2021,0.023,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.070001,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Buprenorphine,2021,1.26335,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Codeine,2021,0.065,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Codeine,2021,0.915,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Codeine,2021,0.51575,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Fentanyl,2021,0.011,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Fentanyl,2021,0.00335,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Methadone,2021,0.002,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Methadone,2021,0.1844,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Methadone,2021,5.373,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.015,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.077,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Oxycodone,2021,3.2223,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Tramadol,2021,7.732,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Tramadol,2021,17.842,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Tramadol,2021,104.15965,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Barbiturates,Barbiturates,2021,0.0107,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Barbiturates,Barbiturates,2021,0.11,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.419,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,13.46518,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.065,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,1.46392,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,30.604,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,12.15,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,100.721,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,280.91,SWE
Europe,Western and Central Europe,Sweden,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,49.6,SWE
Europe,Western and Central Europe,Sweden,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,34.798297,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,25.8,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.337502,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,1886.9,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.006,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,7.4,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,0.03285,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2022,63.6,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2022,0.022,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2022,1.4,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2022,1.32925,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2022,0.007,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2022,0.1,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2022,1.83275,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,2143.2,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,3.246,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,0.0075,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,27.2,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,5679.3,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,1.209,SWE
Europe,Western and Central Europe,Sweden,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,0.174,SWE
Europe,Western and Central Europe,Sweden,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,0.0179,SWE
Europe,Western and Central Europe,Sweden,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,1001.3,SWE
Europe,Western and Central Europe,Sweden,Cocaine-type,Coca-type,Coca leaf,2022,1.16,SWE
Europe,Western and Central Europe,Sweden,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.064,SWE
Europe,Western and Central Europe,Sweden,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2022,0.342,SWE
Europe,Western and Central Europe,Sweden,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2022,1.934,SWE
Europe,Western and Central Europe,Sweden,Hallucinogens,Other Hallucinogens,Psilocybine,2022,3.054,SWE
Europe,Western and Central Europe,Sweden,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,6.139,SWE
Europe,Western and Central Europe,Sweden,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,1.5314,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Heroin,2022,8.8,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Heroin,2022,0.013,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Illicit morphine,2022,4.4,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Illicit morphine,2022,0.045,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Illicit morphine,2022,0.2859,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Opium,2022,0.01,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Opium,2022,23.1,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.009,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.081,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Buprenorphine,2022,2.2597,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Codeine,2022,2.2,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Codeine,2022,0.037,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Codeine,2022,0.3881,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.004,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Fentanyl,2022,0.01755,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Methadone,2022,0.0046,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Methadone,2022,4.8,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Methadone,2022,0.08945,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Oxycodone,2022,0.005,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Oxycodone,2022,1.361,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Oxycodone,2022,3.5018,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Tramadol,2022,0.2,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Tramadol,2022,0.257,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Tramadol,2022,87.72315,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Barbiturates,Barbiturates,2022,0.0012,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,1.9,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,147.8,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,38.32491,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.012,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.022,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.76471,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2022,46.3,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,0.011,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,2.3,SWE
Europe,Western and Central Europe,Sweden,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,0.003,SWE
Europe,Western and Central Europe,Sweden,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,57.95,SWE
Europe,Western and Central Europe,Sweden,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,51.42496,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,2.1,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,25.892526,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.008,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2023,0.1,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2023,0.00275,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,0.199,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2023,0.101,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2023,1.01725,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2023,2785.6,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,0.014,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,1997.6,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,14.5,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,25,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,62,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,8848.8,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,0.138,SWE
Europe,Western and Central Europe,Sweden,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,63.9,SWE
Europe,Western and Central Europe,Sweden,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,0.0146,SWE
Europe,Western and Central Europe,Sweden,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,1527.8,SWE
Europe,Western and Central Europe,Sweden,Cocaine-type,Coca-type,Coca leaf,2023,0.57,SWE
Europe,Western and Central Europe,Sweden,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2023,1.0895,SWE
Europe,Western and Central Europe,Sweden,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2023,10.2241,SWE
Europe,Western and Central Europe,Sweden,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2023,124.99,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Heroin,2023,30,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Illicit morphine,2023,0.003,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Illicit morphine,2023,0.314,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Illicit morphine,2023,0.1846,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Opium,2023,11.8,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.007,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.04007,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.72685,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Codeine,2023,0.01,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Codeine,2023,0.1985,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Codeine,2023,7.5,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.00055,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Methadone,2023,0.001,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Methadone,2023,0.03405,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Methadone,2023,8.461,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Oxycodone,2023,0.031,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Oxycodone,2023,6.956,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Oxycodone,2023,2.79515,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Tramadol,2023,0.1815,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Tramadol,2023,0.1947,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Tramadol,2023,67.8123,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,84,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,4.857,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,52.44053,SWE
Europe,Western and Central Europe,Sweden,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,175,SWE
Europe,Western and Central Europe,Sweden,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,25,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,24,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,997,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,3,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2019,0,SWE
Europe,Western and Central Europe,Sweden,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,"Methylphenidate (Ritalin, Concerta)",2019,2,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,1422,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,25,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,1419,SWE
Europe,Western and Central Europe,Sweden,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,3,SWE
Europe,Western and Central Europe,Sweden,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,121,SWE
Europe,Western and Central Europe,Sweden,Cocaine-type,Coca-type,Coca leaf,2019,1,SWE
Europe,Western and Central Europe,Sweden,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,SWE
Europe,Western and Central Europe,Sweden,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2019,6,SWE
Europe,Western and Central Europe,Sweden,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,3,SWE
Europe,Western and Central Europe,Sweden,NPS,Plant-based NPS,Khat,2019,5205,SWE
Europe,Western and Central Europe,Sweden,NPS,Plant-based NPS,Mushrooms (hallucinogenic),2019,3,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Heroin,2019,64,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Illicit morphine,2019,6,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Illicit morphine,2019,0,SWE
Europe,Western and Central Europe,Sweden,Opioids,Opiates,Opium,2019,35,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Buprenorphine,2019,10,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Buprenorphine,2019,1,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Codeine,2019,7,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Codeine,2019,0,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Methadone,2019,5,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Methadone,2019,2,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Oxycodone,2019,0,SWE
Europe,Western and Central Europe,Sweden,Opioids,Pharmaceutical opioids,Tramadol,2019,84,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Barbiturates,Barbiturates,2019,0,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,272,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,36,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Benzodiazepines,"Flunitrazepam (Disomnilan, Flumipam, Rohypnol)",2019,0,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,6,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,7910,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,GBL/GHB,GBL,2019,36,SWE
Europe,Western and Central Europe,Sweden,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2019,16,SWE
Europe,Western and Central Europe,Switzerland,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,23.17,CHE
Europe,Western and Central Europe,Switzerland,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,0.086,CHE
Europe,Western and Central Europe,Switzerland,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,4.52299,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.035,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,43.08,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.561154,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,9.49,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.517,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,0.261225,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"3,4-Methylenedioxypyrovalerone (MDPV)",2020,0.51,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"3,4-Methylenedioxypyrovalerone (MDPV)",2020,0.0075,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2020,0.17,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,0.673,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,1669.07,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,1.1515,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,2.363,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,19.83,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.0117,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,1.059,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,7.9,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,120.67,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,5649.5,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,0.01863,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,997.4,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,7.66,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,0.01561,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,0.51232,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Cocaine,"""Crack"" cocaine",2020,0.12,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Cocaine,"""Crack"" cocaine",2020,0.0001,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,0.101,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,0.0123,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,349.47,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Coca-type,Coca leaf,2020,4.38,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.14,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.223,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.00018965,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Mescaline,2020,0.14,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Mescaline,2020,0.0052,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Mescaline,2020,0.0176,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Psilocybine,2020,0.01,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Psilocybine,2020,0.0048,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Psilocybine,2020,64.08,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Psilocybine,2020,0.0112,CHE
Europe,Western and Central Europe,Switzerland,NPS,Plant-based NPS,Khat,2020,1542,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Heroin,2020,0.00138,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Heroin,2020,0.101,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Heroin,2020,167.67,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Illicit morphine,2020,0.64,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Illicit morphine,2020,0.0441,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Illicit morphine,2020,1.11,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Opium,2020,2.68,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Opium,2020,0.0015,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Pharmaceutical opioids,Methadone,2020,0.31,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Pharmaceutical opioids,Methadone,2020,1.426,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Pharmaceutical opioids,Methadone,2020,0.12435,CHE
Europe,Western and Central Europe,Switzerland,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,0.00007,CHE
Europe,Western and Central Europe,Switzerland,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,8.65,CHE
Europe,Western and Central Europe,Switzerland,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,17.304,CHE
Europe,Western and Central Europe,Switzerland,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,23.64,CHE
Europe,Western and Central Europe,Switzerland,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,0.04,CHE
Europe,Western and Central Europe,Switzerland,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,4.471229,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.034,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,48.56,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.171534,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.005,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,27.63,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,0.09945,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"3,4-Methylenedioxypyrovalerone (MDPV)",2021,0.04,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"3,4-Methylenedioxypyrovalerone (MDPV)",2021,0.002,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,0.08,CHE
Europe,Western and Central Europe,Switzerland,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0,CHE
Europe,Western and Central Europe,Switzerland,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,115,CHE
Europe,Western and Central Europe,Switzerland,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,5.105,CHE
Europe,Western and Central Europe,Switzerland,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0,CHE
Europe,Western and Central Europe,Switzerland,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2021,0.0275,CHE
Europe,Western and Central Europe,Switzerland,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2021,96.15,CHE
Europe,Western and Central Europe,Switzerland,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2021,1.163,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,0.4,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,0.5555,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,0.8615,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,2195,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,0.0057,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,201,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,4.414,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,0.6,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,2059,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,5575,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,0.018765,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,2708,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,240,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,0.01354,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,0.32044,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,0.11,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,0.0002,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,0.001,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,0.0091,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,295,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Coca-type,Coca leaf,2021,18.63,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.34,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.177,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.00041675,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Mescaline,2021,0.23,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Mescaline,2021,0.0005,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Other hallucinogens,2021,5.06,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Other hallucinogens,2021,0.0194,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.0002,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Psilocybine,2021,60.36,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.07,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.0183,CHE
Europe,Western and Central Europe,Switzerland,NPS,Plant-based NPS,Khat,2021,654,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Heroin,2021,0.002,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Heroin,2021,0.00036,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Heroin,2021,160,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Illicit morphine,2021,0.01,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Illicit morphine,2021,0.0204,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Illicit morphine,2021,0.617,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Opium,2021,0.0003,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Opium,2021,0.002,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Opium,2021,12.84,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Other illicit opioids,Other illicit opioids,2021,2.56,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Other illicit opioids,Other illicit opioids,2021,0.012725,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Other illicit opioids,Other illicit opioids,2021,6.069,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Pharmaceutical opioids,Methadone,2021,1.05,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Pharmaceutical opioids,Methadone,2021,1.082,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Pharmaceutical opioids,Methadone,2021,0.0926,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2021,5.01,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2021,46.293,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2021,2.8917,CHE
Europe,Western and Central Europe,Switzerland,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,0.00004,CHE
Europe,Western and Central Europe,Switzerland,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,14.16,CHE
Europe,Western and Central Europe,Switzerland,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,9.613,CHE
Europe,Western and Central Europe,Switzerland,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,0.01758,CHE
Europe,Western and Central Europe,Switzerland,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,4.251719,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.001,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,16.54,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.130295,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,11.06,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,1.406475,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2022,0.03,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2022,0.00275,CHE
Europe,Western and Central Europe,Switzerland,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,23.43,CHE
Europe,Western and Central Europe,Switzerland,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0,CHE
Europe,Western and Central Europe,Switzerland,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0,CHE
Europe,Western and Central Europe,Switzerland,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,112.422,CHE
Europe,Western and Central Europe,Switzerland,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2022,0.0225,CHE
Europe,Western and Central Europe,Switzerland,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2022,45.42,CHE
Europe,Western and Central Europe,Switzerland,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2022,10.35,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,0.9915,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,2.445,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,2.159,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,4729,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,0.0366,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,136,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,5.577,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,319,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,346.4,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,2106.2,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,60,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,0.038475,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,4969,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,1.88,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,0.00303,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,0.10427,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,0.27,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,0.0015,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,0.002,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,0.0085,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,839,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Coca-type,Coca leaf,2022,22.9,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,"3,4-Methylenedioxyphenyl",2022,0.06,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,"3,4-Methylenedioxyphenyl",2022,0.0103,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Mescaline,2022,0.5,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Mescaline,2022,0.0023,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Mescaline,2022,0.003,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Other hallucinogens,2022,0.0001,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Other hallucinogens,2022,3.64,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Other hallucinogens,2022,0.06,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Other hallucinogens,2022,0.0145,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Psilocybine,2022,0.0012,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Psilocybine,2022,53.4,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Psilocybine,2022,0.0582,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Psilocybine,2022,3.67,CHE
Europe,Western and Central Europe,Switzerland,NPS,Plant-based NPS,Khat,2022,0.41,CHE
Europe,Western and Central Europe,Switzerland,NPS,Plant-based NPS,Khat,2022,1191,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Heroin,2022,0.021,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Heroin,2022,0.00087,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Heroin,2022,146,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Illicit morphine,2022,0.27,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Illicit morphine,2022,0.0082,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Illicit morphine,2022,0.456,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Opium,2022,0.0015,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Opium,2022,21.75,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Opium,2022,0.4,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Other illicit opioids,Other illicit opioids,2022,0.008,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Other illicit opioids,Other illicit opioids,2022,29.86,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Other illicit opioids,Other illicit opioids,2022,0.00995,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Pharmaceutical opioids,Methadone,2022,0.22,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Pharmaceutical opioids,Methadone,2022,0.885,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Pharmaceutical opioids,Methadone,2022,0.0661,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2022,2.12,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2022,6,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2022,2.946,CHE
Europe,Western and Central Europe,Switzerland,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2022,0.00001,CHE
Europe,Western and Central Europe,Switzerland,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2022,10.04,CHE
Europe,Western and Central Europe,Switzerland,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2022,29.586,CHE
Europe,Western and Central Europe,Switzerland,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,0.01,CHE
Europe,Western and Central Europe,Switzerland,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,54.5,CHE
Europe,Western and Central Europe,Switzerland,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,5.473929,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.012,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,26.03,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.270457,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,8.03,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.015,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,0.08325,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,0.01,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,0.002,CHE
Europe,Western and Central Europe,Switzerland,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,CHE
Europe,Western and Central Europe,Switzerland,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,165,CHE
Europe,Western and Central Europe,Switzerland,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,1.396,CHE
Europe,Western and Central Europe,Switzerland,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,CHE
Europe,Western and Central Europe,Switzerland,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2023,10.28,CHE
Europe,Western and Central Europe,Switzerland,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2023,0.02,CHE
Europe,Western and Central Europe,Switzerland,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2023,0.094,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,0.638,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,1.36,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,2378,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,5.23,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,13.68,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,0.1002,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,1.041,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,1201,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,280.7,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,6627.5,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,0.02727,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,1195,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,1.28,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,0.0039,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,0.23631,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,0.71,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,0.0021,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,0.002,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,0.0101,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,322,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Coca-type,Coca leaf,2023,10.75,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,"3,4-Methylenedioxyphenyl",2023,0.04,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Mescaline,2023,0.03,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Mescaline,2023,0.001,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Other hallucinogens,2023,6.49,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Other hallucinogens,2023,0.0393,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.0012,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Psilocybine,2023,155,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.0493,CHE
Europe,Western and Central Europe,Switzerland,NPS,Plant-based NPS,Khat,2023,765,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Heroin,2023,0.012,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Heroin,2023,0.00306,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Heroin,2023,122,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Illicit morphine,2023,1.04,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Illicit morphine,2023,0.09,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Illicit morphine,2023,0.0239,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Opium,2023,0.0006,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Opium,2023,5.01,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Other illicit opioids,Other illicit opioids,2023,3.36,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Other illicit opioids,Other illicit opioids,2023,0.012,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Other illicit opioids,Other illicit opioids,2023,0.009725,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Pharmaceutical opioids,Methadone,2023,0.29,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Pharmaceutical opioids,Methadone,2023,0.0704,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Pharmaceutical opioids,Methadone,2023,2.058,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2023,17.36,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2023,11.848,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2023,3.01335,CHE
Europe,Western and Central Europe,Switzerland,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,1.41,CHE
Europe,Western and Central Europe,Switzerland,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,0.00006,CHE
Europe,Western and Central Europe,Switzerland,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,8.532,CHE
Europe,Western and Central Europe,Switzerland,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,112,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,63,CHE
Europe,Western and Central Europe,Switzerland,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,8,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,1436,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,1,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,144,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,654,CHE
Europe,Western and Central Europe,Switzerland,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,8,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,0,CHE
Europe,Western and Central Europe,Switzerland,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,857,CHE
Europe,Western and Central Europe,Switzerland,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Heroin,2019,117,CHE
Europe,Western and Central Europe,Switzerland,Opioids,Opiates,Opium,2019,0,CHE
Europe,Western and Central Europe,United Kingdom,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,554.321015,GBR
Europe,Western and Central Europe,United Kingdom,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,308,GBR
Europe,Western and Central Europe,United Kingdom,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2020,0,GBR
Europe,Western and Central Europe,United Kingdom,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,18689,GBR
Europe,Western and Central Europe,United Kingdom,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,82052.9,GBR
Europe,Western and Central Europe,United Kingdom,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,1998,GBR
Europe,Western and Central Europe,United Kingdom,Cocaine-type,Cocaine,"""Crack"" cocaine",2020,48,GBR
Europe,Western and Central Europe,United Kingdom,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,11179,GBR
Europe,Western and Central Europe,United Kingdom,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.0073,GBR
Europe,Western and Central Europe,United Kingdom,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,187,GBR
Europe,Western and Central Europe,United Kingdom,Opioids,Opiates,Heroin,2020,1974,GBR
Europe,Western and Central Europe,United Kingdom,Opioids,Opiates,Illicit morphine,2020,2.5,GBR
Europe,Western and Central Europe,United Kingdom,Opioids,Pharmaceutical opioids,Methadone,2020,4,GBR
Europe,Western and Central Europe,United Kingdom,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,7.15,GBR
Europe,Western and Central Europe,United Kingdom,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,4.15,GBR
Europe,Western and Central Europe,United Kingdom,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2020,55,GBR
Europe,Western and Central Europe,United Kingdom,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,379.4,GBR
Europe,Western and Central Europe,United Kingdom,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,308,GBR
Europe,Western and Central Europe,United Kingdom,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,0.14725,GBR
Europe,Western and Central Europe,United Kingdom,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2021,0,GBR
Europe,Western and Central Europe,United Kingdom,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,18689,GBR
Europe,Western and Central Europe,United Kingdom,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,82052.9,GBR
Europe,Western and Central Europe,United Kingdom,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,1998,GBR
Europe,Western and Central Europe,United Kingdom,Cocaine-type,Cocaine,"""Crack"" cocaine",2021,48,GBR
Europe,Western and Central Europe,United Kingdom,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,11179,GBR
Europe,Western and Central Europe,United Kingdom,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.0073,GBR
Europe,Western and Central Europe,United Kingdom,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,187,GBR
Europe,Western and Central Europe,United Kingdom,Opioids,Opiates,Heroin,2021,1974,GBR
Europe,Western and Central Europe,United Kingdom,Opioids,Opiates,Illicit morphine,2021,2.5,GBR
Europe,Western and Central Europe,United Kingdom,Opioids,Pharmaceutical opioids,Methadone,2021,4,GBR
Europe,Western and Central Europe,United Kingdom,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,55,GBR
Europe,Western and Central Europe,United Kingdom,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,161.787,GBR
Europe,Western and Central Europe,United Kingdom,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,243,GBR
Europe,Western and Central Europe,United Kingdom,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2022,0,GBR
Europe,Western and Central Europe,United Kingdom,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,35436,GBR
Europe,Western and Central Europe,United Kingdom,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,78595.5,GBR
Europe,Western and Central Europe,United Kingdom,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,611,GBR
Europe,Western and Central Europe,United Kingdom,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,43,GBR
Europe,Western and Central Europe,United Kingdom,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,18767,GBR
Europe,Western and Central Europe,United Kingdom,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0019,GBR
Europe,Western and Central Europe,United Kingdom,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,1837,GBR
Europe,Western and Central Europe,United Kingdom,Opioids,Opiates,Heroin,2022,1412,GBR
Europe,Western and Central Europe,United Kingdom,Opioids,Opiates,Illicit morphine,2022,1.3,GBR
Europe,Western and Central Europe,United Kingdom,Opioids,Pharmaceutical opioids,Methadone,2022,5.25,GBR
Europe,Western and Central Europe,United Kingdom,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.23,GBR
Europe,Western and Central Europe,United Kingdom,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2022,21,GBR
Europe,Western and Central Europe,United Kingdom,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,423.031,GBR
Europe,Western and Central Europe,United Kingdom,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,331,GBR
Europe,Western and Central Europe,United Kingdom,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2023,0,GBR
Europe,Western and Central Europe,United Kingdom,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,69302,GBR
Europe,Western and Central Europe,United Kingdom,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,51588.4,GBR
Europe,Western and Central Europe,United Kingdom,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,1467,GBR
Europe,Western and Central Europe,United Kingdom,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,54,GBR
Europe,Western and Central Europe,United Kingdom,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,18580,GBR
Europe,Western and Central Europe,United Kingdom,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.0019,GBR
Europe,Western and Central Europe,United Kingdom,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,1434,GBR
Europe,Western and Central Europe,United Kingdom,Opioids,Opiates,Heroin,2023,950,GBR
Europe,Western and Central Europe,United Kingdom,Opioids,Opiates,Illicit morphine,2023,1.8,GBR
Europe,Western and Central Europe,United Kingdom,Opioids,Pharmaceutical opioids,Methadone,2023,2,GBR
Europe,Western and Central Europe,United Kingdom,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,4.64,GBR
Europe,Western and Central Europe,United Kingdom,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.2,GBR
Europe,Western and Central Europe,United Kingdom,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2023,6,GBR
Europe,Western and Central Europe,United Kingdom,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,643,GBR
Europe,Western and Central Europe,United Kingdom,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,460,GBR
Europe,Western and Central Europe,United Kingdom,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2019,,GBR
Europe,Western and Central Europe,United Kingdom,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,22084,GBR
Europe,Western and Central Europe,United Kingdom,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,50404,GBR
Europe,Western and Central Europe,United Kingdom,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,1588,GBR
Europe,Western and Central Europe,United Kingdom,Cocaine-type,Cocaine,"""Crack"" cocaine",2019,84,GBR
Europe,Western and Central Europe,United Kingdom,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,4432,GBR
Europe,Western and Central Europe,United Kingdom,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,GBR
Europe,Western and Central Europe,United Kingdom,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2019,69,GBR
Europe,Western and Central Europe,United Kingdom,Opioids,Opiates,Heroin,2019,2621,GBR
Europe,Western and Central Europe,United Kingdom,Opioids,Opiates,Illicit morphine,2019,2,GBR
Europe,Western and Central Europe,United Kingdom,Opioids,Pharmaceutical opioids,Methadone,2019,2,GBR
Europe,Western and Central Europe,United Kingdom,Sedatives and tranquillizers,Barbiturates,Barbiturates,2019,0,GBR
Europe,Western and Central Europe,United Kingdom,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,65,GBR
Europe,Western and Central Europe,United Kingdom,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,GBR
Oceania,Australia and New Zealand,Australia,“Ecstasy”-type substances,“Ecstasy”-type substances,Non-specified “ecstasy”-type substances,2020,32.349,AUS
Oceania,Australia and New Zealand,Australia,“Ecstasy”-type substances,“Ecstasy”-type substances,Tenamfetamine (MDA),2020,0.151,AUS
Oceania,Australia and New Zealand,Australia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,2155.29,AUS
Oceania,Australia and New Zealand,Australia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2020,3.411084,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2020,3622.34,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,"Methylphenidate (Ritalin, Concerta)",2020,0.001,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2020,80.35138,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2020,0.69,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2020,0.17775,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2020,1.6715,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2020,10.98303,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2020,12559.42,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2020,21.8151,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2020,7.2233485,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2020,0,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,209.18631,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,4255.03673,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2020,0,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2020,8.13995,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,3.013,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,6224.81,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,6328.3,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,1.53,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,743.69,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,0.6987,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,3137.18,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,7355.4,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,15191.6,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,9.5,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,0.043605,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,17.2,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,492.79,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2020,0.17939,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,0,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2020,114.527,AUS
Oceania,Australia and New Zealand,Australia,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,0.0359,AUS
Oceania,Australia and New Zealand,Australia,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,1.51,AUS
Oceania,Australia and New Zealand,Australia,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2020,4289.16,AUS
Oceania,Australia and New Zealand,Australia,Cocaine-type,Coca-type,Coca leaf,2020,7,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,Other Hallucinogens,Other hallucinogens,2020,16.329,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,Other Hallucinogens,Phencyclidine (PCP),2020,0.0066,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,153.92,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,0.6017,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2020,0.8714,AUS
Oceania,Australia and New Zealand,Australia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,0.000325,AUS
Oceania,Australia and New Zealand,Australia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,0.031,AUS
Oceania,Australia and New Zealand,Australia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2020,3.831993,AUS
Oceania,Australia and New Zealand,Australia,NPS,Piperazines,Piperazines,2020,0.0002,AUS
Oceania,Australia and New Zealand,Australia,NPS,Plant-based NPS,Khat,2020,0.079,AUS
Oceania,Australia and New Zealand,Australia,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2020,0.007952,AUS
Oceania,Australia and New Zealand,Australia,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2020,0.01,AUS
Oceania,Australia and New Zealand,Australia,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2020,0.0155,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Heroin,2020,0.01545,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Heroin,2020,0.95715,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Heroin,2020,647.40308,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Illicit morphine,2020,2.076,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Opium,2020,0.0213,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Opium,2020,79.52175,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Poppy plants,2020,0.0576,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Poppy plants,2020,6.8,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2020,8.01,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Other illicit opiates,Acetylated opium,2020,0.001,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Other illicit opioids,Other illicit opioids,2020,0.000275,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Other illicit opioids,Other illicit opioids,2020,8.57301,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.1435,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Buprenorphine,2020,2.963,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Codeine,2020,6.143,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Fentanyl,2020,0.027,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Methadone,2020,2.508,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Oxycodone,2020,1.844,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Tramadol,2020,0.038,AUS
Oceania,Australia and New Zealand,Australia,Precursors,Non-specified precursors,Non-specified precursors,2020,0,AUS
Oceania,Australia and New Zealand,Australia,Precursors,Non-specified precursors,Non-specified precursors,2020,0.097,AUS
Oceania,Australia and New Zealand,Australia,Precursors,Non-specified precursors,Non-specified precursors,2020,1897.36956,AUS
Oceania,Australia and New Zealand,Australia,Precursors,Non-specified precursors,Other precursors,2020,485.786,AUS
Oceania,Australia and New Zealand,Australia,Precursors,Precursors,Ephedrine,2020,0.001,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2020,328.297,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,2278.08,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,0.06487,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2020,13809.4,AUS
Oceania,Australia and New Zealand,Australia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,0.0265,AUS
Oceania,Australia and New Zealand,Australia,“Ecstasy”-type substances,“Ecstasy”-type substances,Tenamfetamine (MDA),2021,0.001,AUS
Oceania,Australia and New Zealand,Australia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,4.477824,AUS
Oceania,Australia and New Zealand,Australia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2021,261.24832,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Other stimulants,2021,0.0001,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2021,0.22,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2021,0.087,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2021,0.4049,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2021,1.48125,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2021,10.33831,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2021,6981.90911,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2021,2.11311,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2021,0,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2021,46.73045,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,0,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,250.4422,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2021,1313.99254,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2021,8.477,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,1.982,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,12.3205,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,7117.65287,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,0.1797,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,8.04982,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,372.38,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,266.9,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,13200.6,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,4108.23297,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,0.15,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,0.156465,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,56.10826,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,0.00138,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,33.2,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2021,348.59554,AUS
Oceania,Australia and New Zealand,Australia,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2021,0.00001,AUS
Oceania,Australia and New Zealand,Australia,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2021,2825.15706,AUS
Oceania,Australia and New Zealand,Australia,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,0.2018,AUS
Oceania,Australia and New Zealand,Australia,Cocaine-type,Coca-type,Coca leaf,2021,17.2,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.0182,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,Other Hallucinogens,Mescaline,2021,0.002,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,Other Hallucinogens,Phencyclidine (PCP),2021,0.00465,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,Other Hallucinogens,Phencyclidine (PCP),2021,0.0148,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.0005,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,2.9179,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2021,213.1765,AUS
Oceania,Australia and New Zealand,Australia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,0.00085,AUS
Oceania,Australia and New Zealand,Australia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,1.001,AUS
Oceania,Australia and New Zealand,Australia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2021,194.92476,AUS
Oceania,Australia and New Zealand,Australia,NPS,Phenethylamines,Phenethylamines,2021,0.001,AUS
Oceania,Australia and New Zealand,Australia,NPS,Piperazines,Piperazines,2021,0.0001,AUS
Oceania,Australia and New Zealand,Australia,NPS,Plant-based NPS,Khat,2021,4444.98,AUS
Oceania,Australia and New Zealand,Australia,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2021,0.0265,AUS
Oceania,Australia and New Zealand,Australia,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2021,1.77461,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Heroin,2021,0.26648,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Heroin,2021,0.03543,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Heroin,2021,1261.66885,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Illicit morphine,2021,0.002,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Illicit morphine,2021,0.037,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Illicit morphine,2021,1.33001,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Opium,2021,0.0039,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Opium,2021,24.5006,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Poppy plants,2021,0.002,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Poppy plants,2021,0.7,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2021,3.02,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Other illicit opiates,Poppy seed,2021,8.77,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Other illicit opioids,Other illicit opioids,2021,0.028,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.33,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Codeine,2021,1.171,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Fentanyl,2021,0.63,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Methadone,2021,3.14,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Oxycodone,2021,2.929,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2021,4.62,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Tramadol,2021,0.022,AUS
Oceania,Australia and New Zealand,Australia,Precursors,Non-specified precursors,Non-specified precursors,2021,1635.87,AUS
Oceania,Australia and New Zealand,Australia,Precursors,Precursors,Acetone,2021,0.001,AUS
Oceania,Australia and New Zealand,Australia,Precursors,Precursors,Ephedrine,2021,2.52,AUS
Oceania,Australia and New Zealand,Australia,Precursors,Precursors,Methylamine,2021,1110,AUS
Oceania,Australia and New Zealand,Australia,Precursors,Precursors,Pseudoephedrine,2021,644.631,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.17701,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.00014,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,0.0102,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2021,0.1129,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,929.05131,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2021,6306.80412,AUS
Oceania,Australia and New Zealand,Australia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,0.723672,AUS
Oceania,Australia and New Zealand,Australia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,5.068,AUS
Oceania,Australia and New Zealand,Australia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2022,779.974917,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,"Methylphenidate (Ritalin, Concerta)",2022,0.0003,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2022,1.6,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2022,0.01275,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2022,0.6145,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2022,1590.87886,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2022,0.60575,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2022,19359.96736,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2022,23.30747,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2022,0,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2022,12.7651,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,0,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,621.63,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2022,1389.54597,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2022,1.31348,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,0.0005,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,1.97501,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,3755.89293,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,325.63645,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,0.138,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,5.5431,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,22,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,2916.99729,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,18456.25,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,0.0075,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,10.03823,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,0.061695,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2022,109.55665,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,0,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,0.05,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2022,573.57852,AUS
Oceania,Australia and New Zealand,Australia,Cocaine-type,Cocaine,"""Crack"" cocaine",2022,0.0049,AUS
Oceania,Australia and New Zealand,Australia,Cocaine-type,Cocaine,"Cocaine (total of the above, including if unspecified/undistinguished, but excluding coca leaf and coca bush)",2022,8347.47795,AUS
Oceania,Australia and New Zealand,Australia,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,0.2,AUS
Oceania,Australia and New Zealand,Australia,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,0.0691,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.0108,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,Other Hallucinogens,Psilocybine,2022,0.0104,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,162.24411,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2022,0.8298,AUS
Oceania,Australia and New Zealand,Australia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,0.006,AUS
Oceania,Australia and New Zealand,Australia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2022,0.86535,AUS
Oceania,Australia and New Zealand,Australia,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2022,1.07,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Heroin,2022,0.3259,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Heroin,2022,0.01227,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Heroin,2022,651.888597,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Illicit morphine,2022,6.06645,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Opium,2022,63.972,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Opium,2022,0.0207,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Poppy plants,2022,2,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2022,5.24,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Other illicit opioids,Other illicit opioids,2022,15.551,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.056,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Codeine,2022,57.6313,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Fentanyl,2022,28.3001,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Methadone,2022,8.7192,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Oxycodone,2022,5.20393,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Tramadol,2022,0.8043,AUS
Oceania,Australia and New Zealand,Australia,Precursors,Non-specified precursors,Non-specified precursors,2022,65.77,AUS
Oceania,Australia and New Zealand,Australia,Precursors,Non-specified precursors,Other precursors,2022,21.32,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.1916,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.00029,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2022,1237.86883,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2022,2936.83424,AUS
Oceania,Australia and New Zealand,Australia,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,2.83728,AUS
Oceania,Australia and New Zealand,Australia,“Ecstasy”-type substances,“Ecstasy”-type substances,Tenamfetamine (MDA),2023,0.00116,AUS
Oceania,Australia and New Zealand,Australia,“Ecstasy”-type substances,"Reported total ""ecstasy""-type substances","Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2023,1289.3,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,"Methylphenidate (Ritalin, Concerta)",2023,0.00329,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2023,0.07,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2023,0.048,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2023,1.05277,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2023,0.10125,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2023,2.253,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),"Reported total ATS (excluding ""ecstasy"")","Total amphetamine-type stimulants (ATS) (including the above, all other ATS, and any unspecified/undistinguished quantities of ATS)",2023,16426,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2023,0.2,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2023,0,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2023,133.61,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2023,0,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.02,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,33.79,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,254.412,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,333.9,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.0001,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,11.58,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,1.2,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,355.21,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,739.58,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,29.97,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.04,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.08273,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.0031,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2023,0.001,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Synthetic cannabinoids under international control,Synthetic cannabinoids under international control,2023,0.3815,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,1.2495,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,6370.4,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,103.64,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,4.351,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,12.7,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,891.56,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,6833,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,53.85429,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,0.87,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,0.00008,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2023,445.07,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2023,633.94,AUS
Oceania,Australia and New Zealand,Australia,Cocaine-type,Cocaine,"""Crack"" cocaine",2023,117.67,AUS
Oceania,Australia and New Zealand,Australia,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,6849.47,AUS
Oceania,Australia and New Zealand,Australia,Cocaine-type,Coca-type,Coca leaf,2023,0.04,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,Other Hallucinogens,Phencyclidine (PCP),2023,0.0066,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.6002,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,Reported total hallucinogens,"Total hallucinogens (including the above, all other hallucinogens, and any unspecified/undistinguished quantities of hallucinogens)",2023,177.3,AUS
Oceania,Australia and New Zealand,Australia,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,3.31255,AUS
Oceania,Australia and New Zealand,Australia,NPS,Piperazines,Piperazines,2023,0.0104,AUS
Oceania,Australia and New Zealand,Australia,NPS,Synthetic cathinones,Synthetic cathinones,2023,0.006,AUS
Oceania,Australia and New Zealand,Australia,NPS,Synthetic cathinones,Synthetic cathinones,2023,0.014,AUS
Oceania,Australia and New Zealand,Australia,NPS,Synthetic cathinones,Synthetic cathinones,2023,0.00526,AUS
Oceania,Australia and New Zealand,Australia,NPS,Synthetic cathinones,Synthetic cathinones,2023,2.024,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Heroin,2023,0.4267,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Heroin,2023,1467,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Illicit morphine,2023,88.46,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Opium,2023,0.1,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Opium,2023,163,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Poppy plants,2023,0.13,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Other illicit opiates,Poppy seed,2023,2,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Other illicit opioids,Other illicit opioids,2023,3.49,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Buprenorphine,2023,1.77,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.09225,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Codeine,2023,126.86,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Codeine,2023,0.01325,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.34,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Methadone,2023,3.4,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Oxycodone,2023,12.62,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Oxycodone,2023,0.03285,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2023,0.002,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Tramadol,2023,0.18,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Tramadol,2023,0.0088,AUS
Oceania,Australia and New Zealand,Australia,Precursors,Non-specified precursors,Non-specified precursors,2023,576.12,AUS
Oceania,Australia and New Zealand,Australia,Precursors,Non-specified precursors,Other precursors,2023,27.42145,AUS
Oceania,Australia and New Zealand,Australia,Precursors,Non-specified precursors,Other precursors,2023,47.51966,AUS
Oceania,Australia and New Zealand,Australia,Precursors,Non-specified precursors,Other precursors,2023,338.68,AUS
Oceania,Australia and New Zealand,Australia,Precursors,Precursors,Ephedrine,2023,0.00697,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.07411,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2023,112.51,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2023,159.19,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,Reported total sedatives and tranquillizers,"Total sedatives and tranquillizers (including the above, all other sedatives and tranquillizers, and any unspecified/undistinguished quantities of sedatives and tranquillizers)",2023,1431.21,AUS
Oceania,Australia and New Zealand,Australia,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,1736,AUS
Oceania,Australia and New Zealand,Australia,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,2,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,25,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,1,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,3,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,3350,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,53,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2019,13,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Phenmetrazine,2019,3,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Phentermine,2019,6,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2019,0,AUS
Oceania,Australia and New Zealand,Australia,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Prescription stimulants,2019,3,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2019,0,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2019,13,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Anabolic steroids,2019,36,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2019,5,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2019,655,AUS
Oceania,Australia and New Zealand,Australia,Any other drugs/substances,Other miscellaneous,Other drugs/substances,2019,0,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,3727,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,9,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,307,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,8,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,2352,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,6821,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,0,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,10,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,917,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,0,AUS
Oceania,Australia and New Zealand,Australia,Cannabis-type drugs (excluding synthetic cannabinoids),Other types of cannabis,Other types of cannabis,2019,188,AUS
Oceania,Australia and New Zealand,Australia,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,0,AUS
Oceania,Australia and New Zealand,Australia,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,1434,AUS
Oceania,Australia and New Zealand,Australia,Cocaine-type,Coca-type,Coca leaf,2019,0,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,2,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2019,7,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,Other Hallucinogens,Other hallucinogens,2019,0,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,Other Hallucinogens,Other hallucinogens,2019,7,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,Other Hallucinogens,Psilocybine,2019,0,AUS
Oceania,Australia and New Zealand,Australia,Hallucinogens,Other Hallucinogens,Psilocybine,2019,12,AUS
Oceania,Australia and New Zealand,Australia,NPS,Phenethylamines,Phenethylamines,2019,1499,AUS
Oceania,Australia and New Zealand,Australia,NPS,Plant-based NPS,Khat,2019,4400,AUS
Oceania,Australia and New Zealand,Australia,NPS,Plant-based NPS,Plant-based new psychoactive substances,2019,78,AUS
Oceania,Australia and New Zealand,Australia,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (Spice),2019,16,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Heroin,2019,0,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Heroin,2019,211,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Illicit morphine,2019,0,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Illicit morphine,2019,1,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Opium,2019,0,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,Opium,2019,65,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2019,335,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Opiates,"Poppy straw (seed heads, pods or capsules)",2019,7,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Other illicit opioids,Other illicit opioids,2019,0,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Oxycodone,2019,2,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,0,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,0,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,1,AUS
Oceania,Australia and New Zealand,Australia,Opioids,Pharmaceutical opioids,Pharmaceutical opioids,2019,3,AUS
Oceania,Australia and New Zealand,Australia,Precursors,Non-specified precursors,Non-specified precursors,2019,1590,AUS
Oceania,Australia and New Zealand,Australia,Precursors,Non-specified precursors,Non-specified precursors,2019,2,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,Barbiturates,Barbiturates,2019,1,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,1,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,126,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,228,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2019,2721,AUS
Oceania,Australia and New Zealand,Australia,Sedatives and tranquillizers,Other sedatives and tranquillizers,Other sedatives and tranquillizers,2019,765,AUS
Oceania,Australia and New Zealand,New Zealand,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,12.042,NZL
Oceania,Australia and New Zealand,New Zealand,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,4.26351,NZL
Oceania,Australia and New Zealand,New Zealand,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2020,349.12192,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.00005,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,0.11325,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2020,2.74571,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,10.04759,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2020,335.60236,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2020,0.00075,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2020,20.41287,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2020,0.01805,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2020,0.01029,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2020,0.41275,NZL
Oceania,Australia and New Zealand,New Zealand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2020,764.64914,NZL
Oceania,Australia and New Zealand,New Zealand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2020,9.0758,NZL
Oceania,Australia and New Zealand,New Zealand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2020,4435.5,NZL
Oceania,Australia and New Zealand,New Zealand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2020,3.03254,NZL
Oceania,Australia and New Zealand,New Zealand,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,0.0045,NZL
Oceania,Australia and New Zealand,New Zealand,Cocaine-type,Cocaine,Cocaine hydrochloride,2020,13.28831,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2020,0.000598463,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2020,0.0005,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2020,15.3782,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,Other Hallucinogens,Psilocybine,2020,0.03,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,Other Hallucinogens,Psilocybine,2020,7.39417,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Heroin,2020,0.01,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Heroin,2020,0.367,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Illicit morphine,2020,0.0131,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Illicit morphine,2020,0.275,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Illicit morphine,2020,0.0424,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Opium,2020,0.0198,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Opium,2020,22.26,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Opium,2020,368.147,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Buprenorphine,2020,0.01305,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Codeine,2020,0.0109,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Codeine,2020,0.02,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Codeine,2020,0.03955,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Methadone,2020,0.003,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Methadone,2020,0.00065,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Oxycodone,2020,0.1537,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Oxycodone,2020,0.0182,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Tramadol,2020,0.0124,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Tramadol,2020,0.02075,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Barbiturates,Barbiturates,2020,0.0011,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.124,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.44511,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2020,0.20184,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.00012,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.12,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2020,0.0391,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2020,1052.21587,NZL
Oceania,Australia and New Zealand,New Zealand,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,3.734004,NZL
Oceania,Australia and New Zealand,New Zealand,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,30.088,NZL
Oceania,Australia and New Zealand,New Zealand,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2021,184.422,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,0.00325,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2021,3.321,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,32.684,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2021,770.842,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2021,0.08825,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,Cathinone,2021,11.999,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2021,0.516,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2021,0.003,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2021,0.16225,NZL
Oceania,Australia and New Zealand,New Zealand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2021,734.952,NZL
Oceania,Australia and New Zealand,New Zealand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2021,1.89,NZL
Oceania,Australia and New Zealand,New Zealand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2021,2679.1,NZL
Oceania,Australia and New Zealand,New Zealand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2021,0.853,NZL
Oceania,Australia and New Zealand,New Zealand,Cocaine-type,Cocaine,Cocaine hydrochloride,2021,61.235,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2021,0.000904,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2021,0.0025,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2021,40.277,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.07,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,Other Hallucinogens,Psilocybine,2021,0.955,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Heroin,2021,0.001,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Heroin,2021,0.081,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Illicit morphine,2021,0.053,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Illicit morphine,2021,0.0373,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Illicit morphine,2021,2.199,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Opium,2021,0.0012,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Opium,2021,6.065,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Opium,2021,6.84,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Buprenorphine,2021,0.09585,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Codeine,2021,0.03025,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Fentanyl,2021,0.004,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Methadone,2021,0.001,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Methadone,2021,0.00005,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.021,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Oxycodone,2021,0.01465,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Tramadol,2021,0.002,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Tramadol,2021,0.04745,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Barbiturates,Barbiturates,2021,0.045,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Barbiturates,Barbiturates,2021,0.0248,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.015,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.504,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2021,0.12832,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.001,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.08,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2021,0.02334,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2021,1005.639,NZL
Oceania,Australia and New Zealand,New Zealand,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,11.354,NZL
Oceania,Australia and New Zealand,New Zealand,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,6.077796,NZL
Oceania,Australia and New Zealand,New Zealand,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2022,260.745,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,0.08975,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2022,6.853,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,62.85,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2022,1251.502,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2022,1.455,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2022,0.0003,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2022,0.16875,NZL
Oceania,Australia and New Zealand,New Zealand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2022,990.077,NZL
Oceania,Australia and New Zealand,New Zealand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2022,13.887,NZL
Oceania,Australia and New Zealand,New Zealand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2022,5175.3,NZL
Oceania,Australia and New Zealand,New Zealand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2022,0.961,NZL
Oceania,Australia and New Zealand,New Zealand,Cocaine-type,Cocaine,Cocaine hydrochloride,2022,939.849,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2022,0.000088625,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,Other Hallucinogens,"4-bromo-2,5-dimethoxyphenethylamine (2C-B)",2022,0.0103,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2022,0.0027,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2022,14.431,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,Other Hallucinogens,Psilocybine,2022,0.0078,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,Other Hallucinogens,Psilocybine,2022,0.024,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,Other Hallucinogens,Psilocybine,2022,0.391,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,Other Hallucinogens,Psilocybine,2022,1.603,NZL
Oceania,Australia and New Zealand,New Zealand,NPS,Synthetic cathinones,Synthetic cathinones,2022,35.382,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Heroin,2022,0.00605,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Illicit morphine,2022,0.0118,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Illicit morphine,2022,0.621,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Opium,2022,0.922,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Opium,2022,0.54,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Opium,2022,41.914,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Buprenorphine,2022,0.00355,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Codeine,2022,0.14035,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Methadone,2022,0.099,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Oxycodone,2022,0.01315,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Oxycodone,2022,0.295,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Tramadol,2022,0.0104,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.01,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.084,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2022,0.217155,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Benzodiazepines,Diazepam,2022,0.03967,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2022,7.356,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2022,1778.31,NZL
Oceania,Australia and New Zealand,New Zealand,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,12.225,NZL
Oceania,Australia and New Zealand,New Zealand,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,3.992892,NZL
Oceania,Australia and New Zealand,New Zealand,“Ecstasy”-type substances,“Ecstasy”-type substances,"3,4-methylenedioxymethamphetamine (MDMA)",2023,568.315,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,1.031,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,0.333,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2023,11.316,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2023,2519.555,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Other stimulants,"Mephedrone (4-methylmethcathinone, 4-MMC)",2023,0.1,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Prescription stimulants,Methylphenidate,2023,0.75975,NZL
Oceania,Australia and New Zealand,New Zealand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2023,812.516,NZL
Oceania,Australia and New Zealand,New Zealand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2023,21.04,NZL
Oceania,Australia and New Zealand,New Zealand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2023,2540.9,NZL
Oceania,Australia and New Zealand,New Zealand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2023,2.668,NZL
Oceania,Australia and New Zealand,New Zealand,Cocaine-type,Cocaine,Cocaine hydrochloride,2023,3783.895,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2023,0.0010259,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,Other Hallucinogens,Dimethyltryptamine (DMT),2023,35.735,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.0029,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,Other Hallucinogens,Psilocybine,2023,0.233,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,Other Hallucinogens,Psilocybine,2023,3.645,NZL
Oceania,Australia and New Zealand,New Zealand,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,0.000725,NZL
Oceania,Australia and New Zealand,New Zealand,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,25.251,NZL
Oceania,Australia and New Zealand,New Zealand,NPS,Ketamine and phencyclidine-type substances,Ketamine and phencyclidine-type substances,2023,132.69,NZL
Oceania,Australia and New Zealand,New Zealand,NPS,Synthetic cannabinoids (Spice),Synthetic cannabinoids (“Spice”),2023,7.933,NZL
Oceania,Australia and New Zealand,New Zealand,NPS,Synthetic cathinones,Synthetic cathinones,2023,13.774,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Heroin,2023,0.411,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Illicit morphine,2023,0.34,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Illicit morphine,2023,0.668,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Illicit morphine,2023,12.282,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Opium,2023,1.1196,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Opium,2023,8.1,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Opium,2023,36.195,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Poppy plants,2023,7.503,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Other illicit opioids,Other illicit opioids,2023,0.02985,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Buprenorphine,2023,0.0135,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Codeine,2023,0.25,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Codeine,2023,0.13165,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Codeine,2023,41.048,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.00005,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Fentanyl,2023,0.01,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Methadone,2023,0.0142,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Oxycodone,2023,0.12,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Oxycodone,2023,0.089,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Tramadol,2023,0.2,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Pharmaceutical opioids,Tramadol,2023,0.56695,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.061,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.684,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2023,0.33566,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,GBL/GHB,Gamma-Butyrolactone (GBL),2023,523.505,NZL
Oceania,Australia and New Zealand,New Zealand,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,736,NZL
Oceania,Australia and New Zealand,New Zealand,“Ecstasy”-type substances,“Ecstasy”-type substances,"Total ""ecstasy""-type substances (including the above, all other substances of this type and any unspecified/undistinguished quantities of substances of this type)",2019,3,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,2,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Amphetamine,Amphetamine,2019,0,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,0,NZL
Oceania,Australia and New Zealand,New Zealand,Amphetamine-type stimulants (excluding “ecstasy”),Methamphetamine,Methamphetamine,2019,1796,NZL
Oceania,Australia and New Zealand,New Zealand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis herb (marijuana),Cannabis herb (marijuana),2019,502,NZL
Oceania,Australia and New Zealand,New Zealand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis oil,Cannabis oil,2019,4,NZL
Oceania,Australia and New Zealand,New Zealand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis plants,Cannabis plants,2019,3571,NZL
Oceania,Australia and New Zealand,New Zealand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis resin (hashish),Cannabis resin (hashish),2019,4,NZL
Oceania,Australia and New Zealand,New Zealand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,2,NZL
Oceania,Australia and New Zealand,New Zealand,Cannabis-type drugs (excluding synthetic cannabinoids),Cannabis seed,Cannabis seed,2019,2,NZL
Oceania,Australia and New Zealand,New Zealand,Cocaine-type,Cocaine,Cocaine hydrochloride,2019,85,NZL
Oceania,Australia and New Zealand,New Zealand,Cocaine-type,Coca-type,Coca leaf,2019,1,NZL
Oceania,Australia and New Zealand,New Zealand,Cocaine-type,Coca-type,Coca leaf,2019,1,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,LSD,Lysergic acid diethylamide (LSD),2019,0,NZL
Oceania,Australia and New Zealand,New Zealand,Hallucinogens,Other Hallucinogens,25B-NBOMe (2C-B-NBOMe),2019,0,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Heroin,2019,0,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Heroin,2019,0,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Illicit morphine,2019,0,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Opiates,Opium,2019,0,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Other illicit opiates,Other illicit opiates,2019,1,NZL
Oceania,Australia and New Zealand,New Zealand,Opioids,Other illicit opiates,Other illicit opiates,2019,0,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,Benzodiazepines,Benzodiazepines,2019,0,NZL
Oceania,Australia and New Zealand,New Zealand,Sedatives and tranquillizers,GBL/GHB,Gamma-Hydroxybutyric acid (GHB),2019,495,NZL
